ERBI Directory 2010
Want to grow your business globally? UK Trade & Investment can provide you with expert advice and support.
www.uktradeinvest.gov.uk/ukti/export
The highest quality service in custom-made peptides and antibodies Celebrating 30 years in 2010, as the world’s second-oldest peptide manufacturer, Cambridge Research Biochemicals (CRB) combines a progressive scientific approach with a thorough commercial instinct. Customers are at the heart of our business. Specialising in the chemical synthesis of peptides and polyclonal antibodies, we provide a highly focused, highly personal level of service. With long-standing relations with some of the world’s largest pharmaceutical companies, we provide individual, not off-the-shelf solutions.
Jointly owned by Emily Humphrys and Alison White – scientists with commercial backgrounds – our company is keen to build on its success and experience with new strategic partnerships. We look for small, specialist biochemical businesses and research institutes whose work complements ours and whom we can help grow and expand.
What we offer: Peptide synthesis
Fluorescent dyes
Tailored products and services
Antibody production
PNA synthesis
Partnering opportunities
Dye and Radio-labelling
Increased market exposure
High standards Outstanding customer service Operational excellence
CRB proudly sponsors:
Cambridge Research Biochemicals
10 Belasis Court, Belasis Hall Technology Park, Billingham, Cleveland TS23 4AZ United Kingdom www.crbdiscovery.com T +44 (0)1642 567180 F +44 (0)1642 567181 E enquiries@crbdiscovery.com
PARTNER
Babraham BIOSCIENCE TECHNOLOGIES
www.path.cam.ac.uk/campod
Clear leaders in business communications Presentations E-brochures Podcasts Video Conferences and events
www.sga-uk.com
01787 378422
CONTENTS n
Contents Welcome
9
About ERBI
10
Services Provided
12-13
Sponsorship
14-15
Facilites Management Purchasing Scheme Training Courses
Distinctive Publishing 8th Floor Aidan House Sunderland Road Gateshead NE8 3HU
16 17 18-19
Feedback
20
Training Case Study
21
Annual Conference 2010
DIRECTORY DESIGNED AND PRODUCED BY
11
Member Benefits
22-24
Special Interest Groups
25
Lifescience Management
26
European Activities
27
Golden Triangle Partnership
28
Medical Devices and Instrumentation
53-57
NHS East of England
58-63
Supply Chain and Investment
64-71
Legal
75-80
Sponsors
112-115
Gold Members
116-137
Silver Members
138-189
Advertiser’s Index
190
T: 0191 4788300 www.distinctivepublishing.co.uk DISCLAIMER Published by Distinctive Publishing on behalf of ERBI Ltd. While every effort has been made to ensure that the information in this document is accurate at the time of going to press, no liability for damage is accepted by ERBI Ltd arising from any errors or omissions that may appear, however caused – or from any editorial alterations to submitted information. The Editor reserves the right to edit or exclude entries. This publication does not include individual members.
WWW.ERBI.CO.UK 5
n
SIMON GREENE ASSOCIATES
Communicate to accumulate WITH SO MANY OPTIONS AVAILABLE, HOW DO YOU CHOOSE THE BEST TECHNIQUE TO DELIVER YOUR IDEAL BUSINESS MESSAGE? Good communication was once defined as being the shortest distance between two people. It still is. But how can you make a complex message easy to understand? Whether you’re looking to the latest round of VC presentations, to demonstrate your new product - or achieve a behavioural change among your employees the chances are you’ll also need visual support to reinforce your message. But when it comes to delivering these business critical messages or a complex idea many of us go into these arenas “naked” and often rely on personality to carry us through.
Simon Greene Director, Simon Greene Associates Limited
30 MILLION POWERPOINT PRESENTATIONS TAKE PLACE EVERY DAY
THE ONLINE VIDEO REVOLUTION
With so much presentation noise about how do you make yours more memorable? For a start when preparing a presentation a modicum of visual imagination goes a long way. Use the available technology to help. Microsoft’s PowerPoint 2007 offers easy to use ways of creating technical graphics with a professional edge – well worth a small investment. And Apple’s Keynote is even more impressive.
Online video is fast becoming the one to watch when it comes to bringing to life your Product, Brand or Uniqueness. Forrester research predicts that in less than two years over two-thirds of websites will include online video as part of their experience. It is also estimated that the number of video streams will double by 2013. At a basic level using video in email can often double or triple clickthrough rates.
But remember to be ruthless with your content. Put each slide on trial for its life. Ask it to defend itself. Show no mercy.
SO WHAT’S AVAILABLE, FOR LITTLE OR LOW COST?
GRAB THEIR ATTENTION It’s a proven fact that getting the audience to interact with your presentation will encourage greater understanding. So solutions such as fully interactive e-brochures are a great way of engaging users and viewers in your key presentations. And with a little forethought they can be produced so they are easy to update as your products or services themselves evolve.
While for many years major institutions and the big pharmas have been using these tactics the evolution of the technology now means that the benefits are at last within easy reach of even the most modest start-up or small business. A bizcast online video can be produced for as little as £750. You Tube is free. So don’t miss out on the opportunity to dazzle the VCs or to leave your competitors text-only campaigns in the dust: start using the new generation of video elements for your online and offline Marketing.
LIVE AND ON-DEMAND - PODCASTING While the BBC sets the pace, you too can create extra interest in your business by using simple audio and video podcasts. You can use off-the-shelf technology and resources as the outlet or add to your website. But remember that your audience will inevitably make a comparison with the high standards of broadcasting and have ultimate veto of the stop button close at hand. So to get the most value out of the exposure, and to achieve the right level of editorial and technical standards, consider using professional help and advice.
6 ERBI DIRECTORY 2010
WHERE CAN YOU GO FOR ADVICE? Simon Greene Associates Limited have a twenty-year successful track record of creating effective business communications for industrial, scientific and service organisations with specific or complex requirements. And as ERBI members we are always pleased to offer free advice and discounted rates for other businesses in the organisation. For further information contact us on 01787 378422
CAMBRIDGE ONLINE SYSTEMS LIMITED n
Technical solutions and support Incorporated in 1978, Cambridge Online Systems Limited is a highly experienced and trusted provider of value-added information technology solutions and supporting services. Cambridge Online’s Applied Technology Group specialises in the provision, development and support of IT infrastructure – covering computer systems, storage, networks and telecommunications. It is a major UK business partner for Hewlett-Packard and other industry-leading technology vendors and holds ISO 9001:2000 quality accreditation.
SERVICES Cambridge Online offers a broad portfolio of professional, valueadded services to support its IT solutions. These services may be readily tailored to meet individual customer requirements and are delivered by experienced and accredited specialists. COMPUTER SYSTEMS Our expertise and experience is based around the provision of enterprise solutions for business, and HPC (High Performance Computing) systems for research and design. You know that today’s IT environments are complex and challenging, and you insist on suppliers who have the ability to understand the breadth of your existing systems and infrastructure, together with your plans for the future. We have a history of providing customers with proven technology as an enabler for their business goals. This could translate in to systems that run your business applications, provide accurate simulations, offer low time latency transactions, or manage and retrieve large volumes of data. Cambridge Online’s continuing success is built on the services we provide to you; bringing our specialist technology skills to bear on customer problems. As an accredited preferred partner, we offer the complete range of workstation and server products from Hewlett-Packard which scale from Intel or AMD based 32bit x86 industry standard systems with single or multi-cores, 64 bit multiprocessor IA64 Intel Itanium systems, and clusters or GRID compute farms based on these technologies. We provide operating system environments of LINUX, UNIX or Microsoft Windows to suit your applications and existing environment. The availability of powerful industry standard components has opened up the deployment of cost effective HPC systems in innovative solution areas that would have previously been dismissed as uneconomic. This move to deploy the latest IT technology is driven by the need to reduce costs and be first to market, whether it is drug companies saving months of experimentation in a 12 year development cycle, or financial services organisations shaving microseconds off a transaction.
Cambridge Online’s Business Systems Group specialises in applications software for financials, logistics, enterprise resource planning (ERP) and customer relationship management (CRM) for industrial and commercial organisations across a number of vertical markets. It is a leading UK Microsoft certified business solutions partner. Wherever we work, we look to form a close and lasting relationship with every customer with whom we establish a virtual team of immediately relevant, pooled expertise.
demonstrations, benchmarking, porting, testing and technical support. Our build facility enables systems to be designed, built, configured and tested to meet particular application requirements. This capability spans from small single box servers to large multi cabinet clusters, and includes all cable and power management to ensure a reliable and maintainable configuration is provided. Systems are protected by extended warranty options and manufacturer’s maintenance services. We provide a range of value-added technology services to ensure systems fully meet user requirements. System purchase programmes include lease and financial services, equipment trade-in and upgrade. Professionally refurbished equipment is available where product availability or cost is a constraint. STORAGE We have in-depth skills and experience in the design, development and implementation of mid-to-high end data storage solutions. We are an accredited specialist for storage products provided by Hewlett-Packard’s world-leading StorageWorks family. Our portfolio covers directly-attached storage (DAS), network attached storage (NAS) and storage area networks (SAN), and the latest virtualised storage systems. Our High Performance Computing Lab is equipped with latest generation storage technology which is available for proof-ofconcept demonstrations, benchmarking, porting, testing and technical support for all these technologies. Cambridge Online Systems Limited Tel: +44(0)1223 422600 Fax: +44(0)1223 422601 Email: web@cosl.co.uk www.cambridgeonline.net
Our High Performance Computing Lab provides extensive hardware and software facilities for proof-of-concept
WWW.ERBI.CO.UK 7
cgi
A BREAKTHROUGH FOR WORKING ENVIRONMENTS Chesterford Research Park offers the very best working environment for people and businesses from the Biotech and R&D sector. Not only is it an established development, it is a growing community. The rural, yet convenient setting means you can concentrate on delivering ground breaking research without the distraction and congestion of urban locations. Chesterford affords an exceptional opportunity to get the work/life balance just right.
For further information, please contact:
TIME TO DISCOVER
WWW.CHESTERFORDRESEARCHPARK.COM
WELCOME n
Welcome... Welcome to the ERBI Company Directory for 2010.
I am delighted that ERBI continues to be the largest life science and healthcare organisation in Europe, with over 350 members. This Directory profiles all our members. Company details have been supplied to us by the companies featured. I hope these will help you to identify old friends and also new potential partners, customers and suppliers from the ERBI network. ERBI operates two levels of membership – Gold and Silver. Please see inside for details of the benefits of membership if you haven’t yet joined the ERBI family! We have some exciting plans afoot for 2010 and will publish details during the course of the year. If you are interested in finding out more about us and how we can help you to maximise your growth and competitiveness, do contact me or a member of the ERBI team and we will be delighted to help. I know that 2009 was a tough year for many of you. I hope that ERBI support has been worthwhile for our members and look forward to continuing to serve you and new members into 2010.
Harriet Fear CEO ERBI Ltd
WWW.ERBI.CO.UK 9
n
ABOUT ERBI
About ERBI WHAT IS ERBI ERBI is a membership organisation for international life science and healthcare companies. We are based in Cambridge UK, the heart of Europe’s largest cluster. ORGANISATION HISTORY Established in 1997, ERBI is a not-for-profit, membership organisation owned by its members and located in Cambridge – the heart of Europe’s leading life sciences and healthcare cluster. Our 350 members include pharmaceutical, biotech and medtech companies and associated technical and commercial service providers. ERBI’s mission is to maximise the global growth and competitiveness of our members. For our science and technology-based members, that means being global leaders in the research, development and commercialisation of healthcare innovations that radically improve the quality of people’s lives around the world. For our business and professional services members, it means delivering exceptional services that significantly enhance the business performance of their clients.
“
VISION For ERBI and our members to be the top European life science and healthcare network.
“
MISSION We will achieve this by maximising the global growth and competitiveness of our members.
10 ERBI DIRECTORY 2010
SERVICES n
Services provided NETWORK MEETINGS
TRAINING COURSES
ERBI Network Meetings bring together our diverse membership for networking and collaboration in an informal setting. Meetings are usually held in the early evening, starting with presentations on a relevant and current topic and ending with a networking session. We run approximately six network meetings each year. Attendance at Network Meetings is usually between 50 and 150 delegates. Gold Members are entitled to free entry for up to three delegates. Silver Members are limited to one free delegate. Additional delegates are charged at a discounted rate.
ERBI recognises that a company’s employees are its most valuable asset. Many rapidly growing companies overlook the need for ongoing training of their staff. ERBI has developed a portfolio of training courses designed to help life science and healthcare companies build an experienced and cohesive workforce. Employees should be able to develop their personal skills and also contribute beyond their technical capacity to enhance company growth and success.
ANNUAL CONFERENCE Our annual conference has become the main event of the year for life science and healthcare companies. The conference attracts a significant number of companies from overseas and outside the East of England. In addition to influential keynote speakers, the event provides a unique opportunity to hear presentations by senior executives and an unrivalled opportunity for networking with over 500 delegates. Scheduled partnering is provided using EBD Group’s partneringONE® software. All ERBI members are entitled to discounted tickets to the conference. Gold Members are entitled to bring two delegates for the price of one at the member discount rate. PURCHASING SCHEME The ERBI Purchasing Scheme was set up to deliver low cost purchasing based on the combined spend of our members. By joining together in the scheme, small businesses enjoy the same purchasing influence as larger companies and are able to negotiate excellent prices and substantial savings in a number of product areas, including lab consumables, stationery and courier services.
We have developed a range of tailored training courses based on the needs of our member companies. We are constantly developing courses on new subjects as our members’ needs change. Courses are available to members and non-members. Nonmembers pay a commercial list price rate, while Silver Members receive a discount from the list price and Gold Members receive increased discounts off the list price plus priority booking. SPECIAL INTEREST GROUPS (SIGS) We run a range of special interest groups for our Gold Members which include –Purchasing, Human Resources, Facilities, Security & Business Risk and Health & Safety. These meet regularly throughout the year. The aim of these meetings is to provide a platform for people doing similar jobs in different companies to get together informally and discuss the issues that affect their working lives. Meetings are typically held three or four times a year, starting with a presentation on a topic nominated by the SIG, followed by discussion and lunch.
* ERBI reserves the right to exclude individual Gold Members from individual SIGs where we consider there to be a conflict of interests.
In addition to the Support Supply Agreements (SSAs) that are available to all ERBI members, Gold Members also have exclusive access to our Preferred Supply Agreements (PSAs), which are tendered agreements with various suppliers. Our suppliers are selected based on their ability to offer: n Substantial discounts (up to 50% off catalogue prices) n No minimum order requirements n No delivery or handling charges n Guide payment terms of 30 days with the option of monthly
consolidated invoicing
n Delivery within one or two days n Volume rebates for companies exceeding annual turnover
targets
Savings vary from company to company, but on average our members save over 35% on their annual spend.
WWW.ERBI.CO.UK 11
n
MEMBER BENEFITS
Member Benefits We offer two levels of membership – Silver and Gold. Silver Members receive basic entry-level benefits. Gold Members enjoy an enhanced range of exclusive services and benefits. The following ‘benefits table’ compares the services available to Silver Members and Gold Members.
BENEFIT
NON-MEMBER
ERBI Network meetings (typically 6 per year) £150 per delegate
SILVER MEMBER
GOLD MEMBER
1 free delegate £40 for each additional delegate
Up to 3 delegates free of charge
ERBI’s Annual Conference (2009 pricing) £799 £595
Buy one ticket for £595, get one ticket free
Participation in Special Interest Groups
Not eligible
Not eligible
Free
Access to discounts available under ERBI’s Preferred Supply Agreements (PSAs)
Not eligible
Not eligible
Free
Access to discounts and services available under ERBI’s Support Supply Agreements (SSAs)
Not eligible
Free
Free
Ability to post your jobs, events and press releases on the ERBI website
Not eligible
Free
Free
Receipt of ERBI’s printed newsletter
Not eligible
Free
Free
Your company profile in ERBI’s directory
Not eligible
Free
Free
Your company profile on the ERBI website
Not eligible
Free
Free
Access to ERBI’s training courses List price Discounts off list price
Increased discounts off list price plus priority booking
Hard copy of ERBI’s directory of members Not eligible One copy
Multiple copies if required
12 ERBI DIRECTORY 2010
MEMBER BENEFITS n
ANNUAL MEMBERSHIP PRICES
MEMBERSHIP LEVEL
COMPANY SIZE
SILVER MEMBERSHIP
GOLD MEMBERSHIP
Individual academics
N/A
£150 +VAT
N/A
Start-up – first year only
<10 employees
£220 +VAT
£900 +VAT
Small Company
<20 employees
£305 +VAT
£1,390 +VAT
Medium Company
21-50 employees
£400 +VAT
£2,350 +VAT
Large Company
51-150 employees
£500 +VAT
£3,500 +VAT
Extra Large Company
150+ employees
£600 +VAT
£5,000 +VAT
Prices quoted do not include VAT, which is charged at the prevailing rate.
*
WWW.ERBI.CO.UK 13
n
SPONSORSHIP
Sponsorship ERBI has a successful track record in providing a platform for people from all walks of the life science and healthcare community to meet and interact. We achieve this through hosting a wide range of events in Cambridge, exhibiting at national and international events, hosting delegations from overseas, publishing newsletters and maintaining a content-rich website. Our mailing list currently includes over 8000 people working in the global life science and healthcare fields and we plan to expand this number significantly in the next 12 months through desk research and our international promotional activities.
In summary, ERBI sponsorship will enable you to: 1. 2. 3.
Raise your company profile in one of the top cluster communities in the world. Align your organisation with the leading life science and healthcare network in Europe. Promote your company via ERBI not just to the Cambridge community but to the global industry.
New for 2010: n Corporate Sponsorship attracts all Gold member benefits, n plus one complimentary ticket to the ERBI Conference (2 - 3
June 2010),
n plus a further ‘buy one get one free’ offer for tickets to the
ERBI Conference.
SPONSORSHIP
BENEFIT TO YOUR COMPANY
ERBI Correspondence
n Your company name on ERBI letterhead
Website
n Your logo featured on the home page of the ERBI website
n Your company name listed on the corporate sponsors’ page of the ERBI website
n Your company profile and contact details on the corporate sponsors’ page of the ERBI website with a hyperlink to your website n Your logo on ERBI’s standard PowerPoint Presentation about the life science and ERBI Promotional Materials healthcare sectors in the East of England
n Your logo on relevant promotional flyers
n ERBI logo on your communications as appropriate
n First refusal on further sponsorship opportunities such as Network Meetings
n Your name on ERBI’s hardcopy newsletters – 4 per annum
Newsletter
n Inclusion of one of your flyers in one hard-copy newsletter a year
Events and Conferences
Distribution of your literature by ERBI at the national and international events where ERBI is exhibiting e.g. Genesis
14 ERBI DIRECTORY 2010
SPONSORSHIP n
ERBI’S CORPORATE SPONSORS
CORPORATE PATRON
WWW.ERBI.CO.UK 15
n
ERBI FACILITIES MANAGEMENT SERVICES
Facilities Management Facilities management can be a nightmare for small technology companies with exacting demands for laboratory, workshop and office space. Did you know that ERBI provides a range of Facilities Management Services to help member companies to expand or relocate? We can provide project management for office and laboratory fit-outs (no job too small) and can help with laboratory service contracts, maintenance contracts, cleaning contracts, utility bills, insurance, purchasing and budgeting. As with all ERBI services, these are provided at discounted rates to members. Our Facilities Management Services and Purchasing Scheme are managed by Richard Dickinson, ERBI’s Director of Specialist Services, who has more than 10 years experience in laboratory and facilities management. Before ERBI Richard worked for Cantab Pharmaceuticals and Astex Therapeutics, where he project-managed the fit-out of a 45,000 sq ft building, plus another of 36,000 sq ft. In addition to procurement of lab and office equipment and furniture, he managed the move from one building to another over a weekend. Richard has extensive local contacts in the Cambridge area and is also NEBOSH certified in Health and Safety. Richard can provide help by phone or email as well as providing full onsite consultancy. Please contact Richard Dickinson on 01223 497 408 or richarddickinson@erbi.co.uk if you have any questions about ERBI’s Facilities Management Services.
“
“
We can provide project management for office and laboratory fit-outs (no job too small) and can help with laboratory service contracts, maintenance contracts, cleaning contracts, utility bills, insurance, purchasing and budgeting
16 ERBI DIRECTORY 2010
ERBI PURCHASING SCHEME n
Purchasing Scheme The ERBI Purchasing Scheme has been running for over 10 years with an annual turnover exceeding £6 million, with more than 80 Gold Members and is the longest running purchasing consortium of its kind. The purchasing scheme is directed by an Operations Steering Group composed of Gold Member companies and delivers substantial cost savings to Gold Members with most member companies saving more than their annual subscription to ERBI. ERBI currently has seven Preferred Supplier Agreements (PSAs) in place which are selected, not by ERBI, but by the Steering Group, following a rigorous tender process. The PSAs, available only to Gold Members, are: n Fisher Scientific Laboratory consumables, laboratory chemicals
and low value apparatus.
n Sigma-Aldrich Molecular biology, cell biology and cell culture
products.
n STARLAB Pipette maintenance and calibration services. n Air Liquide Laboratory gases and dry ice. n GE Healthcare Servicing and maintenance of laboratory
equipment.
n Harts Office Supplies Stationery, office goods, IT consumables
and office furniture.
n Deliver Plus Courier services including dangerous goods and
items on dry ice.
ERBI also offers Support Supply Agreements (SSAs) which are available to all members. If sufficient interest is generated by an SSA, then the contract will be considered for upgrading to PSA status (following the tender process). n Pressplan Travel Discounted business travel solutions. n Grundon
Waste Management management services.
Ltd
individual file management, data scanning and secure destruction of data, including destruction under the WEE regulations.
n The Royal Cambridge Hotel Discounted room rates. n Science Warehouse Spend management in a dedicated
web-based procurement solution.
n The Digital Office A wide range of digital office equipment
and software solutions.
n Core Cambridge Offers “Deskcoach”, a unique scheme to
treat postural pain, and is the only company in the UK to provide access to techniques used by top athletes to avoid or recover rapidly from injuries, most of which are due to poor posture.
n S-Tech Insurance commercial insurance, credit insurance,
personnel insurance, employee benefits and financial services to companies and their employees.
n Pro-Active
Security
Solutions
Security
n No minimum order requirements
n Show Carriage Ltd Exhibition services.
n No delivery or handling charges
n Thomson
n Option for monthly consolidated invoicing n Internet ordering with additional discounts
ERBI can perform a cost-benefit analysis for Silver Members thinking of upgrading or companies wanting to be Gold Members. Please contact Richard Dickinson 01223 497408 or richarddickinson@erbi.co.uk.
waste
n File and Data Storage Container archiving, file inventories,
BENEFITS OF PSAS
n 30 days payment terms
Specialist
screening
and
intelligence. Pharma database Comprehensive global pharmaceutical information solution that covers the entire drug discovery and development pipeline.
n The Safe Box Document and data storage. n World Courier BioPharm and Clinical Trial logistics. n Adelphi Healthcare Packaging Healthcare packaging. n Arkadin Audio and web conferencing. n CLS Communication Multilingual communication. n Daisy Telecommunications. n ARCO Safety and maintenance supplies.
WWW.ERBI.CO.UK 17
n
TRAINING COURSES
Training Courses It all began in 2002 when a group of biotech companies in Cambridge asked ERBI to develop training courses that addressed the needs of their employees in the Michelle Marsh drug discovery and development Training Manager sector. After interviewing around 70 companies to ascertain their training requirements, it was evident that new recruits to the industry wanted to gain a complete overview of the entire drug discovery and development process, from early stage research to the marketing of approved drugs. So we set out about developing “Introduction to Drug Development”, our first course. Since then we have significantly expanded our portfolio of courses for the life science and healthcare industry, working alongside our members to develop courses which address the current skills gaps within their organisations. Each of our courses is designed by industry experts, and piloted to small classes, before being offered to all relevant companies. Feedback from the hundreds of delegates who have attended our courses has, without exception, been positive. Based on this success we are now delivering these bespoke courses to life science and healthcare companies and service providers throughout the UK and Europe.
“
Our current range of courses includes: n Small molecule drug discovery – a biological perspective n Introduction to drug development n Introduction to management n Health and safety for representatives and managers n Laboratory health and safety n Commercial awareness...from bench to balance sheet n Scientific presentation skills n Project management n Directing safely (IOSH accredited) n The safe use and management of laboratory gases n Cultural awareness workshops n Biological safety officer training n Mail handling and security in the workplace n Managing safely (IOSH accredited)
All courses can be delivered in-house, tailored and/or combined to create a bespoke training package which meets the exact needs of your organisation. Member organisations which have incorporated some of our courses into their induction programmes include: n MedImmune n Kudos n Institute of Cancer Research
“
ERBI is dedicated to providing bespoke training and support to the life science & healthcare industry, through a comprehensive portfolio of industry-specific short courses
Each of our courses is designed by industry experts, and piloted to small classes, before being offered to all relevant companies
18 ERBI DIRECTORY 2010
TRAINING COURSES n
Organisations which have participated in ERBI Training Programmes include: Abcam Ltd
National Policing Improvement Agency
Acambis
Novacta Biosystems Limited
Alizyme plc
Novobio Ltd.
Amgen
Orthomimetics Ltd.
Antisoma Research Limited
Oxygen Healthcare Ltd.
Arrow Therapeutics Ltd.
PA Consulting Group
Astex Therapeutics Ltd.
Pathology Diagnostics Ltd.
Avesthagen (UK)
Peakdale Molecular Ltd.
Avita Medical
Pharmis Biofarmaceutica
Babraham Bioscience Technologies
Pharmorphix
Babraham Institute
Phico Therapeutics Ltd.
BioBridge Limited
Plastic Logic Ltd.
BioFocus DPI
Polytherics
Biosynergy (Europe) Ltd.
ProMetic Biosciences Ltd.
Biotica Technology Ltd.
Quotient Bioresearch Ltd.
BTG plc
Robert Alston Chartered Surveyors
Cambridge Biostability Ltd.
Sareum Limited
Cambridge Theranostics Ltd.
Sartorius Stedim UK Limited
Canadian High Commission
ScopeMedical Ltd.
Carbogen Amcis AG
Selcia Limited
CMR Fuel Cells (UK) Ltd.
Sigma
Colonix Ltd.
Siltbuster Ltd.
DBA Group Ltd.
Sosei R&D Ltd.
Domainex Ltd.
Sphere Medical Ltd.
Domantis Limited.
S-Tech Insurance Services Ltd.
East of England International (EEI)
Stem Cell Sciences Ltd.
EBD Group
Stokes Bio
Emergent BioSolutions
Stratagem IPM Ltd.
GeneMedix plc
Stratech Scientific Ltd.
Genzyme
Summit plc
Giles Insurance Brokers Ltd.
Synairgen Research Ltd.
Global Regulatory Services
Takeda Cambridge Limited
Health Protection Agency
UK Trade and Investment
KuDOS Pharmaceuticals Ltd.
University of Cambridge
Lab21
Vectura Limited
Lectus Therapeutics Limited
Verius Ltd.
Lonza Biologics Plc
Vernalis
Matrix MicroScience
Xenova Biomanufacturing Ltd.
MedCell Bioscience Ltd.
York Pharma plc
MedImmune Limited Medivir AB Melbourn Scientific Ltd. Mewburn Ellis LLP
For more information: Visit www.erbi.co.uk/training Email training@erbi.co.uk Call 01223 497402
WWW.ERBI.CO.UK 19
n
FEEDBACK
Feedback PRESENTATION SKILLS TRAINING COURSE
The course was time well spent for anyone who has to give presentations, both if they are new to presenting or are experienced and are looking to improve. The format was informal and interactive, and, most of all, enjoyable. Kaycia Wilde, PhD; Clinical Research Program Manager, Amgen Ltd.
COMMERCIAL AWARENESS...FROM BENCH TO BALANCE SHEET
Stimulating course, presented in a clear manner, providing essential background knowledge for any one moving from the lab to a business role within the biotech industry. Sascha Hartmann Client Manager– Selcia Ltd.
LABORATORY SAFETY
A thorough and enjoyable course covering all important aspects of Laboratory Health and Safety, invaluable to staff with a responsible role in this area. Sarah Bartram - Bioanalab Ltd.
PROJECT MANAGEMENT
I thought the course was presented in an excellent fashion and provided a good training balance between theoretical and practical skills. Scott Pollack, Principal Scientist – BioFocus DPI
20 ERBI DIRECTORY 2010
CASE STUDY n
Training Case Study JULIE WARNECK, PROTOGENIA CONSULTING LTD I have been involved in outsourcing to support research and development for 15 years and working in the virtual/semivirtual pharmaceutical industry since 2002. In my role at Takeda as Biology Outsourcing Manager, I was responsible for outsourcing DMPK and safety studies and management of CTA enabling programmes to support first-in-man clinical trials. In 2007, I joined a virtual start-up company, Serentis Ltd, as Head of Pre-clinical Operations, and was responsible for all aspects of non-clinical development activities to support clinical regulatory submissions including pre-clinical development strategy, selection and management of CROs, protocol design and monitoring of studies on time and within budget. In 2009 I took the decision to transfer my knowledge and expertise to my own business, Protogenia Consulting Ltd, offering operational and strategic development services to the small pharma sector. In 2007 I attended two ERBI training courses: Commercial Awareness and BioProject Management, having helped develop the latter while on the Training Special Interest Group.
The Commercial Awareness course provided a valuable insight into corporate finance and its impact on our R and D budgets. An introduction to the concepts of profit and loss accounts, balance sheets and cash flow, came into its own during monthly forecasting discussions at Serentis. Understanding how part-time consultants can help reduce bottom line costs for a clientâ&#x20AC;&#x2122;s business, as well as the marketing and strategy advice (e.g. focusing on ensuring I can provide and deliver a service that my clients really need) are essential to my new venture. The course manual is on hand as a reference to keep those concepts alive. The BioProject Management course was an interactive session and there were plenty of opportunities to share experiences (the good, the bad and the ugly!) and improve our interaction and efficiency with project teams and management as well as external teams within CROs. The course was invaluable, even for an experienced Project Manager. We are never too old to challenge ourselves and to take on board new ideas and different ways of working. Both courses have provided me with new insights and skills which have stayed with me through my last two career moves and have enabled me to adapt from the security of a corporate organisation to the freedom of my own virtual world.
WWW.ERBI.CO.UK 21
n
ANNUAL CONFERENCE
12th Annual Conference 2-3 JUNE 2010 The theme of the conference is to showcase the best of the best life science companies as well as to bring together industry experts from major pharmaceutical companies, international investors and biotech entrepreneurs. The conference programme includes debates, discussions and presentations pertaining to issues concerning the sector.
Partnering is free to all delegates throughout the conference and offers the perfect opportunity for one-to-one meetings with the cream of European biotechnology. Registered delegates may request meetings online through the website and we plan to exceed the 1000 meetings that took place at last yearâ&#x20AC;&#x2122;s event in June.
The meeting is now considered the UKâ&#x20AC;&#x2122;s leading partnering meeting with over 500 attendees from over 400 companies and 1000 one-to-one meetings last year. Typically half the delegates are from outside the Cambridge region and of those 30% are from outside the UK. Approximately 60% of attendees are from life science and healthcare companies and 50% are Board Directors.
We have some excellent social networking highlights. On the Wednesday in the evening we are holding the conference Dinner with a difference, and Thursday offers a drinks reception in the beautiful orchard at the back of the conference centre. Following the reception tours are available of the Sequencing Centre at the Sanger Institute, the largest provider of genomic information in the UK. Or you may take a trip into Cambridge city centre for a private guided tour.
Presentations are mainly from biotech CEO/senior executives, pharma company executives and thought leaders from organisations within the biotech/pharma communities. Agenda Sessions will include: n Financial forecast n Financial models of the future n Company presentations n Diseases related to ageing n Convergent Technologies and Platforms n Future Trends
22 ERBI DIRECTORY 2010
Register now to maximise your networking and partnering potential for 2010 www.erbiconference.co.uk If you have any enquiries please emailconference@erbi.co.uk or telephone 01223 497401.
Save the date!
conference
Europeâ&#x20AC;&#x2122;s largest Life Science and Healthcare gathering Wellcome Trust, Genome Campus, Hinxton Hall, Cambridge
www.erbiconference.co.uk
Save the date!
conference
“At last, like minded people with enthusiasm!” Caroline Pennington, BBSRC enterprise fellow, University of East Anglia
“Another outstanding partnering event. ERBI continues to grow and develop to reflect its membership base. See you next year.” Tarquin Bennett-Coles, Director RSA Interims, RSA Consulting Limited
“An excellent event, that I would happily recommend and would aim to attend next year.” Sotiris Missailidis, Lecturer in Chemistry and Analytical Sciences, The Open University
“Probably the most enjoyable way of combining business with learning that I’ve yet discovered.” Brian House, Managing Director, Brainwave Media Limited
For more information and to book, visit www.erbiconference.co.uk email conference@erbi.co.uk or call +44 (0) 1223 497 401
Europe’s largest Life Science and Healthcare gathering 2009 statistics > Over 500 delegates, 70+ overseas > Representatives from over 400 companies > 60+ companies from overseas > Delegates from 17 Countries attended Partnering Highlights > Largest UK organised partnering event > 3 out of 4 companies participated in meetings > 18 countries participated including 15 multinationals > Over 4000 meeting requests > Over 1000 meetings took place
SPECIAL INTEREST GROUPS n
Special Interest Groups Special interest groups are typically run four times a year and are only open to Gold Members.
HR
SECURITY
The HR Special Interest Group has been established for a number of years. The group meets regularly throughout the year for a series of workshops and seminars on HR hot topics. The SIG is kindly sponsored by Taylor Vinters Solicitors.
Special Interest Group that focuses on risk management and Business.
Taylor Vinters is a leading law firm based in the heart of the high technology cluster in Cambridge. Our main office is situated right on the edges of both the Cambridge Science Park and the Cambridge Business Park. With our Brussels office, we specialise in servicing the legal needs of the biotechnology and pharmaceutical sectors, both nationally and internationally. Our specialist T2 team brings not only top quality legal advice to its clients but also up-to-date industry knowledge, making that advice relevant, understandable and practical. Our aspirations as a firm match those of the people with whom we work - to be recognised internationally as a Centre of Excellence
The aim of this SIG is to bring together individuals responsible for both security and operational management. Recent talks have covered industrial espionage, security contractor management and managing risk in a laboratory setting. HEALTH AND SAFETY The aim of the health and safety SIG is to provide an area of communication for health and safety Managers. These meetings were developed at the request of health and safety managers who wished to meet with their industry peers. Topics covered include stress management, waste reduction, legislative updates and the overview of the challenges facing health and safety managers.
FACILITIES These meetings are relevant to people who are responsible for the day-to-day running of their companyâ&#x20AC;&#x2122;s facilities. Discussions focus on key areas of facilities management such as equipment management and bench marking the cost of running labs and offices. PURCHASING This SIG supports ERBIâ&#x20AC;&#x2122;s well-established purchasing scheme, where Gold Member companies gain significant discounts on items such as laboratory consumables and office supplies and services such as pipette maintenance.
WWW.ERBI.CO.UK 25
n
LIFESCIENCE MANAGER
Lifescience Manager
The job entails ensuring that EEDA’s regional strategic investment and sector activities are aligned with those of national policy in the life sciences as laid down by central Government with the appropriate regional context expected by all the stakeholders, many of whom are ERBI members. The Technology Strategy Board, the research councils (mainly BBSRC and MRC), the Department for Business, Innovation and Skills and more recently, the Office for Life Sciences have all laid out a direction of travel for the industry which EEDA is also adopting. Belinda also holds the Chair of the UK Life Sciences Network (composed of the sector specialists in the UK’s regions and Devolved Assemblies) which is currently led by the East of England.
“
There is a wealth of support for companies available, but joining it all up to present a easily understandable “offer” remains a challenge. Another of Belinda’s responsibilities is to chair the regional Business Support Forum, composed of representatives of all those specialist advisers dedicated to supporting the sector. These include UK Trade and Investment (for advice on international business development), Business Link East (providing general sector business support), East of England International (supporting companies moving into the region) and, of course, EEDA. The aim of the Forum is to ensure cross-referral between the numerous support mechanisms and so that, as customers, you get to hear about, and take advantage of, trade missions, new funding opportunities and any activities to help support the regional environment for the sector.
“
With a keen interest in the success of the regional health and life sciences sector, ERBI naturally works closely with the East of England Development Agency (EEDA), the regional body responsible for economic development. This close relationship extends to hosting the Life Sciences Manager role within the ERBI team, currently carried out by Belinda Clarke.
In addition to national representation on Government and research council policy and strategy panels, there is much to do in the east of England! In early 2008 Belinda led the refresh and review of EEDA’s strategy for the sector, and subsequent investments by EEDA (along with other partners) included The Genome Analysis Centre at the Norwich Research Park, a new Innovation Centre at Colworth Science Park and the new biotechnology campus to support open innovation on the GSK site in Stevenage. In addition, EEDA has held a capital equipment competition as well as administering the national Finance for Business portfolio aimed at SMEs (including the Grant for Research and Development and the Proof of Market schemes).
There is a wealth of support for companies available, but joining it all up to present a easily understandable “offer” remains a challenge
26 ERBI DIRECTORY 2010
EUROPEAN ACTIVITIES n
European Activities ERBI’s mission is to maximise the global growth and competitiveness of our members. One of the key strands of our strategy is to internationalise our activities and encourage our members to take advantage of platforms and initiatives we work on in this respect. We recognise that for UK companies to be strong, they need to have access to and relations with other exceptional global companies. The sector is global and the success of it hangs on us working in partnership for mutual benefit.
n The production of a database of European and Indian
companies and researchers; and a number of studies analysing the EU/India common areas of interest in the biotech sector and the current Indian legal framework in the biotech sector.
n A presence at BioAsia and Bangalore Bio 2010. Funding is
also available for a small number of companies to attend some of the events taking place in India.
2. ABCEurope is a new inter-cluster project coordinated by the Milan Innovhub (Milan Chamber of Commerce) and funded by Europe Innova. It brings together 13 biotechnology clusters across Europe, including ERBI as a leading partner. The overall objective of the project is very tangible: raising the standard of services to SMEs and defragmenting the delivery of such services to SMEs across Europe. This will be achieved by assessing what services are already available, creating templates using the best elements of existing ones and rolling out the templates across Europe.
With this in mind, ERBI plays an important role as partner in two EC-funded projects: 1. The European Business and Technology Centre (EBTC) aims at further developing the EU-India trade and business relations. The project is coordinated by Eurochambres, and includes ERBI and 15 other European partners. The Centre’s activities are organised in four key sectors: Environment, Energy, Transport and Biotechnology. The Milan Innovhub (Milan Chamber of Commerce) is coordinating the Biotechnology cluster which comprises ERBI and Commercial Promotion of Catalonia (COPCA, Barcelona). The aim of the project is to create a Centre which will become a point of reference for European companies wanting to enter the Indian market. The Centre is planning to achieve this by acting as a multiplier and facilitator, increasing the understanding among EU SMEs and researchers about the opportunities offered by India, and providing an active link between policy makers and private bodies. The project has now entered its second year and the key activities for the Biotechnology cluster include: n A
workshop in Cambridge on the “Outsourcing and collaborative R&D opportunities in India”.
Examples of the activities that will be targeted by the project include entrepreneurship support in the form of self assessment tools and boot camps, facilitation of access to research infrastructures, centralisation of intellectual property support mechanisms, a non-executive Directors database and technology showcases. If you are interested in receiving more information about the above projects please contact ERBI’s European Project Manager, Dr Gigi Møller (01223 497 404 or gigimoller@erbi.co.uk).
n A flagship event in India aiming at introducing European
companies and researchers to their Indian counterparts.
WWW.ERBI.CO.UK 27
n
GOLDEN TRIANGLE PARTNERSHIP
Golden Triangle Partnership The Golden Triangle Partnership is a collaboration between ERBI, the Oxfordshire Bioscience Network (OBN) and the London Biotechnology Network (LBN) – the combination of these three groups representing Europe’s most active region in life sciences and healthcare. The aim of the partnership is to provide members with access to potential partners and investors from other global centres of excellence. ERBI members have expressed a desire for us to develop strategic partnerships with other leading clusters. With this in mind, Harriet Fear, ERBI CEO is working closely with Tony Jones of LBN and Jon Rees of OBN to open doors with leading US clusters. Plans progressed at the 2009 BIO conference in Atlanta when a meeting between the GTP and the Massachusetts Biotechnology Council (MassBio) discussed the concept of formalising a relationship for the benefit of all members. In October 2009 the GTP signed its first Memorandum of Understanding (MOU) -with MassBio to encourage and promote cooperation between all members. The MOU confirmed a commitment to facilitate transatlantic investment and partnering by encouraging collaborations between each group’s member companies. The GTP and MassBio will promote each other’s investment and partnering events, offering members reduced rates.
As well as discounts on each others events, of equal significance is a mutual agreement to create a ‘soft landing’ for each others members when they are looking to access/set up or do business in the US or the UK. MassBIO stands ready to support our members in gaining access to new contacts and helping them establish themselves locally on the East coast. We also have the firm commitment and support of Susan Wyndham-Bannister, the President of the Mass Life Sciences Center. The GTP signed a second MOU in December 2009 with the Massachusetts Medical Device Industry Council (MassMEDIC), to actively encourage cooperation and collaboration between UK and US companies in the medical device sector. As the collaboration continues to grow we look forward to offering new and exciting opportunities for our members to enable them to do business in the global market. For more information please contact CEO Harriet Fear on tel +44 (0)1223 497407 or email harrietfear@erbi.co.uk.
“This is a significant partnership that brings together the trade groups for two of the world’s largest life sciences clusters”, said Robert Coughlin, President & CEO of MassBio. “The UK is This is a significant partnership a recognised leader in drug that brings together the trade groups for and two development, of the world’s largest life sciences clusters”, discovery said Robert President & CEO of MassBio. “The UK and we are Coughlin, pleased to offer is recognised leader in drug oura members opportunities to discovery and development, and we are and pleased to offer collaborate partner with our members opportunities to collaborate some of the and UK’s partner premierwith life some of the UK’s premier life sciences sciences companies. companies”.
28 ERBI DIRECTORY 2010
“
“
chemiSPEC: Characterisation and Analysis Services for Industry Project management consulting for the life sciences sector Can you afford not to engage the world leading experts on pharmaceutical project management? Harpum consulting has worked with many of the major pharmaceutical companies around the world helping to develop and improve their project management expertise.
Why use Harpum Consulting? n Access to wide ranging academic research n Consultants with many years experience in life sciences project management as
well as experience across the project management profession n Support for the development of your professional project managers, driving
significantly increased value into your pipeline
At chemiSPEC we help our customers in a wide range of industry sectors – including pharmaceutical, fine and specialty chemicals and health care – with the characterisation of their products, by products, contaminants, etc. We offer a wide range of services from the routine provision of NMR and MS data through to complex problem solving. Examples of our services include: l Provision of NMR and MS spectra to your desktop l Spectral Interpretation l Complex Mixture Analysis l LC-MS and LC-NMR Analysis
n Development of bespoke project management methodologies that meet your needs
l Structure Elucidation
n Learn from other project-driven industries in a way that translates to the needs
l Method Development
of life science firms Harpum consulting work across the life sciences sector offering step change improvement in organisations’ ability to deliver products to market. This is centred on best practice portfolio, program, and project management (P3M) behaviours and processes. To support improvements, we work with you to create high performance drug program and functional project teams. Gary Aldam Director Life Sciences e-mail: gary.aldam@harpumconsulting.com
Tel: 07900 051951 www.harpumconsulting.com
contact: Bill Campbell 01388 779051 07711771289 bill.c.campbell@gmail.com www.chemispec.co.uk
BioTrans Pre-clinical Interim Management and Consultancy Services n Drug metabolism and pre-clinical drug discovery and development n Application of new technology to improve success rates in early compound development n Process re-engineering n Staff training and continued professional development
BioTrans has a wealth of knowledge from compound discovery to regulatory support Contact Dr Richard Chenery for access to drug metabolism and pre-clinical expertise BioTrans T 01462 457568 M 07505710947 E Richard.Chenery@ntlworld.com
Vision where it counts Intelligent vision systems for Checking Classifying Measuring Data Logging Counting Reading For more information call
01480 891801 or email
sales@orionautomation.co.uk
www.orionautomation.co.uk WWW.ERBI.CO.UK 29
Influencing Progress - Enabling Connections Enable
Develop
BIA business development an extension to your business development team
Industry leading training and development programmes
Connect Industry leading events
Communicate The voice of UK bioscience
Influence Creating an environment for success
www.bioindustry.org
/DE 0ROHFXODU 6HUYLFHV IRU WKH 3KDUPDFHXWLFDO ,QGXVWU\ /DE LV WKH 3DUWQHU RI &KRLFH IRU Â&#x2021; &RPSDQLRQ 'LDJQRVWLFV Â&#x2021; &OLQLFDO 7ULDO 6XSSRUW Â&#x2021; %LRPDUNHU $VVD\ 'HYHORSPHQW Â&#x2021; $VVD\ 0DQXIDFWXULQJ &RPPHUFLDOLVDWLRQ
:H 3URYLGH Â&#x2021; ([SHUWLVH LQ &RPSDQLRQ 'LDJQRVWLFV Â&#x2021; ([SHULHQFH LQ 3KDUPD 3DUWQHULQJ Â&#x2021; $FFUHGLWHG &OLQLFDO /DERUDWRU\ Â&#x2021; 3KDVH &DSDELOLWLHV Â&#x2021; &DWHJRU\ DQG ODERUDWRULHV Â&#x2021; &)5 3DUW Â&#x2021; 5HJXODWRU\ ([SHULHQFH Â&#x2021; ,62 Â&#x2021; 0DQXIDFWXULQJ )DFLOLWLHV Â&#x2021; 2SHUDWLRQV /RJLVWLFV Â&#x2021; &RPPHUFLDO $FXPHQ
8. DQG ,QWHUQDWLRQDO 3DUWQHULQJ /DE +HDOWKFDUH /LPLWHG &DPEULGJH 6FLHQFH 3DUN &DPEULGJH &% *$ 8. 7 ) ( LQIR#ODE FRP : ZZZ ODE FRP
Providing a Cost Effective Cure for all your Clinical Trial Equipment Global OnSite Service / Calibration Strategic Equipment planning.
Lowest Total Cost Solution
MESM
Equipment Storage
Management System
Sourcing Products
Full Life Equipment Management
tel. +44 (0)1257 225776 fax. +44 (0) 1257 225539
Sourcing and Supplying
P ECG Machines P Refrigerated Centrifuges -80 °c Freezers P Temperature monitoring. P
MESM making the industryâ&#x20AC;&#x2122;s heart beat
WWW MESM CO UK s sales@mesm.co.uk
The Company began trading in April 2009, formed by Paul Graham and Indira Walker, both highly experienced QP’s. Paul and Indira had worked together previously, 15 years ago, when they were both employed by a large Pharmaceutical Company. They remained in contact despite moving to other companies in different parts of the country, while both progressing in their careers. When the opportunity presented itself where they could work together in a Company of their own making, it was an exciting prospect. It has proved to be a winning combination so far, with an amalgamation of a broad spectrum of expertise which can be utilised to the advantage of our clients. Both possess similar interpersonal skills, being approachable and easy to work with, they are able to rapidly build good working relationships with clients. After two months of trading, as the client numbers increased and more projects were won, Beverley Graham and Andrew Walker joined the Company; Beverley holds a BSc in Chemistr y and has a broad experience in the Pharmaceutical industr y with companies including Glaxo, Pitman Moore a CMO and Sterling Winthrop while Andrew has a BA, a commercial background and a legal qualification. Paul has an MSc in Analytical Chemistr y, is a chartered chemist and Fellow of the Royal Society of Chemistr y. With over 25 years experience in the Pharmaceutical business he is a QP (through the permanent provisions) with companies such as MSD, Glaxo, Sanofi Aventis and a specialist CMO. Indira has a BSc in Chemistr y, is a chartered chemist and a member of TOPRA, has 20 years experience and is also a QP (through the permanent provision) holding senior positions in QA and Regulator y Affairs with US, EU and Japanese companies including Glaxo, Pharmacia and Daiichi.
From left to right: Andrew Walker, Indira Walker, Paul Graham and Bev Graham.
Following nine months of trading we have achieved a substantial turnover and have established a broad client base, including innovative SMEs seeking regulatory and quality advice, and CMOs and biotechnology companies who require advice on various quality initiatives and interim management positions. In addition, several clients have now revisited, requesting our support with new and additional projects. The company is well networked with GCP quality experts, Microbiologists and Analytical Chemists and an expert in Human Error. We are looking to expand further by hand picking associate QPs, who we know to share the same work ethos and who complete work in the same manner and to the same standard as ourselves. The success, so far of the company has been recently highlighted by the nomination and
subsequent short listing to the last four, for the ERBI Business Start-Up Award. As well as supplying quality advice we value good business advice, from the likes of David Molian, who has been involved with entrepreneurship education at Cranfield University and with whom we meet regularly. Recently we have exhibited at Liverpool, at the Medicines for Children Research Network conference and the Genesis exhibition in London. Should you wish to learn more about our company we have a website which describes the services we offer, how to contact us and a free news letter subscription. In addition, you can also see the Walker Graham team.
info@walker-graham.com www.walker-graham.com
Services: Our service offerings include n Quality and Regulatory Consultation Services n Qualified Person on Manufacturer’s/Importer’s IMP and Commercial Licences n Pharma Human Error Risk Reduction n Responsible Person on Wholesaler Dealer’s Licence
n Supplier and Contractor GMP Auditing n Pharmaceutical Training n Trainee QP/RP Mentoring n Quality Risk Management n QP Emergency Response Consultation
Welcome to a world of integrated manufacturing solutuions Piramal Healthcare is one of the world's top 10 pharmaceutical contract development and manufacturing organisations. With a growing network of assets located across Europe, North America and Asia, Piramal Healthcare's integrated services offer a truly customised solution. Our end-to-end capabilities span: ä API process Development ä Non-GMP & GMP Intermediates ä Biocatalysis Technologies ä High Potency Substances ä Commercial API ä Analytical Services ä Pre-formulations & Formulations Development ä CMC Services ä Clinical Trial Manufacturing & Distribution ä Commercial Formulations ä Commercial Packaging Learn more at www.piramalpharmasolutions.com call +44(0)1670 562 400 or email us via Enquiriespharmasolutions@piramal.com
Integrated
Solutions from drug discovery to patient care
Pall Life Sciences – Developing solutions for life science industries from drug discovery to patient care Pall Life Sciences provides cutting-edge products and services for discovering, developing and producing biotech drugs, vaccines and classic pharmaceuticals. In hospitals, patient therapy has become increasingly complex and our medical filtration products play a key role in the reduction of serious complications and Healthcare Associated Infections. © 2010 Pall Corporation. Pall and are trademarks of Pall Corporation. ® indicates a Pall trademark registered in the USA. Filtration.Separation.Solution.SM is a service mark of Pall Corporation. GN09.4279
Filtration. Separation. Solution.SM
www.pall.com/lifesciences
Protein Biomarker Specialists
Rapid Assay Development For Your Protein Biomarkers Ä Discover new protein biomarkers Ä Develop robust, accurate and precise
multiplexed assays Ä Validate protein biomarkers Ä Test pre-clinical and clinical samples Ä Low cost Ä Short timelines
NextGen Sciences offers a suite of services for biomarker discovery and rapid development of multiplexed quantitative assays. NextGen Sciences' methods significantly decrease timelines, and increase the traditionally low success rates associated with biomarker development. discoveryexpressÄ - Discovery of new protein biomarkers assayexpressÄ - Development of multiplexed assays testingexpressÄ - Biomarker testing laboratory BiomarkerlibraryÄ - Protein biomarker informatics Protein Analysis Services - NextGen Sciences offer a suite of services for protein analysis, including protein identification, characterization, quantitation and proteome mapping. Using state of the art sample preparation, mass-spectrometry and data-analysis platforms, we offer a high quality service for biotechnology and drug-development customers.
For More Information Phone: +44 (0) 1462 685788 info@nextgensciences.com
www.nextgensciences.com
Thereâ&#x20AC;&#x2122;s a buzz about Helena Biosciences
al C l i n i c p h o re s i s ro El e c t
Full product range
l et Plate ation eg Ag g r
u l at g a o C
ion
re & u t l u gy eC T is su ula r Biolo c Mole
Tel +44 (0)191 482 8440 marketing@helena-biosciences.com www.helena-biosciences.com
MK03
Helena Biosciences have more than thirty years of expertise in clinical diagnostics and molecular products. To ďŹ nd out how we can help you meet the challenges of 2010, please get in touch with us:
n
CHESTERFORD RESEARCH PARK
Chesterford Research Park
The Nucleus Building
Breakout space within the Nucleus Building
The joint developers of Chesterford Research Park, Aviva Investors and The Churchmanor Estates Company plc, realise the advantages of locating within an environment that actively helps to foster innovation. Providing a supportive and nurturing environment not only attracts the right people and businesses, but equally enables them to interact. Chesterford Research Park plays a pivotal role in this process.
Offering a unique working environment in this increasingly soughtafter location has attracted world-class bioscience companies to the Park, including Pfizer, Illumina Inc, Isogenica Ltd, BioFocus, Biolauncher, Biotica, Cellzome, Medivir, UKSPA and Cellcentric.
Set in 250 acres of open parkland within the South Cambridgeshire Biotech Cluster, Chesterford Research Park provides a secure and relaxed working environment for R&D companies of all sizes wanting to be positioned at the epicentre of UK drug discovery. It is not only an established development, but also a growing community. The vision for Chesterford Research Park was to create highquality, state-of-the-art laboratory and office space specifically designed for research and biotech companies at all stages of their life cycle, with the team at Chesterford work closely with its occupiers, to continually satisfy their property requirements, as they change and grow. Now in its tenth year that vision is fast becoming reality as the Park continues to attract leading R&D companies and increase the pool of skilled labour. On completion, the Park will comprise 600,000 square feet of R&D facilities within a low-density, landscaped environment served by state-of-the-art amenities. Architectural excellence, too, is a high priority at Chesterford, with the developers striving to maintain the highest design standards. The Nucleus, the central facilities building at Chesterford Research Park, sets new standards for the provision of amenities on science park developments. Housing the Park’s management offices and 24-hour manned site security centre, it also features top quality support services for occupiers, including state-of-theart conferencing facilities, a health club, 7 hole par three golf course, shop, award winning restaurant, chauffer driven transport and café bar. The location also offers excellent communications to London, Cambridge and Stansted Airport.
40 ERBI DIRECTORY 2010
US based Illumina, one of the world’s leading developers, manufacturers, and marketers of next-generation life-science tools and integrated systems for the analysis of genetic variation and biological function, moved into its bespoke European headquarters at Chesterford last November. The Gonville Laboratory, Illumina’s new HQ, provides them with 41,500 sq ft of state-of-the-art laboratory space. Another landmark development known as the Emmanuel Laboratory is now home to Pfizer, the world’s biggest pharmaceutical company. In a major deal, signalling expansion in its Cambridge-based drug delivery research activities, Pfizer now occupies two buildings at Chesterford Research Park, totalling some 52,000 sq ft. Development plans continue apace at Chesterford to increase the facilities available to new occupiers. Planning permission has now been granted on both the Robinson Laboratory and the Science Village development and the joint venture partners remain keen to push these projects forward. Representing the ultimate in flexible design, the Robinson Laboratory will provide two wings of laboratory space, linked by an elegant atrium designed to house an impressive reception area and a versatile range of meeting rooms. The Science Village is similarly forward thinking in design. The low energy building will allow for flexible use as R&D offices and/or laboratory suites. Providing excellent facilities for companies at all stages of their development, the Village is able to offer up to a maximum of 16 self-contained suites ranging from 1,510 sq ft to 1,965 sq ft, each equipped with two fume hoods and laboratory benching offered on inclusive rental terms. To find out more visit www.chesterfordresearchpark.com
For over 40 years World Courier has been dedicated to time-critical deliveries
AVIVA - EDITORIAL Specialists in temperature-sensitive, infectious and diagnostic shipments s X X PREMIUM COURIER SERVICE
s , OCAL EXPERTISE AND )!4! CERTIFIED STAFF AT EVERY OFFICE
s ! GLOBAL NETWORK OF OVER COMPANY OWNED OFFICES IN COUNTRIES
s ! LL DOCUMENTATION CUSTOMS AND SECURITY
s /VER YEARS EXPERIENCE s 3 AME DAY DELIVERY TO %UROPE HOUR DELIVERY TO MOST OTHER GLOBAL DESTINATIONS s N o CONSOLIDATION ALL CONSIGNMENTS ARE TRANSPORTED BY FASTEST AND MOST RELIABLE MEANS
&OR INFORMATION AND SERVICE CALL &REEPHONE IN THE 5+ OR EMAIL US AT SALES WORLDCOURIER CO UK WWW WORLDCOURIER COM
s !LL PACKAGING TO 5. SPECIFICATIONS s / PTIONAL HANDCARRY SERVICE AIRCRAFT CHARTER IF REQUIRED s 7 EB TRACKING AND EMAIL ALERTS ENABLE YOU TO MONITOR STATUS OF YOUR SHIPMENT
When you have a time-critical delivery, we are the only company who can give you undivided attention on a global basis
5SING "IO 34!23- 7ORLD #OURIER S OWN PROJECT MANAGEMENT SYSTEM FOR THE BIOMEDICAL COMMUNITY
n
NORWICH RESEARCH PARK
Thriving community in the Park The Norwich Research Park (NRP) is a thriving community of research groups and high quality businesses, recognised as a world-leading centre for research and innovation in health, food and environmental sciences. NRP is a partnership between the University of East Anglia, The Norfolk and Norwich University Hospital Foundation Trust and four Bioscience Institutes including three funded by the Biotechnology and Biological Sciences Research Council – the John Innes Centre, Institute of Food Research and Genome Analysis Centre. With over 10,000 people, including 3,000 research scientists and clinicians employed on site, we have a critical mass that makes it possible for researchers and businesses to exchange ideas, to devise innovative research programmes, to shape new commercial projects and to seize the opportunities presented by breakthroughs in research. BIOTECH, HEALTH AND CLINICAL RESEARCH IN NORWICH Norwich has longstanding strengths in Biotechnology – particularly in the white and green sectors for the generation of novel chemical entities and production of proteins. Health is a major focus of research on the Norwich Research Park. The opening of the new Norfolk and Norwich University Hospital in 2001, along with one of the first new Medical Schools in the UK for almost 30 years and the new Pharmacy School, enables the NRP to integrate health research into its spectrum of life sciences and clinical expertise. The Biomedical Research Centre on the UEA campus houses 20 major biomedical research groups and encourages further collaboration across the site. The recently opened Clinical Trials Unit is well supported by clinicians and research nurses in a wide range of specialisms with an excellent local population for clinical
“
studies through the well-engaged Primary Care Trusts. Oral route drug delivery is a particular research strength combining groups from several disciplines across the Park. COMPANIES The NRP is home to 30 science and technology related companies based in the 20,000 sq ft Norwich BioIncubator or embedded within the partner institutions. Novacta started up in the Norwich BioIncubator to develop technology from the John Innes Centre. The biotech and pharma companies; Procarta, Inspiralis and London Pharma are all based here. The Dynamic Gastric Model from the Institute of Food Research is proving to be a very useful tool for the pharma industry in accurately replicating the conditions in the stomach for prediction of bioperformance of APIs and dosage forms. NEW LAB/OFFICE ACCOMMODATION FOR BIOTECH COMPANIES ON NORWICH RESEARCH PARK FROM 2010 We are opening a further 40,000 sq ft of mixed laboratory and office space from July 2010. This will suit both start-ups as well as small companies wishing to expand and take advantage of the location with respect to value of the deal and the combined expertise of the partner institutions. Actively supported by local and regional government, the Park is also developing an additional 55 hectares for commercial tenants over the next few years, taking the total estate to over 200 hectares. We look forward to showing you the difference Norwich Research Park could make to your organisation. Please contact us: 01603 450925 or see www.nrp.org.uk
“
NORWICH RESEARCH PARK
The main strength of the NRP is the concentration of world-leading scientists coupled with the capability for multidiscliplinary research.
42 ERBI DIRECTORY 2010
NORWICH RESEARCH PARK n
WWW.ERBI.CO.UK 43
peace of success Newmarket, Mildenhall, Brandon, Red Lodge and surrounding villages offer some of the best countryside in the country, access to the finest academic and research facilities of Cambridge enhanced by University Campus Suffolk, competitive land and property prices and a strong transport network including the A11 from London to Norwich, the A14 from the East Midlands to east coast ports and access to international airports.
Spotlight on Newmarket: • Newmarket, a bio-science cluster and the home of horse racing offering the largest group of horseracing yards, trainers and international bio-science related firms in the world • Location of the Animal Health Trust with an annual research budget in excess of £4million
Spotlight on Mildenhall: • Procurement opportunities worth £33million each year through the United States Airforce based at Mildenhall and Lakenheath • Location of Marshall Specialist Vehicles and Nestor Pharmaceuticals – the largest Indian investment in the East of England
Spotlight on Brandon: • Brandon, gateway to the Brecks, opening up a wealth of opportunities for business across Suffolk and the neighbouring county of Norfolk
Spotlight on Red Lodge: • Kings Warren Business Park a unique development offering a wide variety of opportunities • Location of Groupe Hamlin’s headquarters
www.forest-heath.gov.uk/business
For further information on how to benefit from expansion within Forest Heath contact Masart Razaq on +44 (0)1638 719471 or econdev@forest-heath.gov.uk and for a comprehensive land and property register visit www.choosesuffolk.com
MEDICAL RESEARCH COUNCIL n
World class medical research
The MRCâ&#x20AC;&#x2122;s mission is to improve human health through world class medical research. ÂŁ60m is invested annually in the 8 MRC research establishments in Cambridge, alongside funding for research in the University. The new MRC Laboratory of Molecular Biology building will be the flagship of the Cambridge Biomedical Campus and will provide facilities to ensure it continues as a world-class institute for basic science. AMONG THE KEY STRATEGIC AREAS ARE: n Neurosciences, with research in molecular and cellular
approaches, cognitive neuroscience, brain imaging and population cohorts. n Cancer, where work in the MRC Cancer Cell Unit is contributing
to new diagnostic and therapeutic approaches. n Diabetes and Obesity, where the MRC Epidemiology Unit is
part of the Institute of Metabolic Science and complements both other research in the Institute, and MRC research elsewhere in the region on nutrition and health.
www.mrc-centre.cam.ac.uk Tel: 01223 248011
WWW.ERBI.CO.UK 45
n
VERIUS
Verius Limited is a specialised provider of support services to the pharmaceutical, biotechnology and medical device sectors. Our principal business areas are in the fields of pharmacovigilance (including safety management for clinical trials), regulatory affairs and general development consulting. PHARMACOVIGILANCE
REGULATORY SERVICES
Verius Limited offers a complete range of clinical safety and pharmacovigilance services, with a unique ability to tailor our services directly to your needs. We have global capabilities and work within all applicable regulatory requirements.
Our full range of regulatory services covers all stages of drug and medical device development, and encompasses manufacturing and quality, non-clinical and clinical aspects. We have experience with new and existing synthetic molecules, biologicals and other novel technologies and devices. We are compliant with the requirements and guidance of the International Conference on Harmonisation (ICH) and all major regional and national regulatory agencies in Europe, North America, Japan and elsewhere.
In todayâ&#x20AC;&#x2122;s environment there is an ever increasing focus on the safety of new products. Verius can provide services ranging from a basic clinical safety service for a new drug or device candidate through to a sophisticated system encompassing data capture, medical monitoring, narrative writing and electronic adverse reaction reporting to regulatory authorities and the EMEA thus supporting an entire development programme. With our E2B and 21 CFR part 11 compliant industry standard fully validated safety database systems we can produce Individual Case Safety Reports, monthly line listings, annual safety reports and periodic safety update reports. Starting with protocol and case report form review and investigator training through to the end of study reports and case narratives, we are able to provide the clinical safety expertise needed for clinical trials at every stage. Verius also offers a full pharmacovigilance service for marketed products, including the provision of EU qualified persons for pharmacovigilance, capture of spontaneous reports, literature searches, signal detection and establishment and maintenance of a complete global safety database. Risk/benefit analysis and risk management plan reviews can be provided by Verius at any stage of the product life cycle. We have the required skills to monitor the safety of your product from the clinical stages through to post marketing. With our wide experience and knowledge we offer the complete solution.
46 ERBI DIRECTORY 2010
We have a successful track record in Orphan Drug applications in the EU and elsewhere, and have guided clients through Scientific Advisory procedures at National and European level. GENERAL CONSULTING SERVICES These cover all aspects of drug development. We have specific in house experience in molecular biology and genetics, cell culture, microbiology and immunology. We are currently helping clients with their development plans in a wide range of therapeutic areas, creating focussed project teams working in tandem with clientâ&#x20AC;&#x2122;s in house development staff. Through our associate FSA registered company, we are able to help with fund raising and other aspects of venture management, legal services and corporate finance. Verius Limited would be pleased to provide further information on these and other services we can offer. For further information please contact Dr Stephen Bentley on +44 (0)1223 402660 or by e mail at sbentley@verius.co.uk
The UK’s leading supplier of safety products is celebrating 125 years of trading! • Our Trade Counters stock 3,000 of our best selling products of Personal Protective Equipment, Clothing, Footwear, Gloves and Workplace Safety products. • The biggest and best range of leading safety and workwear brands including 3M, CAT, UVEX, Berghaus and Snickers. • Visit your local Trade Counter in Bury St Edmunds or check out our website at www.arco.co.uk
Get your FREE Catalogue call 01482 222522 order online www.arco.co.uk
Arco House, Easlea Road, Moreton Hall Industrial Estate, Bury St Edmunds, Suffolk, IP32 7BY Sales Enquiries and Orders: 01284 773030 General Enquiries: 01284 702533 fax: 01284 750529 e-mail: burystedmunds.branch@arco.co.uk
n
ACTIVOTEC
Quality peptide synthesis Activotec is a peptide synthesis Company providing innovative custom peptide synthesis services, peptide synthesizers and chemicals for chemical research and development. Our mission is to establish Activotec as the partner of choice for peptide-based drug discovery. The Company was formed in December 2002 as a spinout from the University of Southampton, with the support of Southampton University’s Enterprise Office, the CEI, and benefiting from its partnership with IP Group.
Activotec’s core focus is customer service whether it’s instrument development and support, delivery of quality custom synthesis services or chemicals, all critical to the success of your science. Our stock of instrument parts, consumables and chemicals offers a first class commitment to customer support. Activotec offers scientists a single point of expertise and assistance in research, design, manufacture of new, innovative and practical solutions.
PEPTIDE SYNTHESIZERS
R & D - PEPTIDE THERAPEUTICS
The Company develops and manufactures automated peptide synthesizers to sell worldwide to the peptide synthesis community. All development and production takes place at its facility in Cambridge, UK. The Activo-P11 peptide synthesizer is an easy to use and affordable instrument for synthesis of very high quality peptides on a scale from 0.05 to 2.0 mmole.
Activotec has an extensive R & D programme based on the modification and production of peptides and proteins for therapeutic use. The Company has filed a number of patent applications based on various synthesis techniques. Further patents have been filed relating to the development of novel peptide-based products for the treatment of cancer, HIV and diabetes.
CUSTOM PEPTIDE SYNTHESIS
The Company welcomes collaborative projects with biotechnology and pharmaceutical partners to develop new strategies for peptide and protein synthesis.
“
Activotec has a highly skilled team of research and production scientists, product specialists and service engineer’s with unique experience in serving the scientific community. Activotec is unique in its level of knowledge of the peptide research and development markets, and offers experienced technical, sales and marketing support. The company sells direct to the end-user community.
“
Activotec provides a fast reliable custom peptide synthesis service, using solid and solution phase chemistry employing Fmoc and t-Boc methodologies for the design and production of peptides for research purposes. Activotec offers custom peptide services from small research scale to large scale manufacture with a full range of C and N terminal modifications. Particular expertise focuses on difficult to synthesise sequences, nonnatural modifications, and the design and synthesis of highly effective peptide immunogens.
Activotec always delivers peptides of the highest quality at competitive rates and their customer support is excellent
50 ERBI DIRECTORY 2010
Contract customer – Cambridge UK
ACTIVOTEC n
FAST RELIABLE CUSTOM PEPTIDE SYNTHESIS At its peptide facility Activotec has a team of scientists using solid and solution phase chemistry employing Fmoc and t-Boc methodologies for the design and production of peptides for research purposes. Activotec offers a range of custom peptide services from small research scale to large scale manufacture. n mgs to grams n All peptides are delivered with HPLC and Mass Spectroscopy
data n Purity range to suit customer requirements n Peptide Quality Guarantee n Multiple peptides for eg.epitope mapping n Fast, on time delivery n Development of new synthesis technologies
We can offer a wide variety of modifications that include: n N-terminal acylation n C-terminal amidation n Site specific peptide modifications n Biotinylated peptides n Conjugation to KLH, BSA, ETC n Fluorescent tagged peptides n Incorporation of unusual amino acids n Cyclic and phosphorylated peptides n Peptide libraries
“We have been very pleased with Activotec’s support over the years for our peptide synthesiser, they always respond quickly and are very knowledgeable about the synthesiser and it’s applications Katalina Digleria – Institute of Molecular Medicine, Oxford, UK
CHEMMATRIX® RESINS, THE 100% PEG RESINS
Some facts about ChemMatrix resin:
Activotec supplies amino acids, resins and reagents for peptide synthesis and combinatorial chemistry. Most products are stocked locally for fast delivery across Europe.
n Higher purity - The longer, the more complex or hydrophobic
Today’s challenge is to synthesize long, complex and highly hydrophobic peptides. For this purpose, the use of a 100% PEG resin has demonstrated tremendous advantages over polystyrene.
n Fully biocompatible resin - The high swelling of ChemMatrix
your peptide is, the more improvement you will see with ChemMatrix in water allows High Throughput post-synthetic downstream screening n No peptide loss during long sequence synthesis - No leaching
is observed on microwave synthesizer at 80C for 40 residues+ n Direct synthesis of mini-protein are now possible - Full length
116 residues peptide has been synthesized with great purity
Tel: +44 (0)1223 260008 Fax: +44 (0)1223 260068 e-mail: info@activotec.com skype: activotec.com
WWW.ERBI.CO.UK 51
CVcd8ZcigVa PhjXXZhh i]gdj\] cVcdbViZg^VahR
CVcd8ZcigVa ^h Vc Vaa^VcXZ d[ aZVY^c\ dg\Vc^hVi^dch XgZViZY id jcadX` i]Z kVhi XdbbZgX^Va VcY hdX^ZiVa ediZci^Va d[ cVcdbViZg^Vah# CVcd8ZcigVa ]Zaeh [dg\Z ^cYjhign l^YZ XdaaVWdgVi^dch VXgdhh bVg`Zih VcY hjeean X]V^ch0 VcY egdk^YZh VXXZhh id `Zn ZcVWa^c\ iZX]cdad\^Zh! [VX^a^i^Zh VcY ZmeZgi^hZ#
NanoCentral’s providers include: Nanomaterial Synthesis • Johnson Matthey • Intrinsiq Materials Ltd • Promethean Particles • nanoLake • Innovnano • Harman Technology Limited • Nanogap Dispersion & Formulation • University of Liverpool • Netzsch Mastermix Ltd • Maelstrom APT Ltd • Buhler Limited • Lubrizol Advanced Materials • Imerys Minerals Ltd • Hosokawa Micron Ltd • Primary Dispersions Ltd Applications Development • The Electrospinning Company • Teknek Ltd • Printed Electronics Ltd • Nanoforce • Macdermid Autotype • Ilika Technologies Ltd • The Wolfson Centre Characterisation • Intertek MSG • CEMMNT Nanomaterial SHE • Safenano • AssuredNano
As a not-for-profit organisation, NanoCentral can offer significant benefits to organisations which may currently be put off by perceived high cost, risk or lack of knowledge of using nanomaterials. As world-class experts in nanomaterials technology, we can help you to overcome problems that you are already facing, or assist you to develop innovative bespoke solutions. Backed by the Technology Strategy Board, the Regional Development Agency, One NorthEast, and the Centre for Process Innovation, NanoCentral is based in the traditional heart of the science and chemical sector on Teesside at the Wilton Centre. NanoCentral was set up to help industry gain from the revolution that’s taking place in nanomaterials. It is about creating jobs and profits for companies and thereby increasing the UK gross domestic product.
Why use NanoCentral? NanoCentral can provide you access to technologies and expertise from our extensive Alliance of Providers to help you find solutions to the issues you have identified. If you require a new technology to solve your problem, NanoCentral can introduce you to potential partners to add expertise and capability to the development process. This part of the process is completely free of charge.
At NanoCentral you can get help from a team of people with an unmatched combination of industrial, technological and business expertise. A major part of NanoCentral’s mission is also to ensure the safe use of nanomaterials both in their development and for end users. NanoCentral is in partnership with the SAFENANO initiative at the Institute of Occupational Medicine to incorporate health, safety and environmental expertise. NanoCentral has also instigated AssuredNano® which is the first nanomaterials Safety, Health & Environment (SHE) Accreditation Scheme featuring annual Compliance Auditing. To assist nanotechnology practitioners in all market areas, NanoCentral is instituting a Resource Guide to Nanotechnology and Nanomaterials Services. Called NanoPerspective, the resource guide is the prime listing publication for all organisations within the global nanotechnology supply chain, ranging from research through product development to manufacture and supply, plus ancillary services such as legal, IP consultancy and business finance. It will be a who’s who of the nanotechnology sector. Due for publication in May, if you want to ensure your organisation is listed in the publication, or to just ensure you get a copy of this inavluable Resource Guide on its publication, please contact a member of the team below.
If you are interested in joining the nanomaterials revolution or would like to know how NanoCentral can help you as a technology provider or user, get in touch with the team: NanoCentral at the Centre for Process Innovation, Wilton Centre, Wilton, Redcar, TS10 4RF E: steve.devine@nanocentral.eu T: 01740 625 729
www.nanocentral.eu 52 ERBI DIRECTORY 2010
NanoCentral continually captures emerging technologies from a wide range of sectors and makes these available to you. A key advantage we offer is access to facilities to create and test these nanomaterial solutions in a cost-effective way.
Medical Devices and Instrumentation
n
MEDICAL DEVICES AND INSTRUMENTATION
Make the deal happen Argo’s principal consultant, Stephen Lang, has a background in R&D and general management roles in the Medical Technology and Pharmaceutical sector. He has 20 years experience in acquisition and licensing activities having latterly been Director of Business Development for the UK’s largest medical device company, Smith and Nephew. In 2004 he started up as an independent advisor and has subsequently been involved with numerous commercial deals in the medical sector. Over his career he has successfully brought his experience and expertise to bear on all kinds of transactions and at all levels - from £100 thousand to £500 million.
“Steve did a marvelous job in coordinating a strategic acquisition for our Company with limited direction or oversight. He identified many potential opportunities and risks that added value well beyond the fees paid. We would consider utilizing him in the future based upon our experience.” VP Finance Arrow International Inc. Stephen Lang
RECENT ASSIGNMENTS BUSINESS DEVELOPMENT CONSULTANT TO THE MEDICAL PRODUCTS INDUSTRY Whatever size your company may be, developing and growing your business through mergers, acquisitions, licensing or technology co-development can be a fraught and sometimes risky undertaking. Invariably it means entering a world that is outside your field of expertise – areas of commerce, law and negotiation that can prove to be a minefield for the uninitiated. Before embarking on such a venture, there is one crucial question to ask yourself: do I or any of my work colleagues have the necessary qualities, experience and skill-set to undertake such a project? In reality, very few people have any experience of the merger, acquisition and licensing process. For many it is too scary, and they simply hand it over to their lawyers and accountants. A few decide to tackle it on their own but soon begin to regret it as unforeseen problems arise. Before long, with their eye off the ball, their core business suffers and they fail to negotiate a good deal or any deal at all - even when one is there to be made.
n Assisting a medium sized (>$300m) US company acquire part
of its UK based distributor and form a new UK subsidiary. n Helping a small ‘university spin-out’ to find suitable partners
and conclude an Option and Licence agreement with a US commercial partner for their arthroscopic image processing software. n Assisting a small Swedish company in finding and concluding
agreements with a commercial partner for their drug-device technology in orthopaedics. n Identifying potential acquisition targets for a large ($4bn)
US food company seeking to diversify into the Med Tech sector. n Identifying potential acquisition targets for a very large ($8bn)
US chemical company seeking to develop its technologies into the medical materials sector. n Assisting a small development stage company find a buyer
for its near market product and technology platform. NEGOTIATION COURSES
THIS IS WHERE ARGO CONSULTING CAN HELP Argo specialises in providing advice and practical assistance in developing a company’s business through partnerships with other enterprises. We can also help maximise the value of the company or its specific product line should the decision be taken to sell it.
54 ERBI DIRECTORY 2010
As well as ‘making deals happen’ for its clients, Argo also designs and runs specialist negotiation courses. These provide a focussed, practical and enjoyable environment in which to learn about negotiation via interactive exercises and role plays. Attending such a course could be one of the best investments you or your company could ever make.
After the course, I wanted to go straight out and do a deal... Marketing Manager. Smith & Nephew
AREAS OF EXPERTISE Argo can work with you and your team on a wide range of activities including: Formulation of business development strategy Business valuation Identifying and qualifying potential partners Structuring appropriate transactions Preparing for and conducting negotiations Managing Due Diligence investigations Drafting and revising agreements Initial implementation
For more information about how Argo can help you develop your business or hone your negotiation skills, please contact Stephen Lang. 01799 513209 stephenm.lang@btinternet.com
Don’t miss out…
Beyond 2010 could support up to 50% of your training costs.*
Does your company have a base in the East of England? Does your company operate in the Life Science and/or Healthcare sectors? If you have answered yes to both of the above… you could save money on your training costs.** Beyond 2010 – a new programme of funding from the European Social Fund (ESF) and East of England Development Agency (EEDA) that could contribute towards the cost of employee training which focuses on skills critical to improving your business. *A maximum grant of up to £2500 available per business. **SME eligibility – up to 250 employees globally.
Call: Michelle Marsh on 01223 497402 Email: michellemarsh@erbi.co.uk
MEDICAL DEVICES AND INSTRUMENTATION n
WWW.ERBI.CO.UK 57
Call for Regional Innovation Funding Applications NHS East of England’s 2009/10 Regional Innovation Fund (RIF) is being launched to find ways to support innovation at the front line to help improve the lives of those with longterm conditions in the region. n Applications invited for between £50,000 and £300,000 n Launch Date 29 January 2010, closing on 29 March 2010 n Check our website for more details at www.eoe.nhs.uk
The 2009/10 RIF will be used to: n Support the adoption and spread of innovation within long-term conditions n Aligned to our clinically led vision Towards the best, together n Help deliver the NHS’s Quality, Innovation, Productivity and Prevention (QIPP) agenda
www.eoe.nhs.uk
NHS East of England
n
NHS EAST OF ENGLAND
Promoting Innovation NHS East of England is the Strategic Health Authority for the east of England, covering Bedfordshire, Cambridgeshire, Essex, Hertfordshire, Norfolk and Suffolk. We are the regional headquarters of the NHS, and provide strategic leadership to all NHS organisations across the six counties. Our tripartite mission is to: n Deliver a better patient experience n Improve people’s health n Reduce unfairness in health
Our goal is to provide the best health service in England. The NHS in the region has produced a vision called Towards the best, together – which is clinically led, evidence based, and patient centred. It will give our population a better patient experience, improve people’s health and will reduce unfairness in health. These improvements will be driven, in part, by innovation and we are fortunate to be in a region where there are already excellent examples. The challenge now is to foster the adoption and spread of these innovations. We need both large scale and smaller scale innovations, which can be integrated into current or new patient pathways and improve the quality and effectiveness of care. Of particular note is Cambridge University’s international reputation for innovation and excellence in biomedical science, including the specialist MRC-funded epidemiology unit, with particular expertise in nutrition and obesity. The University of Hertfordshire has also achieved world leading and international excellence performance ratings for research in a number of fields including Nursing and Midwifery, psychology and pharmacy in the Research Assessment Exercise 2008. In addition, the east of England is home to one of only five national Biomedical Research Centres, a number of large pharmaceutical companies and many biomedical science and technology companies. The opportunities that this creates to develop research that links fundamental biomedical science to improvements in patient care are considerable, which is why we will be working with our academic colleagues and some of the brightest and best in business. To view our clinical vision Towards the best, together visit www.eoe.nhs.uk/vision
60 ERBI DIRECTORY 2010
We work with 40 local NHS organisations across the east of England and are responsible for ensuring that the £8.1 billion spent on health care in our region delivers the best services and value-for-money for both patients and the taxpayer. Growth in public sector spending is expected to reduce considerably over the coming years to support economic recovery. Within the NHS we need to find ways to continue to achieve better outcomes with no increase in funding. Our QIPP – quality, innovation productivity and prevention – agenda is providing a new approach to delivering our vision within this challenging context and innovation will play an integral role.
NHS EAST OF ENGLAND n
Promoting innovation at the front line The region’s healthcare workforce is being called upon to help drive forward changes through innovation and research, in order to meet the NHS East of England’s pledges laid down in Improving Lives; Saving Lives and meet the 10year vision for health, Towards the best, together. Director of Workforce at NHS East of England, Stephen Welfare explained: “The Strategic Health Authority has a new statutory duty to promote innovation. It is important that we encourage innovation to Stephen Welfare take place as close to the patient as possible, stimulating and supporting frontline organisations to innovate, actively encouraging people to develop new ideas and adopt and adapt ideas from elsewhere.”
“At the same time, we need to identify and implement new and best practice approaches in order to ensure continuous improvement in the commissioning and provision of high quality health care, contributing to the impetus for Quality, Innovation, Productivity and Prevention, QIPP.” “Awards help to identify, recognise and promote innovation. We have been working with others to offer prizes for innovation which help to achieve our goals, including funding the 2009 ERBI NHS Partnership Award to identify groundbreaking new innovations. This has played an important part in improving the working relationship between industry and the NHS, which is fundamental to increasing our rate of innovation.” Read on to find out how we are supporting the capacity and capability of NHS organisations to innovate, how we are working with small businesses to stimulate innovation and our new coalition for innovation within the NHS in the east of England. For further information, please contact Gareth Jones, Head of Innovation on tel: 01223 596929 or e-mail: gareth.jones@eoe.nhs. uk or visit www.eoe.nhs.uk
Scouting for new ideas The NHS innovation hub in the east of England – Health Enterprise East – has been piloting an Innovation Scout Scheme with four NHS organisations in the region. Given the success of the pilot, NHS East of England is working with Health Enterprise East to expand the scheme to a further 20 NHS organisations in 2009/10, providing resources to train and support this wider scout network. In the pilot study, Health Enterprise East trained and supported four nominated scouts to both promote and seek out innovations in their Trusts. The scouts each devoted two days a month to this activity. The results have been of great benefit to the Trusts which participated in terms of increased innovation flow, increased innovation and intellectual property awareness, along with the enhanced personal development and satisfaction of all those involved.
Among those involved in the pilot programme was Chris Cook, from the Princess Alexandra Hospital NHS Trust in Essex, whose job has now been adapted to Research and Innovation Manager, enabling her to continue the innovation work she has been undertaking. She said: “We started by asking people to think about problems and what their needs are, which has led to them thinking of their own solutions and ultimately disclosures for innovations. “What we found is that many people have really good ideas and, instead of keeping it to themselves, they now have someone who will listen and try to help make those improvements a reality.”
The Scouts search for new ideas and improvements within primary and secondary care that can improve the way patient care is delivered, benefiting both staff and service users. The Innovation Scouts are chosen from people who work within the Trusts and spend two days a month quite literally scouting around among colleagues for ideas, attending meetings to inform staff about their work and holding awareness days. Stuart Thomson, Head of Medical Technology at NHS Innovations East who is leading the programme, said: “We have seen a four-fold increase in the number of innovation disclosures coming forward from the PCTs, with a good two dozen ideas which we are looking at.” “We’re now working on a number of medical device innovations in order to secure their successful approval and reviewing various service improvement ideas which will help both patients and staff.”
WWW.ERBI.CO.UK 61
n
NHS EAST OF ENGLAND
Reaching out to industry Eleven companies working on the development of innovative healthcare technology devices have each been awarded up to £100,000 of funding through a new competition. The Small Business Research Initiative (SBRI) is a new crossgovernment programme for the procurement of technology development projects including the demonstration and evaluation of new technologies. It recently ran a very successful pilot competition to seek out innovative ideas from businesses across the region, which could be used to meet current healthcare priorities. NHS East of England, the East of England Development Agency (EEDA), the Technology Strategy Board (TSB) and the European Regional Development Fund jointly funded the regional pilot SBRI competition which proved to be very successful. It was very well-subscribed to and Lord Mandelson recently referred to it as an example of excellent practice. NHS East of England allocated a proportion of its Regional Innovation Funds to the scheme which invited companies to submit ideas that could be turned into practical solutions to make a substantial difference in three priority areas: n Managing Long Term Conditions n Patient Safety n Keeping Children Active
Applications needed to address the priorities set out in the NHS East of England Vision Towards the best, together, in particular those where innovation and new technology can make the most impact. In each case the challenge was to produce practical solutions which will make a substantial difference to the effective management of patients and improve healthcare outcomes. All proposals needed to demonstrate that they can contribute to reducing the carbon output from healthcare provision.
Building a coalition for innovation
For more information, including the list of companies awarded funding, visit the Health Enterprise East website www.hee.org.uk.
Regional Innovation Funds Each Strategic Health Authority has £1.94 million of Regional Innovation Funds in 2009/10. NHS East of England has already successfully allocated £330,000 to SBRI – the Small Business Research Initiative (see article above). The remaining £1.6 million will be used to support the adoption and spread of innovation within long-term conditions, aligned to our vision Towards the best, together and our quality, innovation and productivity (QIPP) agenda. We aim to open the fund to applications from 29 January to 29 March 2010. To find out more, see the advert on page 58.
62 ERBI DIRECTORY 2010
Sir Neil McKay
Alan Barrell
Sir Neil McKay, Chief Executive of NHS East of England, said: “We have set ourselves a firm foundation for how we stimulate and promote innovation by completing a review involving industry, academia, the NHS and other partners which has informed our strategic framework for innovation. This stressed the need for a coalition of partners to be formed across east of England. We are very fortunate to be working in a region that has such an excellent track record in research and innovation. The new Innovation Council is already opening up new opportunities for innovation within the health service.”
NHS EAST OF ENGLAND n
The Innovation Council’s role is to help develop these new partnerships to stimulate and promote innovation across the NHS in the region. The Council will also have oversight of, and advise on, the allocation of the Regional Innovation Funds for 2009/10, with accountability to the east of England NHS Management Board. Alan Barrell, Chairman of the Innovation Council, said “This is an exciting time in the NHS. The challenging economic climate presents many opportunities, with innovation as a means to
secure high quality care being a uniting factor on which to base and develop new partnerships”. The Innovation Council’s inaugural meeting took place in October 2009. Membership includes key stakeholders from industry, academia, the NHS, voluntary and public sectors including representatives from the Academic Health Science Centre, East of England Development Agency and the Collaboration in Applied Health Research and Care.
CASE STUDY 1: ATRIAL FIBRILLATION SCREENING PROJECT: NHS NORTH EAST ESSEX Carried out annually at flu vaccinations, the Atrial Fibrillation Screening Project was set up to assess major stroke risk factors in 65 year olds. GP practices were commissioned to take the pulse of every patient over the age of 65 and those found to have undiagnosed atrial fibrillation were treated to minimise the risk of stroke. Atrial Fibrillation, if untreated, is a silent killer which carries an average 5% stroke risk per year. Stroke is a major health risk in the UK and particularly in North East Essex which has one of the highest elderly populations in Europe. The annual cost of stroke to the UK economy is estimated to exceed £8.9 billion, with a direct cost of £4.9 billion to the NHS. Treatment includes Aspirin or Warfarin, which thin the blood slightly to reduce the risk of blood clotting.
The project was launched in October 2008 and is part of a range of community based services which have been set up to reduce vascular disease, including intensive risk factor management of patients living in deprived areas and community monitoring for paroxysmal arrhythmias and blood pressure. This project has significantly improved the prognosis of patients found with atrial fibrillation. In Autumn/Winter 2008, 37,000 patients were tested in 12 weeks and 249 new cases of atrial fibrillation were detected. Two patients had complete heart block and were treated immediately, saving two lives. Approximately nine strokes will be prevented in the next year by preventative treatment with Warfarin or Aspirin. It is also highly cost effective, with a return on investment of over 300%.
This is a fantastic scheme which will save lives quickly, is cost-effective and can be easily replicated across the UK.
Dr Shane Gordon
CASE STUDY 2: THE PEEZY - FUNNELLY ENOUGH LTD Peezy is a revolutionary, user-friendly, hygienic urine-collection device that dignifies sample delivery for patients. It was created by Dr Vincent Forte and his sister Giovanna Forte.
samples, which often need to be repeated with additional inconvenience to the patient, additional cost to the healthcare provider and a possible delay in the commencement of treatment.
The device makes huge contributions to infection control and workplace hygiene, reducing potential for contamination and risk of MRSA and other infections in medical settings to patients and staff alike.
Peezy’s high-quality mid-stream sampling means significantly reduced sample contamination and therefore a reduced retest rate.
Contamination of samples by bacteria from the skin leads to inaccurate results in up to 30% of samples. Little clinical significance can be attached to these
The NHS Centre for Evidence Based Purchasing reports that using a midstream collection device yields an average saving of £2 per sample, over and above the cost of Peezy. Trials are currently underway in a number
of clinical settings to establish the user acceptability and hygiene benefits of Peezy, as well as the contamination and re-test rate reduction. Peezy has already been bought by Great Yarmouth Practice Based Commission Consortium. The Consortium will be examining feedback on the 3000 units it has purchased. To date information feedback has revealed very high patient satisfaction. In March 2009, Peezy was awarded the ‘Best Industrial Product’ and ‘Best of Show’ awards at the Design Week Awards.
WWW.ERBI.CO.UK 63
S-Tech Insurance Services Ltd 154-156 Victoria Road Cambridge CB4 3DZ ERBI free-phone enquiry number 0800 8406540 Tel: 01223 324233 Fax: 01223 464150 Web: www.S-Tech.co.uk Email: info@s-tech.co.uk
S-Tech recommends and provides solutions: At S-Tech, we have available a complete Insurance service to manage your business and personal insurance requirements. All ERBI member companies and their staff can benefit from the services we offer.
Commercial Insurance:
Financial Services:
n
Specialist policy wordings with cover enhancements are available to the membership
Our independent Financial Advisors can provide companies and individuals with solutions to match their requirements in areas such as:
n
Discounted premium rates
n
Employee Benefits
n
We have a number of insurance facilities available that are specifically designed to accommodate the requirements of the Biotech, Medtech and Life Science industries and Start Up Companies.
n
Pensions
n
Shareholder Protection
n
Investment Advice
Credit Insurance:
Personal Insurance:
Our Credit Insurance team have access to a number of Underwriters who will consider enquiries including:
Our Personal Lines Insurance team provides: n
Bespoke home and contents insurance
n
Whole Turnover
n
Motor Insurance
n
Key Accounts
Supply Chain & Investment
n
S-Tech
About S-Tech: For more than 25 years we have successfully supported the Life Science and related industries by facilitating protection against tangible and intangible risks faced by these dynamic sectors. S-Tech is a large and fully independent Insurance Broker based in Cambridge. Founded in 1982, we now employ more than 60 industry professionals
We aim to provide all customers, irrespective of size, with the highest standard of insurance broking and risk management service. Operating across the UK and in collaboration worldwide, this philosophy is underpinned by; n
Retaining our full independence
n
Honesty and integrity in all our dealings with customers and insurers
n
Employing professional and motivated staff in all areas of our business
n
Going the â&#x20AC;&#x2DC;extra mileâ&#x20AC;&#x2122;
66 ERBI DIRECTORY 2010
and are ranked within the UKâ&#x20AC;&#x2122;s top 30 independent brokers in terms of gross written premium. Our client base is UK wide, many of whom have global operations. Personal customer service is our aim combined with a detailed understanding of your business meaning you can be confident that the solution we provide fits with your needs.
S-Tech n
Evolving business insurance coverage
Getting started
Newly emerging Technology and Research businesses often start with entrepreneurs and innovators in a small way. The initial insurance requirements and the risk protection changes radically as the Company grows. The chosen insurance carrier needs to be flexible and able to react to the various stages of the Companyâ&#x20AC;&#x2122;s development to manage the changes and risks involved.
n Assets
The business may be self funded or reliant upon the support of private investors. At this stage the business should be considering protection of: n Cover for tangible assets, research materials, libraries and
consumables n Research and Development operations n Protection for recreation or reconstruction of research data n Liabilities
WWW.ERBI.CO.UK 67
n
S-Tech
Getting started continued n The statutory requirement of Employers Liability n Public Liability, especially where there are leased or rented
premises n Key Persons
In the event of the death or long term incapacity of entrepreneurs and ‘key’ persons, what will be the future for the business?
Research Data An area not often correctly addressed is the cost of recreating or restoring Research and Development samples and/or data. The value of Research and Development work and the associated Intellectual Property is the core of most Technology and BioTech Companies. Surprisingly few Insurance Companies are able to insure adequately this exposure. It is important to ensure the correct insurer is selected to insure this risk.
Seed/First Round Funding
On to Grown Up
Having achieved initial targets the business may need to seek funding from external sources. With new investors and shareholders on board there may be a need to extend the insurance program with regard to:
With the business entering and hopefully succeeding in its chosen niche, decisions regarding the future and the investors’ final exit route will have to be taken. While this continues there may be a need for more funding to see the business through to trade sale, merger or a listing
Assets and Stock n Insured values will need to be under constant review
Liabilities n Inclusion of Product Liability
Clinical Trials n Errors and Omissions cover for those businesses providing
services, designs and consultancy
The insurance program will need ongoing reviews with the possibility of further cover required including, for example: Debtor Insurance Selling products and technology worldwide is one thing – ensuring payment is another. Insurance cover can be put in place to protect the business against the financial failure of major customers.
Contractual Liabilities
Employees
n Directors and Officers Liability
Provision of bespoke benefits packages including Death In Service, Income Protection and Pension Schemes.
Key Persons Investors will normally insist on insurance being provided to protect their financial investment.
Specialist covers There are a number of insurance contracts that are particularly relevant to Life Science, Pharmaceutical and Research and Development institutions
Clinical Trials Clinical Trials insurance is arranged to provide cover for companies conducting clinical trials and investigations for claims made against them by the trial participants. The cover can extend to include Sponsors, Clinical Research Organisations (CROs) and the Ethics Committee A trial participant has the normal common law right to make a claim of negligence against the trial organisers. Contractually this is normally extended to provide ‘No fault’ compensation.
68 ERBI DIRECTORY 2010
Insurance should be arranged on an ‘All risks’ basis to provide this wider cover. Insurance cover is available through a small number of specialist underwriters who will require detailed information in order to underwrite correctly. The areas underwriters need information about includes: n A copy of the Trial protocol together with the Ethics
Committee approval n Details of the Trial Centre locations n Number of participants n A copy of the patient consent form
S-Tech n
Directors and Officers The increase in successful litigation highlights the need for the personal protection of Directors in their capacity as managers of the business. Common sources of litigation may come from shareholders, employees, customers, suppliers, regulatory and environmental groups and fellow directors. Incidents can arise from many sources. A few areas of legislation or exposure where claims might arise include:-
Investors will often require Directors and Officers insurance to be arranged as a prerequisite of any investment they might make.
Investment Agreement Protection It is not unusual for Directors to be asked to give Personal warranties and indemnities as part of any funding arrangement and adequate protection of their individual interests is very important.
n The Companies Act 2006
Your Insurance Arrangements
n The Health and Safety at Work Act
Specialist Technology and Pharmaceutical Insurers coupled with advice from a specialist Insurance Broker, is essential for a bespoke program. This can be designed to respond, correctly and in full, to claims and ensure the continuity of the business.
n The Disability Discrimination Act n Corporate manslaughter n E.U. directives and regulations
n The Insolvency Act
S-Tech Insurance Services Ltd 154-156 Victoria Road Cambridge CB4 3DZ
n Racial, sexual and age discrimination
ERBI free-phone enquiry number 0800 8406540
n Pollution
Tel: 01223 324233 Fax: 01223 464150 Web: www.S-Tech.co.uk Email: info@s-tech.co.uk
n The Data Protection Act
n Former directors and non-executives n Mergers and Acquisitions
WWW.ERBI.CO.UK 69
n
SUPPLY CHAIN AND INVESTMENT
Getting it right from the start Recent years have seen a remarkable increase in the health sciences sector, which has been reflected by the growth of smaller companies into major players and the emergence of new businesses. The success of the sector, driven as it is by technological development and innovative thinking, is good news for those companies but also presents them with a series of challenges which need to be overcome. A key challenge is keeping up with the developments of new applications and products and the demand which follows their launch onto the open market. The market is thirsty for new products and coming up with significant advancements can make a company. However, many a business knows that success can also bring problems, not least because demand can outstrip supply if a product proves particularly popular.
But all is not lost because there are plenty of highly skilled companies out there who can help clients surmount all these problems. For a start, there are companies who specialise in finding the funding which companies need to make the next step in their development. These companies knew who is investing and what their interests are and what is more, they have good contacts which mean they can get in front of the right people. That may be private investors with an interest in the field or venture capitalists who know a good idea when they see one. Once the deal has been signed, and the investment is in place, companies can do much more to ensure that their supply chain is robust.
Suddenly, a company can found itself inundated with orders but struggling to meet them without further significant investment in equipment and personnel.
There are plenty of companies who can, who understand how to advise on subjects as diverse as workplace reorganisation, dealing with suppliers abroad and how to meet logistical challenges when it comes to delivering products to the end user.
Attracting that investment is doubly important because breaks in the supply chain can have serious ramifications for a company, particularly an emerging one which is still establishing itself.
Once such companies are involved in the process, their clients will feel much happier, secure in the knowledge that help is at hand and that their supply chains remains secure.
A company which makes the breakthrough with a much-soughtafter product can find itself in deep trouble if the supply chain breaks down and it simply cannot deliver on its promises. The danger is that clients will go other more reliable competitors.
And that is important: it is an old business adage but a true one that if a company is well organised that side of things will run themselves leaving managers free to come up with new ideas. And new ideas are what is driving the industry forwards.
70 ERBI DIRECTORY 2010
SUPPLY CHAIN AND INVESTMENT n
WWW.ERBI.CO.UK 71
$EDICATED¬TO¬LIFE¬SCIENCES¬AND¬HEALTHCARE )NVESTING¬IN¬VENTURE ¬GROWTH¬EQUITY¬¬ AND¬PUBLIC¬COMPANIES /VER¬ ¬BILLION¬UNDER¬MANAGEMENT ,ONDON ¬3AN¬&RANCISCO¬AND¬"OSTON¬OFlCES 3PECIALIST¬TEAM¬OF¬OVER¬ ¬PROFESSIONALS
London Associates Industrial Design Consultancy and ERBI member
www.la-design.co.uk For a discussion or full presentation on London Associatesâ&#x20AC;&#x2122; product development capability, telephone Les Stokes on 01442 862631 or e-mail les@la-design.co.uk
LA client: ELGA www.purelabflex.com
&VMHKI 4EVXRIVW TVSZMHI TVSJIWWMSREP VIPMEFPI ERH GSWX IJJIGXMZI -8 WIVZMGIW ¯ IREFPMRK ]SY XS GSRGIRXVEXI SR KVS[MRK ]SYV FYWMRIWW
±1ER] XLEROW XS &VMHKI 4EVXRIVW JSV ]SYV ¾I\MFMPMX] ERH WXIVPMRK IJJSVXW - ZIV] QYGL ETTVIGMEXI MX² (EZMH *PERHIVW 1( 9/ 7XIQ 'IPP 7GMIRGIW &EFVELEQ
Â&#x2C6; -'8 7YTTSVX WIVZMGIW 8EOMRK GEVI SJ ]SYV IZIV]HE] WYTTSVX VIUYMVIQIRXW Â&#x2C6; + LSWXMRK WIVZMGIW ,SWXIH IQEMP WIVZIV [IFWMXI ETTPMGEXMSRW ERH TLSRIW Â&#x2C6; +MKEWXVIEQ MRXIVRIX 7TIGMEPMWX TVSZMHIV XS FYWMRIWW TEVOW ERH QYPXM XIRERXIH SJ½GIW Â&#x2C6; (MWEWXIV VIGSZIV] -J ]SYV W]WXIQW JEMPIH XSHE] [SYPH MX FI GLESW SV FYWMRIWW EW YWYEP# 7X .SLR´W -RRSZEXMSR 'IRXVI 'S[PI] 6SEH 'EQFVMHKI '& ;7 X I MRJS$FVMHKITEVXRIVW GS YO [[[ FVMHKITEVXRIVW GS YO
WWW.ERBI.CO.UK 73
The Document and Data Storage Company
Your Information is Our Business! Safebox Document Storage n n n n n n n n n n n
Purpose built, modern warehouse facility. Fire rated cladding to all external walls. Digital recorded CCTV across entire site. Access control systems to all entrances. Secure, unbranded site. State of the art barcode software offers complete traceability of files and boxes. Dehumidifiers in all storage areas. Fire detection to BS5839. Daily Deliveries across the region. Urgent deliveries within 2 hours of receipt of request. Fire-safe storage and dedicated 2 hour fire rated Deed Store.
Safebox Data Storage n Purpose built, 2 hour fire rated data vaulting and fire-safes. n Disaster Recovery delivery within 2 hours of receipt of request. n Virtually indestructible data storage and data transit cases. n Deliveries and collections to suit your rotation schedule. n Password protected request verification. n Store back up tapes, external hard drives, CDs, DVDs, original software..
As an ERBI member you can benefit from our special ERBI prices. Contact us to discuss your requirements in full.
Tel: 01223 29 11 33
(Option 2)
Fax: 01223 29 11 77 Email: sales@TheSafebox.co.uk Web: www.TheSafebox.co.uk
Legal
n
REDDIE & GROSE
Patents in a recession Dr Neil Thornton from Reddie & Grose explains the importance of good communication with your patent attorney during a recession. Venture capitalists have been investing smaller sums in very earlystage companies and traditional sums in fewer and much laterstage companies. When they do invest, VCs are increasingly interested in patent quality as they seek to reduce the risk in their investment by ensuring that patent protection is effective. Consequently, some of the region’s biotech companies are under increasing pressure to make existing funds go further, without compromising patent quality. Patent costs can be significant for any company, and are sometimes the next biggest cost after personnel. It is ever more important, therefore, that patent budgets are spent wisely. Patents are territorially limited (a US patent provides protection only in the US), and worldwide patent protection is usually prohibitively expensive, so decisions must be made regarding which territories to choose. For example, patent coverage may extend to those territories with significant projected product sales, or where competitors may wish to operate. However, the foreign filing strategies used by some companies can be somewhat arbitrary, often employing a series of country lists, with the appropriate list selected on the basis of the importance assigned to each product. A more systematic and logical approach is desirable since the decisions made can involve high costs and have a major impact on the sales or royalties of an eventually-successful product. In most territories, renewal fees are payable to maintain a patent in force. Renewal costs can be significant and usually increase with the age of the patent, so patent families should be reviewed regularly to see whether sensible cost savings can be made. It should also be borne in mind that patents are easier to enforce in some territories than others. If a patent holder is not prepared, or able, to enforce a patent in a particular territory, it may not be worth having patent protection there at all.
Good communication with your patent attorney is essential. Patenting procedures differ from territory to territory, and there are often steps that can be taken to avoid or defer costs. This can only be achieved effectively if the patent attorney fully understands the company’s commercial strategy, so that they can advise on the options available. At a time of increased redundancies, it is especially important for companies to ensure that suitable contracts are in place with employee inventors requiring them to sign patent-related documents whenever required. Inventor signatures are necessary in some territories, and it can be costly to obtain these after an inventor has left a company, particularly if they don’t feel they owe the company loyalty. A general power of attorney empowering the company to execute documents on an inventor’s behalf may be desirable. It is also important to have procedures in place to make sure that employee inventions are identified and captured in a timely manner. If an inventor leaves and then files a patent application individually, it can be expensive to try to prove that the company rightly owns the invention. In times of financial difficulty, the temptation may be to reduce communication with the patent attorney for fear of incurring additional cost. However, it is precisely at these times that good communication is most important so that effective, high quality patent protection can be obtained and unnecessary expense avoided.
Talk to us: Dr Neil Thornton, Dr Michael Roberts, Helen Wakerly and Dr Philip Bates r&g@reddie.co.uk
www.reddie.co.uk
PATENTS | TRADE MARKS | DESIGNS | PLANT VARIETIES
76 ERBI DIRECTORY 2010
INNOVATION Intellectual property law can be complex. We apply direction, clarity of thinking and commercial understanding to your IP requirements, ensuring your creativity and innovation is protected in Europe and around the globe. We are committed to designing cost-effective IP strategies that will give your business a competitive edge. Youâ&#x20AC;&#x2122;ll find us pragmatic, thorough and cooperative. Talk to us 5 Shaftesbury Road Cambridge CB2 8BW Tel: +44 (0)1223 360350 Fax: +44 (0)1223 362080 r&g@reddie.co.uk www.reddie.co.uk
16 Theobalds Road London WC1X 8PL Tel: +44 (0)20 7242 0901 Fax: +44 (0)20 7242 3290 PATENTS | TRADE MARKS | DESIGNS | PLANT VARIETIES
n
LEGAL
Keeping on the right side of the law The law, it is said, is a minefield, which is why seeking expert legal advice is crucial in so many situations. Those people who have tried to save money by dispensing with the services of a solicitor have often found themselves deep in trouble because they ignored that basic mantra. The reason lawyers are so important lies in the complexity of law, a complexity that is constantly changing. Take business law: everything from health and safety rules to production legislation can present challenges and a single mistake can lead to a potentially costly breach. The result could be a fine, a court appearance or a large compensation payout. There is also a myriad of law surrounding competition: when is a claim unfair, is a product over-hyped, are the statements made about it correct, is an unfair advantage being taken over a competitor? Or by a competitor? But within the medical sciences field, there is another reason why the law is so important. In a sector where innovation is constantly bringing forward new ideas, companies need to be aware of the legislation governing Intellectual Property (IP) and Patents. IP is crucial because many companies within the industry come up with ideas which are developments of existing science and technology and defining how to protect them is crucial. That is why understanding IP and knowing how best to register new ideas is important for companies. More than one company has lost out on millions in profits because they were too slow to register their idea as unique.
78 ERBI DIRECTORY 2010
Patent law is important as well because, once an idea is recognised as unique and owned by one particular individual or company, then it is protected. By registering a product or idea, there is a paper trail which can be used should it turn up elsewhere. Each and every one of these areas presents great challenges for companies and may require expert legal guidance and so it is always worth seeking out those companies that specialise in the field in question. Some lawyers specialise in workplace legislation, for instance, others are experts in IP and Patents, others can advise on health and safety and the law relating to contractors. Each area holds within it the potential to cause a business major problems but by hiring in experts the chances of anything going amiss is greatly reduced. The basic, overriding message is never mess with the law. Never assume that you know better than the experts, never gamble on the â&#x20AC;&#x2DC;barrack room lawyerâ&#x20AC;&#x2122; who reckons they are right and never leave something till tomorrow that you need to know today. Ignoring the advice can be as costly as it comes, seeking and taking advantage of it leads to peace of mind and a company that is much more secure.
LEGAL n
WWW.ERBI.CO.UK 79
Life Sciences: some of the finest minds,
ideas, research, funding and
foreign
investment
are
in
Cambridge
, making it an exciting and dynamic
place to do business.
Taylor Vinters
is at the heart of the action, working closely in this
ever-changing environment, on every legal issue affecting the sector. We are proud sponsors of ERBI HR Special Interest Group. We work closely with ERBI members to deliver HR training designed to help life science and healthcare companies with HR issues. For information on HR issues contact: Eleanor Freeman, Partner on 01223 225252 or Eleanor.freeman@taylorvinters.com On all other Life Sciences legal issues contact: Patrick Farrant, Partner & Head of Technology sector on 01223 225 122 or Patrick.farrant@taylorvinters.com
Business | Individual | Not for Profit
LAWYERS WHO THINK LIKE YOU www.taylorvinters.com
Service Providers
n
TUKAN PARTNERS
Innovative biotech business models â&#x20AC;&#x201C; the route to commercial success Financially speaking, the biotechnology industry performed surprisingly well in 2008 (Beyond borders: Global biotechnology report 2009, Ernst & Young), set against a backdrop of global financial uncertainty. Despite this, the recognised cause for concern, very evident during the past five years, has been the prolonged shortage of follow-on funding for companies at the smaller end of the pharmaceutical industry food-chain. Running as it does, in parallel to the recognised shortfall of new drugs, let alone blockbusters, flowing onto the pharmaceutical market, has in turn forced biotech companies and allowed pharma companies to re-evaluate their previously tried and tested business models. As a direct consequence of the aforementioned drought in both finance and molecules, the market has seen a dramatic rise in the number of preclinical deals and risk-evading, option arrangements, in addition to the well documented and numerous M&A events. Smaller companies have on occasion taken the opportunity to reverse into seemingly larger organisations and
82 ERBI DIRECTORY 2010
there has been a significant increase in the applications for early stage grant funding with a heavy reliance on protracted seed financing rounds for those just starting out. For the companies who have managed to successfully develop later stage assets, these remain a key favourite and continue to capture the imagination and focus of prospective pharma partners. Though even here competition has remained high, at least amongst the diminishing number of major players, not already engaged in restructuring, post-merger or otherwise. It is evident that business models have been forced to adapt to the new conditions which now strongly govern the fundamentals and timetables of how new companies are established. Managing this process effectively and, perhaps more significantly, being able to spot, the often creative, commercial routes that suitably match our valuable and innovative technologies and pipelines, is rapidly becoming the key factor for commercial success in the biotech sector. Nigel Crockett, PhD, Tukan Partners Ltd
www.cambio.co.uk Our whole Chromosome paints are available in concentrated form for performing multiple staining experiments. This prevents the possible reduction of signal encountered when multiple paints are applied to the same slide. These probes are supplied with separate hybridisation buffer to allow optimisation of each experiment. Human Chr 1 FITC Label
Distributors in UK & Ireland for:
and many more...
From research to bulk quantities Obtain your research products from us and you don’t have to change suppliers when you require large quantities for manufacturing or scale up!
Global reach and in-depth knowledge of IP for all industries Intellectual Property: Release its potentiall
For further information please contact: Jason Lumber on +44(0) 113 233 0100 or email jlumber@hgf.com
hgf.com
Europa bioproducts is a European distributor of speciality biochemicals, immunologicals and reagents used by diagnostic companies and in R & D/ HTS/QA by biopharmaceutical companies. Our main business is to supply these products in bulk but we very pleased to supply researchers with the same quality products. We deliver to research organisations free of charge. The minimum quantity is listed on our web site, and all products are available in semi bulk to bulk quantities. We are very receptive to customer’s special requirements so please contact us for a discussion. Our product areas are: ■ ProZyme’s, GLYKO, tools for glycan profiling and sequencing ■ Fluorescently labeled proteins and antibodies for Flow cytometry, Luminex, Multiplexing and FRET applications. ■ Bovine serum albumins, animal sera and immunoglobulin’s for manufacturing ELISA reagents ■ Natural and recombinant proteins ■ Antibodies for research and diagnostics ■ Protein and Antibody purification products We are certified ISO9001:2008 and are a DEFRA audited facility for handling animal by product intermediates under the 1774/2002 regulations. If you are experiencing difficulties importing products derived from animals then please contact us. We may be able to import on your behalf.
For more information, please visit: http://www.europa-bioproducts.com
Or call us on Tel: +44 (0)1353 721118 ENGLISH AND GERMAN, MONDAY - FRIDAY 9AM - 5PM
Europa Bioproducts Ltd, 15-17 North Street, Wicken, Ely, Cambridgeshire CB7 5XW
WWW.ERBI.CO.UK 83
I Ion Channel Discovery Services www.essen-instruments.com
As the inventors of FLIPRTM, IonWorksTM & IncuCyteTM we like to think you will recognise our innovation in cellbased assay solutions. But did you know that Essen is also a successful and growing Discovery Services provider? OUR APPROACH A problem solving mindset. Flexible & customer focussed, with emphasis on high quality, translational science. Competitively priced, fast turnaround. Customised contracts & collaborative agreements OUR SPECIALITY Contract services for ion channels. Custom reagent and assay development. Electrophysiology profiling & screening - SAR, focussed set & MoA screening. ‘Panel’ assays including hERG, hNaV1.5, hCaV1.2 OUR TEAM Highly experienced management team with strong track record of innovation & ion channel drug discovery. Kirk Schroeder, Brad Neagle, Vince Groppi, Del Trezise, Dave Rock, Tim Dale
A unique meld of ion channel drug discovery know-how and cutting edge technology Essen European Discovery Services, Biopark, Broadwater Road, Welwyn Garden City Hertfordshire UK, AL7 3AX T: +44 1707 358688 F: +44 1707 358686 Mailbox: ics@essen-instruments.com
“Connect Medical Resources was established in 1995 and has since become one of the leading suppliers of sales marketing and technical staff to medical technology companies. Managing Director Robert MacPherson, has more than 30 years experience of the medical device industry and has served on the board of several companies. Areas of particular interest are cardiovascular technologies and life sciences.
Connect Medical Resources Ltd 13 William Close Banbury Oxon OX16 0UE
Start up companies are another area of expertise and our experience includes the raising of investment and working with management teams prior to and during stock market flotation. Our activity covers all areas of the UK and Europe and we have strong connections to a vast network of experts and candidates in every area of medical technology.”
Tel: 01295 272996 Fax: 01295 254146 Email: robert@connectmed.demon.co.uk www.connectbio.co.uk
84 ERBI DIRECTORY 2010
Melbourn Scientific provides high quality analytical and formulation services to the lifescience industry n n n n n n
Analytical R&D Method development and validation Pre-formulation services Formulation development Testing for drug delivery technology Stability programmes
Melbourn Scientific Ltd Saxon Way Melbourn Royston SG8 6DN T +44 (0) 1763 261648 F +44 (0) 1763 261791 Info@melbournscientific.com www.melbournscientific.com
New for 2010! Rapid Prototype Manufacturing Service Briton EMS Ltd has been established since 1979 and has a turnover of £8M with 90 staff. We offer a complete electronic product build facility and manufacture a diverse range of products for instrumentation, medical, broadcast and transport applications. At Briton we are always striving for continuous improvement. As part of our plan to enhance our extensive electronic manufacturing facility we are now proud to announce the launch of our new Rapid Prototype Service (RPS). We have always had a strong prototype production capability but we have now created a package that our new and existing customers will identify with more readily. Aimed particularly at design engineers and project managers, we are confident that RPS will benefit your company from day 1. We have a proven track record of assisting our customers to get from development into production. Our skilled team of Engineers and Production staff work with our customers and their third party designers to achieve a manufacturable and profitable product. Our business aim is to provide a quality service and maintain strong business partnerships with our customers.
EXCELLENCE I N E L E C T RO N I C M A N U FA C T U R I N G S E RV I C E S
We provide • SMT & Through Hole PCB Assembly • Complete Product Build
• Low/Medium Volume Manufacturing • BGA/µBGA Placement & Inspection • Test Solutions/JTAG/AOI • Global Procurement • Lead Free Services
• Engineering and Design Support To meet your
Quality, Flexibility & Delivery targets
Call our sales department today
01234 266300 www.britonems.co.uk
KM85790
Briton EMS Ltd 4 Shuttleworth Rd Elms Industrial Estate Bedford • MK41 0EP
[e]: sales@britonems.co.uk
WWW.ERBI.CO.UK 85
n
PHARMIDEX
Fast forwarding drug discovery Pharmidex provides high quality, specialist CNS, ADME/PK, drug safety & bioanalytical services for lead optimisation through to drug development allowing our clients to quickly and costeffectively identify and progress their new medicines. We have years of drug discovery expertise to help you fast forward your drug discovery programmes Since 2002, Pharmidex has established itself as the world leading centre for studying CNS drug distribution and biochemical responses to new drugs using its proprietary NeuroPK® and NeuroPD® technologies. Using these technologies drug action can be associated with free drug levels at the target site and systemic pharmacokinetic data. Clients can therefore progress their compounds based-on high quality, translational scientific data which can be much more closely linked to clinical outcomes and likely clinical success. We focus on the key data, decision-points and milestones that allow our clients to make the best decisions possible for their programmes and portfolio. PHARMIDEX PRIDES ITSELF ON: n n n n n
Customer care and satisfaction Flexible and broad range of study options High quality data Fast turnaround times Value for money
Today Pharmidex provides an extensive range of in vitro, in situ and in vivo ADMET/PK technologies covering a wide range of species, to underpin its world leading CNS expertise. Clients can select from the extensive platform technologies or request bespoke studies to address specific needs, all of which are rapidly undertaken by highly qualified scientists from academic and industry backgrounds. The Scientists and Management Team at Pharmidex have extensive knowledge of discovery and development of new drugs, covering a broad range of drug targets. Pharmidex has its own research activities which include providing clients with a drug delivery technology to the brain called Cerense; this technology can improve the brain uptake of both large (macromolecules) and small, new or existing drugs offering better efficacy, less side-effects or just delivering therapies that could never access the brain. Pharmidex has a very successful track record in obtaining financial support for our scientific development via grant applications in the US, UK and EU and by partnering on a ‘shared risk-shared reward’ basis with other companies. This proven approach has led to the co-development of the CNS delivery system, Cerense with Genzyme Pharmaceuticals. Tel: +44(0)870 240 5978 Email: business@pharmidex.com www.pharmidex.com
Pharmidex service offerings are not limited to the below:
IN VITRO SCREENS
IN VIVO ADME / PK
CNS
SAFETY
BIOANALYSIS
CYP450 inhibition, induction, TDI, phenotyping
Freely moving cannulated or terminal PK in range of species
Microdialysis - free drug & neurochemicals in various brain regions) in freelymoving species
Acute or chronic dose ranging / escalation studies
LCMSMS Platform for drug discovery support
Permeability/ Pgp interactions (MDCK/ CaCo2)
Cannulated (combined) portal, biliary vascular studies
Brain uptake index and In situ brain perfusion
Pathology / toxicology studies
Small and large molecule quantitation
Metabolic clearance (microsomes /heps /S9)
In-situ organ perfusion studies
Serial CSF and plasma sampling and “Brain free fraction” assay
Clinical biochemistry, histology and IHC
Radiolabelled studies
Protein & tissue binding (free and bound)
Pulmonary absorption studies
CNS safety / efficacy studies In conscious rodents
Toxicokinetics and PKPD
Bioassay method dev. and validation
Biofluid stability / blood distribution
Tissue distribution / uptake studies
CerenseSM - Improved delivery of small and macro molecules to the brain
CV safety in rodent species
Neurochemicals by EC
86 ERBI DIRECTORY 2010
Â&#x2030;Â&#x2030;Ă Â&#x152;Â?tbÂ&#x152; O ÂźĂ&#x160; 8Â&#x152;Y 8Â&#x152;Ă n8OŸà ¹8F Â&#x2020; ÂźĂ&#x160; * ´Â&#x2026; Ă&#x153;´´b´´Â&#x2030;bÂ&#x152;Âź
Â?Â&#x152;Ă?8Ž´ Ă&#x153;YĂ&#x2021;8Â&#x152;ObY (ÂąÂ?Âźb Â&#x152; ,bO|Â&#x152;Â?Â&#x2020;Â?t b´ Â&#x17E;Ă&#x153;(,Â&#x; FÂą Â&#x152;t ÂŚĂ 8Â&#x2020; ÂźĂ&#x160;~FĂ&#x160;~Yb´ tÂ&#x152; Â&#x2030;bÂź|Â?YÂ?Â&#x2020;Â?t b´ ÂźÂ? Âź|b YbĂ&#x2021;bÂ&#x2020;Â?Â&#x153;Â&#x2030;bÂ&#x152;Âź Â?n F Â?Â&#x153;|8ÂąÂ&#x2030;8ObĂ Âź O8Â&#x2020;´ ÂźÂ? Â&#x153;ÂąÂ?~ YĂ Ob FbŸŸbÂą 8Â&#x152;Y ´8nbÂą Â&#x2030;Â?Â&#x2020;bOĂ Â&#x2020;b´¥ ,|b Â&#x153; F8´bÂż ÂźbO|Â&#x152;Â?Â&#x2020;Â?tĂ&#x160; nÂąÂ?Â&#x2030; Âź|b ÂąbObÂ&#x152;ÂźÂ&#x2020;Ă&#x160; 8ÂŚĂ ÂąbY OÂ?Â&#x2030;Â&#x153;8Â&#x152;Ă&#x160; Ă&#x153;Â&#x2020;tÂ?Â&#x152;Â?Â&#x2030; O´ ÂźÂ?tbÂź|bÂą Ă&#x2C6; Âź| Â?Â&#x152;Ă?8Ž´ Ă&#x153;ttÂąb~ +Â?Â&#x2020;Ă&#x2021;bÂż Â&#x153;Â&#x2020;8ÂźnÂ?ÂąÂ&#x2030; Â&#x152;ÂźbtÂą8Âźb Ă Â&#x152; ÂŚĂ b Â&#x2030;Â&#x2030;Ă Â&#x152;Â?tbÂ&#x152; O ÂźĂ&#x160; 8Â&#x152;Y ´Ÿ8F Â&#x2020; ÂźĂ&#x160; Âą ´Â&#x2026; 8´´b´´Â&#x2030;bÂ&#x152;Âź 8Â&#x152;Y Âąb~bÂ&#x152;t Â&#x152;bbÂą Â&#x152;t O8Â&#x153;8F Â&#x2020; Âź b´ nÂ?Âą Âź|b YbĂ&#x2021;bÂ&#x2020;Â?Â&#x153;Â&#x2030;bÂ&#x152;Âź Â?n FbŸŸbÂą 8Â&#x152;Y ´8nbÂą F Â?Âź|bÂą8Â&#x153;bĂ Âź O´¥ Ă&#x153;(, Â?nnb¹´ OÂ?Â&#x2030;Â&#x153;Âąb|bÂ&#x152;´ Ă&#x2021;b ´bÂąĂ&#x2021; Ob´ Â?Â&#x152;U j Â&#x152; ´ Â&#x2020; OÂ? ,~ObÂ&#x2020;Â&#x2020; Â&#x153; ÂźÂ?Â&#x153;b ? Â&#x2030;Â&#x2030;Ă Â&#x152;Â?tbÂ&#x152; O ÂźĂ&#x160; (ÂąbY OÂź Â?Â&#x152; j Â&#x152; ´ Â&#x2020; OÂ? (ÂąÂ?Âźb Â&#x152; Ă&#x153;ttÂąbt8Âź Â?Â&#x152; ? +Âź8F Â&#x2020; ÂźĂ&#x160; (ÂąbY OÂź Â?Â&#x152; j Â&#x152; ´ Â&#x2020; OÂ? +bÂŚĂ bÂ&#x152;Ob Ă&#x153;Â&#x152;8Â&#x2020;Ă&#x160;´ ´ ? +Ÿ¹à OŸà ¹8Â&#x2020; Â?YbÂ&#x2020;Â&#x2020; Â&#x152;t j (ÂąÂ?Âźb Â&#x152; Â&#x152;t Â&#x152;bbÂą Â&#x152;t ? +Âź8F Â&#x2020; Ă?8Âź Â?Â&#x152;
j Ă&#x153;Â&#x152;Âź FÂ?YĂ&#x160; Ă Â&#x2030;8Â&#x152; ´8Âź Â?Â&#x152; Â?Â&#x153;Âź Â&#x2030; ´bY nÂ?Âą Â&#x2030;8Â&#x152;Ă n8OŸà ¹8F Â&#x2020; ÂźĂ&#x160; j Â&#x152; Ă&#x2021; Ÿ¹Â? Â&#x2030;Â&#x2030;Ă Â&#x152;Â?Â&#x153;ÂąÂ?oÂ&#x2020; Â&#x152;t 8Â&#x152;Y Â&#x2030;Â&#x2030;Ă Â&#x152;Â?tbÂ&#x152; O ÂźĂ&#x160; 8´´b´´Â&#x2030;bÂ&#x152;Âź j Â&#x152; Ă&#x2021; Ÿ¹Â? (ÂąÂ?Âźb Â&#x152; b´ tÂ&#x152; 28Â&#x2020; Y8Âź Â?Â&#x152; Â&#x17E;Â&#x153;ÂąÂ?YĂ OÂź Ă&#x2021; ÂźĂ&#x160;V 8OÂź Ă&#x2021; ÂźĂ&#x160; 8Â&#x152;Y ´Ÿ8F Â&#x2020; ÂźĂ&#x160;Â&#x; j +Âź8F Â&#x2020; ÂźĂ&#x160; ? Ă&#x153;ttÂąbt8Âź Â?Â&#x152; Ă&#x153;´´8Ă&#x160; bĂ&#x2021;bÂ&#x2020;Â?Â&#x153;Â&#x2030;bÂ&#x152;Âź
Ă&#x153;ttÂąb+Â?Â&#x2020;Ă&#x2021;bDÂ&#x2020;Â?Â&#x152;Ă?8ÂĄOÂ?Â&#x2030; ,bÂ&#x2020;U ¤ss Â&#x17E;Ă&#x17D;Â&#x;Â&#x2014;Ă&#x20AC;Ă&#x20AC;½ sÂ?ppĂ&#x17D;Ă&#x17D;
B B8.63$ LQGG
Do you need help to access NHS expertise? Health Enterprise East (HEE), the regionâ&#x20AC;&#x2122;s NHS Innovation Hub, is committed to supporting closer working relationships between industry and the NHS, helping them access clinical expertise in the development of new products.
HEE can:
Ę&#x201E; Ę&#x201E; Ę&#x201E; Ę&#x201E;
Provide a single point of contact for MedTech healthcare companies Help companies access NHS clinical, scientific and technical expertise to ensure relevant products and processes are developed as quickly as possible Facilitate initial product evaluations in a clinical setting, bench-testing and clinical studies within the NHS Help identify and enable communication with key opinion leaders and early adopters of innovations in the eastern region Further details from Dr Juan F RomĂĄn, Medtech Services Manager, Health Enterprise East 01480 364925
www.hee.org.uk
WWW.ERBI.CO.UK 87
The comparison site for biotech
search
compare
One search for all suppliers over 2,500,000 products online Compare product features, as well as price Place orders in seconds and save!
Working in partnership with ERBI, Science Warehouse has developed a dedicated online purchasing solution for members. It delivers fast and easy ordering with full procurement control.
â&#x20AC;&#x153;It makes ordering easy for scientists but also provides the financial controls that are critical for companies in the biotech sectorâ&#x20AC;?
Find out more today, contact: Jonathan Betts Telephone: +44 (0)113 384 4200 Email: jonathan.betts@sci-ware.com
Richard Dickinson, Operations Director, ERBI
www.sci-ware.com
Unlocking the full potential of open-source Open-source bioinformatics software gives you unparalleled access to the very latest algorithms, data and techniques to use in your R&D. However, it can be hard to obtain timely technical support when things don’t go quite to plan. This can cost you time and money from lost productivity. Eagle Genomics provides that support. We guarantee our response times under a Service Level Agreement and provide you with prompt fixes and customisations.
We’re also experts at packaging opensource bioinformatics into data analysis pipelines and appliances. We can build bespoke solutions that fit your exact requirements and run them anywhere from desktops to grids, clusters to clouds. You get the support and solutions you need exactly when you need them. Your own developers get to spend more time working on your valuable internal projects. It’s a win-win situation.
¶It’s a pleasure to deal with someone you can rely on for impartial decoding of a complex subject.· Martin Lawrie Cytocell
Enabling Bioinformatics from Research to Reality
Support
Appliances
info@eaglegenomics.com
+44 (0)1223 654481
Pipelines www.eaglegenomics.com
Clinical Trial Supply Services YOUR SAMPLES IN SAFE HAND From Phase I - IV clinical studies through to commercial supply, our core services include: n Storage from +4 to -180 n Global cold chain logistics n Sample collection, storage and shipment to site n Project Management and QP Services n Clinical packaging, label design and printing n Patient kit assembly n Return of supplies, reconciliation, storage and disposal n Comparator sourcing
Fisher BioServices is a professional contract services business with an earned reputation for responsiveness to client needs and technical excellence. We are experts in logistics and repository services, and we understand the special needs involved in clinical studies and in the research and development process. Our global capabilities include: transportation, inventory, biorepository services, biological lab support services, specimen collection kit assembly, pharmacy, and specimen processing.
Fisher BioServices UK Woodside, Bishops Stortford, Herts CM23 5RG
T: +44 (0) 1279 713320 F: +44 (0) 1279 713329
WWW.ERBI.CO.UK 89
n
O2h
Providing world class discovery services to clients at the forefront of drug discovery…
Oxygen Healthcare Ltd. 23, Cambridge Science Park Cambridge CB4 0EY
T: 01223 437014 F: 01223 437013 www.o2h.com
Discovery delivered COMPANY PROFILE
NEW BIOLOGY SERVICES
O2h is a 5+ year old discovery services company and is colocated in Cambridge, UK, and Ahmedabad, India. O2h provides a range of discovery services – Medicinal Chemistry, Multi-FTE Synthetic Chemistry, Custom Synthesis, Computational Chemistry and In vitro biology to its international clients based in UK, USA, Japan and Europe.
The core strengths of O2h – Medicinal chemistry and Multi-FTE synthetic chemistry were supplemented with the introduction of In vitro Biology services in 2009. O2h Biology services are aimed at providing comprehensive discovery services and reducing discovery cycle times for our clients. Our repertoire of in-house assays is also supported by affiliate partners with expertise in CNS and Oncology based assays. More information about biology services can be obtained at www.o2h.com/InvitroADME.asp.
O2h SERVICE MODEL O2h has designed its discovery services model with speed and real-time communications at its core. Our project management includes detailed metrics and milestone charts provided on a weekly basis to transparently monitor areas for continuous improvement. We also constantly monitor our starting material procurement performance to ensure a fast-start for all discovery projects. Discovery services at O2h are supported by its fullyequipped analytical suite containing 400 MHz NMR, LC-MS, LCMS/MS, HPLCs, combiflashes and microwaves. O2h PEOPLE O2h is a people-centric business and has a unique template for recruitment, training and skill-enhancement of its employees. This has resulted in the company growing from 3 employees to over 100 today, with employee retention rates averaging 98% over the last 5 years.
90 ERBI DIRECTORY 2010
NEW RESEARCH CAMPUS O2h has expanded to its new, “Shirish Research Campus”. This 10,000 sq.mt. campus will offer our clients 28 fully-customizable lab units. It incorporates the latest in both proven and experimental environmental thinking applicable to discovery research activity for extreme Indian climatic conditions. CONFIGURABLE LAB UNITS The highlight of the Shirish research campus are highly spacious 12 fume-hood reconfigurable lab units designed to be selfsufficient IP-secure areas with a dedicated write-up area. This new building has been designed in a modular fashion to ensure a high level of security for each of the lab units whilst benefitting from integrated engineering, services and support. These lab units have exclusive card-key access only and can be personalized according to client specifications.
Harten Group Delivers Benefits for Biotechs Increasing cost pressures brought on by the current economic climate and contracting VC funding means that it’s more important than ever for biotechs and small pharma companies to use resources more efficiently and look for cost-effective ways to realise objectives. Harten Group can help by: Providing specialist expertise By tapping into our network of highly skilled consultants, you can establish a ‘virtual company’ with minimal central resource. These bought-in experts could perform almost any role within the organisation, from CEO to Research Scientist to Medical Adviser to Business Development Director.
Controlling your overheads Using Harten Group’s consultancy services means you have tight control of overheads and you only pay for what you use. This expertise can be used to meet fixed project deadlines, to cover essential knowledge gaps quickly and cost-effectively or to bring strategic direction
to a new business without the financial commitment of a permanent employee.
Giving you international reach Medical research is truly international, conducted in research institutes, hospitals and biotech companies worldwide. By tapping into Harten Group’s ‘knowledge portal’, small or start-up businesses are realising the potential of working with international organisations through leveraging our consultants’ contacts within these institutions.
Delivering cost-effective access to experts Feedback from Key Opinion Leaders (KOL) can be obtained remotely by tapping into Harten Group’s knowledge and contacts, saving time
and money in terms of researching and seeking out the right KOL to comment on a specialist area.
Strengthening your pitch to investors Proving expertise to ‘virtually’ augment the team, for example using consultants who have previously been involved in raising money for start-ups and can help you to build a strong case to present to investors when looking for VC funding.
Harten Group is a leading established provider of consultancy and interim services to biotech and pharma industries www.hartengroup.co.uk
Tel: +44 1223 233777
WWW.ERBI.CO.UK 91
selected ad
8/1/10
11:06
Page 1
Great minds think alike. Theyâ&#x20AC;&#x2122;ve met here for 40 years. With its international reputation, prime location and university connections, itâ&#x20AC;&#x2122;s no surprise that Cambridge Science Park is the first choice for ground-breaking high-tech and bio-tech companies, from new start-ups to major corporations. All enquiries: Michelle Cantwell 01223 559565 michelle.cantwell@bidwells.co.uk www.cambridgesciencepark.co.uk
Founded in 1970 by TRINITY COLLEGE CAMBRIDGE
Managed by Bidwells 01223 841 841
novus environmental bespoke waste management solutions novus environmental is a specialist waste management company providing high quality, value-for-money solutions for the collection and disposal of challenging wastes including: clinical waste
pharmaceutical waste
medicines
sharps
animal by-products
confidential waste
novus environmental is fully licensed and has the technical and logistical ability to provide a dedicated, responsive and reliable service. Whether you are a based in the private or public sector, please contact us, we are here and happy to discuss the best method for managing your requirements. Phone us on 0844
770 0012 or visit our website www.novus-environmental.co.uk
Vetspeed - Novus Environmental Half Page Advert for ERBI Directory.indd 1
92 ERBI DIRECTORY 2010
novus environmental Part of the Vetspeed family
23/12/2009 09:04:13
InhalationTechnology
Bringing new technology to life Technology Research Innovation Product Development Design for Manufacture
42 Technology Ltd
The Product Development Company
Meadow Lane, St Ives | Cambridgeshire PE27 4LG | tel +44 (0)1480 302700 |www.42technology.com
Pipette Calibration & Servicing WE SERVICE ALL BRANDS, ALL MODELS & ALL TYPES OF PIPETTE: • Three Standard Service Levels • Custom Servicing
re
lie r
BI
ER
p
• Loan Pipettes Available
SERVIC
pp
• On-Site Servicing
E
G IN
• Mail-In Service with Free Postage
PIPETT
• UKAS Accredited Servicing
f e rr e d s u
For further information please contact STARLAB on 01908 283800, or call to arrange a meeting with your Account Manager, where you can discuss your calibration requirements at your convenience
www.pipettes.co.uk STARLAB (UK) Ltd, 4 Tanners Drive, Blakelands, Milton Keynes, MK14 5NA Tel: 01908 283800 Fax: 01908 283802 caltech@starlab.co.uk www.starlab.co.uk
clear practical advice
When managing risk and making complex business decisions you need a law firm that understands your point of view. At Watson Burton we take the time to understand your business objectives and work in partnership to help you achieve long-term success. To discuss your business needs call our legal experts
0191 244 4444 www.watsonburton.com
Synapse Clinical Research Services was founded by Dympna Starling in 2007, offering flexible and independent GCP and GMP QA consultancy. Services offered are tailored to meet clientâ&#x20AC;&#x2122;s needs, and include MHRA inspection preparation, internal system and facility audits, process improvement, GCP and GMP training, SOP writing and review. Most organisations have times when the workload is too much: a project is starting up, an MHRA inspection is due, internal audits or vendor audits are overdue or a member of staff is unexpectedly away. A flexible and independent QA consultant is just what you need at times like this, so pick up the phone, or e-mail me!
6 Harding Way, St. Ives, Cambridgeshire PE27 3WR M: 07775 923997 | E: dympnastarling@synapsecrs.co.uk
www.synapsecrs.co.uk
WWW.ERBI.CO.UK 95
RESOURCING PEOPLE FOR YOUR BUSINESS IS OUR BUSINESS. We are the global resourcing experts for the pharmaceutical, biotechnology and medical device industries. Whether you are in need of a single Clinical Project Manager or Marketing Manager to cover a peak in development activity, a team of CRAs to address an unforeseen study need or wish to partner with a Functional Service Provider, we are able to meet your resourcing requirements. With more than 1000 resourced employees in 25 countries, we are a company with a global reach and a personal focus. To find out more about how we can help you with your resourcing needs, contact us on +353 1 291 2100 or email info@docsglobal.com
www.docsglobal.com
Join the debate that affects you and your business at MedilinkUK.com We know that the best people to identify and resolve the UK’s industrial issues are those on the front line and we believe it’s time for the agenda to be driven from the bottom up. Backed by the Office for Life Sciences (OLS), MedilinkUK.com features tailored content and topics for the pharmaceuticals, medical biotechnology, medical technology and medical diagnostics markets. So whether you are part of an SME or a global corporation, find your voice and help shape future Government policy, influence new NHS policies and change the way the sector does business. Change will happen more quickly and with greater benefit for all, when the Life Sciences agenda is set for the policy makers, not by the policy makers.
the voice of
UK Life Sciences.
up to a hundred trillion different clones can be easily generated in a few hours and quickly processed so that better products and motifs can be selected in just a few days. Active peptides with antibody-like levels of affinity and specificity for target compounds can be isolated and then rapidly matured to optimise desirable qualities. CIS display technology has provided hits and information against a wide range of targets and has advantages over alternative technologies. It has particular benefits against biological membrane preparations, cells and bacteria. The technology is adaptable for the display of different proteins and has been licenced for the Centyrin scaffold. Licences are available for scFv and other polypeptide scaffolds.
Isolate the best binders from protein libraries with CIS display Isogenica specialises in providing protein engineering and molecular evolution services using its core technology, “CIS display”, to pharmaceutical and biotechnology companies for the discovery, identification and design of new peptide, polypeptide and antibody lead compounds. CIS display can rapidly construct polypeptide libraries of unprecedented size and complexity in vitro, without the need for cloning. A library of
Isogenica has secured more than a dozen partnering and licensing deals to date and is seeking further collaborations with companies actively engaged in developing peptide and polypeptide systems including protein scaffolds, hormones, enzymes and antibodies.
Faster hits, better leads
For more information: Dr Kevin Matthews CEO, Isogenica +44(0)1799533682 kevin.matthews@isogenica.com
WWW.ERBI.CO.UK 97
n
BABRAHAM BIOSCIENCE TECHNOLOGIES LTD (BBT)
Bioinnovation at Babraham biomedical companies are based at Babraham, delivering new products and innovative solutions for the healthcare challenges of the 21st century. However, over 60 companies have passed through the Bioincubator and these companies have raised in total over £300M in equity finance. CATALYSING ACADEMIC-COMMERCIAL COLLABORATION
Acknowledged as one of the UK’s leading enterprise hubs, home to both world-class academic research and commercial biomedical companies, the Babraham Research Campus has earned a reputation for nurturing early-stage enterprises and delivering excellence in bioscience innovation. Having just announced plans for a new building, designed specifically with the biomedical start-up in mind, the campus is embarking on a new phase of expansion in 2010, underscoring Babraham’s continuing commitment to supporting early-stage enterprises. At the heart of the campus is the internationally regarded Babraham Institute, an institute of the Biotechnology and Biological Sciences Research Council (BBSRC) underpinning government’s national responsibilities for healthcare research and training. The Institute commercialises its discoveries through its commercial arm, Babraham Bioscience Technologies (BBT) Ltd, a recent example being the creation of Crescendo Biologics, and aims to initiate and facilitate partnerships to promote knowledge transfer and translate innovative science into viable ventures. INVESTING IN INFRASTRUCTURE FOR INNOVATION BBT has developed the campus infrastructure significantly over the last twelve years; central to this are Babraham’s Bioincubator buildings, which offer attractive flexible terms and serviced facilities to support new bioventures and catalyse the commercial exploitation of biomedical research. Today 30 early-stage
A clear draw of the campus is the ability for companies to interact and collaborate with academics. Institute research, exploring the science of cell signalling, epigenetics, gene regulation and how defects in these processes trigger disease, has given insight into conditions like hypertension, heart failure, autoimmunity, infertility, cancer and neurodegenerative diseases such as Alzheimer’s Disease and today has a strategic focus on ‘healthy ageing’. Several collaborations are flourishing between academic researchers and Bioincubator companies, exchanging knowledge and taking ideas forward to deliver benefits in disease diagnosis and treatment for society.
“Babraham is an exciting place to work and is based within a vibrant academic community both in the immediate environment of the Research Campus and across the wider regional network of scientists. The critical benefit that this brings to our regional biocluster is a ready pool of motivated scientists with the right practical skills to compete with businesses internationally. As Senexis, we moved to Babraham in 2004 and have benefited enormously from working with both academic and industrial scientists across the Research Campus and beyond.” Dr Mark Treherne, CEO of Senexis ACCELERATING INNOVATION Another distinct feature of the Babraham site is the Technology Development Laboratory (TDL), established to provide access to resource, equipment and space so that early-stage concepts can be developed to commercial reality. This provides the benefit of offering bespoke, state-of-the-art R&D services and scientific assistance across many fields including molecular biology, protein biochemistry, cell biology, medicinal and synthetic
“The access to short term rented lab space within the TDL at Babraham has been of real benefit to Cellexus Ltd. The speed with which the contract was set up, the flexible approach and the competitive pricing all made for a smooth process. Additionally the TDL staff was readily available for advice and access to the on-site stores facility was another key benefit. The flexible provision of such short-term space is not, to my knowledge, available elsewhere in the Cambridge area.” Clive Mason, Technical Manager of Cellexus Ltd, Hinchingbrooke Business Park
98 ERBI DIRECTORY 2010
BABRAHAM BIOSCIENCE TECHNOLOGIES LTD (BBT) n
chemistry. A new suite for biopharmaceutical development was recently added with financial support from the East of England Development Agency (EEDA). It includes a medium-scale cell culture and fluorescence-based assay platform, together with state-of-the-art protein purification and analysis systems. All the campus companies, Institute scientists and external companies can use and access the TDL. BIOINCUBATOR FACILITIES BLOSSOMING Plans for a new Bioincubator building programme were unveiled in December, further expanding Babraham’s capacity to support early-stage ventures and biomedical innovation in the region. The new 8800 sq ft facility, providing accommodation for up to 16 early stage biomedical companies, will be ready for tenants in September 2010. The building has been designed to allow maximum flexibility, so that combinations of office, laboratory, cell-culture and containment level 2 facilities can be provided according to the specific needs of early-stage companies. the potential to be truly differentiated medicines. We believe that the combination of distinguished scientific founders with such a great track record and high quality investors will prove to be great advantages for the company as we start to build our organisation. Babraham was chosen as the site for our laboratory because of the impressive facilities available there, the great location and the track record of support for small companies shown by BBT.”
“The creation of a supportive, entrepreneurial environment promoting bioscience innovation is one of our key objectives as we develop the Babraham Research Campus. I am delighted at the progress we have made, and with the opportunity that the new building will provide to us.” Derek Jones, Chief Executive of BBT
The most recent company welcomed to the campus is Bicycle Therapeutics, the latest start-up from the MRC’s Laboratory of Molecular Biology. Based on the work of Christian Heinis and Sir Gregory Winter, the company’s scientific founders, this innovative platform technology has truly transformative potential - a new class of stable and low cost drug molecule likened to ‘mini-antibodies’ with organic cores, which should overcome the weaknesses of previous generations of peptidebased therapeutics. Dr John Tite, CEO of Bicycle Therapeutics said, “We are delighted to have created this exciting new start-up company based upon such an innovative technology emanating from the MRC Laboratory of Molecular Biology in Cambridge. Bicycle Therapeutics aims to develop its proprietary technology, which involves the generation and development of small bicyclic peptides, to create a pipeline of drugs which have
WWW.ERBI.CO.UK 99
n
RSA
Global recruiting made easy RSA is a global leader in Life Sciences Executive Search and Interim Management. RSA consultants talk to hundreds of industry leaders daily, our network reaches every corner of the global life sciences industries. Our unique blend of knowledge, teamwork and integrity has made us a world leading executive recruiter but we’ve never lost sight of the values we started with: respect, integrity, quality and professionalism. EXECUTIVE SEARCH
QUALITY. EASY TO PROMISE, HARD TO DELIVER
Top people are sought-after people. We use our experience to create the right approach for each key appointment, deploying our network and industry knowledge to achieve exceptional success rates.
Harder to prove! At RSA we set up the toughest test we could think of and we’ve stuck to it for more than 20 years. Every RSA assignment is assessed by independent experts. Clients and candidates are asked to rate their experience using detailed questionnaires. To make it tougher still, they’re asked to compare our performance against the company they see as ‘best in class’. More than 95% of clients and candidates are delighted or satisfied with our service.
In the executive search industry, around 65% of assignments are successful. With RSA, it’s more than 90%. Why? Firstly, we have inside knowledge. Many of our consultants and researchers have worked in life sciences, all of them are highly qualified and experienced. Secondly, everyone at RSA shares information and contacts across the globe and we reward them as a team not just as individuals. It’s a team effort dedicated to the long-term interests of clients, candidates, and our reputation. INTERIMS RSA helps you engage the most talented people exactly when you need them for as long as you need them. As the leading provider of interim managers to the life sciences industry, we have dedicated interims teams worldwide. THE RIGHT PEOPLE ACROSS THE VALUE CHAIN In most organisations, different people do different jobs. We think recruiters should be the same. RSA is organised in ‘specialist practices’, teams of expert recruiters who understand the details of your business and are skilled in finding you the right people, from management levels up to Board and Non-Executive Directors. As your company grows, different practices will help you apply the right expertise in the right place, at the right time. EXPERTISE ACROSS THE SECTORS We don’t just specialise in life sciences, we specialise in every part of it. We understand that different sectors present different challenges. Each of our dedicated consultants and researchers has a wealth of experience and knowledge of the life science industries. They’ll start by listening to you to understand your needs, they’ll deliver objective advice and intelligent, targeted solutions. Our team-centred approach means they can draw on specific advice and industry contacts from other experts in the worldwide RSA family. Life sciences and recruitment. Some people understand one. Some understand the other. RSA understands both.
100 ERBI DIRECTORY 2010
AT RSA, MORE THAN 80% OF OUR BUSINESS IS REPEAT BUSINESS We know there’s more to recruitment than qualifications and experience. You need people who fit into your culture. The time we spend getting to know you, your corporate culture and the people we interview is never wasted. That’s why our network is such a valuable resource. You get the people you need and we get the satisfaction of a job well done. WE’RE IN THIS FOR THE LONG HAUL Since 1981, we’ve built RSA to be truly global. You don’t create a network like this overnight. It’s built on expertise, industry contacts and trust. We can help you identify, attract and retain the best talent, wherever you need it. That’s because we resource the life sciences industry right across the globe, from our own strategically-situated offices, not third party franchises. Wherever you are and whatever the time, we’re ready to get to work. Call or email us now: +44 (0)1707 259333 or nick.stephens@theRSAgroup.com.
COMPANIES NAME n
MDTc
Medical Device Technology Consultants Ltd
MDTc is a specialist consultancy for the Medical Devices and Healthcare Industries with highly experienced consultants offering a comprehensive range of services. We provide: Clinical Investigation
Regulatory Strategy n
Development of Regulatory Strategy and roadmaps for compliance with EC Medical Devices Directives, FDA and global regulatory requirements for all medical devices and drug delivery systems
Quality Systems n
n
Market Research n
Development of Quality Management Systems to meet European, US and International Standards (MDD CE, FDA Quality System Regulation, ISO 13485, ISO 9001)
Clinical Evaluation Reports based on scientific and technical literature searches, Clinical Investigation Plan development, approvals and implementation Web research and telephone/F2F interview based studies to determine Market size, competitor analyses, technology applications, customer satisfaction, identification of business partners
Technical Services n
Project Management for new product development and design transfer to manufacture, Technical Files, Risk Management, Usability Engineering, Process, Sterilisation and Software Validation
Your Partner for Successful Market Entry
Medical Device Technology Consultants Ltd, Vicarage Farm, Upthorpe Road, Stanton, Bury St Edmunds, Suffolk, IP 31 2AP www.mdtconsultants.co.uk Email: Info@mdtconsultants.co.uk
The Property People
carterjonas.co.uk
Our Technology team provides a full range of property services for owners and occupiers of Science Parks and Laboratory buildings To see how we can help, contact: Nick Hood Technology Team
Carol Pawsey Technology Team
Walter Herriot Technology Team
T: 01223 346607 E: nick.hood@carterjonas.co.uk
T: 01223 346645 E: carol.pawsey@carterjonas.co.uk
T: 01223 346641 E: walter.herriot@carterjonas.co.uk
or visit carterjonas.co.uk/technology OfďŹ ces throughout the UK
UKSPA 2009 directory - Nov 09.indd 1
The Science of Property â&#x201E;˘ 11/12/2009 17:09:12
WWW.ERBI.CO.UK 101
n
MEDICAL RESEARCH NETWORK
Specialised clinical trials The Medical Research Network (MRN) is a unique Clinical Trial Support Organisation (CTSO) offering specialised expertise to leading pharmaceutical companies, health organisations and investigators conducting clinical trials. The MRN is quickly becoming Europe’s leading specialist in Home Healthcare within clinical trials – and is presently initiating its first independent* home trial study in North America. The move demonstrates the MRN’s commitment to operate globally, bringing the total number of countries with active projects to 12 – a six fold increase on last year. In addition subsequent International studies are already in the pipeline for 2010. With an anticipated 100% growth in their home trial support service over the next 12 months the MRN is confident that their global strategy will continue to thrive as more companies realise the cost advantage potential to this innovative service. Founded in 2006 the MRN was a management buy out of a business within parent company, Healthcare at Home Ltd, which had been operating a successful trials support service for many years, but on a smaller scale. The aim of the MRN was simple – to combine the advantages of treating clinical trial patients in their own homes with the placement of experienced research nurses at study sites using an established centralised pharmacy and logistics operation resulting in faster trial delivery and site resource optimisation in today’s challenging research environment. With over 10,000 nurses at their disposal, working from over 15 countries, the MRN support the conduct of clinical trials both in the trial site and in the patients’ homes, allowing additional flexibility in study design. MRN ensure all their nurses are qualified and experienced in administering complex therapies (both licensed and unlicensed), standard patient assessments, questionnaires and the recording of clinical trial data into source documents or case report forms. In many cases, the MRN nurses take on the traditional role of the study monitor in addition to their research responsibilities at the site and the patient home while clinically trained Project Managers are always available to support site activities.
102 ERBI DIRECTORY 2010
SINCE THEIR FORMATION, THE MRN HAS LAUNCHED FOUR SPECIALISED CLINICAL TRIAL SUPPORT SERVICES. THESE SERVICES ARE: n Site Support – The MRN can provide specialist clinical and
research nurses that are placed directly in the research site. These additional resources will not only manage the patients but will also perform day to day administrative burdens to release investigators for patient care and other principle investigator activities. n Home Trial Support – nurses run from 30% to 60% of each
trial’s visits in the patients own home. The tasks that can take place in the home are many and varied – ranging from the delivery and administration of the product such as is common for biologicals that need to be kept cool right up to the moment they are given to the patient, through to efficacy and safety assessments, completing con meds and intercurrent illness CRF pages, taking (and centrifuging) bloods or other samples etc. Almost anything can be done in the home environment – supporting and enhancing the usual out-patient setting of most clinical trials. n Pharmacy Support – The pharmacy facilities can distribute
complex medications throughout the UK and several other countries in which we operate, in a cold or ambient temperature environment, direct to the patients home for the nurse to administer or the patient to self administer if appropriate. They can compound the medication, label or over label, pack, store, dispense, distribute, collect and destroy medications according to the requirements of GCP. n Trial Management Support – The MRN are able to run
and manage all aspects of clinical trials. From identifying the sites, allocation of nursing resources through to data management and report writing – thus allowing the MRN to take full responsibility for delivery of the finished product
www.themrn.co.uk
UNIQUE SOLUTIONS FOR PATIENT ACCESS AND RECRUITMENT For every site running clinical trials, there are four more in our database who would like to. Medical Research Network (MRN) services can bring these sites on-line for client’s trials. MRN home trial support, running trial visits in the patient’s home, routinely increases recruitment by 60% or more. Complex studies – e.g. with weekly or daily visits – become much more achievable when the home therapy option is included. MRN provides a unique service portfolio for Biotech companies within the UK supported by an accomplished management team with many years of clinical development experience both in pharmaceutical and biotech companies and CROs.
Should you wish to find out more about our services or discuss a specific project please contact us. Telephone: 0800 032 2348 email: susan.mayne@themrn.co.uk or write to: 15 Presley Way, Crownhill, Milton Keynes, Bucks. MK8 0ES www.themrn.co.uk
MEDICAL RESEARCH NETWORK
A CLINICAL TRIAL SUPPORT ORGANISATION
WE’RE NOT TELEPATHIC
www.kendle.com
BUT WE’RE WORKING ON IT
When you find us, you’ll discover a great meeting of minds. As a world-leading CRO we’ll share your goals and add value to every partnership, giving you a head start.
n
UK TRADE & INVESTMENT
Exporting regional expertise UK Trade & Investment supports companies across the East of England that want to trade and invest overseas by providing a wide range of unique services to help local businesses go global. Support ranges from participation at appropriate trade fairs, outward missions to bespoke market intelligence. With UKTI support, companies crack foreign markets and get to grips quickly with overseas regulations and business practice. The East of England consistently provides over 10% of the UK exports annually and a main driver for this is that the region leads the way in a number of key industry sectors. Our team of
International Trade Advisors and regional sector specialists can help companies throughout the region to internationalise their business. If you are a company based in Norfolk, Suffolk, Essex, Cambridgeshire, Hertfordshire or Bedfordshire the first step to successful exporting is to contact your International Trade Team to access the wide ranging advice and support services available from UKTI. For more information visit: www.uktradeinvest.gov.uk. And for a couple of regional companies over the past few months, UKTI support has been invaluable.
CASE STUDY 1: UK STEM CELL BANK For Hertfordshire-based UK Stem Cell Bank who joined UKTI’s Passport to Export programme, global growth has lead to international recognition. When it was set up in 2003, among the Bank’s objectives was ensuring the quality of stem cells used in research and in developing clinical therapies as well as holding stocks of such stem cells and supplying them to UK and overseas researchers. As it has become well established so its international role has strengthened as its Director, Glyn Stacey explains. “We have, in many ways, become an international and national neutral broker working with regulatory authorities and health-service groups as well as companies developing stem cell products and therapies.
“
“
We have found them helpful in facilitating contacts and we have taken part in a number of overseas events. It has also been invaluable to tap into the specialist knowledge of Chris Ilsley at UKTI.
“The result is that we have stem cells stored with us from a range of countries and organisations and, in turn, supply them to a wide-ranging user community. One of the key actions for us is to establish the credentials of potential ‘clients’ and collaborators which is where UKTI have been of great support. By tapping into the local knowledge of in-country teams we are able to gather
106 ERBI DIRECTORY 2010
the right intelligence to enable us to make informed decisions. “We have found them helpful in facilitating contacts and we have taken part in a number of overseas events. It has also been invaluable to tap into the specialist knowledge of Chris Ilsley at UKTI. The ‘internationalism’ of our work is of growing importance and within our plans we have well defined strategic objectives in this respect. As a result I’m sure we’ll be continuing to work with UKTI; indeed, one of the first things we need to look at is ensuring relevant information about the UK Stem Cell Bank is delivered in the language of the country we’re working with.” The UK Stem Cell Bank is based at the National Institute for Biological Standards and Control (NIBSC) at South Mimms, Hertfordshire and is working with research and development groups from South East Asia to Australia and Europe to the USA. Specifically, among its international remit it aims to: Develop the UK Stem Cell Bank website as a valuable tool for stem cell researchers on cell lines, associated technology and best practice as well as an additional mechanism for organisations outside the UK to gain access to UK stem cell networks; Consolidate the Bank’s profile as an ‘honest broker’ in regulatory issues relating to stem cell products in support of national and international regulatory authorities and health-service groups and companies developing stem cell products; Establish the Bank as the international partner of choice for training initiatives in the stem cell field and as a valuable independent partner in stem cell collaborative projects and initiatives. Chris Ilsley, Regional International Trade Adviser for the Biotech and Pharmaceutical Sector, says, “The Bank is an unusual example of an exporter but clearly demonstrates the breadth of organisations that enhance our dealings with the rest of the world. It also shows that Passport to Export is for everybody no matter how large or small or how different. The Bank is one of many groups that contribute to the strength of the sector in the East of England and is increasing its influence on the world scene and we look forward to working together.” For more information about the UK Stem Cell Bank visit: www.ukstemcellbank.org.uk
UK TRADE & INVESTMENT n
CASE STUDY 2: PLANT BIOSCIENCES LTD THE COMPANY’S BUSINESS DEVELOPMENT MANAGER MARTIN STOCKS SAID: “We source and market our technologies internationally and have every reason to think the DGM will be a major success story. It was very well received in Los Angeles. The general level of interest was excellent. “It was originally devised for the food science community as a tool to look at how food is processed by the stomach. But its most valuable utility has turned out to be for the pharmaceutical industry to examine how drug formulations work when they are taken into the stomach. This is very definitely a world first, and we are currently focussed on developing this aspect of the market. “We already have several blue-chip pharmaceutical companies as customers, and the trip to AAPS is likely to bring in many more.
Dr Martin Wickham
Scientists in Norwich have been busy developing the world’s first accurate model of how the human stomach works to break down the food we eat. Now they plan to market it globally with the help of export expertise provided by UKTI. The breakthrough equipment – developed by the Institute of Food Research – is being taken to market by Plant Biosciences Ltd, a technology development company based at the Norwich Science Park on the outskirts of the city. PBL were part of a trade mission organised and part-funded by UKTI to the prestigious American Association of Pharmaceutical Science conference, held recently in Los Angeles, where their Dynamic Gastric Model (DGM) generated considerable excitement.
“UKTI have been very enthusiastic and given us huge moral support, as well as providing some financial assistance in terms of getting us over to the US. They provided logistical support while we were there to get us in touch with key customers in the US and are offering to find us further contacts both in the US and worldwide.” “Everyone thinks of the stomach as just a bag full of fluids and enzymes, but it’s a very complicated organ and this machine replicates those complexities exactly.” Regional International Trade Advisor for the biotech and pharmaceutical sector at UKTI, Chris Ilsley said: “We have been working with PBL for about 18 months and they have used our Passport to Export services in the past. It was a perfect fit from them to be part of our trade mission to AAPS and we were delighted to put them in touch with companies who will be very interested in making use of this technology.” For more information visit: www.pbltechnology.com and www. modelgut.com
The computer-controlled DGM essentially replicates the working of the human stomach and provides a vital tool to scientists investigating the way food and pharmaceuticals are dealt with after swallowing. It simulates all the key processes that take place in the stomach, mimicking the complex biochemical conditions and gastric forces to create an accurate model of what really goes on in the human body, and processes real food in the form that is it eaten rather than unrepresentative homogenised material. The equipment took more than ten years to develop, under the leadership of top scientists Dr Martin Wickham and Dr Richard Faulks, at the Institute of Food Research in Norwich. PBL’s role is to develop innovative technologies by investing in and promoting the commercialisation of public sector research innovations, such as the DGM, turning ideas into patented, scientifically validated and licensable products.
Dr Richard Faulks, along with Dr Whickham, the two top scientists involved in the development.
WWW.ERBI.CO.UK 107
n
ALCYOMICS
Skin Explant Assay ASSAY TECHNOLOGY This unique, non-artificial, human in vitro assay technology allows the study of primary and secondary immune responses in the presence of immunomodulatory drugs or allogeneic stem cells, reducing the need for extensive animal testing. Incubation with human skin, allows skin damage to be assessed by histopathology. The skin is graded for histological damage using criteria similar to that used and observed in the clinical setting. Results correlate with systemic disease and have been shown to predict outcome. ABOUT ALCYOMICS Alcyomics is the UK biologics and cellular therapeutics service company offering Skin Explant Assay (SEA) for the discovery of therapeutics for immunomodulation and GvHD (graft versus host disease). Alcyomics believe that SEA benefits the pre-clinical stage of the drug development process and in particular safety, efficacy and dose studies. These novel advantages will aid in speeding drug development times, lowering development costs and minimising risk by evaluating drug candidates (including stem cells) at an early stage using criteria similar to those used and observed in the clinical setting. Contact: Dr Ian Scoular, CEO Mobile: +44 (0) 7736 226999 ian.scoular@alcyomics.com www.alcyomics.com
Skin Explant Assay - a unique tool for the Biotechnology and Pharmaceutical industry minimising risk in drug research and reducing animal testing. SPEEDING DRUG DISCOVERY n Skin Explant Assay offers the opportunity to minimise risk by
evaluating drug candidates in vitro at an earlier stage, thus lowering drug development costs n Investigate mode of action, e.g. cytokine response, and
target identification, including mRNA analysis, aiding in drug discovery n Test safety and efficacy n Improve drug design and optimisation for drug dosage prior
to a clinical trial. Identify patient drug response n Detect adverse reactions earlier e.g. allergic or hypersensitivity,
prior to clinical studies
108 ERBI DIRECTORY 2010
Heptares Therapeutics is a drug discovery company focused on identifying novel drug candidates targeting high-value, validated G-protein-coupled receptors (GPCRs) in multiple disease areas. The Company’s unique StaR™ technology enables Heptares to engineer and purify stable GPCRs to which it can apply contemporary drug discovery approaches, such as crystallisation and structure-based design, biophysical analysis of ligand interactions and fragment screening.
Checklist assified Material Cl
3
ents re requirem 3 Temperatu derstood un d an designed and provided Packaging sit 3 an tr r fo prepared
This unique approach is expected to radically improve the chances of finding novel drug candidates (small molecules and biologicals) to previously intractable targets and will enable the development of safer and more selective therapeutic agents.
ry d regulato d Customs an epared an pr on ti ta documen 3 completed 3 t checked quiremen Licence re ansit 3 ady for tr Material re
Based on this integrated drug discovery capability, Heptares aims to progress promising candidates internally and through strategic alliances. For more information, please contact:
We’re more than a courier… UK Cambridge: (01223) 245223
USA Boston: (+1) 617 623 0544 San Francisco: (+1) 650 685 5511
Japan Osaka: (+81) (0) 6-664-6664
China Shanghai: (+86) 21 6160 1550
Heptares Therapeutics Ltd BioPark Broadwater Road Welwyn Garden City Hertfordshire AL7 3AX, UK Tel: +44 (0)1707 356 100 Email: info@heptares.com Web: www.heptares.com
Putting Safety into Practice
Langt n Howarth Ltd Placing People with Passion Langton Howarth is a market leading Scientific Recruitment Company. HEALTH AND SAFETY WORKS LTD
can provide
n
Reviews, audits, risk assessments. We have knowledge of the Biotech industry, Biosafety, radioisotope use, DSEAR and REACH n Refurbishment and Construction safety, site audits, safety plans and CDM requirements. n IOSH Safety Training and Bespoke Safety Courses n
TEL:FAX EMAIL n
01223 265622 MOBILE 07974 799808 advice@healthsafetyworks.co.uk
REDUCE BUSINESS COSTS BE LEGALLY COMPLIANT n REDUCE ABSENTEEISM n
HSW Health & Safety Works Ltd
Our reach is global. Our service is local. We make your business our goal through our first class search and selection solutions. For more information on our recruitment services please contact us on:
0113 380 1645
info@langtonhowarth.com
www.langtonhowarth.com WWW.ERBI.CO.UK 109
dis.tinc.tive [di-stingk-tiv] - adjective 1. serving to distinguish; characteristic; distinguishing: the distinctive spots of the leopard. 2. having a special quality, style, attractiveness, etc.; notable. - distinctively a. distinctiveness n.
7th Floor | Aidan House | Sunderland Road | Gateshead | NE8 3HU T: 0191 478 83 00 | E: enquiries@distinctivegroup.co.uk
Corporate Sponsors
Activotec’s mission is to establish themselves as the partner of choice for solid phase peptide/organic synthesis.
Barclays Commercial Bank
A B
Mr Nick Baker barclays.co.uk/commercial
C
Telephone : 07775 544302 Fax : 01223 545532
D E
CORPORATE SPONSORS
P O Box 885, Mortlock House, Histon, Cambridge, Cambridgeshire CB24 9DE
Barclays Commercial Bank provides relationship banking to 81,000 business customers in the UK (£1m to £1bn turnover). Customers are served by a network of relationship and industry sector specialist managers who provide local access to an extensive range of products and services, as well as offering business information and support. Customers are also offered access to the products and expertise of other businesses in the Group, particularly Barclays Capital and Barclaycard. Barclays Asset & Sales Finance – a specialist business within Barclays Commercial Bank provides customers with asset based lending and leasing solutions.
F G H I
Deloitte
J K L M
Mr Stuart Henderson www.deloitte.co.uk Telephone : 01223 460222 Fax : 01223 350839 City House, 126-130 Hills Road, Cambridge, Cambridgeshire CB2 1RY
N
Deloitte is the UK’s fastest growing major professional services firm in 21 locations, with over 10,000 staff nationwide. The Cambridge office of Deloitte boasts an allencompassing client base with a highly diverse spectrum in terms of industry sector and size of clients, from small start-ups to multinational corporations. 10 Partners and over 200 staff deliver a full range of professional services to the East Anglian region. The Cambridge office has focussed on the opportunities in the technology sector; which the region has been renowned for, and the life and health sciences sector includes a diverse range of businesses. Our Life and Health Sciences practice words with a wide number of clients ranging from some of the most influential multinationals to dynamic new start-ups. To address challenges faced by these organisations we provide a broad spectrum of services spanning audit, tax, corporate finance, strategy, risk assessment and technology advice.
O P Q R
IQ Cambridge
S Ms Kate Dean
T
www.iq-cambridge.com
U
Fax : 01223 471053
V
Telephone : 01223 471052
Management Centre, Beach Drive, Waterbeach, Cambridgeshire CB25 9PD
W
IQ Cambridge is a low-density technology park that has outline planning consent for 600,000 sq ft of prestige office / R&D accommodation. Set within 112 acres of parkland and lakes, it benefits from on-site security, a café-bar, conference centre and 32 acre nature reserve. IQ Cambridge customers include Elecheck, whose Sales Director Marco de Cotis comments: “As a national company we travel into the office from across the country. With easy access to Stansted Airport and good road and rail transport links the park is comfortably situated in the heart of the UK”. Another customer, George Gimenez, Senior Marketing Coordinator for NEC Philips, adds: “The IQ Cambridge office has a technology infrastructure of the highest standard, and this was a key requirement for our business”. IQ Cambridge is owned, managed and developed by SEGRO plc, a commercial property company that provides flexible business space across Europe. Their property portfolio includes offices, light industrial, logistics and data centre properties.
X
SEGRO provides a ‘one-stop-shop’ for fast track construction of office / R&D units. Development finance is provided from SEGRO resources, and the company can give unconditional approval and immediate go-ahead for projects, whether or not customer funding is available.
Y Z 112 ERBI DIRECTORY 2010
CORPORATE SPONSORS
Activotec’s mission is to establish themselves as the partner of choice for solid phase peptide/organic synthesis.
MedImmune Limited – Corporate Patron Mr Jon Green info@medimmune.com www.medimmune.com Telephone : 01223 471471 Fax : 01223 471472 Milstein Building, Granta Park, Cambridge, Cambridgeshire CB21 6GH
A B
Renowned for our originality and creativity and backed by a 20-year heritage, MedImmune is synonymous with intelligent risk-taking, innovation and entrepreneurial spirit. As AstraZeneca’s worldwide biologics unit, we strive to address unmet medical needs by developing novel proprietary products and cutting-edge technologies. As a result of incorporating translational sciences - otherwise known as “customized medicine” - into some of our programs, MedImmune is continually working towards the future. With two actively marketed infectious disease products and an advancing pipeline of promising candidates in the areas of infection, oncology, respiratory disease and inflammation, cardiovascular/gastrointestinal disease and neuroscience, MedImmune strives to provide better medicines to patients, new medical options for physicians and rewarding careers to employees. We have approximately 3,000 employees worldwide and are headquartered in Gaithersburg, Maryland with facilities in Pennsylvania, California, Kentucky, the United Kingdom, and the Netherlands. UK facilities include vaccine manufacturing operations in Speke and antibody discovery and research laboratories in Cambridge.
C D E F G H
CORPORATE SPONSOR
I Remtec Search & Selection Ltd Mr Nigel Job candidate@remtecsearch.com www.remtecsearch.com Telephone : 01223 550860 Fax : 01223 847630 Unit 1, Breaks House, Mill Court, Great Shelford, Cambridgeshire CB22 5LD
J
Remtec Search and Selection is a Cambridge UK based specialist executive search company working across the lifescience and medical device industries. Remtec manage UK and international search assignments for a range of roles including those listed below. Our many years of industry expertise as well as our research and project management experience enable us to manage search assignments in a high quality and timely manner. We work with large global corporations as well as small investor backed start up companies. We can offer a range of flexible service levels enabling us to tailor our offer to meet the timescales and budget requirements of our clients. Search Assignments we undertake: • CEO • HR and Finance • General Managers • Health Economics • Sales and Marketing • Regulatory Affairs • Quality Managers • Technical and Clinical
K L M N O P Q R
Taylor Wessing Mr Simon Walker cambridge@taylorwessing.com www.taylorwessing.com Telephone : 01223 446400 Fax : 01223 446401 24 Hills Road, Cambridge, Cambridgeshire CB2 1JW
S
Taylor Wessing is a major European law firm with offices in Cambridge, London, Berlin, Brussels, Düsseldorf, Frankfurt, Hamburg, Munich, Paris and Shanghai. It is recognised as a market leader in intellectual property and corporate finance and has considerable expertise in pharmaceuticals and biotechnology having acted for start ups, growing companies, big pharma and big biotech.
T U
Solicitors with leading corporate and intellectual property lawyers specialising in advising pharmaceutical and biotechnology companies and venture capital funds.
V W X Y Z WWW.ERBI.CO.UK 113
A Peptide Synthesis Company Activo-P11 Automated Peptide Synthesizer • High quality peptides • Heated reactor drives coupling efficiency • New UV monitoring of Fmoc removal • Inert atmosphere throughout • Any scale from 0.05 mmol to 5.0 mmol • Fast cycle times • Easy to use; flexible software and peptide wizard • Performs any Fmoc or t-Boc chemistries • Synthesize long and difficult sequences
Activo-P12 Cleavage Device
UV Monitoring
Activo-S44 Automated Oligosaccharide Synthesizer • Cooling to – 40 °C, heating to + 80°C • Efficient mixing system • High quality compounds • Any scale from 0.05 mmol to 2.0 mmol • Fast cycle times Cooling of Reactors
Call us now on +44 (0)1223 260008 www.activotec.com Email: info@activotec.com
Heated Reactor
Gold Members
Activotec’s mission is to establish themselves as the partner of
n
COMPANIES choiceNAME for solid phase peptide/organic synthesis.
Abcam Ltd
A B
Mr Jeff Iliffe info@abcam.com www.abcam.com
C D E
Telephone : 01223 696000 Fax : 01223 696001 330 Cambridge Science Park, Milton Road, Cambridge, Cambridgeshire CB4 0FW
Abcam was founded in 1998, by Dr. Jonathan Milner, to supply a global resource for scientists to find and purchase high quality research antibodies (essential tools for scientists that enable them to analyse the components of living cells at the molecular level). The company has grown rapidly to over 90 employees in the UK and US, and now has customers in over 60 countries. The business is profitable and now has an annualised turnover in excess of GBP18 million with sales continuing to grow rapidly. Abcam is now recognised as one of the leading companies in its field. The success of Abcam comes from the speed with which it can bring high quality cutting-edge products to market and its customer service efficiency, so that scientists’ research is not impeded by the lack of, or inability to find, a particular reagent. This speeds up the pace of research into important diseases such as cancer and coronary heart disease. Offering over 21,000 products, Abcam provide reagents for some of the newest and fastest growing research areas, such as Chromatin and Neuroscience.
F G H I
Activotec SPP Mr Chris Littlewood info@activotec.com www.activotec.com Telephone : 01223 260008
J K
Fax : 01223 260008 7 Bennell Court, West Street, Cambridge, Cambridgeshire CB23 7EN
L
The Company was formed in December 2002 as a spinout from the University of Southampton, with the support of Southampton University’s Enterprise Office, the CEI, and benefiting from its partnership with IP Group. Activotec’s core focus is customer service whether it’s instrument development and support, delivery of quality custom synthesis services or chemicals, all critical to the success of your science. Our stock of instrument parts, consumables and chemicals offers a first class commitment to customer support. Activotec offers scientists a single point of expertise and assistance in research, design, manufacture of new, innovative and practical solutions. The Company develops and manufactures automated peptide synthesizers to sell worldwide to the peptide synthesis community. All development and production takes place at its facility in Cambridge, UK. The Activo-P11 peptide synthesizer is an easy to use and affordable instrument for synthesis of very high quality peptides on a scale from 0.05 to 5.0 mmole.
M Amgen
N O P
Dr Jeremy Haigh spurser@uk.amgen.com www.amgen.com Telephone : 01223 420305 Fax : 01895 525102
Q R
240 Cambridge Science Park, Milton Road, Cambridge, Cambridgeshire CB4 0WD
Amgen discovers, develops and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science’s promise by bringing safe, effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people’s lives. To learn more about our pioneering science and our vital medicines, visit www.amgen.co.uk
S T U V
Antisoma Research Limited Ms Fiona McLaughlin enquiries@antisoma.com www.antisoma.com Telephone : 020 3249 2100
W X
Fax : 01707 397009 BioPark, Broadwater Road, Welwyn Garden City, Hertfordshire AL7 3AX
Y Z 116 ERBI DIRECTORY 2010
Based in London, UK, Antisoma is a biopharmaceutical company that develops novel products for the treatment of cancer. Antisoma fills its development pipeline by acquiring promising new product candidates from internationally recognised academic or cancer research institutions. Its core activity is the preclinical and clinical development of these drug candidates. Its lead product AS1404 is licensed to Novartis. All other products are unlicensed and will be developed independently by Antisoma. Please visit www.Antisoma.com for further information.
Activotec’s mission is to establish themselves as the partner COMPANIES of choice for solid phase peptide/organic synthesis. NAME n
Asterand Dr Tony Brown info@asterand.com www.asterand.com Telephone : 01763 211600 Fax : 01763 211555 2A Orchard Road, Royston, Hertfordshire SG8 5HD
A
Asterand is the leading global supplier of high quality, well characterized human tissue and human tissue-based research services to drug discovery & development scientists. Our mission is to provide human tissues and services to accelerate the identification and validation of drug targets and enhance the selection of drug candidates with an increased likelihood of clinical success. Formed in January 2006 from the merger of Asterand, a human tissue biorepository, and Pharmagene, a human tissue-based drug discovery company, we are uniquely positioned to provide a comprehensive approach to meet the research needs of pharmaceutical and biotechnology companies. From our offices in Royston (UK) and Detroit (US)we have ~80 employees focused on providing services and products to accelerate drug discovery & development, from target identification through to compound evaluation and drug safety. Asterand’s Services division offers exemplary scientific expertise in human tissue research. Through our PhaseZERO® drug discovery services platform, we provide a collaborative scientific approach to deliver human tissue-based data on target & biomarker validation as well as compound potency, efficacy, disposition and safety. Our studies can be custom designed and are conducted on a feefor-service basis where our clients own and retain all resulting IP and data.
info@astex-therapeutics.com www.astex-therapeutics.com Telephone : 01223 226200 Fax : 01223 226201 436 Cambridge Science Park, Milton Road, Cambridge, Cambridgeshire CB4 0QA
Astex Therapeutics is using an innovative fragment-based drug discovery platform, PyramidT to identify and develop new medicines, primarily for the treatment of cancer. The company has established a clinical stage pipeline of novel oncology drug candidates, as well as significant partnerships with leading pharmaceutical companies. All of the products being developed have been discovered at Astex through use of the company’s proprietary technologies. PyramidT is an integrated, fragment-based approach that rapidly delivers tailored high-quality small molecule drug leads with enhanced therapeutic potential. PyramidT defines a process by which a range of high throughput biophysical and computational techniques are used to experimentally characterize the interactions of very low molecular weight synthetic ligands with their target proteins. The productivity of PyramidT has allowed the company to generate a robust pipeline of novel ‘best in class’ drug candidates which the company is advancing independently and through valuable strategic partnerships with industry leaders such as Novartis and AstraZeneca. Going forward, the company expects PyramidT to continue to deliver at least one IND candidate per year into its portfolio. In addition, the company’s ability to address targets that have been regarded as ‘intractable’ by the pharmaceutical industry has led to separate drug discovery collaborations with AstraZeneca, Boehringer Ingelheim, and Schering AG.
Avita Medical Ms Claire Darby info.eu@avitamedical.com www.avitamedical.com Telephone : 01223 341150 Fax : 01223 341170 Terrington House, 13-15 Hills Road, Cambridge, Cambridgeshire CB2 1NL
C D E F G
Astex Therapeutics Ltd Mr Neil Jones
B
H I J K L M N
Avita Medical’s products are in the high growth, rapidly developing fields of Respiratory and Regenerative Medicine. The Company has recently implemented a major restructuring which has included introduction of a new management team, reduction in headcount, elimination of extraneous R&D costs, and improvements in manufacturing efficiencies. Brief development plans and/or business plan: Avita Medical has put in place a focused strategic plan built on five key components: - Drive sales in key markets with regulatory approvals in place, working through established distributors and where appropriate, creating a direct sales presence; - Implement ‘continuous improvement’ models in operations and manufacturing to improve efficiencies and maximize margins - Tight management of working capital - Obtain regulatory approval for current products in key markets to ensure access to global economies; - Enhance product portfolio and expand applications of intellectual property through acquisitions and partnering.
O P Q R S T
Azopharma Product Development Group Dr Colin Crowley www.azopharma.com
Analytical Services Clinical & Pre-clinical Formulation Inhlation product development Cytotoxic drug formulation Pre-clinical services Clinical trials GMP manufacture.
U V
Telephone : 01707 358660 Fax : 01707 241100
W
BioPark, Broadwater Road, Welwyn Garden City, Hertfordshire AL7 3AX
X Y Z WWW.ERBI.CO.UK 117
Activotec’s mission is to establish themselves as the partner of
n
COMPANIES choiceNAME for solid phase peptide/organic synthesis.
Babraham Bioscience Technologies Ltd
A B
Mr Derek Jones info@babraham.co.uk www.babraham.com
C D
Telephone : 01223 496269 Fax : 01223 496020 Babraham Research Campus, Cambridge, Cambridgeshire CB22 3AT
The Babraham Research Campus is situated six miles south of the city if Cambridge, and is close to many world leading academic research centres such as the Laboratory of Molecular Biology (LMB), Cancer Research UK, the Sanger Centre et al, as well as the University of Cambridge itself. The Babraham Research Campus is a 450 acre site that combines world leading biomedical research with a Bioincubator that is home to more than 30 companies to create a culture and environment where the academic and commercial can develop and create innovative new products and translate scientific advances. The campus is able to provide a number of services to the companies on site including access to a Technology Development Laboratory that can be used undertake experimental work to develop early stage concepts in to viable commercial opportunities.
E
BBT also has the responsibility for the Knowledge Transfer of the Institutes research through industry collaborations, patent and know-how licensing.
F
BBT plays an active role in supporting local, regional and national innovation initiatives relevant to biomedical research and the creation of start-up businesses.
G H I
Beckman Coulter Genomics Mr Paul Tomlin www.cogenics.com Telephone : 01279 873837 Fax : 01279 873838
J K
Hope End, Takeley, Essex CM22 6TA
With facilities located across the US and Europe, we consistently provide both the expertise and cutting-edge technologies to deliver the highest quality data and robust analyses.
M
BioFocus DPI
N
P
Dr Christopher Newton biofocusdpi@glpg.com www.glpg.com Telephone : 01799 533500 Fax : 01799 531495
Q R
Chesterford Research Park, Little Chesterford, Saffron Walden, Essex CB10 1XL
S T U V
X
BioFocus is a 281 person company located in four countries offering a comprehensive suite of discovery products and services. These are available separately or as an integrated drug discovery solution, backed by a centralized project management system. • Integrated drug discovery: conducting gene-to-candidate discovery programs using multidisciplinary teams • Target discovery: identifying novel targets using human primary cells • Assay development and screening: compound screening using tailored biochemical and cellular assays • Natural products: hit finding and lead generation from 8,000 fungal and 15,000 actinomycete strains • Structural biology: structure-based drug discovery • Fragment-based drug discovery: fragment screening by label-free binding using surface plasmon resonance (SPR), high concentration biochemical assay and protein/ligand crystallography • Virtual screening/in silico drug discovery: accelerating drug discovery using computational technologies • Medicinal chemistry: designing and synthesizing novel drug candidates • ADME/PK: performing comprehensive ADME and pharmacokinetic studies • Compound libraries: accessing synthetic and natural product compound libraries for high-throughput screening • Compound management: acquiring, managing, controlling quality and distributing client screening collections
BioPark Mr Bill Sprigings www.biopark.co.uk Telephone : 01707 356101 Fax : 01707 356115
W
• Genomic characterization and sequencing by Sanger and Nextgen approaches • Genotyping assay development and validation • Gene expression profiling and validation • Drug efficacy and safety-related analyses • Biologics evaluation and safety testing • Data management, analysis and interpretation • Sample management (incl nucleic acid extraction)and biobanking • Scientific consulting Integral to our laboratories are information management systems and standard operating procedures (SOPs) that comply with GLP (FDA/OECD), cGMP and CLIA regulations. Your data will be accurate and secure, with full chain of custody assured.
L
O
Our scientists provide a truly personalized outsourcing partnership, adding critical value at every step of your process, by applying our expertise in the latest applications and technologies including:
Broadwater Road, Welwyn Garden City, Hertfordshire AL7 3AX
Incubator: just 30 minutes by rail from Central London offering flexible, realistically-priced space for University spin-outs and start-ups. Grow-on and Relocation: laboratory and office accommodation in various configurations. Inward Investment: ideally centred within the research ‘golden triangle’, Cambridge-London-Oxford offering prestigious accommodation for bioscience and health technology businesses intending to establish a base in the UK. Excellent location, close to the railway station and motorways - around an hour to Heathrow, Luton and Stansted airports. Professional Service Providers: flexible office accommodation with comprehensive meeting, conference and event facilities including a 66 seat lecture theatre and the larger ‘Pillars Suite’.
Y Z 118 ERBI DIRECTORY 2010
Activotec’s mission is to establish themselves as the partner COMPANIES of choice for solid phase peptide/organic synthesis. NAME n
Biotechnology Industry Organization (BIO) Ms Rosemary Garcia www.bio.org Telephone : 001 202 857 0244 Fax : 001 202 857 0237
A
BIO represents more than 1,200 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world.
1201 Maryland Avenue, SW, Suite 900, Washington DC USA 20024
B C D E F G
Biotica Technology Ltd Dr Edward Hodgkin info@biotica.com www.biotica.com Telephone : 01799 532920 Fax : 01799 532921 Chesterford Research Park, Little Chesterford, Saffron Walden, Essex CB10 1XL
Biotica is a Cambridge (UK) biotechnology company focused on identifying novel therapeutics based on polyketides. The company uses its proprietary biosynthetic engineering platform to identify novel polyketides, with improved pharmaceutical benefits, which could not be made using medicinal chemistry approaches. The company has implemented partnerships based on differentiated compounds derived from its technology platform, including the following: Pfizer and Biotica are developing novel analogs of the immunosuppressant drug, rapamycin, in new indications. There are more than 40 marketed polyketide therapeutics, including the statins, erythromycin, rapamycin and FK506. Six polyketide drugs have each achieved annual sales in excess of $1 billion. Polyketides are a successful drug class because they have diverse and complex chemical structures, resulting in important biological properties which are not attainable using synthetic small molecules. Biotica has developed a competitive advantage in the discovery of polyketide therapeutics. The company’s business model is to integrate with partners that have extensive therapeutic biology and other complementary capability. Biotica’s approach represents a transformational opportunity to discover a new generation of engineered polyketide therapeutics.
BioWisdom Ltd Dr Gordon Baxter info@biowisdom.com www.biowisdom.com Telephone : 01223 874800
H I J K L M N
BioWisdom is a biomedical informatics company developing systems to help R&D professionals access and analyse critical information and to assist them in the discovery and development of novel medical strategies and pharmaceuticals. Life sciences, drug discovery and development, IT, data mining, data integration, business development, ontological engineering, database management.
O P
Fax : 01223 874801
Q
Harston Mill, Harston, Cambridge, Cambridgeshire CB22 7GG
R S T
Cambridge Biotechnology Ltd (CBT) Mr Robin Turner www.proximagen.com Telephone : 01223 497300 Fax : 01223 496083 Minerva Building (250), Babraham Research Campus, Babraham, Cambridge, Cambridgeshire CB22 3AT
The company’s founders originate from a Pfizer Global Research & Development drug discovery team in what had previously been the Parke-Davis Neuroscience Research Centre. The founders, together with some key academic collaborators, created the company to exploit several opportunities in drug discovery as well as their world class “gene to lead” drug discovery capability. The company has well equipped modern laboratory and office facilities situated on the Babraham Research Campus. This location allows the company to forge links with a host of world class research groups based in the Cambridge area.
U V W X Y Z
WWW.ERBI.CO.UK 119
Activotec’s mission is to establish themselves as the partner of
n
COMPANIES choiceNAME for solid phase peptide/organic synthesis.
Cambridge Research Biochemicals
A B
Ms Emily Humphrys info@crbdiscovery.com www.crbdiscovery.com
C D E
Telephone : 01642 567180 Fax : 01642 567181 10 Belasis Court, Belasis Hall Technology Park, Billingham, Cleveland TS23 4AZ
F
I J K L
Our business works in partnership with other complementary specialist businesses or research institutes to extend our portfolio to offer: unique fluorescent dyes (Cyanagen, Italian partner), monoclonal antibody production and chemistry services (Babraham Bioscience Technology, Cambridge), Radiolabelling (RC-Tritec, Switzerland) and PNA synthesis (Panagene, South Korea). In 2009, CRB was granted EC support of 196,400 Euros as a contributing SME partner in the FP7 BIOSCENT project for providing peptide design and synthesis expertise to develop self-assembling peptides within the context of biomaterials for heart patches. This followed shortly after a Capital Expenditure programme and the support from One North-East Development Agency for 35% towards funding. The company is privately owned by two female directors who were winners of the North-East Women Entrepreneur Awards, for the Innovation through Technology category.”
G H
“Cambridge Research Biochemicals (CRB) celebrates 30 years of providing custom-made research tools to the Life Science community. The company, founded in 1980 is the second oldest peptide company in the world and specialises in everything peptide from design, synthesis, modification and labelling. We generate target specific antibodies to novel proteins and their peptide surrogates. Our chemical expertise is further applied to fluorescent labelling of peptides, antibodies and proteins and we can advise on appropriate fluorescent dyes for FRET and other fluorescence based applications.
Cambridge Theranostics Ltd Dr Ivan Petyaev info@cambridge theranostics.co.uk www.cambridge theranostics.co.uk Telephone : 01223 497130 Fax : 01223 497133 Meditrina Building (260), Babraham Research Campus, Babraham, Cambridge, Cambridgeshire CB22 3AT
Cambridge Theranostics has identified a new mechanism of atherogenesis, caused by a certain class of catalytic antibodies that cross-react with the host serum lipoproteins and cause their peroxidation. We have named these catalytic antibodies ‘AtheroAbzymes’. We show that the presence of these AtheroAbzymes correlates with the level of stenosis of coronary and/or cerebral arteries and with the severity of angina, and that this process is active in most cardiovascular patients. Cambridge Theranostics has developed a new product Ateronon®/TM that inhibits these atherogenic antibodies. Ateronon will be sold as a prescription medical food in the US, and as a health supplement with medical claims in Europe. Cambridge Theranostics also developed the AtheroAbzyme®/TM ELISA tests which support the administration of Ateronon: identification of patients or asymptomatic individuals with active atherogenesis and monitoring and optimisation of their treatment. CTL has clinical research partners in the UK, Russia, USA and Europe and works with major corporations to develop, manufacture and market it products.
M Cantab Biopharmaceuticals Ltd
N O P
Ms Victoria Allen www.xenovabio.com 310 Cambridge Science Park, Milton Road, Cambridge, Cambridgeshire CB4 0WG
Q
Cantab Biopharmaceuticals Ltd (CBL) is a drug development company focused on the development of “biosuperior” products. Cantab is based in Cambridge, UK at the heart of the largest biotech cluster in Europe. The company uses its extensive experience in biopharmaceutical discovery, process development and GMP manufacturing to expedite the development of biosuperiors from inception through clinical development. The strategy of the company is to add value to previously marketed, off-patent, biologics by applying cutting-edge technologies that address sub-optimal characteristics of the marketed product. Particular areas of drug characteristics that Cantab seek to improve upon are product presentation and stability, pharmacokinetics, pharmacodynamics, immunogenicity and drug delivery.
R S T U V
Cellzome Limited Dr Richard Hale www.cellzome.com Telephone : 01799 532800 Fax : 01799 532801
W X
Chesterford Research Park, Little Chesterford, Cambridge, Cambridgeshire CB10 1XL
Y Z 120 ERBI DIRECTORY 2010
Cellzome is a privately-owned drug discovery and development company identifying a new generation of kinase-targeted drugs to treat inflammatory diseases. Its pipeline of small-molecule therapeutics is driven by Kinobeads™, a proprietary technology for the screening and profiling of kinase inhibitors in physiologically-relevant cells and tissues. The most advanced program, targeting PI3K?, is anticipated to enter the clinic in 2010, and several other programs are in early preclinical testing. Cellzome is expanding its distinctive technology, in a novel form called Episphere™, to the discovery and development of novel drug candidates for epigenetic targets in their protein complexes. Cellzome has significant collaborations with GSK and Johnson & Johnson. Its holding company is domiciled in the US and it employs about 90 people at its two laboratories in Cambridge, UK and Heidelberg, Germany.
Activotec’s mission is to establish themselves as the partner COMPANIES of choice for solid phase peptide/organic synthesis. NAME n
Coherent Logic Ltd Mr Thomas Fuller info@coherentlogic.com www.coherentlogic.com
A
Our goal is to help life sciences organisations in the UK move from the desktop to the enterprise. We accomplish this by focusing on key areas of software development that are critical to keeping life sciences businesses competitive, agile, and able to proactively plan for change rather than reacting to change in the market - these include enterprise software application development, service-oriented software development, and business process management and workflow solutions.
2nd Floor, 145-157 St John Street, London EC1V 4PY
B C D E F G
Colonix Medical Limited Ms Kal Khelie info@colonixmedical.com www.colonixmedical.com Telephone : 01223 750490 Fax : 1223 1 Riverside, Granta Park, Abington, Cambridge, Cambridgeshire CB21 6AD
Colonix Medical Limited is a UK based organisation with offices in mainland Europe and the U.S.A. The company is dedicated to researching, developing and commercialising new products for the early and accurate detection of bowel disorders, in particular colorectal cancer. Many thousands of hours of research by our own research and development team, combined with our clinical collaborators have enabled the launch of our first commercial IVD based product, ColoGenixTM Pre-View. ColoGenix™ Pre-View is an innovative, minimally invasive and inexpensive test that can be used as a colonoscopy qualification tool for symptomatic patients. This product is the first of a series of tests to be released. All of these products utilise the Colonix Cell Sampling device. This is an operator and patient friendly device that has been carefully designed and perfected with the assistance of many clinicians. The final product can be operated by a nurse and the virtually painless cell collection procedure takes less than five minutes to perform. As a company Colonix is interested in talking to global distributors, potential partners and customers with a view to driving this unique product forward.
Crescendo Biologics Ms Amanda Bettison www.crescendobiologics.com Telephone : 01223 497140 Meditrina Building, Babraham Research Campus, Cambridge, Cambridgeshire CB22 3AT
H I J K L M N
Crescendo Biologics is a Cambridge-based biotech company whose vision is to deliver nextgeneration antibody therapeutics based on novel class-leading platforms. The focus of the company is on developing platforms that will address key issues in generating high-affinity, soluble, human VH antibody fragments (the smallest fragments that retain antibody binding, and have many desirable properties as potential therapeutics). Crescendo will then utilise these platforms for product development of in-house targets or in partnership with other companies.
O P Q R S T
Cresset BioMolecular Discovery Ltd Dr Beatrice Leigh info@cresset-bmd.com www.cresset-bmd.com Telephone : 01707 356120 Fax : 01707 356118 BioPark Hertfordshire, Broadwater Road, Welwyn Garden City, Hertfordshire AL7 3AX
While conventional modelling approaches rely on the atom and bond representations of compounds, Cresset’s field technology provides a powerful ‘protein’s view’ of the key molecular features required for biological activity. Furthermore, using molecular field patterns to compare molecules enables a robust structure-independent method of identifying novel chemical classes that can take a project into new intellectual property space. This technology is especially valuable for certain classes of receptors such as GPCR and ion channels, which are highly valued by the pharmaceutical industry but which lack sufficient X-ray crystallographic structures to allow easy molecular design. Cresset has a global client base which includes six major pharma companies and more than twenty biotechnology companies.
U V W X
Access to Cresset’s field technology is currently through three business models:
Y
1) FTE-based Projects 2) Technology Development 3) Software Leasing
Z WWW.ERBI.CO.UK 121
Activotec’s mission is to establish themselves as the partner of
n
COMPANIES choiceNAME for solid phase peptide/organic synthesis.
Cyclofluidic Ltd
A B
Dr David Parry www.cyclofluidic.co.uk Telephone : 01707 358673
C D
BioPark, Broadwater Road, Welwyn Garden City, Hertfordshire AL7 3AX
Cyclofluidic is a young technology company integrating chemistry and biology for drug discovery application. We are developing an integrated chemical synthesis through biological assay platform utilising microfluidic technologies to dramatically improve the efficiency of structure activity data generation for pharmaceutical research. Small molecule drug discovery typically involves many iterations of synthesis of novel molecules and their characterisation both chemical and biological in an iterative manner. In a typical large pharmaceutical company each iteration will take a minimum of a couple of weeks. In contrast the platform Cyclofluidic is developing will be capable of undertaking the entire process in just a couple of hours. This dramatic improvement in efficiency will enable not only faster discovery but also provides greater oopportunity for the exploration of more areas of chemical space with the potential to improve the quality of clinical candidates.
E
Alongside research and development of the integrated platform Cyclofluidic is also exploring an open access laboratory for microfluidics in chemistry and biology and would be interested in talking to companies who have an interest in this rapidly developing arena.
F
Cyclofluidic shareholders are Pfizer and UCB with additional funding through a Technology Strategy Board grant.
G H I
Cytocell Technologies Dr Martin Lawrie probes@cytocell.com www.cytocell.com
A small medical device manufacturing company, recently been acquired through a management buy-out from Cytomyx Holdings plc. Manufacturers of innovative screening solutions for a variety of genetic disorders using Fluorescence in situ Hybridisation as a core technology. Current strengths are in the routine cytogenetics field, though new developments based on a proprietary delivery platform for FISH probes are aimed at the Oncology market, specifically in Haematology.
Telephone : 01223 294048
J K
Units 4 Technopark, Newmarket Road, Cambridge, Cambridgeshire CB5 8PB
L M Domainex Ltd
N O P Q
Dr Eddy Littler www.domainex.ltd.uk Telephone : 01993 201801 Fax : 01993 200401 324 Cambridge Science Park, Milton Road, Cambridge, Cambridgeshire CB4 OWG
R
T
V
Combinatorial Domain Hunting or CDH is a unique patented technology conceived by Prof Laurence Pearl’s team of leading structural biologists and is specifically aimed at expressing protein targets for drug discovery that can not be expressed by other approaches. CDH has been applied to targets from many leading Pharma.
Domantis Limited Dr Ian Tomlinson reception@domantis.com www.domantis.com Telephone : 01223 226900
W
Fax : 01223 226901
X
R&D Headquarters, 315 Cambridge Science Park, Milton Road, Cambridge, Cambridgeshire CB4 0WG
Y
Our unique LeadBuilder technology for finding in a highly cost effective manner robust developable hits. LeadBuilder has been used many times for clients in the academic or biotech areas with great effect. Our medicinal chemistry expertise is based upon a team of highly experienced medicinal chemists based in Cambridge with a history of working for leading European Pharma and Biotech. We specialise in tackling a broad range difficult targets for drug discovery, including peptidomimetics.
Domainex also has its own drug discovery pipeline. Domainex’s lead project is IKK epsilon which is in lead optimisation for breast cancer. Domainex also has a pipeline of lysine methyl transferases (KMTs) all targeted at cancer. Our unique CDH technology has been applied to a number of KMTs with the aim of producing unique x-ray structures and assays.
S
U
Domainex offers services including highly experienced computational and medicinal chemistry and a unique patented technology called CDH.
Z 122 ERBI DIRECTORY 2010
Domantis develop a range of platform technologies for the in vitro evolution and engineering of recombinant proteins. The field of recombinant proteins is showing immense potential and is expected to yield both new medicines together with vital diagnostic and proteomic tools.
Activotecâ&#x20AC;&#x2122;s mission is to establish themselves as the partner COMPANIES of choice for solid phase peptide/organic synthesis. NAME n
Dx Tech UK Ltd Ms Emma Jones www.dxtech.com Telephone : 01799 533160
A
Dx Tech LLC was created by XL Tech group in July 2005 & is developing a unique microfluidic platform that replaces essentially all common blood tests performed at reference laboratories with a fully automated, point of need device. This technology has applications in significantly lowering costs & increasing efficiency for major pharmaceutical companies in their clinical trials, the provision of diagnostics in developing countries & delivering a new revenue stream for doctors.
Fax : 01799 531385 4 Abbey Barns, Duxford Road, Cambridge, Cambridgeshire CB10 1SX
B C D E F G
Eagle Genomics Ltd Dr Abel Ureta-Vidal info@eaglegenomics.com www.eaglegenomics.com Telephone : 01223 654481 Fax : 01223 281125 Babraham Research Campus, Babraham, Cambridge, Cambridgeshire CB22 3AT
Open-source bioinformatics software gives you unparalleled access to the very latest algorithms, data and techniques to use in your R&D. However, it can be hard to obtain timely technical support when things donâ&#x20AC;&#x2122;t go quite to plan. This can cost you time and money from lost productivity. Eagle Genomics provides that support. For a range of open-source bioinformatics technologies we guarantee our response times under a Service Level Agreement and provide you with fixes and customisations. This saves you time and effort, and helps minimise the cost of your projects. Our team of high calibre developers and researchers is drawn from both industry and academia with over 30 years combined experience in bioinformatics and software development. Eagle is extremely flexible in the ways we can work with our customers. Whether you are a big pharma or a university research group, a CRO or a small biotech startup, we can provide exactly what you need to make the most of your investment in open-source bioinformatics.
H I J K L M
East of England International (EEI) Mr Chris Ilsley info@eeia.com www.eeia.com Telephone : 01707 398116 2 Quayside, Cambridge, Cambridgeshire CB5 8AB
N
East of England International provides business support to companies seeking to trade internationally and assists foreign-owned businesses looking to invest in the region. Our International Trade Advisers deliver UK Trade & Investment programmes to local businesses while our Business Development Managers provide free and confidential advice to overseas companies, saving clients valuable management time and costs. Our service includes arranging site visits, supplying local and regional socio-economic data, advice on recruitment, introductions to university research contacts and industry partners, and providing supply chain information. Our Investor Development programme provides on-going support to companies located in the East of England.
O P Q R S T
Essen Instruments Ltd Mr Tim Dale ics@essen-instruments.com www.essen-instruments.com Telephone : 01707 358685 BioPark, Broadwater Road, Welwyn Garden City, Hertfordshire AL7 3AX
Essen Instruments is a leading instrument and service provider in the life science research field with a long history of product innovation. Products invented by Essen personnel include the first high-throughput cell-based assay platform, FLIPR; the first high-throughput planar electrophysiology platform on the market, IonWorks and the first live-cell imaging system to fit inside a standard cell culture incubator, IncuCyte. Recently, Essen has expanded their instrumentation-based business model to also include contract services, assembling a team of senior scientists who have successfully managed and driven drug discovery projects at major pharmaceutical companies.
U V W X Y Z
WWW.ERBI.CO.UK 123
Activotec’s mission is to establish themselves as the partner of
n
COMPANIES choiceNAME for solid phase peptide/organic synthesis.
f-star GmbH
A B
Dr Kevin FitzGerald office@f-star.com www.f-star.com
C D E
Telephone : 01223 497113
The company develops improved therapeutic antibodies and antibody fragments based on its Modular Antibody Technology, which allows the introduction of additional binding sites into antibodies and antibody fragments by engineering the non-CDR loops of constant or variable domains. Using Modular Antibody Technology, antibody fragments with antibody functionality and long half-life but much smaller size (FcabT) or full antibodies with additional functionality (mAb2) can be created.
Babraham Research Campus, Building 201, Babraham, Cambridge, Cambridgeshire CB22 3AT
F G H I
Genzyme Mr Matthew Roe research.cambridgeuk@ genzyme.com www.genzyme.co.uk
J
Telephone : 01440 703522
K
12 Rookwood Way, Haverhill, Suffolk CB8 8PB
Fax : 01440 716269
L
Genzyme Europe Research is Genzyme’s first dedicated research facility in Europe based on the Cambridge Science Park. The science team is currently focused on Antibody Technology. Additional complementary therapeutic technologies will be imported to increase the repertoire of the team as opportunities arise. The team is using phage display technology to create reagent antibodies for target validation purposes as well as candidate therapeutic antibodies to targets of interest. Both single chain variable domain (scFv) phage display libraries, as well as FAb phage libraries are being employed. A close working relationship exists between the Cambridge Team and the Framingham (MA) based Molecular Immunology and New Protein Therapeutics Groups. Targets of interest to the Oncology, IMD and Renal Biology Portfolios have been identified and efforts are underway to create single chain and FAb fragments to these targets. Following attainment of proof of concept in pre-clinical models, a major goal for the Cambridge team will be the use of Antibody Technology to create candidate therapeutic antibodies for use in clinical trials.
M Gilead Sciences Ltd
N O P Q
Ms Lisa Bright www.gilead.com Telephone : 01223 897300 Fax : 01223 897282 Granta Park, Abington, Cambridge, Cambridgeshire CB21 6GT
Gilead Sciences is a research-based biopharmaceutical company that discovers, develops and commercialises innovative medicines in areas of unmet need. With each new discovery and experimental drug candidate, we seek to improve the care of patients suffering from life-threatening diseases. Gilead’s primary areas of focus include: antivirals (such as HIV/AIDS and chronic hepatitis), cardiovascular conditions (such as pulmonary arterial hypertension and resistant hypertension) and respiratory diseases (such as influenza and cystic fibrosis).
R
Gilead Sciences has grown from one facility in California to 19 sites with more than 2,900 employees in 15 countries across North America, Europe and Australia. Outside of North America, we have offices in 15 European countries and Australia. Our European headquarters are located in Stockley Park, outside London, in the United Kingdom. Gilead plans to open additional commercial operations in Europe in the coming months.
S
We have created a network of exclusive distributors that work to ensure access to our commercial products in many parts of the world. These distributors currently support Gilead products in more than 40 countries across Eastern Europe, Scandinavia, the Middle East, Asia, Africa and Latin America
T U V
GlaxoSmithKline Dr Malcolm Skingle www.gsk.com Telephone : 01438 745745 Fax : 01438 764502
W X
Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY
GlaxoSmithKline (GSK) is a world leading research-based pharmaceutical company with a powerful combination of skills and resources that provides a platform for delivering strong growth in today’s rapidly changing healthcare environment. Headquartered in the UK and with operations based in the US, the new company is one of the industry leaders, with an estimated seven per cent of the world’s pharmaceutical market. GSK also has leadership in four major therapeutic areas - anti-infectives, central nervous system (CNS), respiratory and gastro-intestinal/metabolic. In addition, it is a leader in the important area of vaccines and has a growing portfolio of oncology products. The company also has a Consumer Healthcare portfolio comprising over-the-counter (OTC) medicines, oral care products and nutritional healthcare drinks, all of which are among the market leaders.
Y
GSK R&D is based at 24 sites in seven countries. The company has a leading position in genomics/ genetics and new drug discovery technologies. The GSK R&D budget is about £2.4bn/$4bn.
Z 124 ERBI DIRECTORY 2010
Activotec’s mission is to establish themselves as the partner COMPANIES of choice for solid phase peptide/organic synthesis. NAME n
Horizon Discovery Ltd Dr Rob Howes r.howes@horizondiscovery.com www.horizondiscovery.com Telephone : 01223 655580 Fax : 01223 862240
A
Central to realizing this ambition is the deployment of a proprietary gene-engineering technology called GENESIS that enables any endogenous gene in a human cell-line to be altered quickly, reliably and without introducing unwanted and confounding genotypes and/or phenotypes. Using GENESIS, a wide panel of genetically-defined and patient-relevant X-MAN (Mutant And Normal) cell models have been developed and these are fast being adopted by academic and industry leaders to find and tailor the ‘right drugs’ to the ‘right patients’ based upon the unique genetic mutations that define their disease.
B C D
Building 7300 (7340), IQ Cambridge, Waterbeach, Cambridge, Cambridgeshire CB25 9TL
E F G
Huntingdon Life Sciences Dr Adrian Hardy strat.dev@ukorg.huntingdon.com www.huntingdon.com Telephone : 01480 892000 Fax : 01480 890693 Woolley Road, Alconbury, Huntingdon, Cambridgeshire PE28 4HS
Huntingdon Life Sciences has considerable experience in supporting the development of biotechnology-derived pharmaceuticals, having been involved in the safety testing of these products since they were first introduced in the early 1980s. We have worked with a large number of companies in developing a diverse range of products including; recombinant proteins, monoclonal antibodies, vaccines, gene and somatic cell therapy, antisense products and conventional biologics. Our services include, • multiple species studies including transgenics • histology / immunocytochemistry laboratory to assess cross-reactivity of monoclonal antibodies with human and animal tissues • methods to detect biopharmaceuticals and antibodies raised to them in biological matrices • methods to assess the effects of biopharmaceuticals on immune status and function • in vitro and in vivo models to assess pharmacology and efficacy • range of safety pharmacology models • range of reproductive toxicity studies • range of genotoxicity studies
H I J K L M
Hypoxium Dr Dan Cowell info@hypoxium.com www.hypoxium.com
N
Hypoxium is a contract research organization specializing in cell biology within the oncology therapeutic area. Using our expertise in drug discovery and oncology translational research, we assist biotechnology and pharmaceutical companies to rapidly and successfully progress their lead compounds.
O P
Telephone : 01223 438240 Fax : 01223 438241
Q
260 Cambridge Science Park, Milton Road, Cambridge, Cambridgeshire CB4 0WE
R S T
Illumina Ltd Mr Alan Kersey info@illumina.com www.illumina.com Telephone : 01799 532300 Fax : 01799 532301 Chesterford Research Park, Little Chesterford, Saffron Walden, Essex CB10 1XL
At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina’s innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic. leading-edge products and services Illumina has developed a comprehensive line of products that address the scale of experimentation and the breadth of functional analysis required to achieve the goals of molecular medicine. Our offering includes leading-edge solutions for: • SNP genotyping • Copy number variation • DNA methylation studies • Gene expression profiling • Low-multiplex analysis of DNA, RNA, and protein Our products and services are used by a broad range of academic, government, pharmaceutical, biotechnology, and other leading institutions around the globe.
WWW.ERBI.CO.UK 125
U V W X Y Z
Activotecâ&#x20AC;&#x2122;s mission is to establish themselves as the partner of
n
COMPANIES choiceNAME for solid phase peptide/organic synthesis.
Ionscope Limited
A B
Mr Noah Freedman noah@ionscope.com www.ionscope.com
C D E
Telephone : 01763 269070 Fax : 01763 280400 A2 Ash House, Melbourn Science Park, Melbourn, Hertfordshire SG8 6HB
F G H I
K
Scanning Ion Conductance Microscopy, developed at Imperial College London and the University of Cambridge and manufactured by ionscope limited, addresses some of these challenges. SICM scans without physical contact or force interaction, operates in electrolytic liquid and causes no disturbance to the target, allowing continuous, repeated scanning over long periods and enabling the study of processes in action: biological - cell interaction, microvilli dynamics, endo- and exocytosis, volume change and protein dynamics; physical - corrosion, etching and deposition. SICM requires minimal sample preparation. SICM uses a nanopipette as its scanning probe. As well as imaging, an SICM probe can be used to steer or carry other sensing techniques at a controlled distance from the target surface. The pipette may also be used to deliver or deposit material at the scanning resolution on a surface of any shape.
Isogenica Ltd Mr Chris Ullman www.isogenica.com Telephone : 01799 533685 Fax : 01799 531940
J
Scanning microscopy is the preferred technique for imaging surface detail too small to resolve using a traditional optical microscope, but it struggles with soft or fragile surfaces. Imaging the plasma membrane of a living cell usually involves killing the cell and modifying the target - whether by fixing, freezing, metalizing or staining.
The Mansion House, Chesterford Research Park, Little Chesterford, Saffron Walden, Essex CB10 1XL
Isogenica is aiming to become a world leader in the commercial exploitation of cutting edge molecular evolution technologies and protein engineering. Isogenica has a proprietary molecular evolution technology called CIS display. The technology allows rapid discovery of new antibody, peptide and polypeptide drug candidates, to the discovery of high specificity diagnostic compounds and to the isolation of target validation and other research reagents, purification reagents, environmental detection reagents and more. CIS display is an in vitro display technology that exploits a cis-acting DNA binding protein to link individual genes from gene libraries (of up to 100 trillion members) to their expressed polypeptides. This linkage of genotype to phenotype enables the faster selection of better lead candidates to commercially relevant targets. The technology is adaptable for the display of protein scaffolds, including scFvs, and licences are available for their use.
L M
KuDOS Pharmaceuticals Ltd
N O P
Ms Siobhan Shadwell info@kudospharma.co.uk www.kudospharma.co.uk Telephone : 01223 719719 Fax : 01223 719720
Q R
KuDOS Pharmaceuticals holds a leading position in the identification and development of drugs that target the DNA Damage Response (DDR) processes in cells. The company has identified potent inhibitors of a number of DNA repair pathways including PARP, ATM and DNA-PK. The company was aquired in 2006 by AstraZeneca and has been developing, in partnership with AZ, DDR inhibitors that specifically target cancer. The PARP inhibitor olaparib is the most advanced clinical agent from the DDR portfolio where it shows powerful single agent activity in tumours that have a genetic mutation known as BRCA.
410 Cambridge Science Park, Milton Road, Cambridge, Cambridgeshire CB4 0PE
S T U V
Lab21 Mr Graham Mullis info@lab21.com www.lab21.com Telephone : 01223 395450
W X
184 Cambridge Science Park, Milton Road, Cambridge, Cambridgeshire CB4 0GA
Y Z 126 ERBI DIRECTORY 2010
Lab21 is a rapidly growing global provider of state-of-the-art diagnostic products and services, supporting blood bank screening, medical diagnostics and drug discovery. Its customers include international healthcare providers, pharmaceutical and biotechnology companies. The product division of the Company manufactures immunodiagnostic kits and reagents that are distributed into 110 countries globally through both direct and indirect channels. A key focus is infectious diseases for the blood banking market, with assays available for syphilis, CMV and malaria. The service division has a growing test portfolio providing companion diagnostics and high technology molecular assays for the growing integration of personalised medicine into healthcare. These services are currently in infectious diseases, oncology, virology and pharmacogenetics areas with emerging interests in cardiovascular and metabolic disease. Lab21 has 5 sites in the UK with two highly accredited reference laboratories and 3 immunodiagnostic manufacturing sites. The Company also has two sites in the State of South Carolina for its US operations.
Activotec’s mission is to establish themselves as the partner COMPANIES of choice for solid phase peptide/organic synthesis. NAME n
Lectus Therapeutics Limited Ms Terri Hullyer info@lectusth.com www.lectustherapeutics.com Telephone : 01223 499050 Fax : 01223 499055 Meditrina Building, Babraham Research Campus, Cambridge, Cambridgeshire CB22 3AT
A
Lectus Therapeutics Limited is a Cambridge (UK)-based pharmaceutical company. Its mission is to build a development pipeline containing first-in-class ion channel therapeutics identified through the use of its proprietary proteomics technologies for pain management and related indications. Lectus exploits its proprietary functional proteomics platform, LEPTICS®, to discover next-generation ion channel modulator drugs. These are anticipated to have fewer side effects bringing a greater likelihood of identifying candidates for subsequent clinical development. Lectus has attracted a top tier syndicate of investors providing >£12M investment, to date, to advance its existing discovery programmes and to provide opportunities for commercial partnerships. Lectus’s current investors include Sofinnova Partners, Spark Ventures, Takeda Research Investment, Inc., (the corporate venture arm of Takeda Pharmaceutical Company Ltd) and Astellas Venture Management (the venture capital arm of Astellas Pharma Inc.). Lectus’s corporate strategy is to generate value by building a portfolio of pharmaceutical assets within the therapeutic areas of pain management and related indications.
www.lonzagroup.com Telephone : 01753 777000 Fax : 01753 777001 Advanced Protein Technologies, Meditrina Building, Babraham Research Campus, Cambridge, Cambridgeshire CB22 3AT
C D E F G
Lonza Biologics Plc Dr Jesus Zurdo
B
Lonza is one of the world’s leading suppliers to the pharmaceutical, healthcare and life science industries. Its products and services span its customers’ needs from research to final product manufacture. Lonza is the global leader in the production and support of active pharmaceutical ingredients both chemically as well as biotechnologically. Lonza’s Advanced Protein Technologies (APT) brings quality-by-design methodologies to the development of biopharmaceuticals to produce better and safer molecules. The recently acquired Epibase® technology (Algonomics) together with Lonza’s AggreSolve™ platform integrate unique immunogenicity and stability risk assessment and re-engineering capabilities for the development of better and safer biotherapeutics. Our technologies have been extensively validated in different molecules with remarkable results.
H I J K L M
Medivir AB Dr Paul Wallace www.medivir.com Telephone : 01799 532100 Fax : 01799 532101 Chesterford Research Park, The Mansion, Little Chesterford, Essex CB10 1XL
N
Medivir AB was founded in 1988 as a spinout from Astra. It is a public pharmaceutical company, listed on the Stockholm Exchange O-list since 1996. Located near Stockholm, Sweden and Cambridge, UK it employs around 100 staff in the research and development of drugs across therapeutic areas, addressing two classes of drug target: proteases and polymerases. With its wholly-owned subsidiary, Medivir HIV Franchise AB, it has 7 development stage products: Lipsovir: phase 3; topical product for the prevention of cold sores MIV-606: phase 2; oral product for the treatment of shingles MIV-310: phase 2; oral product for treatment of multi-resistant HIV infection MIV-210: phase 2; oral product for treatment of HBV and multi-resistant HIV infection HCV-PI: phase 1; oral product for treatment of HCV infection Cat K-PI: phase 1; oral product for treatment of osteoporosis and osteoarthritis MIV-150: phase 1; topical product for prevention of HIV infection The company has several strategic partners including: Tibotec (Johnson & Johnson); Bristol-Myers Squibb, Epiphany Biosciences, Presidio Pharmaceuticals, Population Council, Lantai and Hengrui
info@melbournscientific.com www.melbournscientific.com Telephone : 01763 261648 Fax : 01763 261791 Saxon Way, Melbourn, Royston, Hertfordshire SG8 6DN
P Q R S T
Melbourn Scientific Ltd Mr Mark Hammond
O
Melbourn Scientific provides high quality cGMP analytical and formulation services to the pharmaceutical, biotech and healthcare industries. Our experienced team of analysts and formulation scientists offers method development, method validation, stability studies, expertise in inhaled products and other novel delivery systems, and a wide range of product formulation and testing services. Novel forms of drug delivery are going to be required for many new compounds. Melbourn works with many of the world’s most innovative device developers, biotech and pharmaceutical companies and, as a consequence, offers a significant understanding of a wide variety of delivery platforms from lead optimisation to final dosage form. Quality is at the heart of our business. This is proven time and again through regular audits from clients and the regulatory bodies including many successful FDA and MHRA inspections. Call us on 01763 261648 for more information.
U V W X Y Z
WWW.ERBI.CO.UK 127
Activotec’s mission is to establish themselves as the partner of
n
COMPANIES choiceNAME for solid phase peptide/organic synthesis.
Norwich Bio-Incubator
A B
Dr Jonathan Clarke www.norbio.com Telephone : 01603 450950
C D
Fax : 01603 450951 Norwich Research Park, Colney Lane, Norwich, Norfolk NR4 7UH
F G
I
K
Mrs Lynda Donovan mail@novactabio.com www.novactabio.com
Fax : 01707 356131 BioPark Hertfordshire, Broadwater Road, Welwyn Garden City, Hertfordshire AL7 3AX
L
Q
Biotransformations - Novacta Biosystems enables acceleration of drug discovery and/or improvement in process economics using biotransformations. Active pharmaceutical ingredients, flavourings and cosmetics are amongst the range of products investigated. Metabolites - Novacta Biosystem’s technology is particularly powerful in enabling the prediction and synthesis of drug metabolites. The ability of micro-organisms to mimic mammalian metabolism, producing metabolites in amounts from mgs through to Kgs, is an effective tool for meeting regulatory requirements in the pharmaceutical industry and in expediting the drug discovery process. Pathway Engineering - this involves the deliberate manipulation of the natural biosynthetic pathway(s) of microbial metabolites, in order to generate novel products. Novacta Biosystems uses a range of specialist approaches in the development of new or modified pathways.
Novus Biologicals Ltd
N
P
Novacta’s Biosystems division provides a service to and enters into alliances with chemical and life sciences companies - ranging from SMEs to blue-chip companies. Our core expertise is focussed in three areas: biotransformations, metabolite factories and pathway engineering.
Novacta offers a free consulting assessment in all areas of our services. As with previous clients, Novacta Biosystem’s aim is to establish a long term relationship.
M
O
A wide range of business support and incubation services are available both from the Norwich BioIncubator directly and through its extensive network of experts, specialists and business support service providers.
Novacta Biosystems Limited
Telephone : 01707 356130
J
Located at the John Innes Centre on the Norwich Research Park the Norwich Bio-Incubator is part of one of the largest clusters of world leading life science research. Other institutions on the Norwich Research Park include the Institute of Food Research, Norfolk and Norwich University Hospital, Sainsbury Laboratory and the University of East Anglia who together employ more than 6,500 research staff.
Tenants of the Norwich Bio-Incubator are able to access a wide range of scientific support services including state of the art genomics and proteomics and specialist plant and microbial growth facilities. The Norwich Bio-Incubator works with prospective tenants to develop the service package their company requires to maximise its potential. To find out how the Norwich Bio-Incubator can assist you develop your business please call or email Dr Jon Carter (01603 450950, j.carter@norbio.com)
E
H
The Norwich Bio-Incubator delivers its mission by offering a combination of accommodation, business development and scientific services.
Mr Mark Long novus@nobusbio.com www.novusbio.com 12 Cambridge Science Park, Milton Road, Cambridge, Cambridgeshire CB4 0FZ
The mission of Novus Biologicals, Ltd. is to accelerate scientific discovery by developing and marketing unique products in the forefront of science. Novus Biologicals was organized to provide the biological research community with a mechanism for commercializing unique biological materials. We also focus on continually monitoring scientific trends and supplying materials to serve these trends. Novus Biologicals Ltd. core focus is the serve the research community of the United Kingdom and the European Union.
R S T U V
O2h Mr Sunil Shah info@o2h.com www.o2h.com Telephone : 01223 437014
W
Fax : 01223 437016
X
23 Cambridge Science Park, Milton Road, Cambridge, Cambridgeshire CB4 0EY
Y Z 128 ERBI DIRECTORY 2010
Oxygen Healthcare Research Pvt. Ltd. (O2h) is a privately owned, 5 year old, second generation chemistry services company. 100 employees work within its international HQ in Cambridge, UK and its operations in Ahmedabad, India. O2h have developed powerful specialist capabilities in medicinal and organic chemistry and have a track record with 4 of the global top 20 pharmaceutical companies as well as a wide spectrum of biotechnology companies working in early stage discovery in the UK, Japan, USA and Europe. Service offerings from O2h include FTEbased synthetic chemistry, Medicinal Chemistry, Computational Chemistry, Full-service lab-units and Invitro ADME. O2h vision is to be ‘man-for-man’ the best performing drug discovery services company in the world. Therefore, a client can expect that we have set ourselves the highest standards of performance in terms of confidentiality, quality of work, project facilitation and delivery timelines. We offer an unparalleled level of communication, metrics analysis and performance feedback that provide our clients with an intimate role in ensuring success of the collaboration.
Activotec’s mission is to establish themselves as the partner COMPANIES of choice for solid phase peptide/organic synthesis. NAME n
Orthomimetics Ltd Mr Allen Takawira info@orthmimetics.com www.orthomimetics.com
A
OrthoMimetics (OM) is a privately held company formed as the first spin-out venture from the Cambridge-MIT Institute (CMI). OM brings together a portfolio of world-class technologies and a management team with a proven track record for bringing products to market.
Fax : 01223 437471
The founding of OrthoMimetics in 2005 was preceded by a four-year product and preclinical development programme sponsored by CMI. Drawing on design inputs from a team of worldrenowned surgeons, engineers and scientists, this programme gave birth to the proprietary technology platform upon which the company’s product line is based.
Byron House, Cambridge Business Park, Cowley Road, Cambridge, Cambridgeshire CB4 0WZ
Harnessing this patent-protected platform, OrthoMimetics is focused on the development and manufacture of products that provide surgeons with a practical, reproducible and adaptable means of improving the outcome of existing surgical procedures for the regenerative repair of cartilage, ligament and tendon.
Telephone : 01223 437470
B C D E F G
Oxoid (Ely) Limited Mrs Marianne Muldbjerg contact@thermofisher.com
Oxoid Ely is part of Thermo Fisher Scientific, world leader in serving science. We specialise in products for the in vitro diagnostic market particularly in the area of infectious disease. Contract development and manufacture is also undertaken in our modern, well-equipped facilities.
www.oxoid.com
H I
Telephone : 01353 646200
J
Fax : 01353 646246 Denmark House, Cambridgeshire Business Park, Angel Drove, Ely, Cambridgeshire CB7 4ET
K L M PAION UK Limited
Dr Gavin Kilpatrick www.paion.com Telephone : 01223 266466 Fax : 01223 266467 Compass House, Vision Park, Chivers Way, Histon, Cambridgeshire CB4 9ZR
N
PAION UK Ltd (formerly CeNeS Pharmaceuticals) is a subsidiary of PAION AG, a biopharmaceutical company headquartered in Aachen, Germany. PAION is specializing in developing and commercializing innovative drugs for the hospital-based treatment of central nervous system (CNS) disorders and thrombotic/cardiovascular diseases, indications for which there is a substantial unmet medical need. The company intends to further expand its portfolio of drugs by exploiting its core expertise in identifying high-potential compounds, licensing or otherwise acquiring them and advancing them through the clinical development and regulatory approval process. PAION is listed at the Frankfurt Stock Exchange (Prime Standard Regulated Market, Stock Symbol PA8, ISIN DE000A0B65S3).
O P Q R S T
Pathology Diagnostics Ltd Dr Madhuri Warren info@pathologydiagnostics.com www.pathologydiagnostics.com Telephone : 01223 421334 Fax : 01223 701451 St John’s Innovation Centre, Cowley Road, Cambridge, Cambridgeshire CB4 0WS
Pathology Diagnostics Ltd. is an independent Cambridge-based company delivering specialist tissue laboratory and diagnostic services to clients to support the development of novel drugs and companion diagnostics. We aim to provide a one stop solution to all your human tissue diagnostic needs from preclinical development to clinical trials. Serving major pharmaceutical, biotech and contract research organisations, tissue banks and academia, we provide a complete solution for novel drugs and companion diagnostics from early phase target discovery to clinical trials. Services include tissue distribution, tissue microarray manufacture, laboratory processing, immunohistochemistry, expert diagnostic analysis and delivery of detailed reports to clients for their commercial needs. From target identification to clinical trials, we provide a unique breadth of scienctific and medical laboratory and diagnostics expertise. Our team of experienced accredited pathologists and laboratory personnel ensures high standard of reporting of studies, and GLP compliance, ensuring quality results and peace of mind. Our additional core strengths are our quality consistency and reliability, fast turnaround times, complete confidentiality and competitive pricing.
U V W X Y Z
WWW.ERBI.CO.UK 129
Activotec’s mission is to establish themselves as the partner of
n
COMPANIES choiceNAME for solid phase peptide/organic synthesis.
Pfizer Limited
A B
Dr Ian Smith www.pfizer.co.uk Telephone : 01304 616161
C D
Pfizer will strive to achieve and sustain its leading place as the world’s premier research-based pharmaceutical company. The company’s continuing success benefits patients, customers, shareholders, business partners, families and the communities in which they operate all around the world. Pfizer’s mission is to become the world’s most valued company to all of these people.
Fax : 01304 656978 Granta Park, Pfizer Ltd ipc 300, Cambridge, Cambridgeshire CB21 6GP
E F G H I
Pfizer Regenerative Medicine Ms Marie Compain marie.compain@pfizer.com
Pfizer Regenerative Medicine will operate as one of Pfizer’s new small, independent research units to help it foster a biotechnology culture and environment.
www.pfizer.com Telephone : 01304 643485
J K
UCB Building, Granta Park, Cambridge, Cambridgeshire CB21 6GS
L M Pharmorphix
N O
Ms Jayne Williams
Pharmorphix offers customers tailored products and services across the following key areas:
info@sial.com
• Polymorph Screening and Salt Selection. • Physicochemical Property determinations. • Classical Resolution and Process Research
www.pharmorphix.com
P Q R
Telephone : 01223 425105 Fax : 01223 424930 250 Cambridge Science Park, Milton Road, Cambridge, Cambridgeshire CB4 0WE
S T U V
Phico Therapeutics Ltd Dr Heather Fairhead info@phicotherapeutics.co.uk www.phicotherapeutics.co.uk Telephone : 01223 496562
W
Fax : 01223 496563
X
Building 405, Babraham Research Campus, Babraham, Cambridge, Cambridgeshire CB22 3AT
Y Z
130 ERBI DIRECTORY 2010
Phico is a small biotechnology company developing a groundbreaking antibiotic platform technology known as SASPject. The technology is designed to target any harmful type of bacteria, including ‘superbugs’ such as MRSA and C. difficile. The technology utilises programmable delivery vectors to deliver genes encoding unique antibacterial proteins, SASP, to target bacteria. Phico’s first product, SASPject PT1.2 aimed at S. aureus, including MRSA, has completed a Phase I clinical trial. This product has shown rapid activity in culture against >200 clinical strains of S. aureus killing up to 99.9 % of MRSA bugs within 2 minutes. The technology is patent protected in the US, Europe, Japan and Australia, and pending in Canada. Each product is expected to have separate patent coverage with the PT1.2 product patent granted so far in the UK. Phico plans to licence PT1.2 post Phase II clinical trial and to license, post Phase I, its other products in development, including SASPjects targeted at C. difficile and a group of Gram negative bugs including E. coli/K. pneumoniae/P. aeruginosa. Phico has raised approximately £9 M to date, including a Strategic Translation Award for £1.03 M from the Wellcome Trust to fund the Phase I and II clinical trials with SASPject PT1.2.
Activotec’s mission is to establish themselves as the partner COMPANIES of choice for solid phase peptide/organic synthesis. NAME n
Population Genetics Technologies Ltd Prof Conrad Lichtenstein www.populationgenetics technologies.com Telephone : 01223 497 350 Fax : 0870 122 9121 Building 405, Babraham Research Campus, Babraham, Cambridge, Cambridgeshire CB22 3AT
A
Population Genetics Technologies (PGT) Ltd was founded in 2005 to improve methods for the study of genetic variation in populations since this is the only way in which clinically meaningful information about causal relationships between sequence variation and disease state can be confidently determined. To execute on this vision, PGT has assembled a staff of professionals who have a proven and demonstrable record in the translation of innovative research into commercial success. The company’s scientists have now developed and protected sample preparation and bio-informatic approaches to DNA sequencing which answer well-defined market needs that are currently constrained by the limits of available technologies. PGT will make economically possible the broad adoption of large-scale genetic studies that, alone, can shed light on individually rare but collectively common DNA sequence variations. These variations are increasingly implicated in disease susceptibility or variable drug response in human, animal, microbial and plant populations. In accomplishing its goals, PGT will “democratize” the market for DNA sequencing and be an enabler for both public and private research organizations as they work to make real the promise of personalized medicine.
sales@prometicbiosciences.com www.prometicbiosciences.com Telephone : 01223 420300 Fax : 01223 420300 211 Cambridge Science Park, Milton Road, Cambridge, Cambridgeshire CB4 0ZA
ProMetic Biosciences Ltd (PBL) is a wholly-owned subsidiary of Canadian-based ProMetic Life Sciences Inc., and since 1987 has pioneered the design, development and manufacture of affinity separation products and technologies. PBL specialises in synthetic affinity ligands - Mimetic Ligands™ - which are used by numerous companies making PBL a key supplier to the global life sciences industry. The chemical diversity of PBL’s synthetic ligand libraries allows application to almost any target protein. PBL’s bioseparation products are developed and manufactured in-house and the company is ISO 9001 accredited. PBL’s affinity technology may be applied to the capture of targeted proteins directly from biological source material, the separation of target protein from other components, or the capture of specific contaminants. Applications include the purification of: antibodies, antibody fragments, albumin, albuminfusion proteins, plasma proteins, glycoproteins, proteases and other recombinant proteins. PBL has also applied it’s technology to the capture and removal of prion proteins (vCJD) from blood, plasma and plasma-derived products. In partnership with the American Red Cross, PBL has developed the Prioclear™ range of prion binding adsorbents, applications of which include the revolutionary P-Capt® filter, a CE mark approved prion reduction device (developed in collaboration with MacoPharma SA) which provides a means of significantly reducing the risk of vCJD transmission by blood transfusion. Additionally, Prioclear™ adsorbents have been applied to plasma and plasma-derived products to improve prion safety margins and reduce the risk of vCJD transmission.
Psynova Neurotech Dr George McAllister george.mcallister@ psynova.com www.psynova-neurotech.com Telephone : 01223 334160 Fax : 01223 334162 St John’s Innovation Centre, Cowley Road, Cambridge, Cambridgeshire CB4 0WS
C D E F G
ProMetic Biosciences Ltd Dr Steve Burton
B
H I J K L M N
Psynova aims to revolutionise diagnostic approaches for severe mental illnesses and develop improved and targeted treatments for neuropsychiatric illnesses. Proteomics and metabolomics technologies are being used to study a unique BioBank of postmortem brain and other tissue samples. A proprietary database (PsyData) has been developed, comprising comprehensive data on biomarkers specific to Schizophrenia and Bipolar disorder. Psynova intends to develop proprietary diagnostic tests for its biomarkers, conduct clinical trials to validate its biomarkers and to develop tools to accelerate pre-clinical and clinical development of therapeutics.
O P Q R S T
Quotient Bioresearch Ltd Miss Emma Sutherland info@quotientbioresearch.com www.quotientbioresearch.com Telephone : 01638 720500 Fax : 01638 724200 Newmarket Road, Fordham, Cambridge, Cambridgeshire CB7 5WW
Quotient Bioresearch provides specialist laboratory and clinical services focused on early phase drug development from discovery through to proof of concept. • Integrated preclinical and clinical DMPK with GMP chemistry adiosynthesis • Bioanalytical sciences from the world’s leading sports drug surveillance laboratory • Comprehensive microbiology for discovery and development of antimicrobials • Formulation development, GMP manufacturing and GCP Phase I clinic in the same facility With over 350 highly skilled scientists and facilities in Cambridgeshire, Northamptonshire, Nottingham, Edinburgh and Cardiff, Quotient Bioresearch has comprehensive capabilities and is the only drug development partner which provides a truly integrated service from discovery to proof of concept. This is demonstrated in our unique Synthesis-to-Clinic™ service providing carbon-14 labelled compounds through to pre-clinical metabolism studies and integrated 14C clinical programmes, supported by our purpose built bioanalytical and central laboratory facilities.
U V W X Y Z
WWW.ERBI.CO.UK 131
Activotec’s mission is to establish themselves as the partner of
n
COMPANIES choiceNAME for solid phase peptide/organic synthesis.
Selcia Limited
A B
Dr Dave Roberts contact@selcia.com www.selcia.com
C D E
Telephone : 01277 367000 Fax : 01277 367099 Fyfield Business and Research Park, Fyfield Road, Ongar, Essex CM5 0GS
Selcia is a leading worldwide provider of contract research services in 14-C custom radiolabelling, integrated drug discovery and medicinal chemistry. Headquartered in a 2,500 sqm modern facility with a GLP analytical laboratory, in Ongar, Essex (UK). Selcia’s operating divisions are Selcia Radiolabelling a recognised international leader in 14-C custom radiosynthesis and Selcia Discovery which specialises in fragment-based drug discovery using a patented capillary electrophoresis screening platform – the CEfragTM Screen. Selcia supports clients from all continents including the pharmaceutical, biotechnology, cropscience, veterinary, chemical, household, personal care and nutrition sectors as well as academic institutions. With a passion for synthetic chemistry and a focus on personal service we build strong relationships with our clients and deliver to the highest standards.
F G H I
Senexis Limited Dr Mark Treherne info@senexis.com www.senexis.com Telephone : 01223 496160
J K
Fax : 01223 496161 Babraham Research Campus, Babraham, Cambridge, Cambridgeshire CB22 3AT
L
Senexis is a growing, small-molecule drug development company that is committed to revolutionising the treatment and diagnosis of diseases resulting from the inevitable process of ageing. Senexis is advancing a pipeline of novel treatments for diseases resulting from the toxicity of amyloid-like proteins. Our pipeline is currently focused on discovering potent and selective therapies for the treatment of Alzheimer’s diseases. Optimised lead compounds for Alzheimer’s disease have already shown pre-clinical efficacy in a variety of established models of memory and learning and are currently in development candidate selection studies. Senexis is actively seeking to enter into collaborations and licensing deals with established pharmaceutical and emerging biotechnology companies. Senexis plans to offer a balanced portfolio of pre-clinical or early clinical licensing opportunities to the pharmaceutical sector, particularly in the more costly areas of clinical development.
M Sentinel Oncology Ltd
N O P
Mr Bob Boyle info@sentineloncology.com www.sentineloncology.com Telephone : 01223 437123 Fax : 01223 437125
Q R
Sentinel Oncology is a drug discovery company developing novel drugs for the treatment of cancer. Our business model is to advance innovative ideas from concept to pre-clinical candidate drug selection Our drug pipeline is led by an innovative new strategy for cancer treatment, “Targeted Synergy” in which a single drug delivers two synergistic activities (DNA damage plus inhibition of DNA repair) to the areas of low oxygenation (hypoxic regions) found in many solid tumours
23 Cambridge Science Park, Milton Road, Cambridge, Cambridgeshire CB4 0EY
S T U V
Serentis Ltd Dr Alan Rothaul info@serentis-pharma.com www.serentis-pharma.com Telephone : 01223 432 500
W
Fax : 01223 432 501
X
23 Cambridge Science Park, Milton Road, Cambridge, Cambridgeshire CB4 0EY
Y Z 132 ERBI DIRECTORY 2010
Serentis is a privately-owned biopharmaceutical company Founded in 2006 whose objective is to innovate, develop and commercialise proprietary medicinal products. The company is establishing a development pipeline of commercially attractive products. Products are identified by our inhouse, low-risk discovery function and through in-licensing and acquisition of near-clinical stage assets. The management team of the company are industry veterans with a track record of delivering efficient development programmes. It is the intention of the company to quickly establish a clinical stage development pipeline and to quickly establish clinical proof-of-principle for its development compounds.
Activotec’s mission is to establish themselves as the partner COMPANIES of choice for solid phase peptide/organic synthesis. NAME n
Shire Pharmaceuticals Ltd Mr Francis Pang www.shire.com Telephone : 01256 894000 Fax : 01256 894704 Hampshire International Business Park, Chineham, Basingstoke, Hampshire RG24 8EP
A
As one of the world’s leading specialty biopharmaceutical companies, Shire has emerged as a company fully focussed on a single purpose: to enable people with life-altering conditions to lead better lives. Shire HGT, a vastly experienced and highly dedicated business unit of Shire Pharmaceuticals Ltd, specialises in discovering and developing innovative treatments for rare genetic diseases such as Fabry disease, Hunter Syndrome, Gaucher disease, hereditary angioedema and metachromatic leukodystrophy. Products such as ELAPRASE for Hunter Syndrome, REPLAGAL for Fabry disease and FIRAZYR for hereditary angioedema are available in markets around the globe, with FDA and EMEA regulatory approvals for velaglucerase alfa for Gaucher disease expected in 2010. Shire HGT employs nearly 1000 people worldwide who work across range of research and development, production and commercial disciplines. Shire HGT has offices in Basingstoke, UK and Cambridge/Lexington, US and a network of offices and distribution channels throughout Europe, Middle East, Africa, South America, Canada and the Pacific Rim.
B C D E F G
Sphere Medical Ltd Dr Gavin Troughton enquiries@spheremedical.com www.spheremedical.com Telephone : 01223 875222 Fax : 01223 875201 Harston Mill, Harston, Cambridge, Cambridgeshire CB22 7GG
Sphere Medical develops highly innovative monitoring products to provide clinical and economic benefits in the critical care environment. The products, all of which are based on the company’s proprietary technology, allow minimally invasive, real time measurement of clinical chemistry parameters and therapeutic drug concentrations, giving healthcare professionals the information they require to more effectively manage therapy and optimise patient outcomes. Sphere Medical was founded in 2002 and is based in Cambridge, UK. Our focus is on the continuous improvement of critical care. Our vision is to lead the way in the provision of products that empower medical institutions with tomorrow’s technology today. Our purpose is to deliver real value to all of our stakeholders. Three major funding rounds raising over $30 million have enabled Sphere to grow and develop into one of the world’s leading medical device / diagnostic companies, winning a variety of awards including Frost & Sullivan’s Technology Innovation Award in the Field of Point-of-Care Technologies. Sphere is now working with world leading companies in a range of clinical areas to develop the next generation of critical care products incorporating Sphere’s unique micro-analyser platform.
H I J K L M
Stem Cell Sciences Ltd Ms Jo Kellet www.stemcellsciences.com Telephone : 01223 499162 Fax : 01223 499178 Meditrina Building, Babraham Research Campus, Cambridge, Cambridgeshire CB22 3AT
N
Stem Cell Sciences is an international research and development company with established centres in the United Kingdom, Australia and Japan with strong academic partners placing SCS at the forefront of stem cell research. SCS’ business strategy is accelerating product development by working in partnership with academia and industry in developing cellular products and technologies for high through-put discovery in biopharmaceutical research and development. SCS’ focus is on the application of human stem cells and their differentiated progeny derived from embryonic stem (ES) cells, neural stem (NS) cells and multi-potent adipose derived stem (hMADS) cells. SCS has a substantial portfolio of patents in both adult and embryonic stem cell fields including technologies that can be utilized to provide pure populations of appropriate cell types for transplantation therapies. SCS will continue to build on existing business in stem cell based research and drug discovery and progress technology development of stem cell based therapeutics. The Cambridge laboratory is a well equipped cell culture facility that provides stem cells and outsourced cells to customers.
O P Q R S T
Takeda Cambridge Limited Ms Linda Millett info@takedacam.com www.takedacam.com Telephone : 01223 477910 Fax : 01223 477911
Takeda Cambridge is a drug discovery company specialising in identifying and validating novel drug targets derived from the human genome alongside well-established literature targets.
U
Worldwide, Takeda develops, manufactures and markets a broad range of superior pharmaceutical products to strive toward better health for individuals and progress in medicine.
V
Our key therapeutic focus is in metabolic disease and CNS disorders.
W
418 Cambridge Science Park, Milton Road, Cambridge, Cambridgeshire CB4 0PA
X Y Z WWW.ERBI.CO.UK 133
Activotec’s mission is to establish themselves as the partner of
n
COMPANIES choiceNAME for solid phase peptide/organic synthesis.
TARRC (Tun Abdul Razak Research Centre)
A B
Dr Maria Kolesnikova-Allen general@tarrc.co.uk www.tarrc.co.uk
C D
Telephone : 01992 585915 Fax : 01992 554837 Brickendonbury, Hertford, Hertfordshire SG13 8NL
E F
Routine and specialized analytical techniques are available for nucleic acid and protein studies. Work on sequencing of the Hevea brasiliensis (natural rubber) genome is in progress.
G H I J K
TARRC is the UK-based research and promotion centre of the Malaysian Rubber Board. TARRC’s Biotechnology Unit conducts research into aspects of plant genomics, molecular biology/genetics and proteomics of rubber and other tropical crops. A consultancy service is also offered. • Gene cloning and protein expression in plant or bacteria heterologous systems. • Generation of protein mutants for studies on stability and functionality. • Possibility of studying protein processing, maturation and targeting in vivo and in vitro. • Production of recombinant proteins in E. coli or plant systems • Protein purification from bacteria cultures or plant tissues and protein characterization. • Quantitative and qualitative analysis of total protein content using a ‘proteomic’ approach. • Measurement of stability and kinetics of protein-protein and protein-antibody interaction • Genotyping using range of molecular markers – SNP, SSR, AFLP, RFLP etc. • Genetic mapping. • QTL mapping and Molecular Marker Assisted Selection; Molecular Marker Assisted Breeding • Sanger sequencing. • Sequence assembly and annotation using NG and Sanger sequencing data.
TwistDx Ltd Dr Niall Armes www.twistdx.com Telephone : 01223 496700 Minerva Building, Babraham Research Campus, Babraham, Cambridge, Cambridgeshire CB22 3AT
TwistDx has developed an ultra-rapid DNA NA detection technology. Recombinase Polymerase Amplification (RPA) can detect DNA and RNA within 20 minutes using a revolutionary DNA amplification system which operates at low constant temperatures. No complex sample handling is required, and reaction behaviour can be monitored by fluorescence or in equipment-free formats. TwistDx is currently completing development of the first commercial assays, including a point-ofcare test for MRSA. Reagents for the research market will be available during 2008
L M UKTI R&D Specialists
N O P Q
Ms Julie Cole tara.sharpe@pera.com Telephone : 01664 501271 Fax : 01664 501261 Pera, Nottingham Road, Melton Mowbray, Leicestershire LE13 0PB
R
For the UK to maintain its momentum as a world-class global economy it must maximise its strengths in science and technology. By attracting higher levels of international R&D investment, R&D Programme Specialists will consolidate the UK’s position at the heart of global innovation, raising both its R&D capability and its ability to trade globally. The R&D Specialists have four main objectives: • to promote the benefits of R&D in the UK to a targeted group of overseas owned companies, • to help innovative UK-based companies conduct business overseas, with a view to increasing their R&D levels, • to monitor and feed back on issues affecting investment in UK R&D, • to offer support to overseas knowledge driven companies interested in business partnerships with UK companies through the R&D Partnerships element of the R&D Programme. For further details, please contact Carol Prentice at carol.prentice@pera.com.
S T U V
Vernalis Mr Clive Evans admin@vernalis.com www.vernalis.com Telephone : 01223 895555
W
Fax : 01223 895556
X
Granta Park, Abington, Cambridge, Cambridgeshire CB1 6GB
Y Z 134 ERBI DIRECTORY 2010
Vernalis is a development stage pharmaceutical company with significant expertise both in de novo fragment and structure-based drug discovery and pre-clinical and clinical development. The Group has seven product candidates in clinical development (three of which are partnered), two programmes in pre-clinical, as well as other competitive research programmes. Our technologies, capabilities and products are endorsed by collaborations with leading, global pharmaceutical companies including GSK, Biogen Idec, Novartis, Servier, Chiesi, Menarini, and Endo.
Activotec’s mission is to establish themselves as the partner COMPANIES of choice for solid phase peptide/organic synthesis. NAME n
Xention Limited Dr Tim Brears www.xention.com Telephone : 01223 493900 Fax : 01223 493901 Iconix Park, London Road, Pampisford, Cambridge, Cambridgeshire CB22 3EG
A
Xention is capitalizing on the under-exploitation of ion channel drug targets. To achieve this, we have developed an integrated approach to ion channel drug discovery comprising numerous critical components proprietary to the Company. The Company has clinical programmes in atrial fibrillation and overactive bladder and pre-clinical programmes in atrial fibrillation and autoimmune disease. Atrial fibrillation (AF) is the most common cardiac arrhythmia facing physicians. Xention’s most advanced AF compound is a modulator of the voltage-gated potassium channel Kv1.5 that shows excellent efficacy in pre-clinical in vivo models and is currently in Phase I clinical development. We are also developing modulators of the acetylcholine-regulated potassium channel IKACh, a newly emerging target for atrial fibrillation. Our autoimmune disease programme is aimed at developing therapeutics for the treatment of T-cell mediated autoimmune diseases through inhibition of Kv1.3, a potassium channel expressed in effector memory T-cells. In 2009, the Company entered into significant transactions with Ono Pharmaceutical Co Ltd and the Wellcome Trust.
Telephone : 01223 497111 Meditrina Building, Babraham, Cambridge, Cambridgeshire CB22 3AT
XiangCam, being established in Cambridge in November 2007 by Guangzhou Xiangxue Pharmaceutical Company Ltd. (Xiangxue) which is based in south of China, is interesting in promoting modernization and globalisation of Traditional Chinese Medicine (TCM) with international collaborative research. XiangCam is the first TCM research organisation in the UK invested by Chinese pharmaceuticals. In pursuit of innovative TCM discovery, XiangCam joints theoretical and practical experiences of TCM in China with high techniques and advanced research facilities in the UK. XiangCam has built close relationship with several prestigious universities or institutes both in the UK and China, and has started the mutual benefit research projects already.
www.zoragenbiotech.com Meditrina Building, Babraham Research Campus, Cambridge, Cambridgeshire CB22 3AT
D E F
H I J
Our main strategies are: • Investigating the mechanisms of TCM function; • Developing the new generation Chinese Medicine and natural health care products;
K
Being the platform for UK-China collaboration on TCM research. Our research projects are: • Further development of the existing product on anti-flu and the perfection of its quality control method; • Investigation of selected herbs and their active ingredients, evaluating their potential to become new drugs; • Investigation quality control methods and standards of TCM.
L
Zoragen Biotechnologies Dr Charles Roberts
C
G
Xiangcam TCM Research Centre Mr Frank Wu Jun
B
M N
Zoragen Biotechnologies LLP Inc. is a diagnostic research company dedicated to the discovery, development and commercialization of novel techniques to make prenatal testing safer. We are exploring two related patent families, currently in proof-of-concept trials in collaboration with Oxford University. We are based in the Meditrina Laboratories of Babraham Research Campus.
O P Q R S T U V W X Y Z
WWW.ERBI.CO.UK 135
Sponsors this section
Silver Members
Activotec’s mission is to establish themselves as the partner of choice for solid phase peptide/organic synthesis.
A
42 Technology Ltd Dr John Loveluck
B
www.42technology.com
C
Fax : 01480 302701
D
Telephone : 01480 302700
Meadow Lane, St Ives, Cambridgeshire PE27 4LG
E F G H
J
Mr George Freeman
4D-Biomedical is a specialist venture consulting business with strengths in 3 key areas:
info@4d-biomedical.com
• ‘Translational’ or ‘Experimental’ Medicine. We have advised many of the UK’s leading Hospitals and Universities on the opportunities presented by Industry’s need for patients for research. • Establishing successful new biomedical ventures. We take a ‘hands-on’ role and support founder teams with the planning and implementation of new ventures. • Financing. Our team has a successful track record over 15 years of raising many tens of millions of pounds for new biomedical ventures.
www.4d-biomedical.com Telephone : 01223 393 522
Trinity House, Cambridge Business Park, Cambridge, Cambridgeshire CB4 0WZ
K L M N
Dr John Shields info@abingworth.com www.abingworth.com Telephone : 01223 451032 Prince’s House, 38 Jermyn Street, London SW1Y 6DN
All our projects are handled by Senior Associates, and whilst we maintain a highly professional office systems, we keep a tight control on our costs so that we can offer you the best value for money.
Abingworth is an international investment group dedicated exclusively to the life sciences and healthcare sectors. The firm invests across all stages of company development including early and late-stage venture financing, growth equity and public companies. Founded in 1973, Abingworth has a lengthy track record of building market leading companies. Our specialist team of over 20 professionals has a broad range of skills, including scientific and business expertise as well as investment banking, recruitment and legal knowledge. These resources are made available to portfolio companies. Abingworth has funds under management of over $1.25 billion and offices in London, Menlo Park (California) and Boston. Abingworth has raised nine funds dedicated to investment in life sciences and healthcare. Abingworth Bioventures V expanded to £392 million ($590 million) in December 2008.This fund is actively investing.
P
ABS Laboratories Ltd Dr Mira Doig abslabs@biopark.org.uk
R
www.abslabs.com
S
Fax : 01707 358667
T
We combine strategic analysis of how changes in science, technology, finance and healthcare markets are changing the face of biomedicine with practical solutions to your problems.
Abingworth LLP
O
Q
The services we offer range from technology road mapping and concept generation through to design for manufacture and process optimisation. We have extensive experience of product and instrumentation design for medical device, pharmaceutical and biotech companies. We also provide quality and regulatory support for:- Regulatory road mapping and planning- FDA submissions and CE marking- ISO 13485 and cGMP quality system implementation, training and audit- Risk analysis and management – planning and implementation- Process and computer system validation to FDA standards- Supplier mentoring and quality improvement programs
4D Biomedical
Fax : 01223 281 099
I
42 Technology designs and develops innovative products and processes for medical device, biotech and drug delivery applications. We have a strong team of industry experienced engineers, complemented by a network of associates which allows us to provide teams matched to individual projects and client needs.
Telephone : 01707 358666
BioPark, Broadwater Road, Welwyn Garden City, Hertfordshire AL7 3AX
ABS Laboratories is a MHRA GLP and GCP accredited CRO who specialise quantifying drugs, metabolites and biomarkers in biological fluids. ABS is expert at developing, validating and applying sophisticated techniques to quantify drugs and metabolites in biological fluids using LC-MS/MS, GC and GC-MS. Our skills, experience and state of the art equipment means that we can support a variety of companies: Small, medium and large Pharmaceutical R&D programmes with their pharmacokinetic and biomarker assays; the NHS for specialist assay requirements supporting clinical diagnosis, screening and therapeutic drug monitoring and University and charitable organisations research programmes.
U V W
Acacia Pharma Mr Andrew Muncey andrewmuncey@acacia pharma.com www.acaciapharma.com
X
Telephone : 01223 875 130
Y
Harston Mill, Harston, Cambridge, Cambridgeshire CB22 7GG
Z
Fax : 01223 875 131
138 ERBI DIRECTORY 2010
Acacia Pharma is a pharmaceutical company focused on cancer supportive care - the management of the symptoms cancer, or the management of the side-effects of the treatments of cancer. Acacia discovers and develops cancer supportive care product opportunities based on established drugs which therefore have a high probability of success. This approach allows Acacia to capitalise on publicly available information, thereby lowering development risk, time and cost compared to new chemical or molecular entities, whilst delivering products of high value in areas of unmet need. Acacia operates a virtual business model and has an experienced management team, members of which have successfully conceived, managed and exited similar businesses. The team has extensive expertise in all areas considered core to the business and is complemented by a network of industry consultants.
Activotec’s mission is to establish themselves as the partner of choice for solid phase peptide/organic synthesis.
Accentbio Dr Janette Thomas contact@accentbio.com www.accentbio.com St John’s Innovation Centre, Cowley Road, Cambridge, Cambridgeshire CB4 0WS
We are currently working in areas of Women’s Health, Oncology, Carbon Capture, and Rubber Recycling. We start up and nurture new businesses, perform technology audits for investors, raise funds, and assist with project planning and management of projects. We work in partnership with the originating scientists and share any revenue generated through the commercialisation of technology from the collaboration.
A B C D E F
Adelphi Healthcare Packaging Mr John Hockley www.adelphi.uk.com Telephone : 01444 475983 Fax : 01444 472329 Olympus House, Mill Green Road, Haywards Heath, West Sussex RH16 1XQ
Adelphi Healthcare Packaging specialises in the supply of primary packaging to the pharmaceutical and biotechnology industries. Adelphi are agents and distributors for some of the world leading manufacturers of healthcare packaging and holds a comprehensive range of glass, plastic and aluminium containers, high precision dispensing systems, various closures including stoppers, crimp seals and screw caps as well as a range of boxes. Adelphi stocks a number of specialist vials and stoppers that are particularly suited to new product development and that provide a highly inert product contact surface. Our particular speciality is helping companies in the very early stages of development to ensure that primary packaging choices are the most appropriate, both commercially and technically for their products.
G H I
E-mail: sales@adelphi.uk.com
J K
Advanced Cleaning Services Mrs Lynda King info@advancedcleaning services.co.uk www.advancedcleaning services.co.uk Telephone : 01638 578444 Fax : 01638 578542 40-42 Chapel Street, Exning, Newmarket, Cambridgeshire CB8 9DN
Specialist service delivery depends on more than excellent cleaning skills and a dedicated management team. Keen to build on our record of success, we work closely with our clients to maximise efficiency and minimise exposure to risk. We are acutely aware of the sensitivities that surround the biotech sector. Our range of cleaning services includes:
Telephone : 01234 822047 Fax : 01234 824667 Colworth Science Park, Sharnbrook, Bedfordshire MK44 1LQ
M N
• Daily Office • Laboratory • Window/Cladding • Carpet • Janitorial/Paper Supplies • Floor Renovation/Maintenance
O P
Advanced Microbial Diagnostics Ltd Mr Anthony Carr
L
Advanced Microbial Diagnostics Ltd., was formed in 2006 as a separate entity from other business activities in order to pursue major innovations in clinical microbiological test systems. This was part of a diversification into several operations after some 25 years within Unilever’s Diagnostic business, with experience of R&D involving products such as Sensititre, Rapid Sensititre , Clearview Strep A, Clearview Chlamydia and others, plus generation of substantial diagnostics IP. Advanced Microbial Diagnostics has a very focussed interest in Antibiotic Susceptibility Testing , especially Rapid Methods and dealing with Antibiotic Resistance mechanisms within such tests . The company has some very advanced technologies in photonics, microfluidics and of course microbiology along with various ‘in house’ innovations at various stages.
Q R S T
All of these are being integrated in order to implement a very novel product concept.
U Agenda Resource Management Limited Mr Norman Mortell info@agenda-rm.co.uk www.agenda-rm.co.uk PO Box 24, Hull, Humberside HU12 8YJ
With offices in Hull and Cambridge we provide services to the biomedical industry by delivering high quality, recruitment, security and marketing solutions with a customer focused and friendly approach. We offer services in three core areas, each staffed by professionals in their field of expertise: Resource Management • www.agenda-rm.co.uk Scientific and technical recruitment, contract technicians and facility management. Security Services • www.agenda-security.co.uk Security screening, Criminal Record Bureau checks, security training, social engineering, data network security and consultancy. Marketing and Communication • www.agenda-mc.co.uk We offer concept and design services, publishing, printing/distribution and consultancy.
WWW.ERBI.CO.UK 139
V W X Y Z
Activotec’s mission is to establish themselves as the partner of choice for solid phase peptide/organic synthesis.
A
Air Liquide UK Ltd Mr James Woodward
B
www.uk.airliquide.com
C
Fax : 01675 467022
D
Telephone : 01675 462424
Air Liquide UK have extensive experience in the Biotechnology and Laboratory and Analysis field, offering a wide range of products and services to help you increase yield, improve product quality and reduce production hazards. We are constantly looking at ways we can help our customers improve quality, safety and costs. We work closely with our customers to ensure they can concentrate and focus on their core business, leaving their production and laboratory gases, dry ice and equipment requirements to Air Liquide UK.
Station Road, Coleshill, Birmingham B46 1JY
E F G H
Almac Sciences Mr Denis Geffroy denis.geffroy@almacgroup.com www.almacgroup.com Telephone : +44(0) 2838 332200 Fax : +44 (0)28 3833 2200
I
20 Seagoe Industrial Estate, Craigavon, Northern Ireland BT63 5QD
J K L M N O
Dr Matthew Baker www.antitope.com Telephone : 01223 496190 Fax : 01223 496191
S T
Antitope was formed in Cambridge, UK in 2004 in order to advance previous research of the founders by developing proprietary technologies for immunogenicity prediction, antibody humanization and engineering protein therapeutics. To date, we have entered into over 50 different agreements with pharmaceutical and biotechnology companies worldwide to apply our technologies for the development of improved biologics.
Babraham Research Campus, Babraham, Cambridge, Cambridgeshire CB22 3AT
Applied Medical Technology Ltd Mr Ray Morrissey support@applied-medical.co.uk
R
Almac provides a seamless, fast and efficient route from drug discovery through to market. Our range of services includes: Research: Almac provides genomics based solutions, informing drug discovery and enabling personalised medicine. Chemical & Pharmaceutical Development: Almac accelerates the development of customers’ drug candidates through the effective integration of science and manufacturing to provide drug substance & product. Clinical Development: Almac is unique in the industry, offering fully integrated world class clinical trial supplies & IVR/IWR technology. Commercial: Almac provides solid dosage form commercial manufacture and packaging for EU & US markets. Commercial support services facilitate EU market access for non-EU product.
Antitope Ltd
P Q
Almac is a financially stable, privately owned organisation with over 30 years experience. The Group provides integrated development solutions to over 600 customers worldwide including all the world leaders in the pharmaceutical and biotechnology sectors.
www.applied-medical.co.uk Telephone : 01223 420415 4 Orwell Furlong, Cowley Road, Cambridge, Cambridgeshire CB4 0WY
Applied Medical Technologies Ltd based in Cambridge, is the UKs leading supplier of ambulatory systems for the continuous administration of drugs for a variety of clinical purposes. We also offer the most comprehensive range of high quality subcutaneous infusion administration sets. We develop bespoke solutions for therapies that benefit from a non-intravenous route of drug delivery by providing the most reliable, comfortable and convenient disposable systems available. Therapies which benefit from our technologies include: • Oncology • Pain relief • Pulmonary Hypertension • Primary Immunodeficiency • Intrathecal Infusion • Asthma • Thallasemia • Hormone Therapy • Rehydration
U V W X Y Z
Applikon Biotechnology UK Dr Sharon Brownlow sales@applikon.co.uk www.applikon.co.uk Telephone : 08453 373306 Fax : 01684 851282 Basepoint Business Centre, Oakfield Close, Tewkesbury Business Park, Tewkesbury, Gloucestershire GL20 8SD
140 ERBI DIRECTORY 2010
Applikon Biotechnology UK is a branch of the privately owned Dutch global supplier of bioreactors for research and production. Applikon are unique among bioreactor suppliers in manufacturing their own sensors and incorporating innovative sensors within their standard control strategies. They are perhaps best known introducing the Biosep acoustic cell separator and the magnetic drive. Recent developments have expanded the scale down technologies. The screening range includes the Micro-24 (24-place micro-bioreactor), shake flasks and micro-titre plates with pH & dO measurement plus micro-titre plates with the oxygen delivery of a shake flasks plus a bench top disposable STR. With an experienced sales and service team, plus a number of collaborators / consultants, they offer a range of practical bioreactor training courses and hold annual cell culture and fermentation symposia.
Activotec’s mission is to establish themselves as the partner of choice for solid phase peptide/organic synthesis.
Arco Limited Mr Matt Steed burystedmunds.branch @arco.co.uk www.arco.co.uk Telephone : 01284 702533 Fax : 01284 750529 Arco House, Easlea Road, Moreton Hall Industrial Estate, Bury St Edmunds, Suffolk IP32 7BY
Arco is the UK’s leading supplier of personal protective equipment, workwear and workplace safety products. As such it is widely recognised as a provider of expert advice, services and safety solutions for businesses in every market sector. Founded in 1884, the Hull-based, 4th generation family business now has over 110,000 customers. Through its team of product specialists, its product catalogue and a rapidly expanding 40-strong branch network, Arco offers a world-class range of quality assured, branded and own-brand products, carefully selected from ethically compliant suppliers. Products include personal protective equipment, clothing including front and back-of-house career wear, footwear, gloves, workplace safety and hygiene products. Arco is dedicated to its Corporate Social Responsibility policy and continually demonstrates its support of local business communities and charitable organisations. In 2005, Arco became a member of the BITC Percent Club by donating 1% of pre-tax profits to charities. In 2007, Arco became a member of the Ethical Trading Initiative (ETI).
Telephone : 0179 513 209
B C D E F
Argo Consulting Ltd Mr Stephen Lang
A
Medical Device Consultancy specialising in all aspects of acquisitions, divestments and licensing technology: advising on strategy, finding targets, valuing, negotiating and implementing the deal.
Fax : 01799 513209
G H
Oak Cottage, Catmere End, Saffron Walden, Essex CB11 4XG
I J K
ARU (Medical Engineering Research Group) Dr Rajshree Mootanah
L
Telephone : 01245 493131 Fax : 01245 683493
M
Department of Digital Sciences & Technology, Faculty of Science & Technology, Bishop Hall Lane, Chelmsford, Essex CM1 1SQ
N O P
Aseptika Ltd Ms Jessica Auton jessica.auton@aseptika.com www.aseptika.com Telephone : 01480 352821 Fax : 01480 351646 14 Elizabeth Drive, Hartford, Huntingdon, Cambridgeshire PE29 1WA
Aseptika Ltd was founded in November 2007 and it is a micro, pre-revenue company that seeks to become a developer and supplier of novel and protectable technologies to fill niches in the Medical and Biopharmaceutical supply markets. All of our products are novel and have been identified to fulfil an unmet customer need. Aseptika is a boutique that develops its products using skill sets available through contractors and consultants and manufactures its products via high quality manufacturers. This flexible out-sourcing model reduces the upfront investment required, keeps our overheads to a minimum and allows the Company to rapidly expand or contract according to market demand. Throughout we will acquire a growing portfolio of IP through our research processes and via our collaborations with academic partners.
Q R S T U
ATPBio Ltd Dr Raman Minhas www.atpbio.com 12 The Square, Market Harborough, Leicestershire LE16 7PA
ATPBio is a consultancy providing strategy and transaction support to the life sciences sector. Our mission is to improve human health and well-being through helping to build companies within the healthcare sector. We deliver value through providing: (i) innovative solutions to support transactions, (ii) critical strategic intelligence to assist commercial and technical development. Established in 2002, clients include biotech, pharma, devices, diagnostics, VCs, investment banks, technology transfer and the UK Government. ATPBio’s professionals have worked on a wide range of projects including transactions totaling over $250 million. Our team includes entrepreneurs and investors with expertise in operations, finance, science and IP. Our focus is on companies working within biotech, pharmaceuticals, diagnostics, medical devices and healthcare services.
WWW.ERBI.CO.UK 141
V W X Y Z
Activotec’s mission is to establish themselves as the partner of choice for solid phase peptide/organic synthesis.
A
Avlar BioVentures Ltd Mr Alan Goodman
B
info@avlar.com
C
Telephone : 01954 211515
D E
www.avlar.com
Fax : 01954 211516 Highfield Court, Church Lane, Madingley, Cambridgeshire CB23 8AG
F G H
Azura Group Ltd Mr Simon Pullum info@azuragroup.com www.azuragroup.com Telephone : 0870 050 3010 Fax : 0870 050 3011
I J
Martells Barn, Slough Lane, Ardleigh, Essex CO7 7RU
K L M
Venture capital, start-up, funding, biotechnology, healthcare.
Formed in 1990, we are an established software development company providing a set of core products together with bespoke software development services. Our main products are our Sample Data Management systems for both research projects and clinical trials. These include features such as sample tracking, consent management, capturing and managing phenotypic and environmental data, together with other products such as LIMS independent BioBanks and Collaboration Systems for Researchers ensuring best use of the samples available. Developed in conjunction with the UK DNA Banking Network, these products are very cost effective to make them available to as many academic and research organisations as possible – allowing them to manage their data more effectively and make far better use of the information that they’ve captured. We are ISO9001 accredited with a UK based development team, dedicated to delivering high quality systems with real benefit to our clients.
Balanced Clinical Research Services Ltd Mr John Hladkiwskyj Telephone : 01480 382132 10 Pavilion Close, Godmanchester, Cambridgeshire PE29 2WQ
N
Considering the individual needs of all the stakeholders across the research process, from Sponsors to patients, Balanced Clinical Research has the expertise to develop products for market. These services include consultancy, project management, monitoring and associated clinical trial services. Drawing upon extensive industry experience and knowledge of research needs and using locally based experts. Balanced Clinical Research ensures the best study designs, locations and services to ensure each project’s success.
O P Q
Barrett Webb Limited Mrs Sue Rossiter info@barrettwebb.com
R
www.barrettwebb.com
S
Fax : 01727 797549
T
Telephone : 01727 857755
Dagnall House, Lower Dagnall Street, St Albans, Hertfordshire AL3 4PA
We find and attract the best Board, Senior and Middle management talent to take our clients’ businesses forward. We work with clients across the life sciences industry, including ethical pharmaceuticals, biotechnology, vaccines, medical devices, diagnostics and consumer healthcare. We manage search assignments across R&D, Marketing, Sales, Business Development, Medical, Technical, Regulatory, Quality, Production and Business Support areas. We can help our clients with Board, senior and middle management assignments.
U V W X Y
BBSRC Mr Alex Chaix www.bbsrc.ac.uk Telephone : 01793 414664 Fax : 01793 414674 Polaris House, North Star Avenue, Swindon, Wiltshire SN2 1UH
Z 142 ERBI DIRECTORY 2010
Activotec’s mission is to establish themselves as the partner of choice for solid phase peptide/organic synthesis.
Beremans Limited Dr Nick Miller info@beremans.com www.beremans.com Telephone : 44 1223 969286 39 Parkside, Cambridge, Cambridgeshire CB1 7WL
Beremans Ltd core activities comprise: Due Diligence - a rigorous examination of the key areas pertinent to the success of a given Life Sciences company, such as competition, technology, products, markets and financial projections. Company Analysis and Tracking - analysis of a given Life Sciences company, and maintenance of coverage over time, to provide continually updated assessments of the company’s prospects in the context of a changing environment. Sector Reports - highly detailed and value-added reports examining key issues and developments pertinent to the Life Sciences sector, such as an analysis of the commercial prospects for a new technology, or an assessment of the unmet needs in a given market segment. Strategic Opportunity Analysis - identification and analysis of M&A / collaboration opportunities in both academic and commercial spheres of the Life Sciences sector.
info@bicycletherapeutics.com www.bicycletherapeutics.com Telephone : 01223 207199 Babraham Research Campus, Cambridge, Cambridgeshire CB22 3AT
B C D E F
Bicycle Therapeutics Limited Dr John Tite
A
Bicycle Therapeutics is a newly formed biotechnology company developing a novel technology for the creation of a new generation of biotherapeutics. Bicycle technology utilises biological selection techniques to select and optimise peptides with high binding affinities which are constrained by an organo-chemical scaffold. This enables the creation of novel molecules which combine the desirable features of small molecules and biopharmaceuticals. The technology is based on the work performed at the MRC Laboratory of Molecular Biology in Cambridge by the scientific founders of the company, Prof. Christian Heinis and Prof. Sir Gregory Winter.
G H I J K
Bio Products Laboratory Ms Jane Martin info@bpl.co.uk www.bpl.co.uk
BPL is one of the leading suppliers of plasma derived products in the global fractionation industry. BPL is a not-for-profit organization wholly owned by the UK government, through the Department of Health.
Fax : 020 8258 2603
BPL operates a single manufacturing site where it manufactures, stores and distributes a wide range of therapeutic products. Our manufacturing facility is among the newest and most modern in the industry, with sufficient capacity to significantly increase our current manufacturing levels.
Dagger Lane, Elstree, Hertfordshire WD6 3BX
BPL currently manufactures fifteen products, including Coagulation factors, IgG’s and Albumin, which are distributed to over 40 countries worldwide. BPL continues to invest significantly in the improvement of existing products and processes and the development of new products.
Telephone : 020 8258 2252
info@basanalytics.co.uk www.bioanalytical.com Telephone : 02476 639574 Fax : 02476 639568 Suite 2, Building 500, Abbey Park, Stareton, Kenilworth, Warwickshire CV8 2LY
Established in 1974, BASi focus on developing innovative services and products that increase efficiency and reduce the costs associated with taking new drugs to market. From our facilities across the US and UK we offer an extensive array of contract laboratory services. BASi’s UK Bioanalysis facility boasts a modern GLP-compliant facility fully equipped with AB Sciex analytical systems. Our team of highly experienced scientists provide full method development/ transfer and validation to support both non-clinical and clinical projects. We have the capacity to analyze samples from small proof-of-concept studies through to late-phase clinical trials. The breadth and depth of our technology and scientific talent ensures that our clients receive the high quality data and fast turnaround they need, every time. A clear focus is placed on quality at all stages, supported by our dedicated, independent Quality Assurance Team. BASi scientific instruments include the Culex family of in vivo sampling systems (whole blood, plasma, microdialysis and ultrafiltration) and electrochemical detectors.
BioBridge Limited Mr Meredith Lloyd-Evans mlloydevans@biobridge.co.uk www.biobridge.co.uk Telephone : 01223 566850 45 St Barnabas Road, Cambridge, Cambridgeshire CB1 2BX
M N O P
Bioanalytical Systems Ltd (BASi) Miss Emily Chinn
L
Q R S T U V
BioBridge® was founded in 1989 to address challenges to commercialisation for innovations in biosciences. We help our clients through the entire product chain, discovery development to market entry and maintenance, including due diligence for investors. Our achievements are in all bioscience sectors including human and animal health, medical technology and bioengineering, food, agriculture, general biotechnology and industrial biotechnology (green chemistry, biomass use for natural products, bioenergy and bioremediation). Our clients are public organisations, private companies and innovation-generators such as Universities and research bodies.
W
Current work includes monitoring, expert oversight and support for publicly-funded projects in industrial biotechnology; regulatory strategy for a novel petfood additive; product-finding for pharmaceutical companies; network creation in environment and algal technologies; strategic analysis of GM crops and food regulations; integrating low carbon strategies with life sciences; membership of an EU working group on marine biotechnology; & product safety and compliance oversight for a biomaterials company.
Y
WWW.ERBI.CO.UK 143
X
Z
Activotec’s mission is to establish themselves as the partner of choice for solid phase peptide/organic synthesis.
A B C D E
BioBusiness Consultancy Mr Peter Thomas peter@biobusiness consultancy.com www.biobusiness consultancy.com
Market assessments, competitor analyses and forecasting. Medical and commercial evaluations of pipeline products/ technologies to support clients’ licensing, acquisition and VC financing negotiations. Due diligence, valuations.
Telephone : 01582 765582
Clinical, marketing and pricing strategy for new product development. Lifecycle management.
Fax : 01582 760057 27 Roundwood Lane, Harpenden, Hertfordshire AL5 3BW
F G H
J
Sales & Marketing Department sales@biocair.com www.biocair.com Telephone : 01223 703306
The Business Centre, Church End, Cherry Hinton, Cambridge, Cambridgeshire CB1 3LB
K L M N O
Dr Rod Baker mail@biooedge.co.uk www.bioedge.co.uk Telephone : 01296 771126 Lower Farm House, Grendon Road, Edgcott, Aylesbury, Buckinghamshire HP18 0TN
Biocair operates a specialist logistics service, which focuses solely on the material produced by the pharmaceutical, biotechnology and medical research communities. We have over 20 years’ experience in this field. Biocair is a global organisation, with main offices in Boston USA, Cambridge UK and Osaka JP. We specialise in giving up to date advice on classification and regulatory requirements of hazardous material which can include infectious, toxic, biological, genetically modified and radioactive. We apply the correct procedures, supply all packaging and documentation and fulfil every legal requirement, while planning the most efficient routes globally, including clinical trial management. Biocair offer full temperature control including dry ice, refrigerated (2 to 8°C), ambient, warm and liquid nitrogen. Our staff, including science graduates and regulatory experts, have received training from accredited dangerous goods schools in the classification, documentation, packaging and labelling of hazardous materials
Bioedge Pharma is a company offering drug development services to virtual pharmaceutical and biotechnology companies around the world, with particular focus on CMC and Project Management services. Bioedge Pharma works with a wide range of companies at all stages of development from late stage research though to marketed products. The company has an extensive network of international service providers and other consultants and hence can offer assistance in virtually all aspects of drug development. Bioedge Pharma is particularly familiar with assisting small virtual companies make the transition from research to development and can either establish a virtual development team or form part of such a team to take drugs through to first in man studies. Assistance with selection and management of external service providers (CROs and CMOs) is a key aspect of development with which Bioedge Pharma is very experienced.
Biosynergy (Europe) Ltd Dr Bob Mason info@biosynergyeurope.com
R
www.biosynergyeurope.com
S
Fax : 01223 579349
T
Other consultancies with complementary expertise.
Bioedge Pharma Consultancy Limited
P Q
Primary market research with scientific and clinical KOL’s and industry decision makers.
Biocair International Ltd
Fax : 01223 245211
I
Insightful, flexible and value-for-money business analysis and consultancy for the biopharmaceutical industry.
Telephone : 01223 579345
12 Pembroke Avenue, Denny Industrial Centre, Waterbeach, Cambridge, Cambridgeshire CB5 9PB
Contract manufacturer of biologics for immunodiagnostic, bio-pharmaceutical and environmental biotechnology applications. Contract RD; creation, development and optimisation of cell lines; process development and validation; production and purification of proteins (milligram to multigram quantities)to enable characterisation, pre-clinical testing, and scale-up for clinical trials. Specialist in hybridoma technology and production/purification of monoclonal antibodies and recombinant proteins from mammalian cell lines. Development of bioassays for environmental monitoring. Microbial and monoclonal antibodybased bioassays for identifying pathogens and determining toxicity of wastewater and groundwater. Technologies: Hollowfibre bioreactors; spinner oller culture; stirred vessel bioreactors; Affinity, ion-exchange and size exclusion chromatography.
U V W X
BioTrans Dr Richard Chenery richard.chenery@ntlworld.com
BioTrans has a wealth of knowledge and experience in progressing drugs from early compound discovery to regulatory submissions and registration. Biotrans provides pre-clinical interim and consultancy services including:
Telephone : 01462 457568
Drug metabolism and pre-clinical drug discovery and development..
Griffin House, 1A Coach Drive, Hitchin, Hertfordshire SG4 9AP
Process re-engineering to improve product delivery. Any process can be improved based upon systematic process mapping and analysis but even simple changes can yield marked improvements in productivity.
Y Z 144 ERBI DIRECTORY 2010
Staff training and continued professional development is mandated in many professions and for good reason. However, in many organisations the sourcing and development of training materials can be problematic to resource. BioTrans can use its experience and pre-existing materials to help your organisation development your staff to their full potential.
Activotec’s mission is to establish themselves as the partner of choice for solid phase peptide/organic synthesis.
Boult Wade Tennant Mr Matthew Spencer boult@boult.com www.boult.com Telephone : 01223 883 000 Fax : 01223 883 001 CPC4, Capital Park, Cambridge Road, Cambridge, Cambridgeshire CB21 5XE
Boult Wade Tennant is a leading firm of patent and trade mark attorneys and the largest full service firm in the Cambridgeshire region. The biotechnology and life sciences team work proactively and responsively to advise on all aspects of intellectual property protection, management and enforcement in the UK and Europe concerning a range of biotechnology, molecular biology, immunology and biological chemistry disciplines and are also well versed in medical and laboratory devices. Our services are tailored to meet the needs of our varied clients and may include patent drafting, filing and prosecution, EPO opposition work, freedom to operate searches, IP due diligence and infringement opinions. Boult Wade Tennant has a number of leading attorneys in their field and is consistently ranked at the top of The Legal 500 and Managing Intellectual Property league tables. In addition to the Cambridge office, Boult Wade Tennant has offices in London, Reading and Oxford.
brian@brainwavemedia.co.uk www.brainwavemedia.co.uk Telephone : 01799 542620
B C D E F
Brainwave Media Limited Mr Brian House
A
We have produced award winning videos and films for some of the world’s biggest companies for over 20 years. With extensive experience of biotech and pharma, we have the ability to explain your products and concepts in a way that’s entirely right for your target audience - whether you’re bidding for funds, launching a new product, selling your services or communicating with stakeholders.
Yew House, High Street, Newport, Essex CB11 3QY
G H I J K
Brian McGuinness Consulting Dr Brian McGuinness brian.mcguinness@ dsl.pipex.com Telephone : 0770 1076731 76 Harbour Avenue, Comberton, Cambridge, Cambridgeshire CB23 7DD
Biotech and pharma consultant specializing in (but not limited to) antibody-based drug discovery and development: • assessment of new business opportunities, • assessment of in- and out-licensing opportunities • assessment of new product opportunities (all aspects of drug discovery and development incl. target assessment, discovery prog, pre-clinical, clinical, commercial)
L M N O P
Bridge Partners Mr Andrew Glover info@bridgepartners.co.uk www.bridgepartners.co.uk Telephone : 01223 750150 Fax : 01223 750110 St John’s Innovation Centre, Cowley Road, Cambridge, Cambridgeshire CB4 0WS
Bridge Partners are an information and communications technology (ICT) support services company providing support in the Cambridge area and London. Our staff are highly experienced ICT professionals who have worked both in-house and with client companies at board level throughout their careers.
Q R
Bridge Partners specialise in helping small to medium-sized organisations to get the best from their information and communications technology. If you are starting from scratch, we can advise you on what to buy to support your business objectives. Where you have already made an investment in ICT, we will show you how to use it for maximum business benefit.
S
We also offer strategic ICT advice to larger firms, helping them manage their technology resources and prepare their organisations and culture for change.
T U
Bridgehead International Mr Tim Fitzgerald info@bridgehead.com www.bridgehead.com Telephone : 01664 503700 Fax : 01664 503705 Pera Innovation Park, Nottingham Road, Melton Mowbray, Leicestershire LE13 0PB
Bridgehead’s mission is to work with commercial organisations, government agencies and the investment community to ensure that: • Companies have the funding, structure and strategic focus to deliver high levels of innovation and financial return. • Patients have rapid and broad access to new innovative medicines, medical devices and diagnostic tools, particularly in areas of high unmet need. • With over 40 consultants and 60 associates in Europe, North America and Asia, Bridgehead provides a powerful combination of strategic, scientific, medical, technical, commercial, economic, decision support, modelling and intellectual property skills and experience.
V W X Y
Bridgehead is globally recognised and renowned for its expertise in: • Technical and commercial evaluation • Due diligence and Experts’ Reports • Forecasting and valuation • Market access • Pricing and reimbursement strategy • Health economics and health technology assessment.
Z WWW.ERBI.CO.UK 145
Activotec’s mission is to establish themselves as the partner of choice for solid phase peptide/organic synthesis.
A
Briton EMS Ltd Mr Peter Towler
B
www.britonems.co.uk
C
Fax : 01234 266488
D
Telephone : 01234 266300
4 Shuttleworth Road, Elms Industrial Estate, Bedford, Bedfordshire MK41 0EP
Briton EMS offers an Electronics Manufacturing Service. With long experience in the controls, sensors and instrumentation sectors, our assembly facility is geared to manufacturing small to medium runs of high reliability electronic systems. The markets we operate in are wide and varied E.g. Gas detection systems, condition monitoring, test instrumentation, control systems and broadcast electronics Our speciality is for complete product or subsystem build: PCBs, final assembly & test. We support prototype PCB and trial batch assembly through development stages. Our Engineering team will work with you or your third party designers throughout the production engineering stages of your development.
E F G H I
BSG Team Ventures Dr Simon Haworth info@teamventures.co.uk www.teamventures.co.uk Telephone : 01223 532650
Over the past few years we have built up a reputation as a highly professional and trusted search partner working ‘with not for’ our clients. We receive a very high level of repeat business from some of the biggest names in the industry including Warburg Pincus, Amadeus Capital Partners, Merlin Ventures, NESTA and Ipso Ventures as well as from many emerging companies backed by the UK/US VCs.
Elizabeth House, 39 York Road, London SE1 7NQ
J K L M N O
BTG International Ltd Mr Ashley Tapp info@btgplc.com www.btgplc.com Telephone : 0207 575 0000 Fax : 0207 575 0010 5 Fleet Place, Limeburner Lane, London EC4M 7RD
P Q
In 2010, US marketing rights for CroFabT, a Crotalid snake bite antivenom and DigiFabT, an antidote for digoxin overdose return to BTG. In anticipation, the company is establishing US commercial operations including a hospital sales force, and is seeking to acquire new products to develop and market to hospital specialists. Key internal development products include Varisolve®, which is in preparatory phase III studies for the treatment of varicose veins. Key partnered programmes include CytoFabT, which is licensed to AstraZeneca and is in mid stage clinical trials as a treatment for severe sepsis and Campath®, which is marketed by Genzyme Corporation for the treatment of chronic lymphocytic leukaemia and is in Pase III development for multiple sclerosis. BTG, which completed the acquisition of Protherics PLC in December 2008, is listed on the London Stock Exchange.
CambiNet Limited Mr Ian McKendrick enquiries@cambinet.com
R
www.cambinet.com
S
Fax : 01223 858351
T
BTG is an international specialty pharmaceuticals company that is developing and commercialising products targeting critical care, cancer, neurological and other disorders. The company is building a sustainable business financed by sales revenues from its critical care products and from royalties and milestone payments on partnered products.
Telephone : 01223 858350
St John’s Innovation Centre, Cowley Road, Cambridge, Cambridgeshire CB4 0WS
By using CambiNet’s services you not only get to enjoy an earlier revenue stream and lower costs but your products and services are getting to the people who need them much more quickly. We are not just consultants, we are also highly experienced practitioners who deliver and demonstrate results. We are results focused and solution orientated, our track record speaks for itself. We not only understand your business but we bring expertise from other business sectors which can be used to your advantage We also respect that every company is different. We work with you and we work sensitively within your unique cultural framework to achieve results so there is minimum disruption to your business
U V W X Y
Cambridge BioRisk Ms Lindy Standing info@cambridgebiorisk.com www.cambridgebiorisk.com Telephone : 01223 245378 St John’s Innovation Centre, Cowley Road, Cambridge, Cambridgeshire CB4 0WS
Z 146 ERBI DIRECTORY 2010
Activotec’s mission is to establish themselves as the partner of choice for solid phase peptide/organic synthesis.
Cambridge Cluster Consultancy Mr David Cudby www.t3cl.co.uk Telephone : 01638 669964 Fax : 01638 669964 14 Meadow Lane, Newmarket, Suffolk CB8 8FZ
We believe that the recorded knowledge and experiences relating to clusters, gained internationally and exemplified by The Cambridge Phenomenon should inform and accelerate economic development. We work with clients, developing strategies, policies and projects designed to enhance enterprise, innovation and economic growth and seek to bring the lessons from cluster theory and practice to those assignments. A current field of interest is Networks for Independent Living, where we are seeking to develop models of independent living and wellbeing that employ wireless, medtech, life science technologies and social networks to enhance the lives of those with chronic illness, disability or infirmity.
info@camcog.com www.cantab.com Telephone : +44 (0) 1223 810 700 Fax : +44 (0) 1223 810 701
Cambridge Cognition Ltd (CCL) develops and markets computerised cognitive testing software under the CANTAB™ brand name. CCL provides software to Academic Research institutions around the world and is the market leader in this sector. CCL is also a leading provider of specialist Cognitive testing products and services to the world-wide pharmaceutical industry, with experience in all phases of drug development in global studies and counts many of the world’s top 15 pharmaceutical companies as clients. CCL has offices in Bottisham outside Cambridge and Cambridge Mass.
Telephone : 01223 264428 The Long Barn, Church Road, Toft, Cambridge, Cambridgeshire CB23 2RF
www.chandb.com Telephone : 01799 530009 Fax : 0870 751 7505 The Mansion House, Chesterford Research Park, Little Chesterford, Saffron Walden, Essex CB10 1XL
G H
Cambridge Design Partnership works with both industry leaders and early stage companies to develop their innovative products for the healthcare market.
L
In addition to core skills in product design and user testing, our multidisciplinary team provides expertise in electro- and biomechanics, microengineering, optics, digital imaging, ergonomics, physiology and biochemistry.
M
We specialise in: diagnostics, drug delivery, minimally-invasive surgery, imaging, wellbeing and exercise science and we are working on projects funded through Department of Health and East of England Strategic Health Authority innovation initiatives. We operate focus groups with health professionals at all levels from NHS Trusts across the country, to gain in depth understanding for each product. This has been pivotal to our clients’ success.
N O P
Cambridge Healthcare and Biotech Ltd info@chandb.com
E
K
Bring us your challenging projects.
Mr Martyn Postle
D
J Cambridge Design Partnership LLP
www.cambridge-design.co.uk
C
I
Tunbridge Court, Tunbridge Lane, Bottisham, Cambridge, Cambridgeshire CB25 9TU
Mr Matt Schumann
B
F
Cambridge Cognition Ltd Mr Ian Harris
A
Cambridge Healthcare & Biotech is a knowledge-based consultancy serving all sectors of the healthcare industry across the globe. Its team of over 50 Consultants and Associates has steered major products through all aspects of research, development and commercialization. The company brings a unique perspective to solving client problems through in-depth understanding of technology, product development, marketing, healthcare systems and corporate finance embedded in its project teams. In particular, the track record of its team in due diligence is second to none, enabling its clients to maximize value and minimize risk in mergers, acquisitions, divestments and licensing transactions.
Q R S T U
Cambridge Imaging Ltd Dr Claire Hooper
V
Consultancy and research and development in biomedical imaging.
Telephone : 01223 421172
W
Fax : 01223 421087 St John’s Innovation Centre, Cowley Road, Cambridge, Cambridgeshire CB4 0WS
X Y Z WWW.ERBI.CO.UK 147
Activotec’s mission is to establish themselves as the partner of choice for solid phase peptide/organic synthesis.
A
Cambridge Medical Innovations Limited Mrs Rachel McGuinness
B
info@cam-medical.com
C
Telephone : 01223 225333
D
181 Cambridge Science Park, Milton Road, Cambridge, Cambridgeshire CB4 0GJ
E
www.cam-medical.com
Fax : 01223 225322
F G H
Cambridge Medical Innovations Limited (CMI, part of Inverness Medical Innovations Inc) is a dynamic R&D organisation specialising in the development of medical diagnostic devices. CMI is dedicated to developing a series of devices that will help in the diagnosis of diseases and enable more efficient monitoring of human health. Our mission is to develop the diagnostics devices to be sold worldwide. The company is located at the Cambridge Science Park, Cambridge, UK. We have access to a number of biosensor platforms; our core technology is based on robust labelfree sensing exploiting high frequency acoustics to specifically diagnose diseases. The systems can directly detect a range of molecules, bacteria and viruses in both crude samples and complex matrices with minimal need for sample processing or purification. This is achieved by attaching a specific target receptor to the surface of an acoustic resonator, using one of a variety of coupling chemistries, followed by delivery of a sample via a micro fluidic flow-based system. The resonant acoustic signal indicates not only the presence of target molecules but also their concentration in the sample.
Cambridge Online Systems Ltd Mr Mike Tissier enquiries@cosl.co.uk
Cambridge Online’s Applied Technology Group specialises in end-to-end solutions covering computer systems, data storage and networking. It has a particularly strong focus upon biotechnology and life sciences.
www.cambridgeonline.net Telephone : 01223 422600 Fax : 01223 422601
I J
163 Cambridge Science Park, Milton Road, Cambridge, Cambridgeshire CB4 0GP
K L M N O
Cambridge Regulatory Services Ltd Mrs Karen James info@cambreg.co.uk www.cambreg.co.uk Telephone : 01480 465755 Fax : 01480 463984
R S T
The Company is experienced in the preparation of all types of regulatory submissions particularly biotech products. Specialist technical advice on all aspects of medicines development including data evaluation for registration or product acquisition can be provided. Dr Mike James, CoDirector, ex-MCA (now MHRA), is a biotechnology specialist who has more than 20 years experience in regulatory affairs.
2 Cabot House, Compass Point Business Park, St Ives, Cambridgeshire PE27 5JL
P Q
Provides a full regulatory service from research and development to the market and beyond, for any company dealing with human pharmaceuticals.
Cambridge Science Park Ms Julie Bushell www.cambridgescience park.co.uk Telephone : 01223 559393 c/o Bidwells, Trumpington Road, Cambridge, Cambridgeshire CB2 9LD
Established by Trinity College in 1970, Cambridge Science Park is the UK’s oldest and most prestigious science park. Now home to over 100 companies and 1,650,000 sq ft of buildings, Cambridge Science Park continues to attract new businesses, from small start-ups and spin-outs to subsidiaries of multinational corporations. For further information please visit www.cambridgesciencepark.co.uk
U V W
CambridgeIP Ltd Ms Elizabeth Hudson elizabeth.hudson @cambridgeip.com www.cambridgeip.com
X
Telephone : 01223 370098
Y
Sheraton House, Castle Park, Cambridge, Cambridgeshire CB3 0AX
Z
Fax : 01223 370040
148 ERBI DIRECTORY 2010
CambridgeIP is a business intelligence provider. Our proprietary methods and tools leverage leading edge data mining and data analysis techniques using patents and other sources of science and technology data: providing clients with critical information and fact-based advice. Benefits are delivered with considerable efficiency and effectiveness compared to traditional approaches. CambridgeIP works with major corporations, the service sector, academic research institutes and individual inventors. Our methods and tools are applicable to the full spectrum of high-technology developments. Our work experience has given us particular expertise in the Energy, Health & Life Sciences, ICT and Nanotechnology spaces.
Activotec’s mission is to establish themselves as the partner of choice for solid phase peptide/organic synthesis.
CambridgeSoft Corporation Dr Juergen Harter info@eu.cambridgesoft.com www.cambridgesoft.com Telephone : 01223 464900 Fax : .1223 464990 1 Signet Court, Swann’s Road, Cambridge, Cambridgeshire CB5 8LA
CambridgeSoft is a market leader in software solutions and services for the chemical, biotechnology and pharmaceutical industries. CambridgeSoft has earned an enviable reputation as a supplier of Enterprise informatics solutions across a very broad range of scientific disciplines, including providing Electronic Laboratory Notebook systems to four of the world’s top five Pharmaceutical companies. CambridgeSoft provides: Enterprise solutions, desktop software, scientific databases, and professional services for biotechnology, drug discovery and chemical research, including software, databases, and web sites which enable customers to create, analyze and communicate chemical, biological, and scientific information more effectively. CambridgeSoft’s products are used primarily in the pharmaceutical, biotechnology and chemical industries, as well as in higher education and in academic and government research. Chem&BioOffice Enterprise enables research information organizations to manage and share life science information enterprise-wide.
www.dfait-maeci.gc.ca/london Telephone : 0207 258 6600 Fax : 0207 258 6384 Commercial/Economic Division, Macdonald House, 1 Grosvenor Square, London W1K 4AB
The United Kingdom is by far Canada’s most important commercial partner in Europe and, from a global perspective, ranks second only to the United States. Two-way trade between Canada and UK was valued at more than £12 billion in 2008. The UK ranks second in Foreign Direct Investment (FDI), with UK FDI stock in Canada valued at an all time high of £22 billion in 2008. The UK is also Canada’s second largest science & technology partner worldwide, with over 40% of S&T collaborations being in the field of biomedical and clinical research. The Commercial and Economic Division of the Canadian High Commission in London works with Canadian companies, universities and research institutes that are seeking market opportunities, collaborative R&D partnerships or technology transfer deals in the UK. We also offer confidential advice and service to UK companies interested in investing in Canada or in finding collaborative opportunities with Canadian partners.
www.capsugel.com Telephone : 01304 644791 Fax : 01223 892326 Cambridge Research Park, Granta Park, Great Abington, Cambridgeshire CB21 6GP
Capsugel is a global leader creating innovative dosage forms for the pharmaceutical and dietary supplements industries. Companies look to our leadership to formulate new products, enhance existing product lines, bring new products to market faster, and ensure their clinical trials are conducted without bias. Capsugel offers a range of systems for filling powder or liquid into capsules and other small containers: • Xcelolab™ powder dispenser: offers fast, flexible precise powder dosing for any laboratory, accurately and reproducibly dispensing tiny amounts of any powder into a variety of containers. • Xcelodose 120S and 600S precision powder micro-dosing systems: enable dispensing of active pharmaceutical ingredients (API) without the need for excipients or bulking agents. • CFS 1200 and CFS 1500 liquid capsule filling and sealing systems As an active industry supporter, Capsugel also gives presentations about dosage forms to pharmaceutical students at universities.
www.carterjonas.co.uk Telephone : 01223 368771 Fax : 01223 369950 6-8 Hills Road, Cambridge, Cambridgeshire CB2 1NH
D E
G H I J
L M N O P
Carter Jonas Mr Nick Hood
C
K
Capsugel Ms Sue Peffer
B
F
Canadian High Commission Dr Caroline Martin
A
Carter Jonas is one of the leading property consultants in the Science Park sector. The Technology Team looks after the property interests of funds, developers and occupier companies in the biotechnology and wider technology sector on a nationwide basis. Within the ERBI region, Carter Jonas act for a number of developer / investor clients on biotechnology focussed projects, including Chesterford Research Park, Cambridge, Colworth Science Park, Bedford and Norwich Research Park. We offer a broad spectrum of services to both public and private sector clients including feasibility studies, demands and needs studies, development agreements, creation of SPV’s, marketing strategy reports, lettings and acquisitions of incubators, laboratory and or R&D buildings in the eastern region and further afield. A multi-disciplinary practice Carter Jonas now has 31 offices in key locations in England and Wales, including London, employing 450 people with a turnover of approx £30 million.
Q R S T U
Cellexus Ltd Mr Clive Mason info@cellexusinc.com www.cellexusinc.com Telephone : 01480 414843 Fax : 01480 431271 12 Ramsay Court, Hinchingbrooke Business Park, Huntingdon, Cambridgeshire PE29 6FY
Cellexus Ltd is an innovative company that provides a range of single-use, disposable bioreactor products designed specifically to simplify cell culture and fermentation. The systems are simple to use with rapid set-up and turn-around times. The CellMaker Regular system, available in 8L and 50L capacity versions is optimised for bacterial (especially E.coli), yeast, algae and bacteriophage applications. The CellMaker PLUS system (available in 2010) is more aligned with mammalian and insect cell culture but has utility for all cell types. Key to the CellMaker products is the disposable, patented CellexusBag (for the CellMaker Regular) and HybridBag (for the CellMaker PLUS). The bag geometry allows efficient mixing and aeration of the culture by the airlift principle, in the HybridBag this is supplemented by gentle mechanical agitation via integrated impellors. The disposable nature of the bags eliminates cross-contamination and validation issues between bioreactor runs. The philosophy behind the company is to provide innovative products to the life science market and to back this with excellent customer support.
V W X Y Z
WWW.ERBI.CO.UK 149
Activotec’s mission is to establish themselves as the partner of choice for solid phase peptide/organic synthesis.
A B C D E
Chesterford Research Park Ms Katherine Maguire katherine.maguire@eu.jll.com www.chesterfordre searchpark.com Telephone : 01799 532252 Fax : 01799 531669 Little Chesterford, Saffron Walden, Essex CB10 1XL
F G H I
Mr Jonathan Hart-Smith www.ckscience.co.uk Telephone : 01438 743047 Fax : 01438 723800 9 The High Street, Stevenage Old Town, Hertfordshire SG1 3BG
N
The central facilities building at the Park, The Nucleus, sets new standards for the provision of amenities on science park developments, including state-of-the-art conferencing facilities, a health club, shop, restaurant and café bar.
CK Clinical is a leading clinical recruitment company handling jobs in clinical research and drug development. Our clients include some of the top Pharmaceutical and Biotechnology companies from around the world and our reputation for honest and integrity is well known. We offer contract and permanent clinical research job opportunities to both experienced professionals and entry level candidates. Here at CK Clinical we pride ourselves on our strong candidate focus. We know that looking for a job can be a stressful and difficult experience and we aim to make the process as simple and enjoyable as possible. CK Clinical is a member of the Recruitment and Employment Confederation (REC) and uphold the highest professional standards in recruitment. We pride ourselves on an ethical and transparent recruitment service and believe that integrity and honesty are the founding principles in all that we do.
K
M
The vision for the Park was to create high-quality, state-of-the-art laboratory and office space specifically designed for research and biotech companies at all stages of their life cycle. Now in its tenth year that vision is fast becoming reality as the Park continues to attract leading R&D companies. On completion, it will comprise 600,000 square feet of R&D facilities within a low-density, landscaped environment served by state-of-the-art amenities.
CK Clinical
J
L
Set in 250 acres of open parkland within the South Cambridgeshire Biotech Cluster, Chesterford Research Park provides a secure and relaxed working environment for R&D companies of all sizes wanting to be positioned at the epicentre of UK drug discovery. It is not only an established development, but also a growing community.
Clasemont Limited Mr Rob Arnold Telephone : 07710 397811 42 Apthorpe Street, Fulbourn, Cambridge, Cambridgeshire CB21 5EY
Clasemont Limited is a company providing corporate finance advice to privately owned life science companies and their shareholders, both individual and institutional. In current markets Clasemont focuses particularly on fundraisings, disposals and spinouts. Clasemont was founded in 2006 by Rob Arnold, who had previously been a corporate finance partner and European life sciences leader for PricewaterhouseCoopers, before deciding to pursue a solo career. Although Rob leads all of Clasemont’s assignments, he is able to assemble appropriate teams as required from a network, built up over many years, of individuals with specialist skills.
O P Q
Clement Clarke International Ltd Mr David Wright www.clement-clarke.com
R S
Telephone : 01279 414 969 Fax : 01279 635 232 Edinburgh Way, Harlow, Essex CM20 2TT
T
Clement Clarke International (CCI) was founded in 1917 and has produced asthma management products for almost 50 years. Based in Harlow, CCI became part of the Hagg-Streit group 20 years ago and manufacture products at various sites across the United Kingdom. The “Mini-Wright” Peak Flow Meter, was first launched in 1976, and became the original portable Peak Flow Meter, supported by hundreds of published papers. It is recognised as “The Gold Standard” for Expiratory Flow. A recent innovation has seen the Digital FEV1 /PEF Meter (Mini Wright Digital) launched, just one example of how Clement Clarke International has used new technology to develop products. Over the years the product range has expanded and the product portfolio assists in screening, monitoring and treating a wide range of respiratory conditions.
U V W X Y
Clinical Development and Support Services Ltd Mr John Illingworth john.illingworth@cdssltd.com www.cdssltd.com Telephone : 01625 617447 Fax : 0870 0940730 Suite 5, Silk House, Park Green, Macclesfield, Cheshire SK11 7QJ
Z 150 ERBI DIRECTORY 2010
CDSS was developed in 1998 and is a dynamic expanding CRO offering a wide range of clinical development services (including contract Research Nursing) to the Pharmaceutical, Biotechnology and Medical Device industries. CDSS deals with all phases of clinical development and have extensive experience in handling large volumes of patient data. Our staff have experience in numerous therapeutic areas including:CNS, Pain, Cardiovascular, Dermatology, Endocrinology, Genitourinary, Immunology, Oncology, Respiratory, Neurology, Surgery and Infertility.
Activotec’s mission is to establish themselves as the partner of choice for solid phase peptide/organic synthesis.
CLS Communication Ltd Mr Michael Ellis michael.ellis@ cls-communication.com www.cls-communication.com Telephone : 020 7901 8770 Fax : 020 7901 8771 132 Buckingham Palace Road, London SW1W 9SA
CLS Communication is one of the world’s leading providers of language services to the life science, biotec, pharma, financial and legal sectors. We offer a wide range of language services such as translation, interpreting, summarizing and copywriting. We are partners to many leading UK and international firms, enabling them to communicate clearly and effectively with a global audience. CLS Communication can help you achieve your goals in various types of projects: • translation of PIL, SmPC, common technical documents, clinical trial documents, centralised procedures, life science, biotech, medical and pharmaceutical documents; • translation of corporate communications, investor relations and press releases; • translation of legal documents; • copywriting/editing of texts, from investor relations and press materials, to annual reports, product outlines, and market commentaries; • coordinated management of large-scale multilingual projects, including annual reports and entire websites – from copywriting to publication; and • language adaptations of advertising and sales documentation
www.law-now.com Telephone : 020 7367 2559 Fax : 0207 367 2000 Mitre House, 160 Aldersgate Street, London EC1A 4DD
B C D E F
CMS Cameron McKenna Ms Sarah Hanson
A
CMS Cameron McKenna is full service, international law firm. The firm has a network of offices in the UK, across Europe and the Far East. We understand that the lifescience sector presents its own unique challenges and needs. As such we have a distinct team who are focused on building the links and expertise required to deliver sector specific service to our clients. This means our clients benefit from commercial no-nonsense advice whether they are longstanding clients or prospective clients needing a second opinion or advice where others are conflicted. Our clients tell us that they value our commercial advice, which is delivered at competitive prices. We are recognised leaders in the industry and have a strong track record of working with the full spectrum of companies, from early-stage spin-outs and pre-IPO companies through to major global companies.
G H I J K
Colliers CRE Limited Mr Michael Jones www.collierscre.co.uk Telephone : 020 7487 1603 Fax : 020 7344 6823
Colliers CRE is part of Colliers International, a global organisation with 267 office in 57 countries able to provide local real estate advice wherever required by our clients.
L
Our Cambridge office, led by Edward Dodson and Michael Jones provide locally based occupiers, landlords, developers and investors with a full range of commercial property transaction and consultancy services.
M
Bishop Bateman Court, Thompson’s Lane, Cambridge, Cambridgeshire CB5 8AQ
N O P
Colworth Park Dr Sally-Ann Forsyth sallyann.forsyth@goodman.com www.colworthpark.com Telephone : 01234 222441 Fax : 01234 782214 Sharnbrook, Bedfordshire MK44 1LQ
Colworth Science Park is a regional enterprise hub and an established location for scientific excellence in food, health and wellness, which is being developed by Unilever and global property group Goodman. Set within 1,200 acres of natural parkland, Colworth Science Park provides a supportive open innovation environment where networking and collaboration are integral to the campus culture. These will soon be complemented by a new innovation and amenities centre, known as The Exchange. Due for completion in January 2011, it will feature modern laboratory and office suites, a café-restaurant, and state-of-the-art meeting and conferencing facilities. It will also provide a research facility for IFR Extra Ltd, part of the Institute of Food Research, and house divisions of Cranfield University and the University of Cambridge’s Institute for Manufacturing.
Q R S T U
CompChem Solutions Dr Susan Boyd info@compchemsol.co.uk www.compchemsol.co.uk Telephone : 07870 571734 Fax : 01223 249312 St John’s Innovation Centre, Cowley Rd, Cambridge, Cambridgeshire CB4 0WS
V
CompChem SolutionsTM was founded in April 2004, to provide computational chemistry and chemoinformatics services to the biotech and pharmaceutical industrial sectors. From 2009, complementary services such as patent searching, medicinal chemistry, process R&D chemistry and pharmacology are also available.
W
Clients range from major pharma companies through to startup companies, where CompChem Solutions’ unique business model can offer flexible access to resources and software as needed. Services offered include:
X
• Full computational chemistry support for medicinal chemistry projects • Virtual screening • Structure-based drug design • Protein homology modelling • Pharmacophore modeling • Medicinal chemistry library design • Management of lead optimisation/discovery projects • Patent searching • Support for regulatory submissions • Management of GMP/PRD phases • Pharmacology protocol design (particularly ADMET) • Pharmacological CRO selection & management
WWW.ERBI.CO.UK 151
Y Z
Activotec’s mission is to establish themselves as the partner of choice for solid phase peptide/organic synthesis.
A
Connect Medical Resources Ltd Mr Robert McPherson
B
www.connectbio.co.uk
C
13 William Close, Banbury, Oxon OX16 0UE
Focussed in healthcare, Connect can provide all of the support required to get a new company established. We are skilled in recruiting all types of staff at all levels. We can help with funding, board structure and appointments and sales and marketing strategy.
Telephone : 01295 272996
D E F G H I
Constellation Technologies Ltd Mr Nick Trigg www.constellation technologies.com Rutherford Appleton Lab, Harwell Innovation Campus, Didcot, Oxon OX11 0QX
K
M N O
Mr Dan Coley info@core-cambridge.com www.core-cambridge.com Telephone : 01223 429998
S T
Core Cambridge is a centre of excellence for injury rehabilitation and the development of athletic performance. Our unique blend of therapy, coaching and facilities can free you from injury faster than you thought possible, and can develop you physically to levels that you never thought you’d be able to achieve – whether that’s improving your long-term health or competing at an international level.
Unit K, Trinity Hall Farm Estate, Nuffield Road, Cambridge, Cambridgeshire CB4 1TG
Costello Medical Consulting Ltd Mr Richard Short www.costellomedical.com
R
Specific applications are any that involve IT expertise and resources but include specifically • Gene sequence analysis (human, animal, plant) • Large data set mining (useful information from large data sets) • Data manipulation using statistical analysis packages
Core Cambridge
P Q
Applications are usually large data compute and storage services/products; they include data – accessing, management and long term storage, and; compute resources – access to many thousands of cores.
Advantages to customers are; • Cost reduction (outsource savings)
J
L
Constellation provides bioinformatics IT products and services on the “cloud” to Pharma and Biotech companies using technology developed at CERN and used widely.
Telephone : 07725 817797 Fax : 01223 421626 58 St John’s Innovation Centre, Cowley Road, Cambridge, Cambridgeshire CB4 0WS
Costello Medical Consulting provides specialised market access and medical communication services to the pharmaceutical industry, where our clients are Global Market Access, Global Medical Affairs and Pricing and Reimbursement teams. Our aim is to set the benchmark for quality in the sector by offering an unsurpassed level of scientific understanding and customer service throughout the course of every project. We have nearly a decade of experience with a variety of leading pharmaceutical companies and a track record of success in a broad range of disease areas. Our services include: • Strategic Market Access Consultancy • Key Value Message Development • Value Dossier Development • Pricing and Reimbursement Dossier Development • National Reimbursement Submissions • Market Access Workshops • Internal Medical Education Slide Sets • External Key Platform Presentations • Congress Support • Publication Summaries • Medical Writing and Publication Management • Lifecycle Communication Planning
U V W X Y Z
Creative Marketing and Research Ltd Mr John Reynard john@creativemarketing.co.uk www.creativemarketing.co.uk Telephone : 01473 832211 Fax : 01473 833890 9 Pegasus, Orion Court, Great Blakenham, Ipswich, Suffolk IP6 0LW
152 ERBI DIRECTORY 2010
We conduct highly creative MARKET RESEARCH with end users such as clinicians, specialist nurses and patients, to determine their illmet, unmet and even unconscious needs. We work across Europe, USA and the Far East and our tools include focus groups, specialist clinician and patient internet panels, telephone research and face to face interviews.
Activotec’s mission is to establish themselves as the partner of choice for solid phase peptide/organic synthesis.
CS-SConsulting Dr Claire Struthers-Semple Telephone : 0208 123 8664 Bartholomew Manor, Argyle Road, Newbury, Berkshire RG14 6BZ
Using only highly experienced pharmaceuitcal development executives allows the provision of a quality service to customers. We can work with clients to advise on • which should be the first asset for a small company to develop (based on potential commercial profile/value, technical developability, likely deal value) • what is the optimal point to partner (analysis of development cost to various stages v potential deal value) • where to get the various aspects of the early development work done • manage the execution of the early development activities mindful of the target profile.
A B C D E F
Daisy Telecoms Limited Mr Sam Pick www.redstone.co.uk Telephone : 0845 200 2030 Fax : 0845 2002022 Daisy House, Lindred Rd Business Park, Nelson, Lancashire BB9 5SR
Daisy Group PLC is a leading provider of integrated voice and data services to the small-medium business market. The company provides hosting, voice, managed services and mobile telephony to some of the UK’s leading organisations, delivering real cost savings and improving business efficiencies. Offering a complete portfolio of competitive business solutions, delivered by industry experts, our combined product set enables business customers to consolidate their communications with one supplier. With business-quality communications underpinned with unrivalled and award winning customer care, you will always speak to a fully trained business advisor based in our UK offices. Contact our specialist ERBI Account Management Team today on 0845 200 2030 or by emailing erbi@daisytelecom.com to find out how we can help you reduce and manage your telecommunications costs.
info@dbagroup.co.uk www.dbagroup.co.uk Telephone : 01223 202166 Fax : 01480 202169 2 Oakington Business Park, Dry Drayton Road, Cambridge, Cambridgeshire CB24 3DQ
DBA Group provide interim and part time Finance Director services to dynamic businesses that need the skills and experience of a senior finance professional on a flexible and cost effective basis.
www.deliverplus.co.uk Telephone : 0845 5001020 Fax : 0208 7589227 1 Spruce House, Durham Wharf Drive, Brentford Lock, Brentford, Essex TW8 8HP
I J
L
DBA Finance Directors have years of experience in working with entrepreneurs and understand the dynamics of keeping the business on track, acting as sounding board to the CEO and providing financial gravitas in third party discussions.
M
In addition to their experience in major accountancy practices, they have all run businesses at Board level and are well used to maintaining enthusiasm for new projects whilst keeping sight of the commercial reality and control needed to bring them to successful fruition.
N
Uniquely, we focus on integrating the strategic and operational aspects of financial and business management so that corporate plans are clearly constructed and efficiently executed with any deviation from target being swiftly identified, analysed and addressed.
O P
Deliver Plus Mr Roger Sumner-Rivers
H
K
DBA Group Ltd Mr David Blair
G
Deliver Plus offers both UK and International express courier delivery. ERBI members have access to extremely competitive courier tariffs with Deliver Plus, offering savings of up to 70%. Here are some of the other benefits: Online web login, enabling you or anyone in your organization to process and track shipments. Deliver Plus offers the combined services of UPS, FedEx and DHL under one umbrella. Deliver Plus offers a complete parcel management service, pro-actively tracking, monitoring and resolving delays on your behalf. Deliver Plus assigns you a dedicated, named account manager, with a direct dial telephone number. Deliver Plus offers a completely portfolio of services, import, export, express, timed and economy delivery to over 220 countries worldwide.
Q R S T U
Delta Consultants Ms Diane Swain delta@delta-consultants.com www.delta-consultants.com Telephone : 01480 495047 Fax : 01480 493310 The Old Courthouse, Priory Road, St Ives, Cambridgeshire PE27 5BB
An independent specialist recruitment agency formed in 1988 to serve the Scientific and Medical Devices industries across the UK and into Europe. Delta Consultants Scientific and Medical recruitment offer staffing solutions across the scientific (including Laboratory, Analytical and Life Sciences) and Medical community. Mainly recruiting for customer facing positions in sales, marketing and field service Delta can also assist our clients with other in-house or field based laboratory and scientific roles. We don’t see problems, just opportunities, and have an enviable record of success based on our knowledge of the industry, the personal service we offer, our “can do” attitude and our ethical approach. Celebrating 21 Years of successful recruiting in 2009 Delta Consultants looks forward to recruiting for ERBI in 2010 on onwards.
WWW.ERBI.CO.UK 153
V W X Y Z
Activotec’s mission is to establish themselves as the partner of choice for solid phase peptide/organic synthesis.
A B C D E
Diamond Pharma Services Ltd Mr Guy Clark info@diamondpharma services.com www.diamondpharma services.com Telephone : 01279 441616 Fax : 01279 418964 Gemini House, Flex Meadow, Harlow, Essex CM19 5TJ
F G H
Diamond Pharma Services provides technical and scientific expertise to the Pharma and biotech industry through its dedicated group of 19 employees in the following areas: • REGULATORY AFFAIRS • DRUG SAFETY/PHARMACOVIGILANCE • COMPLIANCE/QUALITY Diamond Pharma Services specialises at providing support for smaller companies, particularly in the biotech and gene therapy sectors, by supporting companies based in Europe and North America and providing European technical expertise to support their development projects, planning and guiding the regulatory path through EMEA and other EU authorities, and ongoing support for marketed products across some or all of the above disciplines. Diamond Pharma Services was founded in 2005 by Dr Maureen Graham, formerly European Director of Regulatory Affairs at Amgen, and is supported by a team of people with broad and varied industry experience across all sectors, thus bringing a wide range of knowledge and skills to your business.
DOCS International UK Mr Mark Cooper infouk@docs-int.com www.docs-int.co.uk Telephone : 0870 735 1164
DOCS International UK Ltd is a specialty recruitment and staffing company, exclusively dedicated to providing resources to the Healthcare, Industries in the UK and across Europe. We work closely with Pharmaceutical, Medical Devices, Biotechnology and Clinical Research Organisations. We specialise in permanent and contract positions in Clinical, Regulatory, Quality, Pharmacovigilance and Medical disciplines.
Fax : 0870 735 1165
I J
Compass House, Vision Park, Chivers Way, Histon, Cambridge, Cambridgeshire CB4 9AD
K L M N O
Dolomite Microfluidics Mr Tim Landucci info@dolomitemicrofluidics.com www.dolomitemicrofluidics.com Telephone : 01763 242491 Fax : 01763 246125 Unit 1 Anglia Business Park, Orchard Road, Royston, Hertfordshire SG8 5TW
P Q
Dolomite is a world leader in solving microfluidic problems. Microfluidics, also known as ‘Lab on a Chip’ is an emerging technology that is changing the future of instrument design. Microfluidics is an exciting area of science and engineering that enables small scale fluid control and analysis, allowing manufacturers to develop smaller, more cost-effective, and more powerful systems. Dolomite helps customers achieve the benefits of microfluidics by offering a range of standard products, including chips, connectors, valves, pumps, flow sensors, etc. These products are offered alongside Dolomite’s custom designed products and full system design and development. In recognition of Dolomite’s excellence in this field, in 2006 Dolomite won funding from the UK Department of Trade and Industry’s Micro and Nano Technology (MNT) Manufacturing Initiative. This funding allowed Dolomite to establish excellent microfabrication facilities with clean rooms, precision glass processing facilities and applications laboratories.
Dr Bill Primrose Dr Bill Primrose Telephone : 01223 245990
R S
38 Greville Road, Cambridge, Cambridgeshire CB1 3QL
T U V W X Y
EBD Group Dr Philip Ledger pledger@ebdgroup.com www.ebdgroup.com Telephone : +44 1234 721 353 57 The Causeway, Carlton, Bedford, Bedfordshire MK43 7LU
Z 154 ERBI DIRECTORY 2010
EBD Group is the leading partnering firm for the global life science industry. Since 1993, biotech, pharma and medical device companies have leveraged EBD Group’s partnering conferences, technology and services to identify business opportunities and develop strategic relationships essential to their success. Outside of the conference format, EBD Group’s consultants provide hands-on assistance for firms seeking to in- or out-license products and technologies. EBD Group has offices in the USA and Europe. For more information visit www.ebdgroup.com
Activotec’s mission is to establish themselves as the partner of choice for solid phase peptide/organic synthesis.
EG Technology Ltd Mr Andrew Ede info@egtechnology.co.uk www.egtechnology.co.uk Telephone : 01223 710799 Fax : 08707 877 021 Burleigh House, 13 - 15 Newmarket Road, Cambridge, Cambridgeshire CB5 8EG
eg technology is growing into one of the UK’s leading product engineering consultancies. Whether we are working with a small biotechnology start-up or an industry-leading blue-chip, our clients receive a level of service that forms the foundation for a long-term relationship. Based at the heart of the Cambridge technology cluster, we work with companies worldwide to develop engineering solutions to specific product needs. We don’t simply ‘solve problems’ - our experience ensures that we solve the right problems, managing risks and reducing time to market. Our team consists of bright, experienced, can-do people from a variety of backgrounds and disciplines, working together to create ideas - and turn them into reality. eg technology bring the engineering expertise to transform ideas into successful products. Our pragmatic approach combines innovation and experience to quickly and cost-effectively deliver: • step-change innovation • product design • engineering development • prototyping and testing • risk reduction • transfer to manufacture
industrysupport@ebi.ac.uk www.ebi.ac.uk Telephone : 01223 492527 Fax : 01223 494468 EMBL Outstation, European Bioinformatics Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire CB10 1SD
info@enjayservices.com www.enjayservices.ltd.uk Telephone : 01354 657001
The mission of EMBL-EBI is to: provide freely available data and bioinformatics services to all facets of the scientific community in ways that promote scientific progress; contribute to the advancement of biology through basic investigator-driven research in bioinformatics; provide advanced bioinformatics training to scientists at all levels; and help disseminate cutting-edge technologies to industry The research and service activities of EMBL-EBI span the entire spectrum of life science and remain at the cutting edge of the computational sciences. All our major data resources are the products of international collaborations. We work with other data providers to ensure that our data repositories, and those of our collaborators, are comprehensive and up to date. We also actively participate in international efforts to develop data standards. The EMBL-EBI Industry Programme engages our industrial users with the latest bioinformatics research, service development, standards activities, pre-competitive opportunities and training (www.ebi.ac.uk/ industry).
We are an independently owned company, with more than 25 years experience in the service and repair of life science instrumentation manufactured by Packard Bioscience of Downers Grove, Illinois (now owned by and marketed by PerkinElmer). We can service almost the entire original Packard range, including products no longer marketed by PerkinElmer. We are proud of our fast response times and rapid repairs, which result in lower costs for our customers. We also offer on-site customer training and a consultancy service (see our website for more details).
Telephone : 01353 721118
H I J
L M
O P
Europa Bioproducts Ltd
www.europa-bioproducts.com
G
N
P O Box 82, March, Cambridgeshire PE15 0ZB
info@europa-bioproducts.com
D
K
Fax : 01354 657218
Mr Mike Bannister
C
F
Enjay Services Ltd Mr Nicholas Martin
B
E
EMBL-EBI Dr Dominic Clark
A
Our main business is the supply of the GLYKO range of glycobiology reagents manufactured by ProZyme Inc. They are used in the characterisation of glycans associated with recombinant proteins. We supply all of the European Biopharmaceutical companies with one or more products. We supply a range of fluorescent proteins and conjugates used in flow cytometry, FRET technology and multiplexing applications. We use our Ecommerce web site to supply these same products to researchers throughout Europe.
Q R S
Fax : 01353 624589 15-17 North Street, Wicken, Ely, Cambridgeshire CB7 5XW
T U Evotec AG
Miss Angela Burt info@evotec.com www.evotec.com Telephone : 01235 861561 Fax : 01235 863139 114 Milton Park, Abingdon, Oxon OX14 4SD
Evotec is a leader in the discovery and development of novel small molecule drugs. The Company has built substantial drug discovery expertise and an industrialized platform that can drive new innovative small molecule compounds into the clinic. In addition, Evotec has built a deep internal knowledge base in the treatment of diseases related to neuroscience, pain, and inflammation. Leveraging these skills and expertise the Company intends to develop best-in-class differentiated therapeutics and deliver superior science-driven discovery alliances with pharmaceutical and biotechnology companies. Evotec has long-term discovery alliances with partners including Boehringer Ingelheim, CHDI, Novartis, Ono Pharmaceutical and Roche. Evotec has product candidates in clinical development and a series of preclinical compounds and development partnerships, including for example a strategic alliance with Roche for the EVT 100 compound family, subtype selective NMDA receptor antagonists for use in treatment-resistant depression.
WWW.ERBI.CO.UK 155
V W X Y Z
Activotec’s mission is to establish themselves as the partner of choice for solid phase peptide/organic synthesis.
A
Expedeon Protein Solutions Ltd Mr Gareth Bolitho
B
info@expedeon.com
C
Telephone : +44 (0)1223 873364
D
Unit 1A, Button End, Harston, Cambridge, Cambridgeshire CB22 7GX
E
www.expedeon.com
Fax : +44 (0)1223 873371
F G H
J
Mr Tony Pastore enquires@firesafetyservices.co.uk www.firesafetyservices.co.uk Telephone : 01603 731999
Unit 1 Robberds Way, Bowthorpe, Norwich, Norfolk NR5 9JF
K L M
O
Mr Jeremy Andrews jeremy.andrews@ thermofisher.com www.fisherbioservices.com
Fax : 01279 713329 1 Woodside, Bishop’s Stortford, Hertfordshire CM23 5RG
P Q
S
Mr Matt Galvin
Telephone : 01509 231166 Fax : 1509231893 Bishop Meadow Road, Loughborough, Leicestershire LE11 5RG
T
W
Whatever your line of business, we are able to offer professional informative advice and now have a growing list of satisfied clients ranging from small independent companies, property investment companies, local authorities, national retail chains, healthcare trusts and fire and rescue services. Fire Safety Services offer a full range of fire protection products and services
Part of Thermo Fisher Scientific, Fisher BioServices are experts in clinical trial supply, specialising in clinical services for Phase I to IV trials through to commercial supplies, biorepository services & cold chain logistics. Understanding the special needs involved in clinical studies and in the research and development process, we provide secure, controlled temperature storage, sample collection kit assembly, sample processing and logistics. We are licensed by the HTA, MHRA and HFEA and have ISO9001:2000 accreditation. Our key services include: • Import of supplies into the European Union • Qualified Person services • Secondary packaging • Labelling and assembly • Storage at all temperatures • Worldwide distribution • Returns and reconciliation From our site in the UK, our facilities, systems and procedures are professionally managed and are regularly audited by the Medicines and Healthcare Regulatory Agency (MHRA), our clients, and other regulatory bodies worldwide.
Fisher Scientific is a world-leading supplier of laboratory chemicals, consumables and equipment to the scientific community. Fisher Scientific realises that it’s future lies within the biotechnology sector and indeed, building relationships with networks such as ERBI. Fisher Scientific, therefore, recognises the need to support such important initiatives and take it’s role within these arrangements very seriously. As part of Fisher Scientific’s strategy, it looks to support the members of the ERBI community with specific offers and services designed for scientists and researchers within the biotechnology areas. Working with ERBI to bring their members the best in terms of service, support, value for money and high quality products has been hugely successful. Fisher Scientific look forward to working closely with ERBI and acting on their members needs to ensure the company continues to meet and exceed customer requirements for the future.
Fulcrum Pharma (Europe) Ltd Mr Tigran Arzumanov ashley.nagle @fulcrumpharma.com www.fulcrumpharma.com
X
Telephone : 0870 712 0538
Y
Hemel One, Boundary Way, Hemel Hempstead, Hertfordshire HP2 7YU
Z
All our Technicians are certified and trained to the highest standards, thus ensuring all works are carried out by competent and qualified staff.
Fisher Scientific is now part of the Thermo Fisher Group, the world’s largest manufacturer and supplier of products to the scientific community.
U V
Fire Safety Services (UK) Limited is an independent national fire protection service provider. Established in 1999, our company’s growth is based upon providing a high quality service and paying close personal attention to our customers’ individual requirements.
Fisher Scientific UK www.fisher.co.uk
R
In 2009 Expedeon’s RunBlue pre-cast PAGE gels were included in the successful Sigma Aldrich bid for ERBI Preferred Supplier status.
Fisher BioServices
Telephone : 01279 713320
N
• protein electrophoresis • protein purification • protein quantitation • protein stabilisation • protein refolding.
Fire Safety Services
Fax : 01603 749089
I
Expedeon manufactures and supplies novel and innovative products for use in protein research. Expedeon is a rapidly expanding company offering products for;
Fax : 0870 712 0538
156 ERBI DIRECTORY 2010
Fulcrum Pharma is a professional service company providing clients with expert solutions for the development of therapeutic products. Fulcrum offers a range of drug development, drug safety and regulatory services, ranging from nonclinical development of a lead molecule, through all clinical phases and regulatory milestones, to final marketing approval and post marketing surveillance. Our services can encompass the design and delivery of complete development and regulatory programmes or focus on specific areas or services within a larger project, including: • consultancy on development planning, regulatory strategy and issue resolution. • development and regulatory implementation using a mix of outsourcing and in-house capability. • drug safety and pharmacovigilance from clinical trials to post marketing surveillance. We deliver these services using our in-house skills and expertise in drug development and regulatory strategy, and operationally through a combination of external and internal capabilities.
Activotec’s mission is to establish themselves as the partner of choice for solid phase peptide/organic synthesis.
Futureneering Ltd Ms Carol Lee info@futureneering.com www.futureneering.com Telephone : 01223 437032 Innovation Centre, 23 Cambridge Science Park, Milton Road, Cambridge, Cambridgeshire CB4 0EY
Futureneering is an advisory business assisting emerging technology ventures with strategy and commercialisation. We work mainly in the fields of: Lifescience innovation, including biotechnology, medical devices, bioscience research and diagnostics. Technologies for environmental sustainability, including cleantech, energy, renewables, materials. We specialise in cross-disciplinary business developments at the intersection of research into life science and engineering physics. Futureneering is run by a management team with many years of experience advising technologyoriented businesses.
A B C D E F
GB Innomech Ltd Mr Steven Robertson info@innomech.co.uk www.innomech.co.uk Telephone : 01353 667394 Fax : 01353 663472 The Innovation Centre, Witchford, Ely, Cambridgeshire CB6 2HZ
GB Innomech helps organisations, particularly in the pharmaceutical and medical device sectors to manufacture and/or inspect their products through automation. We are experienced with early stage development and with existing products and processes. We are able to offer a number of technologies including: • precision handling and placing • laser • precision gluing • precision welding • micro dispensing of liquids • micro dispensing of powders • multi-axis servo systems • design of intelligent control systems • vision and inspection technologies
H
A thorough knowledge of these technologies enable us to automate even the most complex, highly labour intensive manufacturing, inspection or testing processes. Our systems are used by most of the world’s leading pharmaceutical companies, as well as many biotech and contract manufacturers. Our work is undertaken within an ISO 9001:2008 environment and our processes are based upon GxP practice.
www.gehealthcare.com/uken/ Telephone : 08702 407575 Fax : 08702 407534 Amersham Place, Little Chalfont, Buckinghamshire HP7 9NA
GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Our expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, performance improvement, drug discovery, and biopharmaceutical manufacturing technologies is helping clinicians around the world re-imagine new ways to predict, diagnose, inform, treat and monitor disease, so patients can live their lives to the fullest. Scientific Asset Services from GE Healthcare offers a comprehensive life cycle asset management solution, going beyond equipment maintenance and designed to help Companies improve productivity while reducing costs. GE Healthcare customized programs can offer solutions for pre-purchase planning and predictive maintenance, as well as managing moves, redeployment and disposal of equipment. Data from the program is used by GE Healthcare to provide business intelligence that helps drive informed decision making. With 15 years of understanding life cycle asset management coupled with a global reach, change management and Lean Six Sigma skills, GE Healthcare delivers a consistent solution where companies need it.
jayne.mclaughlin@ georgejamesltd.co.uk www.georgejamesltd.co.uk
J
L M N O P
George James Ltd Mr Neil Burns
I
K
GE Healthcare Mr Peter Batey
G
george james adds value to businesses through its expert services in recruitment and talent management. We have a combined experience of over 150 years in the business areas we support and over 50 years as a service provider. We have a global reach and work extensively throughout Europe and we also network into the US & Canada via our strategic partners.
Telephone : 07977 192209
What makes george james unique are our flexible approaches that allows us to employ proactive search strategies at all levels not just senior appointments.
Hotley Bottom Barn, Hotley Bottom Lane, Great Missenden, Buckinghamshire HP16 9PL
Thus we can offer effective solutions to reduce the lost opportunity costs for business critical hires that may have no solution or take many months with less proactive approaches.
Q R S T U
Giles Insurance Brokers Ltd
V
Mr Howard Pearson www.thebroker.co.uk
W
12 Poverest Road, Orpington, Kent BR5 2TP
X Y Z WWW.ERBI.CO.UK 157
Activotec’s mission is to establish themselves as the partner of choice for solid phase peptide/organic synthesis.
A B C D E
Global Regulatory Services Mrs Greer Deal enquiries@globalregulatory services.com www.globalregulatory services.com Telephone : 01353 774000 Global House, Painters Lane, Sutton, Ely, Cambridgeshire CB6 2NS
F G H I
Ms Alison Seekings www.grant-thornton.co.uk Telephone : 0870 991 2495 Byron House, Cambridge Business Park, Cowley Road, Cambridge, Cambridgeshire CB4 0WZ
K
M
O
Mr John Granger
We have life science specialists in London, Oxford, Cambridge and Scotland acting on behalf of listed, privately held and private equity backed pharmaceuticals, medical devices and biotechnology companies. We advise our clients on issues such as expanding overseas, share incentive plans, international tax transfer pricing, R&D tax credits, fund raising and mergers and acquisitions.
Fax : 01223 893711 Granta Park, Great Abington, Cambridge, Cambridgeshire CB21 6GP
As regards future development at Granta Park there are several undeveloped sites which have outline planning consent. In addition GPL is planning to carry out some speculative development on an area of land recently acquired from TWI and was recently granted an additional 30,500 sq metres of planning consent on adjacent land it already owns.
rquince@mepc.co.uk www.mepc.com/grantapark/ Home.aspx
Great Eastern Investment Forum (GEIF) Ms Larissa Chamberlain geif@nwbrown.co.uk
R
www.geif.co.uk
S
Fax : 01223 345 617
T
With our knowledge of the market, and our international links, we can provide a full range of audit and tax services together with supportive advisory services for companies in the life sciences sector, whatever stage they are at in the business cycle.
Work on the greenfield site of Granta Park commenced in 1998 and since that time around 55,000 sq metres of labs and offices have been developed, including 10,000 sq metres for TWI. The Park has an R&D consent and has focused on providing space for the life sciences sector. Current tenants include PPD, Vernalis, UCB, Alizyme, CAT, Gilead and LiDCO. Granta Park has been attractive to life sciences businesses because of its location (near to Addenbrookes and the Genome Campus at Hinxton), its relatively uncongested approach roads and its environment. The site provides 24 hour, manned entrance security and has high quality and comprehensive CCTV coverage. It houses a 75 place day nursery and café, and it operates a shuttle bus service to the local train station at Whittlesford (on the Cambridge to London Liverpool St line). Broadband and optic fibre connections are available.
P Q
Grant Thornton UK LLP is a leading financial and business adviser, operating out of 30 offices across the UK. We are a member firm within Grant Thornton International Ltd<http://www.gti.org/>, one of the world’s leading international organisations of independently owned and managed accounting and consulting firms. Clients of member and correspondent firms can access the knowledge and experience of over 2,600 partners in over 100 countries.
Granta Park Ltd
Telephone : 01223 893710
N
GRS is well placed to support companies with emerging, novel technologies from stem cell therapy through to borderline products (including medical devices, biomarkers and in vitro diagnostics). We do not shy away from undertaking something which is going to break new ground or be launched overseas. We enjoy the challenges presented to get innovative products from lab to market. We have a good working relationship with key Health Authorities and through open dialogue and good communication we can readily support our innovative clients to achieve their objectives.
Grant Thornton UK LLP
J
L
GRS is a full service regulatory affairs consultancy based in the UK offering resource, support, advice and solutions to life science companies worldwide. We have a global network of several thousand consultants and as a direct result of the high calibre of our people, we can provide strategic advice as well as ensuring compliance with all the current and relevant rules and regulations.
Telephone : 01223 345 616
Ravenscroft House, 61 Regent Street, Cambridge, Cambridgeshire CB2 1AB
The Great Eastern Investment Forum (GEIF) was established by Nigel Brown in 1995, and is one of the UK’s premier business angel networks. GEIF works with both early stage technology companies and later stage ‘non-tech’ businesses helping to attract investment from its members, typically in the range of £100k to £1.5m. GEIF has a diverse range of investor members with a wide range of knowledge and experience in a variety of sectors. Its members have invested in many successful businesses including Artimi, Camrivox, Coffee Nation, DanioLabs, Novacta Biosystems, OnRelay, Revieworld and Quotient Diagnostics. The primary method of introduction between companies seeking funding and the business angels is a Presentation Day, when up to six companies are given an opportunity to present to the GEIF business angels. Companies applying to GEIF represent a range of sectors, including biotech.
U V W X Y
Greatspur Clinical Development Ltd Miss Janice Hedgecock enquiries@greatspur.co.uk www.greatspur.co.uk Telephone : 01953 714942 Fax : 01953 714942 42 Kenninghall Road, East Harling, Norwich, Norfolk NR16 2QD
Z 158 ERBI DIRECTORY 2010
Greatspur Clinical Development Limited is a small, privately owned Limited Company providing a range of advice and support services to pharmaceutical and biotechnology companies on the planning, preparation and conduct of clinical trials. Working with clients from the late pre-clinical stage to develop and manage Phase I trials, Greatspur can provide product development and clinical trials support throughout the development process. The company can offer in-depth knowledge and experience of the clinical research environment and a network of regulatory and other industry associates. Services include project management, medical writing and quality management services, including clinical systems and procedures development and support for regulatory inspections. Our aim is to deliver a professional service tailored to our clients’ needs, coupled with a commitment to high quality and timely delivery.
Activotec’s mission is to establish themselves as the partner of choice for solid phase peptide/organic synthesis.
Gregory Fryer Associates Ltd Ms Sarah Fryer info@gf-associates.co.uk www.gf-associates.co.uk Telephone : 01353 645590 Fax : 01353 645599 30 St Thomas Place, Cambridgeshire Business Park, Ely, Cambridgeshire CB7 4EX
GFA is an expert regulatory, clinical research and GCP QA contract company, providing practical advice and support to the biopharma industry to move products from early concept, into the clinic and on to Marketing Authorisation. Our range of services includes: Agency meetings and briefing document preparation, clinical trial approvals, Orphan Drug applications, MAA, Clinical trial management and monitoring, GCP QA audits and SOP writing, medical writing, US Resident Agent services and EEA Legal Representative services. GFA has an excellent understanding of the global regulatory arena, and with staff in the UK and USA, GFA supports in particular European companies seeking to expand development to the US but also US companies coming to Europe. What sets us apart is our combination of both clinical and regulatory expertise within the one consultancy group, allowing a comprehensive approach to product development encompassing the needs of regulatory requirements and the clinical research process.
clinical@grundon.com www.grundon.com Telephone : 01628 501590 Fax : 01628 501591 Clinical Waste Division, Star Works, Star Lane, Knowl Hill, Berkshire RG10 9XY
H
At our facility near Heathrow Airport. We employ a variety of collectin vehicles operated by fully trained drivers and provide documentation to ensure compliance with all relevant legislation and guidelines.
K
Services range from site selection and negotiation of agreements, with, and financial contributions from, landlords - through to design management and fit-out procurement. We have established an extensive database of design solutions, benchmark costs and development programmes and can give an early indication as to what can be achieved, at what cost and by when.
www.harpumconsulting.com Telephone : 01933 675079 8 Kings Lane, Harrowden, Northamptonshire NN9 5BL
L M N O P
Harpum Consulting Mr Gary Aldam
I J
Telford House, Fulbourn, Cambridge, Cambridgeshire CB21 5HB
Telephone : 01223 882000
E
We have established a large customer base of scientific research companies providing consultancy, collection and subsequent high temperature incineration of their hazardous wastes.
Fax : 01223 881888
www.hannahreed.co.uk
D
G
Project Management consultants focussed on the design and procurement of research facilities. Working on behalf of the end user, we have acted on behalf of the majority of the major occupiers locally. Clients include Acambis, Amedis, Astex, Biofocus, CAT, CCD, Celltech, Cellzome, Domantis, Intercytex, Ionix, Lorantis, MedImmune, Medivir, Millennium, Paradigm, Peptide, Pfizer, PPD, Ribotargets, Vernalis and others. Also teaching and research facilities for the University of Cambridge and University of Nottingham. Total portfolio of developments exceeds 105,000sqm of new build and refurbishments.
cambridge@hannahreed.co.uk
C
Established in 1929, we are proud to be the largest family run waste management company in the UK. We have developed our service over the years to specialise in establishments that require a high level of expertise and technical knowledge.
Hannah Reed Mr Henry Martin
B
F
Grundon Waste Management Limited Mr Andrew Stratton
A
Project management capability will be one of the deciding factors when looking at the successful biotechs of the future. Throughout industry those companies that have grasped project management and made it work for their industries are the ones that have been successful. Harpum consultants through their many years of experience within the life science sector and across industry can help you to understand your project environment. Through our database of academic research we know what best practice looks like and can help you to implement it. We work with your project organisation to identify the areas of need and develop bespoke solutions. Everyone at Harpum has one overriding concern – guaranteeing business benefit is created for you. Our ethos demands that in return for investing with us, you and your people gain high value returns staying with you until you are confident those outcomes, and business value, have been achieved.
Q R S T U
Harrison Clinical Research Ltd Mr Jamie Pearson www.harrisonclinical.com Telephone : 01353 668339 Fax : 01353 661580 Gemini House, Bartholomew’s Walk, Cambridgeshire Business Park, Ely, Cambridgeshire CB7 4EA
Harrison Clinical Research was founded in 1987 and is a privately owned full-service CRO with its headquarters in Munich, Germany. Regional offices are located in Austria, Belgium, France, Israel, Italy, Japan, Spain, Russia, the Ukraine, USA and UK. From these offices the clinical development needs of both Eastern and Western Europe as well as the USA can be achieved. In addition, HCR can offer a truly global approach to trials through its partnerships with like-minded companies in countries such as India, China, Japan and other Far Eastern locations. Clearly, all CROs should complete every study to the highest quality standards. Indeed, Harrison Clinical Research has gone one step further for its clients. We are proud to be one of the first CROs worldwide to have been awarded the ISO 9001:2000 certification for ‘Design and evaluation of clinical trials for the pharmaceutical and device industries, including performance of Phase I trials and management and monitoring of Phase II/III/IV trials.
WWW.ERBI.CO.UK 159
V W X Y Z
Activotec’s mission is to establish themselves as the partner of choice for solid phase peptide/organic synthesis.
A
Harten Group Ltd Dr Vernon Harten-Ash
B
enquiries@hartengroup.co.uk
C
Telephone : 01223 233777
D
7 Pioneer Court, Explorer House, Vision Park, Chivers Way, Histon, Cambridge, Cambridgeshire CB4 9PT
E
www.hartengroup.co.uk
Fax : 01223 235777
F G
Harts Office Supplies Ms Sharon Hayes sharon@harts1836.co.uk www.hartsdirect.co.uk
H I J
Telephone : 01799 500100 Fax : 01799 528082 Hart House, Shirehill Industrial Estate, Shire Hill, Saffron Walden, Essex CB11 3AQ
K L M N O
Mr David Oates advice@healthsafetyworks.co.uk www.healthsafetyworks.co.uk Telephone : 01223 265622 Fax : 01223 265622 14 Harbour Avenue, Comberton, Cambridge, Cambridgeshire CB23 7DD
S T
Dr Peter Blenkinsop
Telephone : 01480 364925 Fax : 01480 831450 CTBI Building, Papworth Hospital NHS Foundation Trust, Papworth Everard, Cambridgeshire CB23 3RE
U V W X Y
Health and Safety Works Limited specialise in the provision of advice to businesses in the following areas: • Review and design of Health and Safety Policy/Systems • Audits • Risk Assessments • Legislation • Building and Construction • Laboratory, Biohazards, DSEAR and REACH consultancy • Training Courses designed around the specific needs of your Company. • IOSH training Discounts available to ERBI members.
Health Enterprise East www.hee.org.uk
R
*Shopping Service for daily consumable/catering/cleaning requirements normally purchased through a Cash & Carry/Supermarket *’Try before you buy’ on a range of office Seating - no more costly uncomfortable purchases *Ergonomic Surveys - we have a range of ergonomic products for all requirements *Office Refurbishments/Project Management *Space Planning (CAD) - Help visualise final environment *Furniture Installations by our own dedicated Team *Leasing solutions - spread your costs *Used Toner Collections - Bins supplied *Print Audits - We can reduce your expenditure with our print solutions *Print Management - We can hold bulk stock for you in our secure storage area *On-site Design Print - All under one roof *Business gifts - any product can be sourced
Health and Safety Works Ltd
P Q
The Harten group provides high-level Interim Managers, Permanent Recruitment solutions and Management Consultancy services to the biopharmaceutical industry. Assignments completed successfully include interim and permanent recruitment provision for Research, Development, Medical Affairs and Senior Commercial and Executive roles at Biotech and Pharmaceutical companies. The provision of CEOs to start-ups, technical and commercial due diligence in support of licensing/Fundraising. Expert report writing for Regulatory and Clinical submissions.
Health Enterprise East (HEE) is the NHS Innovation Hub for the East of England, providing a broad range of professional IP management services to the NHS Trusts across the Region. Through HEE companies in the healthcare sectors can gain access to a wide range of medical technology (devices to software) licensing opportunities invented by NHS staff in response to key unmet clinical needs. For those companies wishing to engage with NHS clinicians in collaborative research programmes access can be provided to a web-site which highlights NHS priorities in the Region. HEE also provides a professional service to healthcare companies who wish to access NHS expertise on a commercial basis. The service covers the full spectrum of needs from clinical trials to healthcare economics evaluations and expert opinions. Through this service HEE has enabled businesses from around the world to access NHS expertise in ways which enable them to develop and progress their products.
Health Protection Agency Dr Phil Luton business@hpa.org.uk www.hpa.org.uk Telephone : 01980 612725 Fax : 01980 612241 Porton Down, Salisbury, Wiltshire SP4 0JG
Z 160 ERBI DIRECTORY 2010
The Health Protection Agency is a public sector organisation which is dedicated to protecting people’s health and reducing the impact of infectious diseases, chemical, poisons and radiation hazards. We work nationally & internationally with commercial companies, governments and non governmental organisations in order to protect human health. Core business areas include research and development of vaccines against infectious diseases, process development and GMP manufacture of biologics derived from microbial fermentation particularly those requiring containment or focused on the bio-defence market. We have a proven track record in process development and optimisation for both in-house and customer derived products, including enzymes, therapeutic proteins and vaccines. In addition, a wide range of support services are offered from biosafety, through GLP immunoassay testing to in-vivo studies and the supply of cell cultures / bacteria / fungi & viruses.
Activotec’s mission is to establish themselves as the partner of choice for solid phase peptide/organic synthesis.
Heptares Therapeutics Dr Fiona Marshall www.heptares.com Telephone : 01707 358627 Biopark, Broadwater Road, Welwyn Garden City, Hertfordshire AL7 3AX
Heptares Therapeutics is a drug discovery company focused on identifying novel drug candidates targeting high-value, validated G-protein-coupled receptors (GPCRs) in multiple disease areas. The Company’s unique StaR™ technology enables Heptares to engineer and purify stable GPCRs to which it can apply contemporary drug discovery approaches, such as crystallisation and structurebased design, biophysical analysis of ligand interactions and fragment screening. This unique approach is expected to radically improve the chances of finding novel drug candidates (small molecules and biologicals) to previously intractable targets and will enable the development of safer and more selective therapeutic agents. Based on this integrated drug discovery capability, Heptares aims to progress promising candidates internally and through strategic alliances.
info@infotogo.info www.infotogo.org.uk Telephone : 01223 354097 Fax : 01223 847487 17 Priory Road, Cambridge, Cambridgeshire CB5 8HT
B C D E F
Info To Go Ltd Mrs Jill Ede
A
info to go ltd is a Cambridge based information research and analysis service, working primarily for companies in the pharmaceutical, biotechnology, medical device and related industries. In effect, info to go acts as a virtual library for small to medium sized companies which do not have the need, or perhaps the budget for a full time in-house information specialist. info to go accesses scientific papers, news, technical and product literature, market reports by the section, patents, conference material, clinical trial details and deal and licensing information from some of the world’s most authoritative sources. By filtering out only the relevant information from a combination of these sources, info to go delivers timely, concise results without information overload.
G H I J K
Ingrid Richardson Consulting Ms Ingrid Richardson ingrid@inconsulting.com www.irconsulting.co.uk
Specialist independent Human Resources consultancy providing strategic and operational HR services to SMEs, including retained search and selection. Building strong collaborative working partnerships with our clients, our CIPD qualified Associates are able to provide HR support throughout the employment cycle.
Telephone : 07887 690360 10 Felsham Close, Burwell, Cambridge, Cambridgeshire CB25 0JP
info@inovacia.se www.inovacia.se Telephone : 0046 8 50 10 30 40 Fax : 0046 8 50 10 30 44 133 Lindhagensgatan, Stockholm, Sweden 11251
M N O P
iNovacia AB Mr Markus Thor
L
iNovacia is a contract research organisation, with long-standing experience from drug discovery. Our goal is to provide excellent research services at competitive prices. The process spans from assay development to lead optimisation. iNovacia has no internal pipeline causing conflict of interest. All work is focused on delivering the best possible result for each customer. Screening can be done on our diverse high quality compound library, which is proven to give hits well suited for lead optimisation. Through collaboration with Asinex Ltd, a large set of their unique libraries is available for screening. Our compound purification line can handle crude material up to 30 mg from library synthesis or singletons.
Q R S T U
Institute of Biotechnology Dr Linda Allan enq@biotech.cam.ac.uk www.biotech.cam.ac.uk/mbe Telephone : 01223 334168 Fax : 01223 334162 University of Cambridge, Master’s in Bioscience Enterprise Programme, Tennis Court Road, Cambridge, Cambridgeshire CB2 1QT
V
The MBE programme is an intensive, taught business course intended for those who have the ambition to found technology companies or take up leadership, executive or consultancy roles in the life science sector. Students are based at the University’s Institute of Biotechnology and have a close affiliation to Judge Business School.
W
The nine month programme comprises a series of compulsory interdisciplinary modules that cover the commercial exploitation of the latest advances in biotechnology, together with the business and management skills associated with bringing scientific opportunities to market.
X
Lectures and case studies are frequently delivered by senior company executives from the life science business sector. There is an opportunity to gain practical experience through consulting and internship projects, together with an international perspective of the industry sector during a study tour to Boston, USA. Attainment is continuously assessed and graduates are awarded the MPhil degree.
WWW.ERBI.CO.UK 161
Y Z
Activotec’s mission is to establish themselves as the partner of choice for solid phase peptide/organic synthesis.
A B C D E
Integrated Medicines Ltd Dr Eddie Blair eddie.blair@integrated medicines.co.uk www.integratedmedicines.co.uk Telephone : 01954 718122 Fax : 01954 719743 Topfield House, Ermine Street, Caxton, Cambridgeshire CB3 8PQ
F G H I
Dr Sue Pearson sue6.pearson@ntlworld.com Telephone : 01462 635327 Fax : 01462 635327 P O Box 170, Hitchin, Hertfordshire SG5 3UP
K
M N
Mr Paul Lawrence www.invitrogen.com Telephone : 01795 411145 3 Fountain Drive, Inchinnan Business Park, Paisley, Scotland PA4 9RF
P
S T
Mr Chris Rogers
www.i-regulatory.com Telephone : 01438 730890 1 Viewpoint Office Village, Babbage Road, Stevenage, Hertfordshire SG1 2EQ
U V W X Y
International Science Writer is run by Sue Pearson, who has been a science communicator since 1990. During her successful communications career, Sue has written over 800 press releases and more than 200 articles for many different biotech and life science companies, providing her with a unique insight into these industries. As well as client writing, Sue is also a well respected journalist and has published articles in GEN, Nature Biotechnology and Bioprocess International. Her excellent writing skills are underpinned by a Ph.D. in molecular biology and 10 years’ experience in PR positions with two global scientific communications agencies and in marcoms roles with life science firms, Stratagene and Pharmacia Biotech.
Invitrogen Corporation (Nasdaq:IVGN) provides products and services that support academic and government research institutions and pharmaceutical and biotech companies worldwide in their efforts to improve the human condition. The company provides essential life science technologies for disease research, drug discovery, and commercial bio-production. Invitrogen’s own research and development efforts are focused on breakthrough innovation in all major areas of biological discovery including functional genomics, proteomics, bio-informatics and cell biology-placing Invitrogen’s products in nearly every major laboratory in the world. Founded in 1987, Invitrogen is headquartered in Carlsbad, California and conducts business in more than 70 countries around the world. The company globally employs approximately 3,000 scientists and other professionals. For more information about Invitrogen, visit the company’s web site at www. invitrogen.com
iRegulatory Ltd chris.rogers@i-regulatory.com
R
International Science Writer is a company specialising in providing timely, well written copy for the biotechnology and pharmaceutical industries. The company produces press releases, articles, brochures, newsletters and advertising copy for a number of international clients including; Capsugel, Invitrogen, Synbiosis, Syngene, The Automation Partnership and Teva.
Invitrogen Life Technologies
O
Q
Services include board-level strategic management, operations-level programme management and fee-for-service consultancy on integrated diagnostics and pharmaceuticals development & marketing. IML operates locally, nationally and internationally to ensure that pharmaceuticals become pharmasuitables for 21st century personalised healthcare. Visit our website for presentations, publications and for registration to receive our monthly newsletter.
International Science Writer - Sue Pearson
J
L
Integrated Medicines Ltd (IML) is developing both products and services that enable stratified medicines, en route to fully personalised medicines. IML offers value assessments for companion products (diagnostic-type tests and/ or proprietary medicines) as well as developing tuneable magnetic proteins for in vitro, ex vivo and in vivo diagnosis and treatment.
iRegulatory are a UK based European Regulatory Affairs consultancy. We provide regulatory advice for drug development, including input at early stages to advise on regulatory strategy. Other services include preparation for scientific advice meetings with regulatory authorities, clinical trial applications and regulatory writing. We have expertise in Quality, Biotechnology, Non-clinical and Clinical aspects of applications at all stages. We have a core team of experienced regulatory affairs consultants supported by the iRegulatory Panel, a group of external consultants with whom we have strong working relationships. The Panel combines the advantages of independent consultants (strength in specific areas of expertise) with the advantages of a regulatory team (depth and breadth). iRegulatory also have expertise and experience in paper and electronic publishing of all application types, including eCTD and NeeS, of clinical trial applications through to full MAAs.
Ithaka Life Sciences Ltd Dr Paul Rodgers info@ithaka.co.uk www.ithaka.co.uk Telephone : 01223 703146 Fax : 01954 202179 St John’s Innovation Centre, Cowley Road, Cambridge, Cambridgeshire CB4 0WS
Z 162 ERBI DIRECTORY 2010
We specialise in the commercialisation of innovative biomedical technologies. Our clients include life science and pharmaceutical companies, investors, public sector bodies, Universities and other research institutions. We offer the following services: - Technology reviews, including technical and commercial review of IP, technical and commercial due diligence and market assessments; - Development and implementation of technology transfer strategies and business plans; - Identification of commercial partners for technology licensing and R&D collaborations; - Strategic and operational advice to public sector bodies involved in technology commercialisation; - Spin out company creation and sourcing of funding; and - Provision of interim management, particularly Chairman, CEO and Business Development roles, for growing companies.
Activotec’s mission is to establish themselves as the partner of choice for solid phase peptide/organic synthesis.
John Innes Centre Ms Carole Thomas jic.communications@bbsrc.ac.uk www.jic.bbsrc.ac.uk Telephone : 01603 450000 Fax : 01603 450045 Norwich Research Park, Colney, Norwich, Norfolk NR4 7UH
JIC has been designed and is managed as a centre for integrated bioscience. Its research approaches exploit cell biology, biochemistry, chemistry, genetics and molecular biology. Research on model organisms is carefully integrated with work on economically important species. JIC maintains an appropriate mix of fundamental, strategic and applied research that is continually being focused at the frontiers of discovery. JIC has over 30,000m sq of laboratory buildings, 8,000m sq of glasshouses and 187m sq of controlled environment growth rooms on a 50 acre site in Norwich. JIC leases these extensive facilities from the John Innes Foundation (JIC), a charity established from the will of our founder John Innes (18291904). JIC also has 400 acres of farmland for field trials.
jon@jonjamindesigns.co.uk www.jonjamindesigns.co.uk
B C D E F
Jon Jamin Designs Mr Jon Jamin
A
We are a design company offering a personal, professional service in design prototyping over a wide range of engineering including the bio-tech and pharma industries. We can project manage and design from concept to prototype. Please see our website for more detailed information and examples of our work.
G H
Telephone : 01449 736707 Fax : 01449 736104
I
Peggs Barn, Drinkstone, Bury St Edmunds, Suffolk IP30 9TW
J K
Juice Resource Solutions Ms Maureen Park mpark@juiceresource solutions.com www.juiceresourcesolutions.com Telephone : 01727 867772 Fax : 01727 861119 Suite 14, 3 Soothouse Spring, St Albans, Hertfordshire AL3 6PF
A full service human resource business specialising in the life sciences sectors. We cover all functional areas in Healthcare, Medical Devices and Drug Development.
L
Juice Interim Management Solutions We provide experienced Interim Managers at short notice, for temporary assignments at specialist or senior level. All are hands on executives and managers with proven track records in their areas of expertise.
M
Juice Permanent Recruitment Solutions Our recruitment process is designed to take the pressure away from the managers and HR departments. We telephone interview all candidates and shortlist down to 3 or 4 specialists that match in skills, personality fit, salary expectation and location. We are extensively networked in the industry across the UK and Europe and use a mixture of database, advertising and head hunting recruitment to make sure that candidate and client are the right fit for each other.
info@keymed.co.uk www.keymed.co.uk Telephone : 01702 616333
O P
KeyMed Ltd Mr Mark Jackson
N
Formed in 1970, KeyMed has grown to become firmly established as an international leader in the manufacture and supply of specialised medical and industrial equipment. A wholly-owned subsidiary of the Olympus Corporation of Japan, KeyMed is an important part of the global Olympus network, with specific responsibility for the development and manufacture of medical and industrial equipment for distribution worldwide.
Q R S
Fax : 01702 465677 KeyMed House, Stock Road, Southend-on-Sea, Essex SG2 5QH
T U Knowledgeworks Ltd
Mr Richard Featherstone info@knowledgeworks.uk.com www.knowledgeworks.uk.com Telephone : 01799 543777 Fax : 07905 979609
“Knowledgeworks is a consultancy firm specialising in the provision of strategic healthcare marketing services for the pharmaceutical, medical device and biotechnology industries. We specialise in the fields of market access, health economics, outcomes research and human factors. Based near the world-famous bioscience hub of Cambridge University in the UK, we work with clients across Europe, and for more than six years we have built a reputation for trust, professionalism and delivery.”
The Old Forge, Wendens Ambo, Saffron Walden, Essex CB11 4JL
V W X Y Z
WWW.ERBI.CO.UK 163
Activotec’s mission is to establish themselves as the partner of choice for solid phase peptide/organic synthesis.
A
La Playa Limited Mrs Hanna Beaumont
B
info@laplaya.co.uk
C
Telephone : 01223 200650
D
The Stables, Manor Farm, Milton Road, Impington, Cambridge, Cambridgeshire CB24 9NG
E
www.laplaya.co.uk
Fax : 01223 237942
F G H I
Headquartered a short distance from Cambridge Science Park, and also with offices in London, La Playa provides expert, independent insurance and risk management advice for life science enterprises of all sizes. Our clients work in some of the most innovative, game-changing sectors in the UK, including drug/vaccine development, medical devices & healthcare sciences, bioinformatics, electronics and nanotechnology - so we know a thing or two about unconventional risk. And how to manage it. We offer FREE Enterprise Risk Planning for all ERBI members, helping start-ups to become investorready and helping more established firms to benchmark their insurance portfolios against current ‘best practice’.
LA-Design Mr Will Bentall www.La-design.co.uk Telephone : 01442 862631 Fax : 01442 874354 London Associates, 105 High Street, Berkhamsted, Hertfordshire HP4 2DG
LA is a well-established Product Design and Development Consultancy, structured for brand-led companies with serious products to deliver. Experts in medical & scientific equipment, LA have clients in the US, Europe, Africa and the Far East. LA differentiated from its competition by implementing a system where a partner always takes both client and project responsibility with project teams structured to provide the optimum mix of skills and experience for specific project needs. These methods have resulted in five International Design Effectiveness Awards for products commercially proven to have had a major impact on company profitability and market share. Recent DBA ‘league tables’ ranked LA as one of the best Product Design Companies in the UK
J K L M N O
Lab Support UK Ms Leigh Gerdes cambridge@labsupport.co.uk www.labsupport.co.uk Telephone : 01223 451021 Fax : 01223 451131 Wellington House, East Road, Cambridge, Cambridgeshire CB1 1BH
P Q
S
All recruiters are scientists themselves with a number of years in industry which gives them the understanding and technical knowledge to find the best match for client and candidate. Lab Support has offices in Cambridge, Windsor, Birmingham, Oxford, Sheffield, Warrington, Glasgow, The Netherlands, Belgium and throughout the USA.
LCG Bioscience Ms Hannah Brooks www.lcg-bioscience.com
R
As part of the Life Science segment, Lab Support is a leading speciality provider that assists our clients with recruiting for their scientific positions. We provide contract, contract to hire and direct hire opportunities at all levels - from technicians through to management positions. We support the biotech, pharma, food, personal care and chemical industries.
Telephone : 01954 717202 Fax : 01954 718826 Bourn Hall Clinic, Bourn, Cambridgeshire CB23 2TN
T
LCG Bioscience is a unique research organisation, specialising in early phase clinical trials, from Firstinto-Man to Proof of Concept. Based in Cambridge, UK, our purpose built facility with a 46-bed clinic, radioisotope ward, dedicated sleep rooms and respiratory facility, together with on-site safety and biomarker laboratories has full MHRA accreditation and allows complete studies to be placed in one location. LCG Bioscience offers a comprehensive range of services, from study design, protocol development and writing, all the way through to the final study report. For all your early phase clinical trials, come to LCG Bioscience.
U V W X Y Z
LE Executive Resourcing Ltd Ms Lynne Evans lynneevans@le-executiveresourcing.com www.le-executiveresourcing.com
LE Executive Resourcing provides Talent Management solutions tailored to your specific requirements. Specializing in finding people for senior management roles and Board positions, we have successfully completed a wide range of assignments for companies ranging from start-up Biotechs to global industry leaders.
Telephone : 0115 932 9922 079 6886 3344
Regardless of the size of your business, we recognize the importance of your project, and value each client equally. You will receive a dedicated bespoke service, the chief goal being to ensure that the appointment will make a measurable difference to your organization. We have an unsurpassed track record in recruiting for all functions and disciplines including:
P O Box 5781, Ilkeston, Derbyshire DE7 4ZD
• Business Development • Discovery Research • Finance • Human Resources • Manufacturing • Marketing • Operations • Product Development • Quality • Regulatory Affairs
164 ERBI DIRECTORY 2010
Activotec’s mission is to establish themselves as the partner of choice for solid phase peptide/organic synthesis.
Leads to Development (L2D) Services Dr Jonathan Kearsey Contacts@L2Dservices.com www.L2Dservices.com Telephone : 0033 1 8228 5372 Fax : 0033 1 8228 5379 Paris Biotech Sante, 24 rue du Faubourg Saint-Jaques, Paris, France 75014
LEADS TO DEVELOPMENT’S mission is to manage the preclinical development of its clients’ lead compounds, from in vivo proof of concept through to phase I clinical trials, using scientific, project management and business expertise. Our services are tailored to our clients’ needs and allow a seamless bridge between the bench and the clinic, whilst avoiding the fixed costs associated with an internal team. Our team of experts is ready to start, allowing you to avoid the lag period associated with hiring and training an internal group. A fusion of project management rigour and a sense of urgency enables us to optimise your development programme, shortening timelines and reducing costs. Our clients include biopharmaceutical companies whose number of leads is insufficient to justify building an internal development team. In a climate where research organizations need to increase productivity whilst stream-lining costs, out-sourcing your non-clinical development management is the most advantageous strategy.
mja@leansigmalab.com
Lean Sigma Lab provides:
www.leansigmalab.com
• Simulation models of laboratories or R&D portfolios to allow “what if?” scenarios to be played out in a risk free environment.
Telephone : 07595 914085
• Training in Lean and Six Sigma targeted at lab and R&D environments.
P O Box 210, Royston, Hertfordshire SG8 1AP
B C D E F
Lean Sigma Lab Dr Michael Allen
A
G H
• Help with identifying the critical parts of your organization that are preventing you from meeting your challenging objectives - invest where it will make the biggest difference and reduce costs without impacting performance.
I J K
Link China Solutions Ltd Ms Nadine Su info@chinapharma.co.uk www.chinapharma.co.uk Telephone : 01223 598070 Fax : 01223 598001
LCPS support UK small, medium and large biotech and pharmaceutical companies to build the collaboration with Chinese partners and provide a full suite of services across each phase of the outsourcing lifecycle from strategy alignment, partnership selection, collaborative partnering, outsourcing transaction in drug discovery and development, clinical trial, contract manufacturing, to China market entry and development. Our clients can minimize the cost; gain the competitive advantage in the global market and access one of the world largest pharmaceutical market-China.
1010 Cambourne Business Park, Cambourne, Cambridgeshire CB23 6DP
L M N O P
Lumora Ltd
Q
Mr Nigel Appleton www.lumora.co.uk
R
Telephone : +44(0)1353 646285 Fax : +44(0)1353 646282
S
Denmark House, Cambridgeshire Business Park, Angel Drove, Ely, Cambridgeshire CB7 4ET
T U Managing Resources Ltd
Mr Alan Williams info@managingresources.com www.managingresources.com Telephone : 01223 566158 Fax : 01223 566159 18 Topcliffe Way, Cambridge, Cambridgeshire CB1 8SH
Many of our present and future clients are based in countries like USA, Canada, Australia and New Zealand. They recognise the European potential for their products; they require our help in understanding the market opportunity, appreciating the varied healthcare structures in different countries, determining the best entry strategy and finding the right partners, possibly including M&A. We provide support in regulatory affairs, finding finance, addressing legal issues and recruiting permanent staff recommending specialists that we work with regularly. We have skilled associates with a wide range of backgrounds; including nationals in countries such as France, Germany and Italy. We have an extensive range of contacts, and some associates, in USA, Canada, Australia and New Zealand. We are frequently asked to assist Universities and Business Schools to help their students understand strategic issues in the sector. Similar information needs expressed by national and regional industry groups have also been addressed. As a result we assist companies with the development of their staff.
WWW.ERBI.CO.UK 165
V W X Y Z
Activotec’s mission is to establish themselves as the partner of choice for solid phase peptide/organic synthesis.
A
Marks and Clerk Dr Tim Andrews
B
www.marks-clerk.com
C
Fax : 01223 365560
D
Telephone : 01223 345520
62-68 Hills Road, Cambridge, Cambridgeshire CB2 1LA
E F G H I J
M N O
Dr Chris Maxwell chris.maxwell@maxwell safety.com www.maxwellsafety.com Telephone : 0845 009 4762 St John’s Innovation Centre, Cowley Rd, Cambridge, Cambridgeshire CB4 0WS
Dr Graham Wylie graham.wylie@themrn.co.uk
S T
Maxwell Safety was formed in 2005 with the aim of providing practical, cost effective health and safety solutions for small and medium enterprises. We have particular expertise within the biotechnology, pharmaceutical and ‘hi-technology’ sectors. The company has very close links with ERBI providing health and safety training for its members, including Biological Safety Officer and Laboratory Safety training. Our H&S consultants are Chartered Health and Safety Practitioners, with extensive experience in delivering pragmatic health and safety solutions and dynamic training. We are committed to supporting managers responsible for health and safety to comply with legislation and to adopt a sensible approach to health and safety that is a benefit to the business, not a hindrance.
The Medical Research Network (MRN) is a unique Clinical Trial Support Organisation offering specialised expertise to leading pharmaceutical companies, health organisations and investigators conducting clinical trials across the United Kingdom
www.themrn.co.uk Telephone : 0800 032 2348 Fax : 0845 241 3839 15 Presley Way, Crownhill, Milton Keynes, Buckinghamshire MK8 0ES
Meditext Dr Catriona Urquhart meditext1cmu@aol.com
R
Our services include strategic IP advice on patent and brand protection and drafting, filing and prosecution of IP worldwide. We also carry out due diligence and freedom-to-operate opinions. We work closely with our IP contacts around the world to provide an integrated international service.
Medical Research Network Ltd
P Q
Good IP protection provides security and adds value to a business; poor IP protection does not. At Marks and Clerk we work closely with our clients to understand their specific business requirements and produce commercially valuable work at a competitive price. We advise a diverse client base, including clients involved in early stage research, and ensure that the needs of our clients are met.
Maxwell Safety & Health Ltd
K L
Marks and Clerk is dedicated to the provision of high-quality, practical and cost effective IP advice. Our patent and trade mark attorneys and solicitors offer expertise in all areas of intellectual property protection covering the pharmaceutical, biotech, electronic, high-tech and software sectors.
Telephone : 01284 705541 Fax : 01284 705541 The Poplars, 5 Grange Farm Barns, Bury Road, Hengrave, Bury St Edmunds, Suffolk IP28 6LW
Meditext was established in the mid-1990’s and provides a high-quality medical writing and editing service for the pharmaceutical industry, medical communication companies and research foundations. Services include the preparation and QC of the following regulatory and associated documents: study protocols; Investigator Brochures; clinical study reports; clinical safety narratives; summary sections of the CTD; PSURs. In addition, Meditext assists in the preparation and editing of peer reviewed manuscripts, review articles, and general health education literature. Therapeutic areas covered include: oncology; cardiovascular; CNS; auto-immune disorders; dermatology; urology; gastroenterology; anaesthesia; blood products; drug addiction and substitution therapies.
U V W X Y
Merck & Co Inc Ms Jacqueline Canham licensing_europe@merck.com www.msd-uk.com Telephone : 01992 455012 Fax : 01992 455013 Hertford Road, Hoddesdon, Hertfordshire EN11 9BU
Z 166 ERBI DIRECTORY 2010
Merck & Co., Inc., of Whitehouse Station, New Jersey, USA and Schering-Plough have now completed their merger in the US and are in the process of forming a new global organisation called ‘Merck’ in the US and Canada and ‘MSD’ in the rest of the world. Merck Sharp & Dohme Limited is a subsidiary of Merck operating in Europe. Through our medicines, vaccines, biologic therapies, and consumer and animal products, Merck and its affiliates work with customers and operate in more than 140 countries to deliver innovative health solutions For more information on Merck Sharp & Dohme Limited, please visit www.msd-uk.co.uk.
Activotec’s mission is to establish themselves as the partner of choice for solid phase peptide/organic synthesis.
Mewburn Ellis LLP Dr Adrian Brasnett mail@mewburn.com www.mewburn.com Telephone : 01223 420383 Fax : 01223 423792 Newnham House, Cambridge Business Park, Cambridge, Cambridgeshire CB4 0WZ
Mewburn Ellis LLP has one of the largest groups of patent attorneys specialising in biotechnology and life sciences in Europe. Our proactive approach and expertise reflect the high level work we do for a wide range of clients, from world renowned biotech companies based in the US and Europe, acting either directly or through their outside counsel, to small and medium sized companies, universities, charities, and funding bodies. We handle a substantial number of oppositions and appeals at the European patent office and have considerable expertise in drafting and prosecuting patent applications, due diligence work, infringement opinions, portfolio management and strategic patent advice.
microbiochips@hotmail.fr
B C D E F
MicroBioChips Mr Mark Bradford
A
• Profiling in autoimmunity, cytokines, cell signaling. • Thematic DNA arrays: human health and agro. • Tissue arrays.
G
www.microbiochips.com Telephone : 0033 609 93 7928
H
London Bioscience Innovation Centre, 2 Royal College Street, London NW1 ONH
I J K
Micron Research Dr Iain Simpson iain.simpson@micronresearch.com
The Micron Group is a contract clinical research company offering global services (consulting, clinical trials [Phase I-IV], communications data management) with offices in the UK, USA and South Africa.
L
www.micron-group.com
The Micron Group has four Core Business Units:
M
Telephone : 01354 697690
- Consultancy - Clinical Research - Communications - Data Management Technologies
N
Fax : 01354 697691 Zion Building, Park Street, Chatteris, Cambridgeshire PE16 6AE
O P
Mills and Reeve LLP Ms Isabel Napper www.mills-reeve.com Telephone : 0870 6000011 Fax : 01223 324549 Francis House, 112 Hills Road, Cambridge, Cambridgeshire CB2 1PH
Mills Reeve is one of the UK’s leading healthcare law firms and advises government, health and academic institutions on IP and related issues such as licensing, MTAs, supply of human tissue, stem cells, clinical trials and medical devices. We have extensive experience in the EU, USA, China and other countries, which allows us to help you achieve your global aspirations. We can help you with the concerns you may face with outsourcing agreements and collaborations, manufacturing and distribution. Our life sciences group is a full service practice and with top ranking lawyers in corporate finance and funding we can support your company from seed to listing and beyond. Our clients include leading biotech companies, investors, key NHS organisations, and world-class universities. Recent work has concerned new tissue legislation, patent licences and litigation, major research collaborations, clinical trials, international stem cell and blood supplies and the supply of pandemic vaccines.
Mintz Levin Cohn Ferris Glovsky and Popeo LLP Ms Susan Foster www.mintz.com Telephone : 020 7776 7300 Alder Castle, 10 Noble Street, London EC2V 7JX
Q R S T U V
Mintz Levin is a full-service law firm with 450 lawyers in the UK and US. Working with biotech, pharmaceutical, and medical device manufacturers - and their investors and underwriters - our Life Sciences practice is one of the largest in the world. We also work extensively with academic and medical institutions, hospitals and physicians, and other health care clients. Because our UK and US offices work seamlessly together, we have a unique ability to advise clients on their trans-Atlantic and international operations. Our clients include emerging companies as well as established privately-held and publicly-listed companies. With practice strengths in areas such as intellectual property, company formation and governance, venture capital and financing, and deep industry experience in life sciences, health care, energy, clean technology and information technology, we serve as a springboard for many UK firms entering the US market and expanding internationally.
WWW.ERBI.CO.UK 167
W X Y Z
Activotec’s mission is to establish themselves as the partner of choice for solid phase peptide/organic synthesis.
A B C D
Miranda Weston-Smith Ms Miranda Weston-Smith miranda.weston-smith@ ntlworld.com Telephone : 01223 511664
Miranda has 20 years’ experience of working with emerging technology businesses, and a track record of commercialising early stage life sciences technology in projects.
9 Selwyn Gardens, Cambridge, Cambridgeshire CB3 9AX
Partner organizations include 4D Biomedical, Cambridge Healthcare & Biotech, Cambridge Intellectual Property, and the Centre for Entrepreneurial Learning. She is a graduate in Natural Sciences, New Hall, University of Cambridge, Fellow of the Linnaean Society, holds the AAT Advanced Certificate in Accounting, and is a Member of the US Association of University Technology Managers.
E F G H I J
Molecular Dimensions Ltd Mr Tony Savill enquiries@molecular dimensions.com www.moleculardimensions.com Telephone : 01638 782610 Fax : 01638 782611 Unit 7 Acorn Business Centre, Oaks Drive, Newmarket, Suffolk CB8 7SY
K L M N O
Mr Bill Mullen info@momentumbio.co.uk www.momentumbio.co.uk Telephone : 07919 538136 Biopark, Broadwater Road, Welwyn Garden City, Hertfordshire AL7 3AX
Molecular Dimensions’ range of analytical instrumentation is at the cutting edge of technologies for crystal imaging to not only monitor the crystal growth process but to also study nucleation and distinguish protein from salt. Molecular Dimensions has formed strong alliances with leading crystallographers. Together, we develop innovative solutions to the challenges of growing, string and mounting protein crystals.
Momentum is developing products for sensitive detection of viable bacteria and fungi in clinical specimens. Our LiMA technology can measure as few as 3 CFU/mL E. coli and 6 CFU/mL Candida glabrata in blood culture in 3 hours. We are developing products for bacteraemia and antibiotic susceptibility testing with a US partner and other products for fungi, normally sterile fluids and hygiene monitoring. LiMA only detects viable organisms and can detect pan-bacterial and/or pan fungal contamination. It uses a conventional qPCR instrument but uniquely it does not detect organism genetic material. The LiMA biomarker is instead DNA ligase. NAD-dependent DNA ligase is only found in bacteria providing a highly selective test that can nevertheless detect all bacterial pathogens.
Morrison & Foerster (UK) LLP Mr James Gubbins info@mofo.com
R
www.mofo.com
S
Fax : 0207 496 8500
T
Molecular Dimensions are specialists in products for biomolecular structure research. Supplies for protein crystal growth include screening kits and plates. We offer a full range of products for cryocrystallography.
Momentum Bioscience Ltd
P Q
Miranda Weston-Smith provides practical business development services for healthcare and biotech. She supports clients with marketing, new venture development and technology transfer expertise offering a cost-effective way to boost a company’s growth.
Telephone : 020 7920 4000
7th Floor CityPoint, One Ropemaker Street, London EC2Y 9AW
Morrison & Foerster provides a full range of services to clients in the biotechnology, medical device, pharmaceutical and healthcare industries. The firm’s Life Sciences Group has over 180 lawyers in offices around the world, working with life sciences companies at every phase of their growth cycle, including formation and financing of early-stage ventures; start-up technology transfer; structuring and negotiating licenses, research and development collaborations, and other technology transactions; corporate partnerships and collaboration; planning and developing intellectual property portfolios; mergers and acquisitions; initial public offerings and follow-on securities offerings; protecting and defending intellectual property rights; and sitting, permitting, developing and financing new research and manufacturing facilities. Morrison Foerster is uniquely positioned to serve the global life sciences industry. Our European life sciences practice offers unrivalled transactional expertise.
U V W X Y
MRC Centre Dr Megan Davies www.mrc.ac.uk Telephone : 01223 248011 Fax : 01223 412515 Hills Road, Cambridge, Cambridgeshire CB2 0QH
Z 168 ERBI DIRECTORY 2010
The MRC’s mission is to improve human health through world class medical research. £60m is invested annually in the 8 MRC research establishments in Cambridge, alongside funding for research in the University. The new MRC Laboratory of Molecular Biology building will be the flagship of the Cambridge Biomedical Campus and will provide facilities to ensure it continues as a worldclass institute for basic science. Among the key strategic areas are: • Neurosciences, with research in molecular and cellular approaches, cognitive neuroscience, brain imaging and population cohorts. • Cancer, where work in the MRC Cancer Cell Unit is contributing to new diagnostic and therapeutic approaches. • Diabetes and Obesity, where the MRC Epidemiology Unit is part of the Institute of Metabolic Science and complements both other research in the Institute, and MRC research elsewhere in the region on nutrition and health.
Activotec’s mission is to establish themselves as the partner of choice for solid phase peptide/organic synthesis.
Mundipharma International Ltd Mr John Roe www.mundipharma.co.uk Telephone : 01223 424211 Fax : 01223 426626 194 Cambridge Science Park, Milton Road, Cambridge, Cambridgeshire CB4 0AB
The Purdue/Mundipharma/Napp independent associated companies are world leaders in the development and marketing of proprietary analgesics for the treatment of moderate to severe pain, with products such as Targin, BuTrans, Norspan, OxyContin and Palladone. A growing franchise in novel oncology therapies comprises the marketed products DepoCyte and Ribomustin, and Fodosine, which is currently in clinical development. Mundipharma has the European rights to FlutiForm and is conducting Phase III clinical trials as an entry strategy into the respiratory market. Product sales are made in over 100 countries worldwide, supported by a worldwide sales and marketing operation that comprises over 1 000 field sales representatives in Europe. The companies are committed to building their presence in the areas of analgesia, oncology and respiratory medicine. In-licensing is a key component of the companies’ portfolio building strategy. Substantial medical research and regulatory affairs functions are located in the UK (Cambridge) and Germany, with expertise in handling European clinical research and worldwide product registrations.
NBS Biologicals supply a wide range of chemicals for the Biotech industry, we represent several major brands in the UK and also have a range of our own branded products Laboratory Products:
info@nbsbio.co.uk www.nbsbio.co.uk Telephone : 01480 433875 Fax : 01480 459868 14 Tower Square, Huntingdon, Cambridgeshire PE29 7DT
B C D E F
NBS Biologicals Ltd Mr Chris DeStefano
A
AMRESCO are specialists in Electrophoresis reagents, Molecular Biology, Microbiology and Biobasics SPECTRUM provide Dialysis and Filtration products DOJINDO innovative products for Cell Biology, protein labelling and tagging and surface active materials. APPLIED BIOLOGICAL PRODUCTS offer a full range of Expression Systems, signalling antibodies and proteins and various kits for molecular biology DYNAMIC ADSORBANTS provide a full range of silica nd alumina products for chromatography and other applications. Our sister company, MADGEBIO Ltd offers high throughput electrophoresis systems Our new website give product details and prices and online purchasing is available at :www.nbsbio.co.uk
G H I J K
NeuroSolutions Limited Ms Melissa Harwood
L
info@nsolns.com www.nsolns.com
M
Telephone : 01223 493948 Fax : 01223 839765
N
Department of Biological Sciences, University of Warwick, Coventry CB4 7AL
O P
New England Biolabs (UK) Ltd Dr Ed Bagenal
Both NEB and CST produce reagents for drug discovery, basic research and scale up in cellular and molecular biology, including custom and bulk preps. NEB’s interests include enzymes used at the DNA, RNA and protein levels. These extend from PCR and Next-gen sequencing to protein expression and analysis. CST’s interests cover cell signalling and including phospho-analysis/profiling.
info@uk.neb.com www.neb.uk.com Telephone : 01462 420616 Fax : 01462 421057
CST produces antibodies that are screened and validated for particular applications (HCS, Flow, IHC etc). CST has novel antibody generating technologies. For more information on CST products and services, please email info@uk.neb.com
75/77 Knowl Piece, Wilbury Way, Hitchin, Hertfordshire SG4 0TY
Q R S T U
NIBSC National Institute for Biological Standards and Control Mrs Amanda King business@nibsc.ac.uk www.nibsc.ac.uk Telephone : 01707 641 000 Fax : 01707 646 858 Blanche Lane, South Mimms, Potters Bar, Hertfordshire EN6 3QG
The National Institute for Biological Standards and Control (NIBSC), a centre of the UK Health Protection Agency (HPA), is a global leader in the field of biological standardisation and its role is to protect public health through assuring the quality of biological medicines. The Institute is responsible for developing and producing over 90% of WHO International Standards which are distributed globally. NIBSC also offers secondary reference materials and working reagents. NIBSC is the UK’s Official Medicines Control Laboratory (OMCL), responsible for testing of biological medicines within the framework of the European Union. NIBSC also offers contract testing services for some biological medicines, e.g. proof of concept testing of early stage biological medicines. NIBSC has an international reputation for excellence in research and is widely consulted on issues of biological medicine safety and efficacy as well as offering training courses, meeting and workshops.
WWW.ERBI.CO.UK 169
V W X Y Z
Activotec’s mission is to establish themselves as the partner of choice for solid phase peptide/organic synthesis.
A
Norwich Research Park Dr Matthew Hills
B
enquiries@nrp.org.uk
C
Telephone : 01603 450925
D E
www.nrp.org.uk
Fax : 01603 450993 The Norwich BioIncubator, Norwich Research Park, Colney Lane, Norwich, Norfolk NR4 7UH
F G H I J
M N O
Mr Mike Bowles customer.services@novusenvironmental.co.uk www.novus-environmental.co.uk Telephone : 0844 770 0012 A505 Main Road, Thriplow Heath, Royston, Hertfordshire SG8 7RR
Mr Rod Weedon rod.weedon@oyezstraker.co.uk www.oyezstraker.co.uk Telephone : 01603 788668 Fax : 01603 406460 8 Hellesdon Park Industrial Estate, Norwich, Norfolk NR6 5DR
Mr Keith Reeds
R
www.orionautomation.co.uk
S
Fax : 08717 142130
Telephone : 01480 891801
2 High Street, Alconbury Weston, Huntingdon, Cambridgeshire PE28 4JP
U V W X Y
The NRP has a great deal of biotech and biomedical expertise and facilities that can accessed via the NRP office. Please see website for further information.
novus environmental is a fully licenced waste management company providing high quality, valuefor-money solutions for the collection and disposal of your wastes. Our service is based on strong ethics, the professionalism of our staff and the speed of our response. Your organisation, like many others, has a legal requirement to dispose the waste it produces in a compliant manner. Whether you are from the commercial, or public sector, to have this responsibility managed quickly, efficiently and legally is of paramount importance and convenience. The company has established itself as one of the leading experts in the disposal of a multitude of wastes including: clinical, sharps, medicines, human, animal, food, seized goods, electrical equipment and confidential. Working with novus environmental gives client’s piece of mind by ensuring compliance with current legislation, protecting an organisation’s reputation and providing certification documenting waste movement right through to destruction.
OfficeTeam (Rebrand for 2010 from OyezStraker) is the UK’s leading office services and products company, with over 21,000 customers nationwide and with a unique infrastructure which provides for local service and support. At OfficeTeam, we are passionate about providing high quality office services and products – and delivering them reliably every time. We do that – and more. We are a Team of specialists providing a single trusted source for a broad range of services and products that can help you run your business more efficiently. As a UK leader, we strive to deliver the highest standards and will always go further for our customers. Expect More from OfficeTeam.
Orion Automation Ltd sales@orionautomation.co.uk
T
The NRP has about 20,000 sq ft of mixed laboratory and office space that can be accessed through the Norwich BioIncubator and a further 40,000 sq ft available from summer 2010. Land is available for new-build to suit and enquiries to the NRP office are welcomed.
Office Supplies Limited
P Q
The NRP office promotes the research capabilities and expertise of the partner organisations and fosters business development on the Park.
Novus Environmental
K L
The Norwich Research Park is a partnership between the University of East Anglia, the Norfolk and Norwich University Hospital Foundation Trust and four Bioscience Institutes including three BBSRC institutes – the John Innes Centre, Institute of Food Research and Genome Analysis Centre. It is also home to over 30 innovative companies.
Based on the edge of the Cambridge Technology Cluster, Orion Automation provides high performance, intelligent, automated vision systems for use in laboratory, R&D and manufacturing applications. Using leading edge hardware and software products we offer custom built, precision, high speed inspection systems using 2D and 3D technologies, where accuracy, reliability and repeatability are paramount. Typical uses include checking, measuring, counting, classifying and recording and we have successfully completed projects in areas as diverse as cytology, seed germination, plastic parts for inhalers and mechanical components for vehicle engines. With our many years of experience in industrial automation we are also able to include any mechanical handling, electrical and control requirements as part of a total turnkey solution. We serve a wide variety of markets including Medical, Pharmaceutical, Nuclear, Automotive, Electronics, Printing & Packaging and Food industries.
Oxford Expression Technologies Dr Richard Broadhead info@oetltd.com www.oetltd.com Telephone : 01865 483236 Fax : 01865 483250 Oxford Brookes University, Gypsy Lane Campus, Oxford, Oxon OX3 0BP
Z 170 ERBI DIRECTORY 2010
Oxford Expression Technologies is a spin out company from Oxford Brookes University. We are specialists in the baculovirus recombinant protein expression system and have developed the patented flashBAC technology. This technology allows the creation of baculoviruses for recombinant protein production to be reduced to a quick, simple one step process that can be easily automated. Additionally the vectors are genetically optimized to enhance recombinant protein expression levels. Because of this the technology offers the opportunity to produce correctly folded, soluble proteins to high levels. It is also very well suited to high level production of difficult to express proteins such as secreted or membrane proteins. We offer the technology in both a kit form for use by customers ‘in house’ and as a part of a very popular custom service offering where we will produce viruses and express proteins according to a customer’s requirements.
Activotec’s mission is to establish themselves as the partner of choice for solid phase peptide/organic synthesis.
P and I Associates Mr Ian Sandison ian@pandiassociates.co.uk www.pandiassociates.co.uk Telephone : 01223 316331 172 Gwydir Street, Cambridge, Cambridgeshire CB1 2LW
Established in 2003 P&I Associates is the consultancy company of Ian Sandison. Ian spent his earlier career in senior commercial roles with Becton Dickinson and Smiths Medical, where he was latterly Global VP of sales for the hospital infusion business. He now works with small to medium sized medical and lifescience companies in the following business development areas; business plan writing, product development activities, market and technology assessment, getting you ‘investor ready,’ raising money, product commercialisation, partnering & licensing activities and sales and marketing. Ian’s expertise covers many global healthcare markets and his technology expertise includes, single use disposables, high value capital equipment and diagnostic testing. He is particularly skilled with the launch and adoption of new products within the NHS. He has assisted with technology judging activities for a number of organisations and is a contributor to the Cambridge University Judge Business School Ignite entrepreneurship programme.
www.paconsulting.com Telephone : 01763 261222 Fax : 01763 262862 Cambridge Technology Centre, Back Lane, Melbourn, Hertfordshire SG8 6DP
B C D E F
PA Consulting Group Ms Lyn Scott
A
PA Consulting Group’s technology capability spans innovation, strategy and delivery. We offer technology consulting and product development services across a broad range of sectors, including Life Sciences and Healthcare, Consumer Products, Communications and Electronics, Public Sector, Defence, Energy and Transport. We have a unique combination of industry expertise and engineering capability. At our dedicated Technology Centres in Cambridge UK and Princeton NJ, we develop award-winning products, automation and manufacturing processes, and help clients understand and use technology more effectively.
G H I J K
Page White and Farrer Mr Jeffrey Daniels www.pagewhite.com Telephone : 0207 831 7929 Fax : 0207 831 8040 Bedford House, John Street, London WC1N 2BF
With each of our practitioners focussing on particular technologies or legal disciplines, we can provide you with a winning combination of technical knowledge, business acumen and a sound appreciation of the workings of the law. IP has become a global issue as national boundaries are transcended by new technology, so an international approach is now vital. We have expertise in handling IP in all countries, and we maintain a strong working relationship with highly respected firms throughout the world. Our biosciences practice serves all areas of biotechnology including drug discovery and delivery, molecular biology, immunology, diagnostics and bioinformatics.
www.peakdale.com Telephone : 01298 816700 Fax : 01298 816701 Peakdale Science Park, Sheffield Road, Chapel-en-le-Frith, High Peak, Derbyshire SK23 0PG
N
P
Peakdale Molecular Ltd enquiries@peakdale.co.uk
M
O
We represent clients before the UK and European Patent.
Dr Matthew Tozer
L
Peakdale Molecular offers a class-leading range of products and services to its pharmaceutical and biotechnology customers to accelerate their drug discovery initiatives. At its very core, Peakdale’s approach is based upon its long & successful track record of problem-solving within our customers’ discovery projects. We are renowned for completing difficult synthetic organic and medicinal chemistry against time & cost constraints for customers big and small the world over. This we do through a huge variety of FTE or Fee-for-Service models designed individually to suit customer requirements. Whether it is a process development project, a small molecule discovery programme that needs computational, chemistry & ADME services or “design & make” projects for cores, scaffolds, back-up lead series, Peakdale offers flexible, creative and confidential support for your discovery project. Put our experience to the test.
Q R S T U
People in Health Ltd Mrs Janet Ellis www.peopleinhealth.com Telephone : 0207 908 4100 Ability House, 7 Portland Place, London W1B 1PP
V
Provision of: Senior interims, scientists, specialist consultants to the healthcare industry - pharmaceutical, biotechnology, medical device, diagnostics/hospital and laboratory equipment consumer health products/alternative medicine, animal health and ancillary companies such as CRO’s and advertising agencies. Specialist consultants or teams of consultants, on a per diem or project basis in Europe and internationally Services to health deliverers, hospitals and primary care, Universities, Life Science Research Organisations, NGO’s, Charities ot for Profit Organisations
WWW.ERBI.CO.UK 171
W X Y Z
Activotec’s mission is to establish themselves as the partner of choice for solid phase peptide/organic synthesis.
A B C D
People Strategies Ltd Ms Heather Whitaker heather.whitaker@peoplestrategies.net www.people-strategies.net Telephone : 07949 349925 8 Home Farm Court, Shantock Hall Lane, Bovingdon, Hertfordshire HP3 0NQ
F
H I
Permedx Consulting Ltd Dr James Clark www.permedx.co.uk Telephone : 07803000258 Baillie Court, Dunbar, Scotland EH42 1SS
J K L M N O
We are a FREE venue finding service tailored to the needs of pharmaceutical and biotech clients.
sue@pharmameetings.co.uk
We can find the most appropriate venue for your conferences, meetings, events and group accommodation.
www.pharmameetings.co.uk Telephone : 01780 484056
Negotiate significant cost savings.
Fax : 0870 1221355
Save you time by handling all the booking and organisational requirements.
6 Southview Business Centre, Tinwell Road, Stamford, Lincolnshire PE9 2JL
Ensure all arrangements comply with the ABPI 2008 Code of Practice.
Dr Simon Forster
www.pharmdservices.com
S
Fax : 0115 912 4278
Telephone : 0115 912 4277
BioCity Nottingham, Pennyfoot Street, Nottingham, Nottinghamshire NG1 1GF
U
W X Y
Pharma Meetings is a new division of Trinity Conferences Ltd, one of the UK’s leading venue-finding companies. Based on this expertise we can provide a service that is second to none. Our speciallytrained pharma team is passionate about delivering what you need on time and on budget.
Pharmaceutical Development Services Ltd
R
V
Our expertise includes: • Strategic planning for Translational/Personalised medicine • Biomarker discovery and validation • Gene expression using formalin fixed paraffin embedded (FFPE) tissue • Set up and management of early stage life science companies • Diagnostic Commercialisation • Regulatory compliance • Reimbursement planning • Investment
Ms Susan Haylock
info@pharmdservices.com
T
Permedx Ltd is a life science consultancy devoted to increasing R&D efficiency and Return of Investment in both pharmaceutical and biotechnology firms by the integration of personalised and translational medicine strategies. We have proven, hands on expertise in biomarker driven translational medicine in large pharmaceutical companies. As well as development and commercialisation of personalised medicine within biotechnology/diagnostic companies.
Pharma Meetings Ltd
P Q
We support you in taking yourselves and your teams through change as positively as possible engaging teams in the journey, getting a high quality solution that sticks. Wherever possible, we make changes measurable so you can see the real benefit of using People Strategies.
E
G
This is a people consultancy providing both strategic and operational services to the pharmaceutical, life sciences and biotech sector. Assignments have included: • Acquisitions and integrations • Selection and implementation of a performance management system with an associated review of reward • Developing HR employees and teams • Restructuring – for growth and reduction
Pharmaceutical Development Services Ltd (PDS) is a consultancy service for integrated drug development and production strategy for chemistry and pharmacy products. This includes new and existing pharmaceutical and biotechnology products. CRO Selection and Management - PDS undertakes contractor identification and project management. New Product Introduction Strategy - PDS advises clients on the strategy for introducing a new product, from pre-clinical technical development to a multi-national commercial launch. Clinical Trials Support - PDS can manage packaging, labelling and supply for studies from Phase 1 to Phase 3. Regulatory Affairs - PDS has an experienced regulatory affairs department across a variety of therapeutic areas.
Pharmidex Mr Nicholas Traynor contact@pharmidex.com www.pharmidex.com Telephone : 0870 240 5978 Fax : 0845 125 9586 72 New Bond Street, Mayfair, London W1S 1RR
Z 172 ERBI DIRECTORY 2010
Pharmidex is a world leading centre for studying and optimising CNS drugs in terms of brain distribution and efficacy ( NeuroPK® and NeuroPD® technologies) and improved delivery (Cerense?) of small and large (macromolecules). Equally impressive is Pharmidex’s extensive ADME/PK, drug safety & bioanalytical services for lead optimisation & drug development. We design and implement studies that are key to progressing client compounds quickly and cost-effectively. We have years of drug discovery expertise to help you fast forward your drug discovery programmes.
Activotec’s mission is to establish themselves as the partner of choice for solid phase peptide/organic synthesis.
PHG Foundation Mrs Carol Lyon cgkp@srl.cam.ac.uk www.phgfoundation.org Telephone : 01223 740200 Fax : 01223 740892 Strangeways Research Laboratory, Worts Causeway, Cambridge, Cambridgeshire CB1 8RN
The PHG Foundation is an independent, non-profit, international organisation with the aim of making science work for health. We believe in the potential of biomedical science and genomics to transform human well-being; our strategic aims are to identify and promote the most beneficial opportunities for biomedical innovation to improve health and tackle disease globally, and to develop and promote models and capacities for the effective mainstreaming of biomedical innovation into improved clinical and public health policies and practices. A founder of the public health genomics movement with over twelve years’ experience, our strength lies in our analytic, knowledge-broking, and influencing skills along with world-class expertise in medicine, public health and biosciences as well as economics, ethics, law, philosophy, politics, and sociology.
pb@philipbedford.com www.philipbedford.com Telephone : 7788410098 234 Queen Edith’s Way, Cambridge, Cambridgeshire CB1 8NL
Philip Bedford Consulting Limited is a Cambridge-based consultancy specializing in clinical development and regulatory services for companies developing biological pharmaceutical products targeted for licensure in Europe and the United States of America. Services include:
J K L M
Telephone : 01438 759850 Fax : 01438 759855
N
Chemical Division, Leyden Road, Stevenage, Hertfordshire SG1 2BW
O P
Phytopharm plc
Fax : 01480 417090 Corpus Christi House, 9 West Street, Godmanchester, Cambridgeshire PE29 2HY
Phytopharm is focused on the development of its pharmaceutical portfolio and has a residual portfolio of functional foods. The Company’s products are developed predominantly from medicinal plants, thereby reducing the development risk of a product. The Company focuses its research activities in areas of high, unmet health needs to deliver cures and relieve suffering for longer healthier lives. As a virtual company, our business model is centred on a lean cash burn with all laboratory, manufacturing and clinical work outsourced to specialists, while core competencies such as strategy and management are maintained in-house. Close collaboration with charitable organisations enhances the Company’s interaction with scientists and clinicians, who lead and develop expert opinion. Cash grant from them accelerate the Company’s development programmes, thereby increasing their value. The Company is currently conducting the development of novel pharmaceutical products in Parkinson’s disease, Alzheimer’s disease, Huntington’s‘ disease, ALS and other orphan motor neurodegenerative diseases, vascular dementia and Asthma and COPD.
PiR Group Mr Maurice Herring
Fax : 01480 469103
PiR Group is an international life sciences consultancy. As a leading specialist in life science executive search we continue to evolve our range of bespoke services to reflect the demands of our clients. Placing highly experienced senior and board-level professionals in global markets including CEO’s, Snr Vice Presidents, Directors, Vice Presidents, Business Leaders, Consultants, Interim Managers and Independent Directors (non-executives), we work with several of the world’s largest life science and pharma organisations and high-growth, medium-sized speciality and emerging biopharma companies, CMOs and CROs.
Raleigh House, 14c Stocks Bridge Way, Compass Point, St Ives, Cambridgeshire PE27 5JL
Over the years we have gained extensive specialist knowledge of life science organisational change, development and management, coupled with a strong network of associate HR and business experts. We are utilising this comprehensive experience to expand our services to include a full range of HR and strategic business consultancy solutions which can be fully tailored to meet our clients’ individual needs.
recruit@pir-group.com www.pir-group.com Telephone : 01480 309010
G
Philip Bedford Consulting offers a unique blend of scientific knowledge with hands-on experience covering most aspects of the biopharmaceutical development process.
www.phs.co.uk
Telephone : 01480 437697
E
I
chemicals@phs.co.uk
www.phytopharm.com
D
H
Mr Michael Over
info@phytopharm.com
C
• Formulation of regulatory and clinical development strategy • Creation of product development plans • Preparation of regulatory and clinical documentation • Advice and help with preparation for meetings with regulatory authorities • Project management from laboratory bench to product licence submission • Due diligence of business opportunities
PHS
Ms Zoe McGowan
B
F
Philip Bedford Consulting Ltd Dr Philip Bedford
A
WWW.ERBI.CO.UK 173
Q R S T U V W X Y Z
Activotecâ&#x20AC;&#x2122;s mission is to establish themselves as the partner of choice for solid phase peptide/organic synthesis.
A
PiR Interims Limited Ms Carolyn Douthwaite
PiR Interims is an innovative supplier of professional interim managers to global pharmaceutical, biotechnology and medtech organizations. Our core skill is identifying and recruiting excellence.
B
interims@pir-interims.com
C
Telephone : 01480 499580
PiR Interims reflect the increasing trend towards flexible, portfolio working amongst life science companies. We identify and place some of the most highly respected interim managers in the sector with clients looking for senior level resources at short notice and within an agreed budget.
3 Cabot House, Compass Point Business Park, St Ives, Cambridgeshire PE27 5JL
We work across a range of functions including: Medical, Clinical Development, Regulatory Affairs, Project Management, Commercial, Manufacturing, Quality Operations, Supply Chain, HR and Finance.
D
www.pir-interims.com
E F G H
Plant Bioscience Ltd (PBL) Dr Jan Chojecki info@pbltechnology.com www.pbltechnology.com Telephone : 01603 456500 Fax : 01603 456552
I J
Norwich Research Park, Colney Lane, Norwich, Norfolk NR4 7UH
K L M N O
Ms Rosalind Russell post@plastid.no www.plastid.no Telephone : 00 47 5187 4023
TECHNOLOGIES SOUGHT: All biosciences, functional foods, agri-biotech and plant science.
Plastid has patented a methodology for the selection and regeneration of plants with genetically modified organelles - plastids. The company produces standard bioreagents used in research labs and undertakes contract research projects for tailor-made protein production in the aquaculture and Pharma markets. Internal research is also ongoing. Requiring only light and water for growth, the platform is both cost-effective and highly scalable.
Fax : 00 47 5187 4001 Prof Olav Hanssensvei 7A, P B 8034, Stavanger, Norway 4068
Polytec Personnel Ltd Mr Kevin Young recruit@polyteck.co.uk
R
www.polytec.co.uk
S
Fax : 01223 420268
T
FOR BIOSCIENCE COMPANIES AND INVESTORS: IP / patent management and advice, and patent due diligence services
Plastid AS
P Q
FOR RESEARCH INSTITUTIONS AND UNIVERSITIES: No fee patent management, investment in technology development and proof of concept, technology marketing, licensing, business development.
Established in 1984, we supply Scientific staff of all levels for either permanent or temporary positions, to clients within a 40 radius of Cambridge.
Telephone : 01223 423267
Orwell House, Cowley Road, Cambridge, Cambridgeshire CB4 0PP
U V W X Y
Potter Clarkson LLP Miss Jane Wainwright info@potterclarkson.com www.potterclarkson.com Telephone : 0115 955 2211 Fax : 0115 955 2201 Park View House, 58 The Ropewalk, Nottingham, Nottinghamshire NG1 5DD
Z 174 ERBI DIRECTORY 2010
At Potter Clarkson LLP we recognise the need to understand our clientsâ&#x20AC;&#x2122; technologies and business objectives in order to devise effective patent strategies. We have a team of over 30 in our biotechnology and chemistry group. Three quarters of the group hold a PhD in a relevant discipline. Many also have research experience in the pharmaceutical industry or academia. We also have patent groups specialising in other technology areas including nanotechnology, computing, electronics, telecommunications, medical engineering, materials science, software, mechanical engineering, textiles, trademarks, etc. Our clients range from start-ups and early-stage companies to multi-nationals. Working closely with such a range of clients over the years has given us an extensive knowledge of the business challenges facing industry and how to use patents and other IP rights for maximum advantage.
Activotec’s mission is to establish themselves as the partner of choice for solid phase peptide/organic synthesis.
PreScript Communications Ltd Dr Barbara Fagg barbarafagg@prescript.co.uk www.prescript.co.uk Telephone : 01462 491171 Fax : 01462 896781 15 Royston Road, Baldock, Hertfordshire SG7 6NW
PreScript is a communications agency specialising in global scientific, medical and marketing communications. Our projects are mostly commissioned by international biotechnology and pharmaceutical companies and are targeted at both professional and public audiences. Our company has particular strengths in: training and project management, copywriting, design and production, and IT, which translate into a high level of service and attention to detail. Whether you need help producing patient education material, product or skills training programmes, congress support, marketing materials or to revamp your website or corporate identity, then look no further. We will see your project through from concept to completion. No job is too small and no project too challenging. You can count on PreScript to deliver timely, quality material to your specification and within budget. ’We pride ourselves on developing innovative communications materials specifically tailored to meet the individual needs of our customers’
www.pressplantravel.com Telephone : 01727 833291 Fax : 01727 867435
B C D E F
Pressplan Travel Limited Miss Nicole Andlaw
A
Pressplan is an independent business travel agency that has been operating for 30 years. Since our launch, our philosophy has always been to provide our clients with services based on comfort, convenience and value. As business needs have grown more dynamic, we have combined our in-depth industry knowledge and use of the latest technology to ensure we also provide our clients with the rapid, flexible response they need in today’s fast changing world.
17 Verulam Road, St Albans, Hertfordshire AL3 4DA
G H I J K
PricewaterhouseCoopers LLP Ms Tamzin Close tamzin.close@uk.pwc.com www.pwc.uk.com
PricewaterhouseCoopers (www.pwc.com) provides industry-focused assurance, tax and advisory services to build public trust and enhance value for our clients and their stakeholders. More than 163,000 people in 151 countries across our network share their thinking, experience and solutions to develop fresh perspectives and practical advice.
Telephone : 01223 460055 Fax : 01223 552297
O P
Prism Training and Consultancy Ltd info@prismtc.co.uk
M N
Abacus House, Castle Park, Cambridge, Cambridgeshire CB3 OAN
Mr Ian Macpherson
L
Founded in 2000, we have customers across the UK, Europe and the US, from start-ups to blue-chip multi-national clients.
www.prismtc.co.uk
We provide practical solutions based upon the effective use of statistical techniques and tools.
Telephone : 01223 844274 Fax : 01223 420844
We are confident that we will be able to assist you in meeting the challenges of your particular environment - whatever your field of discovery, research and development, or manufacturing.
St John’s Innovation Centre, Cowley Road, Cambridge, Cambridgeshire CB4 0WS
As part of our training and consultancy solutions, PRISMTC can show you how to get the most out of your chosen statistical software package. We also produce companion software tools to complement the main statistical packages. Each of our software tools is designed specifically to help you maximise your potential, and that of your team.
Q R S T U
Prosarix Ltd Dr Bill Hamilton contact@prosarix.com www.prosarix.com Telephone : 01223 870400 Fax : 01223 870400 Newton Hall, Town Street, Newton, Cambridge, Cambridgeshire CB22 7ZE
Prosarix uses its proprietary technology platform, ProtoDiscovery, to carry out serviced-based discovery projects with partner companies and generate pre-clinical development candidates in-house for subsequent early stage out-licensing. As a drug discovery service partner, Prosarix can rapidly identify novel hits against targets of interest, using structure-based and ligand-based design approaches, as well as undertaking lead optimisation projects. Prosarix has worked on a wide range of target classes and has specific expertise in GPCR modelling and screening. The Company provides rapid, novel solutions to drug discovery in a cost-effective manner.
V W X Y Z
WWW.ERBI.CO.UK 175
Activotec’s mission is to establish themselves as the partner of choice for solid phase peptide/organic synthesis.
A
Prosynth Ltd Mrs Clare Bonnar
B
info@prosynth.com
C
Telephone : 01787 883320
D
Unit 2 Bull Lane Industrial Estate, Acton, Sudbury, Suffolk CO10 0BD
E
www.prosynth.com
Fax : 01787 883301
F G H I
For the past 16 years we have amassed significant practical production experience and have produced well in excess of 7,000 compounds, which we have supplied worldwide. We have a database of over 14,000 procedures actually carried out in our laboratories. We work closely with our customers and are equally comfortable using information supplied by our customers or developing routes to target molecules ourselves. Providing weekly updates and project reports is standard practice and our chemists are always available to discuss the work if required. ProSynth offer a very cost-effective production service to support your project - on an individual ‘fee for product basis’ or FTE project based work.
Protogenia Consulting Ltd Dr Julie Warneck info@protogeniaconsulting.co.uk www.protogeniaconsulting.co.uk Telephone : 07905 321515 P O Box 289, Ely, Cambridgeshire CB7 9DR
Protogenia Consulting Ltd offers pre-clinical development consultancy services to the pharmaceutical / biotech industry. With 15 years non-clinical outsourcing and project management experience gained through virtual and medium sized pharmaceutical companies. We also assist with research phase pharmacology, screening toxicology and ADME, (lead optimisation through to development candidate selection) identifying appropriate CROs, designing and managing contracts/studies and assisting with candidate nomination. In addition, we have a broad network of Drug Development contacts, and provide expert advice on IP Strategy, Chemistry Process Development and Manufacture, Analytical Services, Pharmaceutical Development and Manufacture, Regulatory Affairs and Quality Assurance.
J K
PULSE Scientific
L
Miss Zuleika Greenham
M
www.pulsejobs.com/uk/ scientific/
N O
matthew.burns@pulse staffing.co.uk
Telephone : 01799 531110 Fax : 0845 2579747 Suite 4, The Mansion House, Chesterford Research Park, Little Chesterford, Saffron Walden, Essex CB10 1XL
P Q
Experienced consultants from a range of scientific & recruitment industries draw on their skills to identify the very best scientific talent available; focusing on recruiting in the following areas: Scientific – laboratory, QA, R&D and related Engineering - Production, Maintenance, Design & Software roles Scientific sales – sales, account management and business development With dedicated scientific offices located within the scientific communities of Manchester, Oxford & Cambridge together with the innovative PULSE web site, clients and candidates have immediate access to a service that extends nationwide.
Quality Care Cleaning Limited Mr Paul Heales info@qualitycarecleaning.co.uk
R
www.qualitycarecleaning.co.uk
S
Fax : 1223873362
T
PULSE Scientific is a leading provider of staff to a diverse range of sectors including Biotechnology, Pharmaceutical, Medical Devices, Laboratory Equipment and Consumables, Chemical, Forensic, Food and Drink, Water and Environmental industries via a network of offices that are strategically located nationwide.
Telephone : 1223833300
Copley Farm Business Park, Cambridge Road, Babraham, Cambridge, Cambridgeshire CB22 3GN
We are a Cambridge based cleaning company, established for 28 years, providing high quality commercial cleaning services to a range of organisations in Cambridge and the surrounding area. Our aim is to provide a consistent, accountable and professional service to all our clients. We specialise in daily office and laboratory cleaning, tailoring cleaning programmes to meet our clients’ requirements. To complement our daily programmes we also offer the following: • Laboratory decontamination (certificated) • Window cleaning • Carpet and upholstery cleaning • Hard floor maintenance • Supply of consumables ISO 9001:2008 Working towards Investors in People and CHAS
U V W X Y
Raumedic Mr Paul Flavell info@RAUMEDIC.com www.raumedic.com Telephone : 0044 7785 714815 Hermann Staudinger Str 2, Helmbrechts, Germany 95233
Z 176 ERBI DIRECTORY 2010
RAUMEDIC is a flexible company full of new ideas offering partnership to innovators and customers in medical devices, advising on materials, design and assembly, packaging and sterilisation, and Regulatory support to enable you to CE mark your product. Current R&D includes non DEHP PVC alternatives, micro extrusion, and full contract manufacturing services. RAUMEDIC supply high quality extrusion and injection moulding technology for a variety of medical applications including Extra Corporeal Circulation, Dialysis, Enteral Feeding and speciality catheters with electronics. RAUMEDIC facilities and quality systems are accredited to Full EN ISO 13485 and EN ISO 14644. We are equally at home with low volume bespoke devices to high volume tubing requirements.
Activotec’s mission is to establish themselves as the partner of choice for solid phase peptide/organic synthesis.
Reddie & Grose Chartered Patent Attorneys & Trademark Attorneys Dr Neil Thornton enquiries@reddie.co.uk www.reddie.co.uk Telephone : 01223 360350 Fax : 01223 360280 5 Shaftesbury Road, Cambridge, Cambridgeshire CB2 8BW
With a client base representing companies from the FT Global 500 and FTSE listed companies, Reddie & Grose is recognised as a leading patent and trade mark firm. In 2009, the Managing Intellectual Property global patent survey ranked the firm as one of the UK’s top patent prosecution advisors. It consistently continues to achieve high rankings in all professional surveys.
oliver@riskrevolution.com www.riskrevolution.com Telephone : 0844 3350598 St John’s Innovation Centre, Cowley Road, Cambridge, Cambridgeshire CB4 0WS
B
The firm’s Cambridge office offers particular expertise in biotechnology, pharmaceutical, chemical, engineering, cleantech, instrumentation, medical device, materials, and software related inventions. Companies/academic institutions represented in this field by Reddie & Grose include: Diagnostics for the Real World, Haemostatix, Funxional Therapeutics, TCP Innovations, Trillion Genomics, Brax, Cambridge Biopolymers, Metalysis, University of Cambridge, Cambridge Broadband, i2, Cambridge Biotechnology Ltd and nCipher.
C
Talk to us ...
E
D
F
Risk Revolution Ltd Mr Oliver Dale
A
We help businesses grow and succeed enabling them to concentrate on what they do best and providing timely, efficient and cost effective management of Health & Safety, Human Resources, Training and Recruitment. We can provide one off advice, or go right through to delivering a fully outsourced service. Our solutions are practical and delivered by industry professionals with sector experience. We are locally based and aim to provide a very personal and peerless level of support which allows you to get on with running your business.
G H I J K
RML Pharma Consulting Dr Ron Lawrence ron.lawrence@rmlpharma.com www.rmlpharma.com Telephone : 07717 801461 65 Clophill Road, Gravenhurst, Bedfordshire
With over 13-years recent experience in a Research & Development environment at a major pharmaceutical company, we are proficient in all CMC (Chemistry, Manufacturing and Controls) activities required for early phase drug development. RML Pharma Consulting can provide you with a tailored development approach in the following key areas: Outsourced API Manufacture, Analytical Chemistry, Project Management, Synthetic Route Selection and Development, Physicochemical studies, Risk Management, Regulatory Submissions and Due Diligence.
L M N O P
Royal Cambridge Hotel Miss Annie Jones www.forestdale.com Telephone : 01223 351 631 Fax : 01223 352 972 Trumpington Street, Cambridge, Cambridgeshire CB2 1PY
The Royal Cambridge Hotel is an elegant hotel located on the edge of the City Centre, within easy walking distance of the famous Backs and renowned colleges including King’s, Queen’s, Corpus Christi and Magdalene. This delightful 57-bedroomed hotel provides an excellent base for exploring this celebrated city, whilst enjoying comfortable accommodation and modern facilities. With a choice of five versatile meeting rooms, catering from 2 to 150 delegates, the Royal Cambridge Hotel is an excellent venue for all types of business events. The Hobson Suite is the largest of the five rooms and can accommodate a variety of layouts, making it an excellent choice for conferences, small exhibitions and training courses. Conveniently located just minutes from the M11, the hotel has a large car park for hotel guests and conference delegates (daily charges apply). BT Openzone wireless internet access is available throughout the hotel 24 hours a day.
Q R S T U
RSA - Global leaders in Life Sciences Executive Search & Interim Management Dr Kay Wardle kay.wardle@theRSAgroup.com Tarquin Bennett-Coles tarquin@theRSAgroup.com www.theRSAgroup.com Telephone : 01707 259333 The Melon Ground Hatfield Park Hatfield Hertfordshire AL9 5NB
RSA is a global leader in the provision of Executive Search and Interim Management to the Life Sciences industry. With offices in the UK - our head office in Hertfordshire and premises in London - plus China, France, Germany, Singapore, Switzerland and the USA, RSA consultants’ talk to hundreds of industry leaders every day, and our network reaches every corner of the worldwide pharmaceutical, biotechnology and allied industries. Our unique blend of knowledge, teamwork and integrity has made us one of the world’s largest specialist recruiters - but we’ve never lost sight of the values we started with: respect, integrity, quality and professionalism. Call us to find out more.
V W X Y Z
WWW.ERBI.CO.UK 177
Activotec’s mission is to establish themselves as the partner of choice for solid phase peptide/organic synthesis.
A
Ruston Poole International plc Dr Paul Edwards
Europe’s leading Executive Search firm specialising in the healthcare industries, including pharmaceuticals and biosciences, across all functions. Our core expertise lies in international executive search for senior management positions, as well as for Board Directors (including Nonexecutive Director and Chairman positions).
B
paul.edwards@rustonpoole.com
C
Telephone : 020 7930 3001 Fax : 020 7930 3002
We also work in the US, SE Asia and Australia through our regional branch offices and associate companies, details of which may be found on our website.
D
Cording House, 34 St James Street, London SW1A 1HD
Key Contacts: David Collingham Executive Chairman Paul Edwards, MBE, Chief Executive Officer.
www.rustonpoole.com
E F G H I
S-Tech Insurance Services Ltd Mr Tim Fitzjohn www.s-tech.co.uk Telephone : 01223 324233 Fax : 01223 464150 154-156 Victoria Road, Cambridge, Cambridgeshire CB4 3DZ
Since 1982 we have been successfully supporting the Life Science and related industries against a range of tangible and intangible risks. Our aim is to fully understand your business and the operating and financial exposures to achieve wide ranging insurance protection. We are fully independent brokers with access to both Company and Lloyds markets. Our clients range from large International organisations to small Start Up businesses. We operate throughout the UK and Overseas through our partners. We have a wealth of experience in supporting new ventures through their growth cycle to the conclusion of a successful trade sale exit, merger, acquisition or an IPO.
J K L M N O
SafeBox Mr James Merrells sales@thesafebox.co.uk www.thesafebox.co.uk Telephone : 01223 291133 Fax : 01223 291177 Scarletts Business Park, Unit 1, West Wratting, Cambridge, Cambridgeshire CB21 5LS
P Q
As an ERBI Support Supplier excellent rates of storage and management are available to member organisations. To enquire about our ERBI rates or for any other queries please call 01223 291133 (Option 2) or email sales@thesafebox.co.uk
Sagentia Ltd (UK) Miss Susan Watson info@sagentia.com
R
www.sagentia.com
S
Fax : 01223 875 201
T
Safebox offers bespoke storage solutions for the lifelong management of all archival data, including physical files and all back up media. Storage areas are secure, fire rated and dehumidified to maintain the integrity of all stored material. Daily deliveries across the Eastern region, including 2 hour delivery for items required urgently, ensures easy recall of items as and when required. Back up rotations to suit your schedule and disaster recovery deliveries are available. Barcode technology guarantees the traceability of all items throughout storage areas, during transit and whilst with customers. Servicing clients across a wide range of sectors and meeting the stringent audit criteria of meditech and biotech research companies.
Telephone : 01223 875200
Life Science Group, Harston Mill, Harston, Cambridgeshire CB22 5GG
Sagentia is one of the world’s pre-eminent technology management and product development companies. For 20 years we have shown an uncompromising commitment to innovation that has led to the launch of breakthrough products that have changed the basis of competition in six global markets. We form highly creative teams that draw on individuality and collective experience. This enables us to take a multi-dimensional approach to opportunity discovery and problem solving, drawing on our combined technical expertise, business acumen and industry experience. We can work with you wherever you are in the world. Our teams are situated in state-of-the-art facilities in Cambridge UK, Frankfurt and Stockholm in Europe, Boston and Baltimore in the USA, and Hong Kong and Shanghai in China.
U V W X Y
Sagittarius IP Dr Mark Gibson
Sagittarius IP specialises in chemical, pharmaceutical and biotechnology subject matter.
mg@sagittariusip.com
We provide the following services: • ‘invention spotting’, drafting, filing and prosecution of patent applications and representation before the UK and European Patent Offices, including oppositions and other contentious work • filing of international patent applications (PCT) and control of worldwide patent prosecution • advice on IP strategy • freedom to operate investigation • IP due diligence and • IP education
www.sagittariusip.com Telephone : withheld 3 The Mill, Copley Hill Business Park, Cambridge Road, Cambridge, Cambridgeshire CB22 3GN
Z 178 ERBI DIRECTORY 2010
Sagittarius IP was set up in 2002. On 1 April 2009, Sagittarius IP opened a Cambridge office and Mark Gibson was appointed Managing Partner of the Cambridge office. In Aug 2009, the Cambridge office relocated to larger premises in Babraham.
Activotec’s mission is to establish themselves as the partner of choice for solid phase peptide/organic synthesis.
Schofield Lothian Ltd Mrs Barbara Brown www.schofields.com Telephone : 01707 390085 Fax : 01707 391411 1 Swallow Court, Swallowfields, Welwyn Garden City, Hertfordshire AL7 1SB
Schofield Lothian is a multi disciplined, specialist consultancy providing professional Facilities Management Solutions, Project / Environmental Management and Commercial services to the Biotech Industry. As part of a £250m group which is a leading provider of support services to the public, private and not-for-profit sectors, we employ over 250 staff throughout the UK and Ireland. Our well established FM team have a track record of effective implementation and maintenance of FM and associated systems on an as-needed basis, while assuring our clients attain optimised productivity in their core business areas. Our philosophy is to provide a tailored, professional, cost-effective service utilising our broad range of technically qualified staff, either on a secondment or consultancy basis.
info@sci-ware.com www.sci-ware.com Unit C5, Grainger’s Way, Roundhouse Business Park, Leeds LS12 1AH
Science Warehouse provides web-based purchasing solutions that make ordering easy. Working in partnership with ERBI, we have developed a solution specifically for members. It provides access to all suppliers’ catalogues online through a single interface. It makes purchasing easy for scientists whilst providing management with full budgetary control. One ERBI member has cut order cycle times by half and gained full budget holder visibility of expenditure. Key attributes of the Science Warehouse-ERBI offering:
grahamfagg@seroba-kernel.com www.seroba-kernel.com Telephone : 07711 415 748 15 Molesworth Street, Dublin, Ireland
C D E
G H
• Dedicated solution for members • One interface to manage all purchasing • Saves time and cash • Essential spend control and visibility
I
Science Warehouse is one of the UK’s fastest growing e-business solution providers. It is committed to the success of its customers in the life sciences industry. Contact us today to lower the costs and hassle of purchasing.
J K
Seroba Kernel Life Sciences Limited Dr Graham Fagg
B
F
Science Warehouse Ltd Dr Jonathan Betts
A
Seroba Kernel is a pan-European life science venture capital firm with funds under management of Euro100m. The firm is currently investing from its second fund, which achieved a Euro75 million first close in 2009. Seroba Kernel invests across the spectrum of the life science industry including therapeutics, diagnostics, medical devices and other selected opportunities that have the potential to fundamentally change medical care. The fund focuses on innovative opportunities that address market needs, investing on average Euro5-7 million over the life of each investment. Seroba Kernel has an experienced venture team based in Dublin and London.
L M N O P
Show Carriage Mr Mike Barrett mbarrett@showcarriage.com www.showcarriage.com Telephone : 01371 820 820 Fax : 01371 820 720
Show Carriage Ltd is an established company supplying Sea, Air and Road freight transportation services to exhibitions and live events - worldwide. Show Carriage can deliver a complete range of shipping and on-site services, designed to fit the varied requirements of our clients. We are in business to be of service to our clients and to provide solutions to freight transportation needs. Even with information technology advances, our belief is that clients want to talk to their suppliers and consolidate relationships face to face and what better arena than at an exhibition? We can transport your stand and exhibits to any destination round the world to enable you to concentrate on promoting your services to existing and prospective clients.
Exhibit House, Dunmow, Nr Felstead, Essex CM6 3LD
Q R S T U
Sigma Dr Matthew Cook customerservice@ europe.sial.com
Sigma-Genosys is a leading supplier of custom synthetic DNA (oligos) and synthetic peptides to the life science research community. Synthesis of oligonucleotides and peptides uses patented, high throughput instrumentation. Sigma-Genosys is part of Sigma-Aldrich Company Limited.
V W
www.sigma-aldrich.com
X
Telephone : 01440 767000 Fax : 01440 767099
Y
Fancy Road, Poole, Dorset BH12 4QH
Z WWW.ERBI.CO.UK 179
Activotec’s mission is to establish themselves as the partner of choice for solid phase peptide/organic synthesis.
A
Simbec Research Ltd Mr Alan Woodward
B
alan.woodward@simbec.co.uk
C
Telephone : 01443 694309
D E
www.simbec.co.uk
Fax : 01443 692499 Merthyr Tydfil Industrial Park, Cardiff Road, Merthyr Tydfil, Wales CF48 4DR
F G H
Services offered: • Phase I Safety, Tolerability and PK/PD Studies in Healthy Volunteers & Phase IIa Proof of Concept Studies in Patients • Bioanalysis, including Assay Development • Central Laboratory • Data Management and Statistics • Quality Assurance • Human Pharmacology Consulting Niche Services include: • Simbec Scintigraphy - gamma scintigraphic imaging for proof of concept of drug delivery systems • SimTest dermatology service for the development of dermatology products and transdermal drug delivery systems • All facilities on one site • Specialist in First-into-Human, Phase I Studies • Optimized services for faster recruitment and study completion. Services tailored for Biotech companies requiring advice on development of new active substances, particularly early (Phase I IIa) exploratory and confirmatory clinical research.
Simon Greene Associates Mr Simon Greene info@sga-uk.com
Specialist provider of business communications, including online video, podcasts, multimedia, presentations and live events. Track record in supporting biotech companies and the scientific community in Cambridge and the East of England.
www.sga-uk.com Telephone : 01787 378422 Fax : 01787 378188
I
1 Old Market Place, Sudbury, Suffolk CO10 1RA
J K L M N O
Smart Holograms Ltd Ms Julie Larkin www.smartholograms.com Telephone : 01223 393400 Fax : 01223 393401 291 Science Park, Milton Road, Cambridge, Cambridgeshire CB4 0WF
P Q
Softwerx Ltd Mr Sean Kiernan info@softwerx.com
R S T
www.softwerx.com Telephone : 01223 834333 Fax : 01223 834330 1 Riverside, Granta Park, Great Abington, Cambridgeshire CB21 6AD
U V W X Y
Smart Hologram is developing and commercializing a revolutionary optical sensor technology developed at the University of Cambridge. This platform technology – sensor holograms - has broadly applicability in a wide variety of different market sectors and in particular, the Company is focused on the medical diagnostics and product verification / anti-counterfeiting markets. Smart Holograms has developed a strong IP position with over 35 filed / granted patents and in addition has a fully operational manufacturing plant.
At Softwerx we help life science and healthcare organisations maximise the value of their investment in IT. We specialise in delivering flexible and cost effective solutions to the IT headaches that Companies like yours face every day, such as : • Effective and timely IT support • Optimising business workflow • IT infrastructure upgrades • Efficient collaborative working Our 70+ team of highly skilled systems engineers and developers, with over 80 Microsoft certifications between them, are ready to help. Whether you’re looking to completely outsource your IT function, supplement an existing internal team or undertake a development project aimed at improving business processes, we’ll work with you to deliver a solution that fits your unique requirements at the right price.
South Cambridgeshire District Council Mrs Nicole Kritzinger tom.barrance@scambs.gov.uk www.scambs.gov.uk Telephone : 01954 713363 South Cambs Hall, Cambourne Business Park, Cambourne, Cambridgeshire CB23 6EA
Z 180 ERBI DIRECTORY 2010
South Cambridgeshire District Council is a Local Authority. The District is the second largest district in Cambridgeshire. It completely surrounds Cambridge City and shares its boundaries with Huntingdonshire, Fenland and East Cambridgeshire on the northern part of its borders. In the south the district has boundaries with Bedfordshire, Hertfordshire, Essex and Suffolk. South Cambridgeshire is highly rated in independent surveys scoring highly on factors such as house prices, labour market, environment, education and health. South Cambridgeshire has played a key part in the economic growth of the Eastern Region. It successfully combines traditional industry such as agriculture and engineering with new sectors such as IT and biosciences, many of which are situated on state of the art business and science parks. It is well connected to the regional, national and international communications network, including airports, sea, rail and road transport.
Activotec’s mission is to establish themselves as the partner of choice for solid phase peptide/organic synthesis.
SRA Global Clinical Development
A
Mrs Carolyn Belcher
B
info@constellagroup.com www.constellagroup.com Telephone : 01235 437400 Fax : 01235 437437
C
20 Milton Park, Abingdon, Oxon OX14 4SH
D E F
SRG Executive Mr Matt Cawood www.srgexecutive.co.uk Trevelyan House, 7 Church Road, Welwyn Garden City, Hertfordshire AL8 6NT
Having pioneered contract recruitment for the scientific community in the early 1990’s, our executive recruitment operation was established more than a decade ago and is retained by clients ranging from multi-national pharmaceutical businesses to SME and start-up organisations. Our Consultants carry out all research in-house and possess an unrivalled knowledge and expertise within this niche market, meaning all clients are assured of a truly expert consultation and search process. Interim Management All our Interim executives are ‘career interims’ with impressive track records of adding value within a wide variety of organisations where specific business skills, technical expertise or change management and systems knowledge are required on a project basis. All assignments are costed on a case by case basis and are tailored to your specific requirements or recruitment budget.
info@stjohns.co.uk www.stjohns.co.uk Telephone : 01223 420252 Fax : 01223 420844 Cowley Road, Cambridge, Cambridgeshire CB4 0WS
St John’s Innovation Centre offers business address and accommodation facilities on different levels according to the needs of the client. A full business incubation service is offered to tenant companies, including support such as networking, training and advice. The Centre aims to provide security and flexibility to tenants, and therefore offers leases for up to three years with the option to break on one month’s notice. Individual units can range in size from 13 to 250 sq.m. For companies seeking an Innovation Centre ‘office’ but who are not yet ready to take up physical residence at the Centre, a virtual tenancy (the ‘Star Service’) offers a business address, telephone and post handling plus access to the Centre’s facilities for tech firms or companies that provide relevant support services. Hot-desking is also available.
www.starlab.co.uk Telephone : 01908 283800 Fax : 01908 283802 4 Tanners Drive, Blakelands, Milton Keynes, Buckinghamshire MK145NA
www.stortmedchem.co.uk 8 Broadleaf Avenue, Bishops Stortford, Hertfordshire CM23 4JY
J
L M N
P
STARLAB specialises in the field of Liquid Handling Technology. STARLAB’s success is founded on its expertise in automated injection moulding processes for the manufacture of high quality laboratory consumables. STARLAB’s portfolio includes, alongside its own TipOne pipette tip range and ErgoOne pipettes, an extensive range of tips, tubes, plates, seals, disposable gloves, labelling, benchtop equipment and sample storage solutions. As an ISO 9001 accredited company, STARLAB ensures high quality service, from order through delivery to after sales care. STARLAB was one of the first UK companies within its sector to be awarded the ISO 14001 for environmental management for their award-winning laboratory waste recycling service and their internal environmental procedures on a day-to-day basis. We like to practice what we preach and our green office and warehouse policy mirrors the ‘REUSE! REFILL! RECYCLE!’ philosophy of our TipOne Pipette Tip system.
Stort MedChem Consulting Dr Stephen Smith
I
O STARLAB (UK) Ltd
Ms Hilde Moseby
H
K
St John’s Innovation Centre Ltd Mr David Gill
G
Stort MedChem Consulting is a Drug Discovery consultancy that works with companies, charities and academia to enhance and facilitate the search for new medicines. Extensive Discovery experience has been gained in many different therapeutic areas. Expertise encompasses many aspects of the entire Drug Discovery process, from early stage research through to Clinical Candidate identification and early Drug Development with particular emphasis on Medicinal Chemistry. Consultation offered in: • Drug Discovery • Medicinal Chemistry • Research Project Co-ordination • Co-ordination of Project Outsourcing • Oversight of Research Proposals and Due Diligence • Competitor viewpoint See website or email Stephen.smith@stortmedchem.co.uk for further information.
Q R S T U V W X Y Z
WWW.ERBI.CO.UK 181
Activotec’s mission is to establish themselves as the partner of choice for solid phase peptide/organic synthesis.
A
Stratagem IPM Ltd Mrs Nicola Baker-Munton
B
mail@stratagemipm.co.uk
C
Telephone : 01223 550740
D E
www.stratagemipm.co.uk
Fax : 01223 550748
H I
Stratagem IPM Ltd fills a developing need within industry for the provision of strategic advice and intellectual property management for life science, medtech, cleantech and high technology companies. Stratagem’s qualified patent and trade mark attorneys use a commercial perspective and hands on management approach to enhance the value of IP assets.
Fosters Wing Anstey Hall, Maris Lane, Trumpington, Cambridge, Cambridgeshire CB2 9LG
F G
Stratagem Intellectual Property Management Ltd is a full-service, Cambridge UK-based, out sourced intellectual organisation and management company with global reach.
Synapse Clinical Research Services Ltd Mrs Dympna Starling dympnastarling@ synapsecrs.co.uk www.synapsecrs.co.uk Telephone : 07775 923997 6 Harding Way, St Ives, Cambridgeshire PE27 3WR
Synapse Clinical Research Services is a flexible and independent QA consultancy. It provides a range of GCP and GMP Quality Assurance Services tailored to meet client’s needs. Services include MHRA inspection preparation, internal system and facility audits, process improvement, GCP and GMP training, SOP writing and review. Synapse also undertakes supplier audits with particular expertise and experience in Clinical Trials Manufacture and Packaging, Clinical Research Organisations, Phase I Units and Clinical Laboratories.
J K L M N
Synapse Medical Resourcing Ltd Dr Stephen Jones
Exclusively recruiting Pharmaceutical Physicians.
info@synapsemr.com
Synapse Medical Resourcing Ltd are dedicated to finding companies talented medical doctors, at every level. Founded by a pharmaceutical physician Synapse has excellent contacts with medical organisations and networks allowing us to find the best candidate for the role. Synapse has built good working relationships with pharmaceutical companies and physicians, providing an excellent service for both. By taking the time to get to know and understand our clients needs, we find the most suitable partnerships.
www.synapsemr.com Telephone : 0207 692 0555 100 Eton Place, Eton College Road, London NW3 2DT
O P Q
Talentmark Ms Amber Taylor Groves enquiries@talentmark.com
R S T
For Recruiters: Company requirements are reviewed, and our candidates screened by an experienced pharmaceutical physician ensuring that only the most suitable candidates are submitted for interview. For Jobseekers: We provide candidates with all the required information to decide whether a job is right for them. Our support helps candidates obtain the role they want and most suited to their needs.
www.talentmark.com Telephone : 0845 095 2626 The Grange, 1 Central Road, Morden, Surrey SM4 5PQ
Main Contact for Communications: Sharon Shields, Consultant Other Consultants • Richard Adams - VP • Bill Steggals - VP • David Nolan - VP Expertise: First in this specialist field and still setting the standard in executive search and selection. Recruitment to the most senior levels in all key functional areas. Nine full-time consultants with broad ‘hands on’ experience, spanning most sectors of the pharmaceutical and healthcare industries. Specialist in-house research team, with multilingual and global capability. Extensive UK and international coverage, with recruitment success in more than 30 countries. Services: Comprehensive recruitment service, primarily by executive search, but also using advertised selection, TalentBank the candidate database service and interim management. Associated companies in Continental Europe, USA, Australia and South Africa.
U V W X Y Z
Team Consulting Ltd Mrs Diane Aston-James info@team-consulting.com www.team-consulting.com Telephone : 01799 532700 Fax : 01799 532701 Abbey Barns, Duxford Road, Ickleton, Cambridge, Cambridgeshire CB10 1SX
182 ERBI DIRECTORY 2010
Team is a leading product development consultancy working primarily in the pharmaceutical and healthcare industry. We’re acknowledged experts in medical and drug delivery device development and we work globally with all kinds of companies, from start-up ventures to multinational organisations. We help our clients at all stages of the product development process. If you need to ensure you have the right product strategy, we can help you map the future. If you need to assess a licensing opportunity, we have a wealth of experience in technical due diligence. We’ll bring creativity to generating product concepts, then test them with hands-on user trials. We can guide a product safely through every stage of development to industrialisation, and throughout we’ll manage and minimise risk. As you’d expect, we have an outstanding team of industrial designers and mechanical, software and electronics engineers, and we’re accredited to ISO 9001-2000. We pride ourselves on the quality and independence of our advice, and the relationships we build with our clients.
Activotec’s mission is to establish themselves as the partner of choice for solid phase peptide/organic synthesis.
Tessella plc Mr Lawrence Hopkins www.tessella.com Telephone : 01438 749886 Elopak House, Meadway Technology Park, Rutherford Close, Stevenage, Hertfordshire SG1 2EF
A
Innovative Informatics and Consultancy for R&D For over 25 years Tessella has worked with some of the biggest names in the pharmaceutical industry. We help clients address a wide range of business goals, including, improving efficiency and productivity in drug discovery, delivering the business benefits of translational medicine, and faster more effective clinical trials. What makes our technology and consulting services effective is our understanding of both the science and informatics of pharmaceutical R&D, as well as unique software assets and intellectual property that reduce project risk, cost and time. With offices in Europe and North America, global companies rely on Tessella for business critical assignments.
B C D E F
The Ann Hayes Consultancy Ltd Dr Ann Hayes annghayes@yahoo.co.uk Telephone : 01763 281375 Fax : 01763 281375 Buntingford, Hertfordshire
I provide independent consulting advice to pharmaceutical and biotechnology companies and venture capitalists, in Drug Discovery (from early research through to clinical Proof of Concept), CNS diseases and pain, Portfolio Management and Company Strategy. I have many years of experience of consulting for the small Pharma/biotechnology industry (2001 to present). During that time, I have: Co-founded two drug discovery companies, Ionix Pharmaceuticals Ltd and Therasci Currently chair the board for Celentyx Ltd Have held several non-executive directorships Co-founded Theradeas Ltd Co-founded ‘Apex-Pharmalyticon’ Sat on many scientific advisory boards eg Biowisdom, Lectus, Braincells, Bionomics. Carried out consultancy/due diligence for many companies and investors.
www.thedigitaloffice.co.uk Telephone : 0870 8505121 Fax : 01462 810081 Manor Farm, Upper Stondon, Henlow, Bedfordshire SG16 6LJ
www.tgac.bbsrc.ac.uk Telephone : 01603 450895 Fax : 01603 450021 Norwich Research Park, Colney, Norwich, Norfolk NR4 7UH
With a dedicated professional team always available to offer support to customers, the Company offers a service, backed by the Manufacturers Ricoh UK Ltd, which is both personal and efficient providing companies with confidence and peace of mind.
M
Committed to supporting the WEE directive on ‘green issues’ TDO focus on assisting companies to reduce their carbon footprint with the supply of state of the art environmentally friendly machines that are both cost effective and produce a fast high quality reproduction.
www.icr.ac.uk
N O P
Through novel approaches in genomics and bioinformatics the centre foucuses on the analysis of plant, animal and microbial genomes to improve food security, protect UK agricuture from exotic animal disease and exploit weaknesses in microbes to develop new ways to kill superbugs. TGAC partners with industry and non-commercial customers in genomics projects across three broad application sectors:
Q R S
• Agricultural - including food security, food processing and animal husbandry • Nutrition and ‘wellness’ • Sustainable energy, and bio-processing including bio-pharmaceuticals TGAC is committed to makings its facilities available to UK companies that could benefit from using advanced genomic approaches and its trading subsidiary, Genome Enterprise Limited, manages its engagement with commercial clients.
The Institute of Cancer Research Mr Neil Walford
J
L
The Genome Analysis Centre (TGAC) tgac.enquiries@bbsrc.ac.uk
I
Owned and run by Richard Kirby, Managing Director of The Digital Office UK Ltd, the Company has some 35 years experience in the supply, installation and servicing of digital printers/photocopiers and software solutions to corporate and private clients.
Over the years our considerable knowledge of the market place has enabled companies to reduce their overheads through the use of alternative equipment supplied by our organisation.
Dr Amanda McMurray
H
K
The Digital Office Mr Richard Kirby
G
The Institute is a college of the University of London and works in partnership with The Royal Marsden NHS Foundation Trust. It employs approximately 1000 staff and students based in 3 sites in London and Sutton, Surrey.
2nd Floor, Sir Richard Doll Building, 15 Cotswold Road, Belmont, Sutton, Surrey SM2 5NG
T U V W X Y Z
WWW.ERBI.CO.UK 183
Activotec’s mission is to establish themselves as the partner of choice for solid phase peptide/organic synthesis.
A
TTP LabTech Limited Dr Jason Mundin
B
sales@ttplabtech.com
C
Telephone : 01763 262626
D
www.ttplabtech.com
Melbourn Science Park, Cambridge Road, Melbourn, Royston, Hertfordshire SG8 6EE
TTP LabTech supplies laboratory instrumentation for the healthcare, biotech and pharmaceutical sectors. Its products include: comPOUND® modular sample store; mosquito® nanolitre liquid handler; Acumen eX3® microplate cytometer for ultra high throughput, high content screening assays and RAPid 4® acoustic biosensor for label-free interaction analysis of biopharmaceuticals. As well as its own products, TTP LabTech offers a contract screening service based on the Acumen® platform. The service provides high quality, high content data to support early drug discovery initiatives by rapidly identifying those targets and compounds most likely to lead to successful products.
E F G H I
Tudor Reilly Ms Julie Walters www.tudor-reilly.com Telephone : 01494 753 990 Fax : 01494 753 991 11 Amersham Hill, High Wycombe, Buckinghamshire HP13 6NR
J
M N O
Dr Nigel Crockett n.crockett@tukanpartners.com www.tukanpartners.com Telephone : 01223 719518 Fax : 01223 719518
S T
Tukan Partners is able to provide both strategic and transactional regular, hands-on input and support to its’ partners’ commercial activities. Nigel Crockett, Director of Tukan Partners has more than 15 years of industrial experience in the biotech-pharma business and has an established and respected commercial network which has resulted in the closing of a multitude of highly valuable, sector-leading collaboration and licensing deals.
166 Gilbert Road, Cambridge, Cambridgeshire CB4 3PB
TWI Ltd Dr Sue Dunkerton www.twi.co.uk
R
• Media relations • Leadership conferences • Corporate positioning • Franchise positioning • Issues and crisis support • Media training • Presentation skills • Digital media
Tukan Partners Ltd
P Q
Tudor Reilly has two outstanding characteristics – a hands-on senior team, with experience in journalism, broadcast media, healthcare PR, marketing and sales - and a rigorous approach to project implementation. The team combines in-depth media knowledge with a solid understanding of science and the pharmaceutical industry to provide strategic counsel and high-level coaching to companies involved in developing the medicines of tomorrow.
For more information visit www.tudor-reilly.com.
K L
Tudor Reilly is a fast-growing corporate communications agency focused on healthcare. Established in 2007, Tudor Reilly has a growing client base both in the UK and internationally.
Telephone : 01223 899000 Fax : 01223 891284 Granta Park, Great Abington, Cambridge, Cambridgeshire CB21 6AL
TWI is one of Europe’s largest independent research and technology organisations. TWI is a nonprofit distributing, membership based company, with 3,500 members from 60 countries around the world. Over 520 skilled staff are dedicated to helping industry apply new materials and manufacturing technologies efficiently and cost effectively. Over the last 20 years, TWI has built up its capability to support the medtech and diagnostics sectors, covering such topics as: drug delivery, implantable devices, orthopaedics, ultrasound devices, novel coatings and packaging. It supports members through its engineering, materials and manufacturing expertise, as well as in sourcing funds for collaborative R&D. TWI is one of the UK’s leading organisations attracting funds from national and European funding programmes. TWI is also a core partner in the Technology Strategy Board’s HealthTech & Medicines KTN.
U V W X Y
Ubichem plc Dr Geoff Porritt www.ubichem.com Telephone : 02380 263030 Fax : 02380 263012 Mayflower Close, Eastleigh, Hampshire SO53 4AR
Z 184 ERBI DIRECTORY 2010
Ubichem provides a comprehensive range of chemistry services (on lab to pilot plant scale) to support pharmaceutical development and meet your drug substance requirements: • cGMP API and intermediate manufacture for preclinical and clinical trials • Process Research and Development • Process validation • Salt screening and crystallisation studies • Stability studies (stress tests, accelerated and long term) • Analytical method development and validation • Radiolabelling • Impurity profiling • Synthesis of Impurities and Reference Standards Our experienced team minimise the risks associated with scaling up medicinal chemistry routes, and have particular expertise in heterocyclic and organometallic chemistry. We are approved by the regulatory authorities for the manufacture of API from preclinical through to commercial supply. Reliability and excellent problem-solving skills make Ubichem a preferred partner for many pharmaceutical and biotech companies.
Activotec’s mission is to establish themselves as the partner of choice for solid phase peptide/organic synthesis.
UK Trade and Investment (Sector Team) Mr Robert Driver www.uktradeinvest.gov.uk Telephone : 01223 484670
UKTI is the Government organisation that helps UK-based companies succeed in an increasingly global economy. UKTI services are tailored to the needs of individual businesses to maximise their international success. We provide companies with knowledge, advice and practical support. UKTI also helps overseas companies bring high quality investment to the UK’s vibrant economy - acknowledged as Europe’s best place from which to succeed in global business. We provide support and advice to investors at all stages of their business decision-making.
Kingsgate House, 66-74 Victoria Street, London SW1E 6SW
UKTI offers expertise and contacts through a network of international specialists throughout the UK, and in British Embassies and other diplomatic offices around the world. UKTI deploys industry specialists to support the marketing of the UK Life Sciences and to identify commercial opportunities in overseas markets. Specialists are also tasked with increasing the level of international Life Science R&D investment in the UK, promoting the benefits of R&D in the UK to a targeted group of overseas owned companies.
enquiries@enterprise.cam.ac.uk www.enterprise.cam.ac.uk Telephone : 01223 760339
Cambridge Enterprise (CE) is responsible for the commercialisation of University of Cambridge intellectual property, working with academics who are seeking: • assistance in distributing their ideas for the public benefit through commercial channels • the optimal route for sharing their ideas and expertise • significant societal, economic, inventor and University benefit There are three general types of business service available to academics through CE:
Fax : 01223 764888
Technology Transfer Services Working with academics to manage and license their patentable inventions and other intellectual property Consultancy Services Support for University staff and research groups wishing to provide expert advice or facilities to public and private sector organisations Seed Fund Services Access to capital and expertise, business planning, mentoring, surgeries and related programmes
10 Trumpington Street, Cambridge, Cambridgeshire CB2 1AQ
www.admin.cam.ac.uk/offices Telephone : 01223 765400 Fax : 01223 765400 University of Cambridge, 16 Mill Lane, Cambridge, Cambridgeshire CB2 1SB
We provide an informed entry point into the University for companies, and can help potential partners define their interests, find the appropriate academic expertise, and identify opportunities for collaboration. We support the development of relationships between academics and industry. RSD can identify opportunities for collaboration between business and academics and negotiate research contracts in exciting interdisciplinary areas, such as computational biology, nanoscience, energy and the environment. We work closely with University Departments that offer licences for intellectual property, graduate recruitment and executive education. Our team of Partnership Development Managers helps companies to navigate the University and build mutually beneficial relationships. For more information on working with the University in specialist industry sectors, email Dr Karen Smith ks390@cam.ac.uk or Mr Richard Reschen rfr20@rsd.cam.ac.uk
Telephone : 01206 874042 Fax : 01206 873334 Research and Business Development Office, Wivenhoe Park, Colchester, Essex CO4 3SQ
D E
G H I J
L M N O P
University of Essex Dr Paul Thomas
C
K
University of Cambridge, Cambridge Research Office Ms Monique Carew
B
F
University of Cambridge Cambridge Enterprise Ms Shirley Jamieson
A
The University of Essex, based at Wivenhoe Park, Colchester, received its Royal Charter in 1965. It is one of the UK’s leading academic institutions and has an international reputation for the quality of its research and teaching. The University has 19 departments spanning the Humanities, Social Sciences and Science and Engineering. There are currently around 8,800 students at the University, 25% of these within the Graduate School. The University is an international community with students from more than 125 countries. In recent assesments Essex has regularly ranked among the top 12 UK universities for the quality of its reseach and teaching, with many of its departments rated as ‘outstanding’ by international standards.
Q R S T U
UroSens Ltd
V
Dr Nick Miller-Jones info@urosens.com
W
www.urosens.com Telephone : 01223 836 556
X
Babraham Research Campus, Babraham, Cambridge, Cambridgeshire CB22 3AT
Y Z WWW.ERBI.CO.UK 185
Activotecâ&#x20AC;&#x2122;s mission is to establish themselves as the partner of choice for solid phase peptide/organic synthesis.
A
UVP Ltd (Ultra-Violet Products Ltd) Mr Bjorn Sundberg
B
uvp@uvp.co.uk
C
Telephone : 01223 420022
D E
www.uvp.com
Fax : 01223 420561 Unit 1, Trinity Hall Farm Est, Nuffield Road, Cambridge, Cambridgeshire CB4 1TG
F G H I
Ms Penny Thorne info@veedacr.com www.veedacr.com Old Convent of Notre Dame, 119 Looseleigh Lane, Derriford, Plymouth, Devon PL6 5HH
K
M N O
Dr Allie Elend aelend@vennershipley.co.uk www.vennershipley.co.uk Telephone : 01223 437971
Veeda Clinical Research is a full-service early phase global CRO with over 20 years of experience in phase 1/2a clinical research. Veeda Oncology is a global oncology CRO providing outstanding oncology expertise that the pharmaceutical and biotech companies require and expect to facilitate successful phase I to phase IV global programs. One of the few CROs whose focus is only Oncology. 77 Oncology trials conducted since 2001 at over 400 sites. Worked with over 440 investigators Access to over 110 ION sites in the United States. Screening possibilities of over 100,000 new patients a year. Exclusive relationships with several oncology hospitals in India which treat over 7,000 new oncology and hematology patients every year.
We have extensive experience of filing and prosecuting patent applications at the British and European Patent Offices, including post-grant opposition and appeal proceedings, and also worldwide through our network of associates overseas. We also carry out infringement clearance work, prepare due diligence reports before launch of new products and organise litigation. We seek out the issues involved in order to understand the commercial objectives and achieve a successful, cost effective outcome.
Fax : 01223 437980 Byron House, Cambridge Business Park, Cowley Road, Cambridge, Cambridgeshire CB4 0WZ
Verius Ltd Dr Stephen Bentley info@verius.co.uk
R
www.verius.co.uk
S
Fax : 01223 413689
T
Ultraviolet Products cover a large selection of UV lamps, Transilluminators, PCR workstations, UV cabinets, UV intensity meters, UV Crosslinkers and UV incubator. Laboratory Products includes Hybridization ovens. Light Sources are configured with standard and custom designs.
Venner Shipley LLP
P Q
UVP offers a wide range of BioImaging Systems from basic entry-level to advanced multifunctional systems for 1D and 2D gel documentation, chemiluminescent, fluorescent and colorimetric imaging plus fluorescent protein, small animal in vivo imaging.
Veeda Clinical Research Ltd
J
L
UVP, established in 1932, is the global leader in life science imaging, supplying BioImaging Systems for academic, biopharmaceutical and biotechnology applications. With core expertise as the leading manufacturer of ultraviolet products, UVP combines its innovative technologies with a specialisation in fluorescent and luminescent-based imaging applications in the life sciences at the molecular, cellular, and whole organism life levels.
Telephone : 01223 402660
Chartwell House, 620 Newmarket Road, Cambridge, Cambridgeshire CB5 8LP
Verius Limited is a Cambridge based Contract Research company, specialising in clinical management, pharmacovigilance, regulatory support and general development consulting. We offer tailor made, individual systems for any size of company, based on our industry-standard, fully validated, safety database system. Our in house clinicians and EU pharmacovigilance Qualified Persons ensure that we can provide safety services from initial phase I studies through to the market and beyond. Our regulatory group specialises in early support for companies, and has wide experience in Scientific Advice procedures in Europe. We have a successful track record in the Orphan Drug Designation process in Europe and the USA and in the preparation and submission of Risk Management Plans. We also provide general consulting support on non-clinical aspects of development.
U V W X
Viaduct Marketing Limited Mr Alan Clabon www.viaductmarketing.com Telephone : 01442 381343 The Counting House, High Street, Tring, Hertfordshire HP23 5TE
Y
Viaduct provides effective, hands-on commercialisation and marketing implementation support to healthcare and technology companies. Our expertise has been gained in a variety of organisations ranging from start-ups to world leading multi-nationals, across healthcare and technology sectors including pharmaceuticals, contract research, drug discovery, medical devices and the NHS. Our aim is to help companies grow their businesses by delivering practical, hands-on marketing support and implementation - when itâ&#x20AC;&#x2122;s needed, in the simplest and most cost-effective way possible, in time and on budget. Contact Alan Clabon : alan.clabon@viaductmarketing.com
Z 186 ERBI DIRECTORY 2010
Activotecâ&#x20AC;&#x2122;s mission is to establish themselves as the partner of choice for solid phase peptide/organic synthesis.
W. P. Thompson and Co Mr Simon Eddowes letchworth@wpt.co.uk www.wpt.co.uk Telephone : 01462 682139 Fax : 01462 676775
W. P. Thompson are a well established company of patent and trade mark agents. We have an international reputation for our expertise in all areas of intellectual property and we provide advice in all technical fields, including pharmaceuticals and biotechnology. We not only help our clients to obtain protection for, and defend, their own intellectual property but also help them to avoid infringement of third party rights. Our advice is tailored to our clientsâ&#x20AC;&#x2122; needs and we are well known for our commercial focus.
Eastcheap House, Central Approach, Letchworth Garden City, Hertfordshire SG6 3DS
info@walker-graham.com www.walker-graham.com Telephone : 07941 259781 2 Park Farm Court, Carriage Drive, Clapham, Bedfordshire MK41 6EF
B C D E F
Walker Graham Pharma Consulting Mrs Indira Walker
A
Indira Walker and Paul Graham have worked in the pharmaceutical industry for many years and have both worked at senior levels within large pharmaceutical companies in both QA and Regulatory Affairs. As active QPs and RPs, they have a thorough understanding of the needs of both new and established companies. Providing outstanding Quality QP, QA, RP and Regulatory services is the mission of the business. Beyond this training, including Human Error training and QP mentoring services are also offered.
G H I J K
WOCP Dr Ajay Agrawal
L
info@wocp.org www.wocp.org
M
12 Grange Avenue, Cambridge, Cambridgeshire PE1 4HH
N O P
World Courier (UK) Ltd Ms Helen Thomas saleslhr@worldcourier.co.uk www.worldcourier.com Telephone : 020 7717 1400 Fax : 020 7928 7105 8th Floor, Sea Containers House, 20 Upper Ground, London SE1 9PD
The shipment of infectious or diagnostic biological samples and clinical trial supplies requires expert handling. World Courier is a pioneer in the transport of sensitive medical and pharmaceutical shipments, delivering the first human heart tissue for transplant in 1984. Specialising in the transport of temperature controlled and time critical samples; World Courier is committed to handling every consignment on an individual, priority basis. This translates into a premium service where our experienced staff ensures that your shipment arrives on time and in perfect condition. Documentation and regulatory requirements are managed by World Courier to ensure your shipment complies with country requirements. Your shipment is dispatched on the first available flight and actively monitored throughout its journey. Confirmation of the delivery is provided immediately upon arrival.
Q R S T U V W X Y Z
WWW.ERBI.CO.UK 187
n
NOTES
188 ERBI DIRECTORY 2010
NOTES n
WWW.ERBI.CO.UK 189
n
ADVERTISERâ&#x20AC;&#x2122;S INDEX
42 Technology Limited
93
Langland
Abingworth LLP
72
Langton Howarth Limited
Activotec SPP Alcyomics Arco Limited Argo Consulting Azopharma Product Development Group Babraham Bioscience Technologies Limited
50-51, 114 108 47
London Associates Lonza Biologics Medical Device Technology Consultants Limited
104-105 109 73 87 101
54-55
Medical Research Council
45, 191
73
Medical Research Network
102-103
98-99, 192
Medilink WM
97
BIA
30
Melbourn Scientific Ltd
85
Bidwells (Cambridge Science Park)
92
MESM Limited
33
109
Nanocentral
52 37
Biocair International Limited Bio Trans
29
Next Gen Sciences
Bridge Partners
73
NHS East of England
Briton EMS Limited
85
Norwich Research Park Enterprise Limited
83
O2h
90
Orion Automation Limited
29
Cambio Limited
58, 60-63 42-43
Cambridge Design Partnership LLP
48-49
Cambridge Online Systems Limited
7
Pall Corporation
36
Cambridge Research Biochemicals
3
Parker Domnick Hunter
91
Pharmidex
86
Cater Jonas ChemiSpec Chesterford Research Park
101 29 8, 40
Piramal Healthcare Reddie and Grose
35 76-77
Connect Medical Resources Limited
84
RSA Search and Selection
100
DOCS International UK
96
Safebox
74
Eagle Genomics Limited
89
Science Warehouse Limited
88
Essen Instruments Ltd
84
Simon Greene Associates Limited
Europa Bioproducts Limited
83
Starlab UK Limited
Fermentas Life Sciences
31
S-Tech Insurance Services Limited
Fisher Bio Services
89
Stemcell Science Limited
38
Forest Heath District Council
44
Synapse Clinical Research Services
95
Harpum Consulting
29
Taylor Vinteres Solicitors
80
Harrison Goodard Foote
83
Tukan Partners
Harten Group Limited
91
UK Trade and Investment
4, 6 94 64, 66-69
82 2, 106-107
109
Verius Limited
46
Health Enterprise East
87
Vetspeed UK
92
Helena Biosciences Europe
39
Walker Graham Pharma Consulting
34
Watson Burton LLP
95
World Courier (UK) Limited
41
Health and Safety Works Limited
Heptares Therapeutics Limited
109
Isogenica Limited
97
Lab 21
32
190 ERBI DIRECTORY 2010
For almost 100 years the Medical Research Council has improved the health of people in the UK and around the world by supporting the highest quality science. The MRC invests in world-class scientists. It has produced 29 Nobel Prize winners and sustains a flourishing environment for internationally recognised research. The MRC focuses on making an impact and provides the financial muscle and scientific expertise behind medical breakthroughs, including the first antibiotic penicillin, the structure of DNA and the lethal link between smoking and cancer. Today MRC funded scientists tackle research into the major health challenges of the 21st century. www.mrc.ac.uk See our advert on page 45 in this directory about MRC in the Cambridge region. Contact Adrian Penrose on 01223 402277 or apenrose@mrc-centre.cam.ac.uk
The new ÂŁ200m MRC Laboratory of Molecular Biology being built on the Cambridge Biomedical Campus will be completed in 2012.
Babraham Research Campus
an environment promoting innovation
Babraham Bioincubator A cost-effective solution for your start-up The Babraham Research Campus is home to a thriving cluster of bioventures located in Babraham’s Bioincubator. Companies benefit from being closely integrated with the world-renowned Babraham Institute, facilitating academic-commercial collaborations and knowledge exchange. Set in an attractive, landscaped estate, the Babraham Research Campus offers:
x A range of lab/office space from 324 sq ft x Flexible, short-term leases to meet x x x
the requirements of entrepreneurs, start-ups and more established businesses Access to scientific services, central laboratory support services and capital equipment Conferencing/meeting room facilities, dedicated coffee shop and catering On-site nursery, gym, parking and 24/7 security
A unique feature distinguishing the campus is the Technology Development Lab (TDL), targeted at the needs of early-stage companies. It offers:
x Bench space in fully-equipped biochemistry/ molecular biology labs on short, flexible terms
x Access to equipment and scientific expertise x Access to core facilities and state-of-the-art specialised equipment of the Babraham Institute
x Biology and chemistry services “Thank you for the work you did on producing a recombinant protein … the work was completed in a short timescale and ahead of schedule. The TDL clearly understands the issues facing start up companies and the flexible approach shown was extremely useful” Dr Nick Miller-Jones, UroSens Ltd www.urosens.com Located at the heart of the Cambridge Cluster The Babraham Research Campus is situated on an attractive 450 acre parkland estate six miles south of Cambridge, close to the University of Cambridge, Addenbrooke’s Hospital and the Sanger Institute. Acknowledged as one of the leading enterprise hubs in the UK, the campus has established a reputation for nurturing nascent biomedical enterprises and delivering excellence in bioscience innovation. Developing technologies in the life sciences? Seeking lab/office space and access to capital equipment? The Babraham Bioincubator delivers a bespoke solution to support your company.
Babraham Bioscience Technologies Ltd (BBT) Babraham Research Campus, Cambridge, CB22 3AT, UK T: +44 (0) 1223 496269 F: +44 (0) 1223 496020 E: info@babraham.co.uk W: www.babraham.com